{"meta":{"query_hash":"619242c0199c","filters":{"venue":"Expert Opinion on Pharmacotherapy"},"cohort_total":239,"direct_labels_cover":0,"predictions_cover":239,"exported":239,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/619242c0199c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Opinion+on+Pharmacotherapy"},"results":[{"id":"W11866677","doi":"10.1517/14656566.3.3.265","title":"Paleomagnetism and Rock Magnetism of \"SEDEX\" Zn-Pb-Cu Ores in Black Shales in Australia and Yukon and of Fluorite Veins in Granite in Newfoundland.","year":2011,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Geomagnetism and Paleomagnetism Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada; University of Windsor","keywords":"Geology; Paleomagnetism; Geochemistry; Fluorite; Rock magnetism; Paleontology","score_opus":0.0359867616465035,"score_gpt":0.30850535029951537,"score_spread":0.2725185886530119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W11866677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942536,0.0034293663,0.00027652993,0.00030803191,0.000010530757,0.000005570088,0.00019586181,0.0000055434375,0.0015148348],"genre_scores_gemma":[0.9978053,0.0011782766,0.00010956509,0.000042445634,0.000011997292,0.0000015270791,0.000119807315,0.000001585174,0.00072951464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999192,0.000015442736,0.000005382434,0.000019353023,0.00001908965,0.000021625754],"domain_scores_gemma":[0.9998771,0.00001867771,0.00005005498,0.000004087689,0.000035304027,0.000014831613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001868718,0.00013709477,0.00024673104,0.0009729475,0.0002664926,0.00032483914,0.0001919116,0.00033282916,0.001485146],"category_scores_gemma":[0.00036184178,0.000105801606,0.00013861312,0.00054096925,0.0003819979,0.00014597834,0.00020277358,0.00018037303,0.00012941766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079549,0.000026086394,0.9427064,0.00023148576,0.00013104866,0.002110532,0.0009851328,0.00022228037,0.023688294,0.00021254364,0.0009263674,0.02796438],"study_design_scores_gemma":[0.0000039681413,0.00004828675,0.99569607,0.000016897273,0.000025748364,0.0017633805,0.00054550293,0.00007888826,0.0009103112,0.00012138038,0.00078608666,0.0000034074737],"about_ca_topic_score_codex":0.034554075,"about_ca_topic_score_gemma":0.05246562,"teacher_disagreement_score":0.96544594,"about_ca_system_score_codex":0.00051821605,"about_ca_system_score_gemma":0.0002972086,"threshold_uncertainty_score":0.06870586},"labels":[],"label_agreement":null},{"id":"W1503429060","doi":"10.1517/14656566.2011.604617","title":"Hyperemesis gravidarum: pathogenesis and the use of antiemetic agents","year":2011,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Hyperemesis gravidarum; Medicine; Antiemetic; Nausea; Pathogenesis; Intensive care medicine; Anesthesia; Internal medicine","score_opus":0.1466441607780156,"score_gpt":0.35410801759989696,"score_spread":0.20746385682188137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503429060","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026016295,0.035569325,0.0015918828,0.87863684,0.02532945,0.00010958257,0.00022707228,0.00016380158,0.032355748],"genre_scores_gemma":[0.21257092,0.036739893,0.002763738,0.37472308,0.353633,0.00014199293,0.0002514813,0.00007301116,0.01910292],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990866,0.00022795587,0.00015211254,0.0001224195,0.0002731409,0.00013780911],"domain_scores_gemma":[0.9981394,0.0010234005,0.00027951782,0.00007463066,0.00027522948,0.00020780205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007026149,0.00095886807,0.0016587173,0.0011005171,0.00087235717,0.0013880811,0.0010720136,0.021750601,0.004203659],"category_scores_gemma":[0.007376575,0.0006305327,0.0016049157,0.0006498286,0.001193068,0.002830532,0.0004593729,0.010811827,0.0022252242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056010345,0.00033502292,0.018483337,0.0005914382,0.0001390108,0.6176138,0.00028900531,0.00042439403,0.0017162424,0.007477675,0.31530267,0.03706739],"study_design_scores_gemma":[0.00067993335,0.00034945237,0.0156971,0.00089793676,0.00023681963,0.8047822,0.00037307478,0.0037396124,0.000869196,0.010245478,0.16200712,0.000121988014],"about_ca_topic_score_codex":0.0020882962,"about_ca_topic_score_gemma":0.0036325438,"teacher_disagreement_score":0.021750601,"about_ca_system_score_codex":0.002268618,"about_ca_system_score_gemma":0.0009854434,"threshold_uncertainty_score":0.016460001},"labels":[],"label_agreement":null},{"id":"W1621345808","doi":"10.1517/14656566.2015.1067680","title":"Choosing drugs for the treatment of diabetic neuropathy","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Glycemic; Intensive care medicine; Diabetes mellitus; Disease; Diabetic neuropathy; Population; Polyneuropathy; Physical therapy; Surgery; Internal medicine","score_opus":0.16214112568720937,"score_gpt":0.47438614460186174,"score_spread":0.3122450189146524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1621345808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111347224,0.9977391,0.00008229898,0.0005032741,0.00021506789,0.000018082721,0.00004366237,0.0000044356616,0.0012826868],"genre_scores_gemma":[0.0008850885,0.99744886,0.00025046218,0.00060103077,0.00017676853,0.000018233966,0.000046579476,0.000001600352,0.0005713923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947244,0.00013340278,0.00011793711,0.00006897098,0.00017361178,0.000033691565],"domain_scores_gemma":[0.9993606,0.00034189047,0.00014377703,0.000012086526,0.00011820754,0.000023399949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006328823,0.0006661672,0.0015876445,0.0027305514,0.00026760067,0.0010542901,0.00077924423,0.0013322078,0.011841041],"category_scores_gemma":[0.0016115276,0.00021110897,0.001067291,0.0023530237,0.00035306008,0.0011981638,0.000507327,0.0012678867,0.0028280993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001177388,0.000054360335,0.00018674422,0.10709879,0.000296747,0.00024789234,0.000074393945,0.00011683502,0.0009127158,0.002048319,0.031075494,0.85776985],"study_design_scores_gemma":[0.00017215264,0.00016124595,0.001960354,0.09891587,0.0011857513,0.0021238409,0.00017273547,0.00012338985,0.0006723292,0.003046387,0.89142376,0.00004208956],"about_ca_topic_score_codex":0.0013313662,"about_ca_topic_score_gemma":0.003268572,"teacher_disagreement_score":0.011841041,"about_ca_system_score_codex":0.00059754093,"about_ca_system_score_gemma":0.0011670219,"threshold_uncertainty_score":0.039612174},"labels":[],"label_agreement":null},{"id":"W1667748414","doi":"10.1517/14656566.2015.1086747","title":"The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Medicine; Gastroparesis; Small intestinal bacterial overgrowth; Constipation; Internal medicine; Gastroenterology; Adverse effect; Cisapride; Disease; Intensive care medicine; Irritable bowel syndrome; Gastric emptying; Stomach","score_opus":0.05051051495634989,"score_gpt":0.3442491884464837,"score_spread":0.29373867349013383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1667748414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000092380484,0.9994288,0.000023556697,0.00012753018,0.000060859726,0.000005249041,0.000010962635,0.0000018336449,0.00024872515],"genre_scores_gemma":[0.0010288791,0.99848336,0.000119989614,0.00014769689,0.00006936887,0.000008605423,0.000016190133,5.630255e-7,0.00012529733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996406,0.000101423655,0.000078551464,0.000044435576,0.00010999998,0.000025057043],"domain_scores_gemma":[0.9995215,0.0002516684,0.00012308083,0.0000066194707,0.00007711955,0.000020019252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005648846,0.0006534371,0.0015060554,0.0019876608,0.0002302484,0.0007051599,0.0006885929,0.0012899505,0.0037653993],"category_scores_gemma":[0.001324895,0.00017306922,0.00093426224,0.0016547904,0.00026347183,0.00064662285,0.00047983302,0.000915046,0.0007459725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001252098,0.000070795766,0.00022594037,0.12401097,0.0004141421,0.00027036443,0.00009323535,0.0001950771,0.00067883066,0.0007338688,0.01771333,0.85546815],"study_design_scores_gemma":[0.0002295892,0.00044797358,0.005085757,0.13087577,0.0022426127,0.0057922523,0.00028466436,0.0002615393,0.0007699738,0.0015350071,0.85242695,0.000047978236],"about_ca_topic_score_codex":0.001419919,"about_ca_topic_score_gemma":0.0032712964,"teacher_disagreement_score":0.0037653993,"about_ca_system_score_codex":0.00041633073,"about_ca_system_score_gemma":0.0009395589,"threshold_uncertainty_score":0.012596548},"labels":[],"label_agreement":null},{"id":"W1740551684","doi":"10.1517/14656566.2015.1088829","title":"Will personalized drugs for cardiovascular disease become an option? – Defining ‘Evidence-based personalized medicine’ for its implementation and future use","year":2015,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Personalized medicine; Precision medicine; Disease; Intensive care medicine; Bioinformatics; Internal medicine; Pathology","score_opus":0.20933489707651082,"score_gpt":0.5118279032799685,"score_spread":0.3024930062034577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1740551684","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004204843,0.0525236,0.000330168,0.15076818,0.7941933,0.000042243526,0.000055400647,0.000059876456,0.0019851753],"genre_scores_gemma":[0.00064303447,0.037066724,0.0005162243,0.09275145,0.86458737,0.000047535133,0.000041012016,0.00003723298,0.0043093297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99194455,0.0024803104,0.0013567851,0.0007630715,0.003092502,0.00036289837],"domain_scores_gemma":[0.9635193,0.021156343,0.0022776662,0.0008624126,0.009681426,0.0025028156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0155684985,0.0018851534,0.004137362,0.0023151108,0.0019303838,0.006331973,0.0043909205,0.0226201,0.008376178],"category_scores_gemma":[0.04469054,0.0007972578,0.0022901206,0.0011351688,0.004451305,0.0065229037,0.0017784144,0.02458977,0.009153144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035544836,0.000014666972,0.000021584687,0.0009402841,0.000034061784,0.00011594627,0.000040729155,0.0000333043,0.000076817196,0.0014604555,0.9816689,0.015557792],"study_design_scores_gemma":[0.00005767992,0.000028633202,0.00015083753,0.0016985965,0.000060659113,0.0002768082,0.00005030649,0.00011060723,0.000075978205,0.0041932,0.9932761,0.000020631474],"about_ca_topic_score_codex":0.0011024299,"about_ca_topic_score_gemma":0.0024116084,"teacher_disagreement_score":0.0226201,"about_ca_system_score_codex":0.0034784572,"about_ca_system_score_gemma":0.0042379657,"threshold_uncertainty_score":0.082335055},"labels":[],"label_agreement":null},{"id":"W1852373983","doi":"10.1517/14656566.2010.512006","title":"Mipomersen as a potential adjunctive therapy for hypercholesterolemia","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Apolipoprotein B; Population; Gastroenterology; Lipoprotein(a); Lipoprotein; Endocrinology; Cholesterol","score_opus":0.07210830279709016,"score_gpt":0.43681410121708286,"score_spread":0.36470579841999273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1852373983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08605975,0.88616556,0.0024736181,0.009887233,0.0023341516,0.00032625365,0.0005011019,0.00017643951,0.012075882],"genre_scores_gemma":[0.30431014,0.6606858,0.003953775,0.014990631,0.004329289,0.00042857428,0.0014099191,0.0000371797,0.009854671],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983823,0.000058424357,0.000013953892,0.00002615332,0.000038579183,0.000024601877],"domain_scores_gemma":[0.9998099,0.00007406608,0.00005802364,0.0000046556456,0.000028081233,0.000025150306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004950844,0.00045450823,0.0011131841,0.00023483382,0.000100930025,0.00054381555,0.0005817239,0.0011281004,0.0035789604],"category_scores_gemma":[0.00037430535,0.00010532999,0.00050554064,0.00022792006,0.00021570269,0.00027118798,0.00014446538,0.0016294158,0.001119215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014370176,0.001562593,0.001772348,0.009792929,0.0014259195,0.001288606,0.000073629686,0.000869632,0.036536165,0.0018929715,0.03696951,0.8934456],"study_design_scores_gemma":[0.09155071,0.05577975,0.055844113,0.006492956,0.0062062847,0.0091066975,0.0003638415,0.0077110515,0.03613685,0.004021715,0.72655636,0.00022966706],"about_ca_topic_score_codex":0.00035719396,"about_ca_topic_score_gemma":0.0013279389,"teacher_disagreement_score":0.0035789604,"about_ca_system_score_codex":0.00026680657,"about_ca_system_score_gemma":0.00023917686,"threshold_uncertainty_score":0.011972845},"labels":[],"label_agreement":null},{"id":"W1917089101","doi":"10.1517/14656566.2015.1074179","title":"The evolving role of dabigatran etexilate in clinical practice","year":2015,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dabigatran; Medicine; Edoxaban; Rivaroxaban; Apixaban; Warfarin; Direct thrombin inhibitor; Atrial fibrillation; Stroke (engine); Vitamin K antagonist; Idarucizumab; Anticoagulant; Intensive care medicine; Pharmacodynamics; Anesthesia; Internal medicine; Pharmacokinetics","score_opus":0.16853925879063442,"score_gpt":0.5070706961620863,"score_spread":0.3385314373714519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1917089101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042074528,0.51381785,0.0033290484,0.44885486,0.0066834935,0.000033601296,0.00021040303,0.00014695279,0.022716315],"genre_scores_gemma":[0.084606364,0.77957445,0.010066434,0.087384425,0.034064684,0.00010686129,0.0003480205,0.0001057904,0.0037429363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924023,0.0026582421,0.0012797614,0.0009645813,0.002367051,0.0003279867],"domain_scores_gemma":[0.95503455,0.020065697,0.006386953,0.00087101245,0.011333044,0.006308763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009824209,0.00049059285,0.0010536396,0.002459317,0.00059038284,0.0050743166,0.0014652412,0.0040631676,0.010186962],"category_scores_gemma":[0.045109387,0.00031766653,0.0005152276,0.0025371294,0.0019880703,0.004852073,0.0019507377,0.0049486267,0.0035543207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010986274,0.000107805325,0.010178401,0.0028699725,0.00009511338,0.00065517233,0.00063371076,0.0005552914,0.00035458582,0.021191657,0.17602156,0.7872269],"study_design_scores_gemma":[0.00012127188,0.0002175574,0.01938677,0.017904926,0.00011426453,0.0047617783,0.0015655531,0.0011490636,0.00028396002,0.03774427,0.9166366,0.00011400394],"about_ca_topic_score_codex":0.0027354613,"about_ca_topic_score_gemma":0.0032561368,"teacher_disagreement_score":0.010186962,"about_ca_system_score_codex":0.004284158,"about_ca_system_score_gemma":0.005430947,"threshold_uncertainty_score":0.05195594},"labels":[],"label_agreement":null},{"id":"W1941427190","doi":"10.1517/14656566.2012.689825","title":"Combination therapy in type 2 diabetes mellitus: adding linagliptin to a stable regimen of metformin and a sulfonylurea","year":2012,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Linagliptin; Medicine; Metformin; Glycemic; Sulfonylurea; Regimen; Type 2 Diabetes Mellitus; Hypoglycemia; Pharmacology; Diabetes mellitus; Internal medicine; Type 2 diabetes; Incretin; Dipeptidyl peptidase-4 inhibitor; Endocrinology","score_opus":0.04079503441523548,"score_gpt":0.3364745502938849,"score_spread":0.29567951587864943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1941427190","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011185311,0.026626753,0.002464049,0.90817344,0.033670884,0.00016191375,0.000095258736,0.00017555921,0.017446836],"genre_scores_gemma":[0.06877212,0.036248874,0.0043816646,0.732468,0.14409918,0.0002494668,0.00012663794,0.00005937325,0.013594718],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892944,0.0004013265,0.0001344314,0.00012649417,0.00030013282,0.00010822128],"domain_scores_gemma":[0.9989588,0.0005963607,0.000115019684,0.00004143209,0.00016308959,0.00012520455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010834462,0.0010884575,0.0015381698,0.00077918416,0.0012299693,0.0013839179,0.0010374602,0.013215277,0.0019991572],"category_scores_gemma":[0.0059133726,0.00037205024,0.0014021044,0.0007131015,0.0012479816,0.0019822065,0.00053433754,0.011410242,0.002233492],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066595664,0.00054428726,0.005511364,0.000732296,0.00017748312,0.20744711,0.0003687399,0.00062139553,0.0017562052,0.00793429,0.6383632,0.13587768],"study_design_scores_gemma":[0.0011496336,0.0008417587,0.0052925423,0.0011656303,0.00023048962,0.37265095,0.0004541331,0.0035785423,0.0013038216,0.015404795,0.59781873,0.00010906649],"about_ca_topic_score_codex":0.0010614167,"about_ca_topic_score_gemma":0.0029864984,"teacher_disagreement_score":0.013215277,"about_ca_system_score_codex":0.0023865032,"about_ca_system_score_gemma":0.00086742867,"threshold_uncertainty_score":0.017315447},"labels":[],"label_agreement":null},{"id":"W1967359512","doi":"10.1517/14656566.7.12.1653","title":"The neurokinin<sub>1</sub>receptor antagonist aprepitant as an antiemetic for moderately emetogenic chemotherapy","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nausea and vomiting management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Aprepitant; Antiemetic; Medicine; Retching; NK1 receptor antagonist; Vomiting; Pharmacology; Anthracycline; Ondansetron; Chemotherapy; Nausea; Cyclophosphamide; Anesthesia; Oncology; Internal medicine; Breast cancer; Cancer; Receptor; Substance P; Neuropeptide","score_opus":0.08242888505116366,"score_gpt":0.42824047697160517,"score_spread":0.34581159192044153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967359512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002079378,0.9975387,0.00010154027,0.000507446,0.0002332567,0.000011252669,0.000021800037,0.0000071029685,0.0013709702],"genre_scores_gemma":[0.0011556675,0.99687374,0.00022167031,0.00056960405,0.00022123694,0.000015024826,0.00003997552,0.000001312598,0.0009017759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973816,0.00006666273,0.000042602675,0.000031643016,0.00010295546,0.000017977094],"domain_scores_gemma":[0.99959844,0.00015544721,0.00011787832,0.000008217347,0.00009236859,0.000027651942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060393754,0.00066621613,0.0020412207,0.0010719851,0.00015184714,0.0006891796,0.00084930955,0.0011683233,0.006562701],"category_scores_gemma":[0.0008814562,0.00016299343,0.0005676551,0.001608539,0.00022004022,0.00083275966,0.0002655795,0.00086806127,0.0034531674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020553559,0.000079677506,0.00015935038,0.029285338,0.00022283672,0.0003492566,0.000028661809,0.00016754604,0.001607302,0.0006364497,0.03729559,0.92996246],"study_design_scores_gemma":[0.0003178874,0.00040586037,0.002975875,0.012252812,0.0006215303,0.0042752638,0.00010008688,0.0001838013,0.0009669935,0.0012675477,0.9766029,0.000029328075],"about_ca_topic_score_codex":0.00061203144,"about_ca_topic_score_gemma":0.001852308,"teacher_disagreement_score":0.006562701,"about_ca_system_score_codex":0.00039009462,"about_ca_system_score_gemma":0.0007177537,"threshold_uncertainty_score":0.021954477},"labels":[],"label_agreement":null},{"id":"W1968477526","doi":"10.1517/14656566.3.7.865","title":"Hormonal therapies in acne","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Acne; Medicine; Flutamide; Hormone; Hormonal therapy; Antiandrogens; Endocrine system; Spironolactone; Androgen; Physiology; Antiandrogen; Endocrinology; Internal medicine; Androgen receptor; Dermatology; Prostate cancer; Cancer; Aldosterone","score_opus":0.13041342788945864,"score_gpt":0.45582349975928155,"score_spread":0.3254100718698229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968477526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035917197,0.99342245,0.00026022986,0.00037125868,0.0003903172,0.000012632621,0.000013753941,0.000013180973,0.005156978],"genre_scores_gemma":[0.0027292122,0.9919228,0.00049923063,0.0006483071,0.00051028136,0.000017021759,0.0000328169,0.0000038735543,0.003636476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996966,0.00007145135,0.000034002966,0.00004081461,0.00013543743,0.000021794112],"domain_scores_gemma":[0.9998171,0.00009905425,0.000029304823,0.000009558628,0.000031866228,0.000013200798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003414114,0.0008055204,0.001167366,0.0017341049,0.00034999137,0.0006559254,0.0004959173,0.0012942466,0.0076882765],"category_scores_gemma":[0.0005021634,0.00016726808,0.00047078604,0.0013585706,0.0004273639,0.0009223305,0.0004650938,0.0012859416,0.003928393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007101395,0.00010582713,0.00015393924,0.00826709,0.000051249717,0.00076842005,0.00006999517,0.00017108674,0.0034058085,0.001620084,0.021179343,0.9641361],"study_design_scores_gemma":[0.000057478315,0.00021429088,0.0015494324,0.0031148843,0.000085442174,0.007797588,0.00009485262,0.000097056705,0.0015168012,0.0019490457,0.9835067,0.00001639257],"about_ca_topic_score_codex":0.0007645634,"about_ca_topic_score_gemma":0.0015040017,"teacher_disagreement_score":0.0076882765,"about_ca_system_score_codex":0.0003886092,"about_ca_system_score_gemma":0.00050136994,"threshold_uncertainty_score":0.025719881},"labels":[],"label_agreement":null},{"id":"W1969921902","doi":"10.1517/14656566.3.4.417","title":"Pharmacoeconomics of long-term treatment of rheumatoid arthritis","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rheumatoid arthritis; Leflunomide; Sulfasalazine; Etanercept; Hydroxychloroquine; Infliximab; Antirheumatic drugs; Methotrexate; Azathioprine; Antirheumatic Agents; Quality of life (healthcare); Intensive care medicine; Arthritis; Disease; Population; Pharmacoeconomics; Internal medicine","score_opus":0.08982429485987818,"score_gpt":0.42961837180263257,"score_spread":0.3397940769427544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969921902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022588886,0.99653876,0.00013792816,0.001406542,0.00014213695,0.000010293057,0.00003319029,0.0000033778017,0.0015018898],"genre_scores_gemma":[0.0029696852,0.9953231,0.0003209536,0.00076772773,0.00022223499,0.00002206125,0.00003999602,0.0000011255447,0.00033309823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985336,0.00062216277,0.0001379183,0.0000679367,0.0005939295,0.00004440174],"domain_scores_gemma":[0.9985677,0.00084336905,0.00030633775,0.000027087854,0.0002162638,0.000039226452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00166613,0.00064339524,0.0022440923,0.0018826402,0.00019416075,0.001074363,0.00070760725,0.0015557974,0.0066362075],"category_scores_gemma":[0.0031509225,0.00021053408,0.00075054716,0.003438009,0.00026856887,0.000764841,0.00028801436,0.0009093765,0.0010093945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017163079,0.00008515256,0.0004566884,0.026727738,0.000661243,0.0002835153,0.000030323134,0.0009183576,0.00039745643,0.0042631887,0.024102092,0.9419026],"study_design_scores_gemma":[0.00043521757,0.0004654274,0.012997579,0.040301424,0.0018135814,0.004238252,0.00017561286,0.0011827181,0.0007001171,0.011613868,0.92601705,0.00005906736],"about_ca_topic_score_codex":0.0023758374,"about_ca_topic_score_gemma":0.00596956,"teacher_disagreement_score":0.0066362075,"about_ca_system_score_codex":0.0017568836,"about_ca_system_score_gemma":0.002552829,"threshold_uncertainty_score":0.022200286},"labels":[],"label_agreement":null},{"id":"W1970579734","doi":"10.1517/14656566.8.18.3133","title":"Management of glioblastoma","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Temozolomide; Carmustine; Lomustine; Radiation therapy; Oncology; Glioma; Chemotherapy; Adjuvant; Internal medicine; Glioblastoma; Chemoradiotherapy; Cancer research; Cyclophosphamide","score_opus":0.1013787361650628,"score_gpt":0.4678047214229079,"score_spread":0.3664259852578451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970579734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011080143,0.98749846,0.0010997828,0.0016780468,0.0007673501,0.00003412361,0.0000663307,0.00004172527,0.007706202],"genre_scores_gemma":[0.011366606,0.9788495,0.0015808407,0.0023570121,0.0009616451,0.000044264074,0.00042073635,0.000012319245,0.004407057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998404,0.000032449752,0.000020709238,0.000024579698,0.000057122208,0.000024708397],"domain_scores_gemma":[0.99989355,0.000018014212,0.00002753932,0.000004677313,0.000034888075,0.000021329277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027269043,0.0009742624,0.0012731502,0.0014480953,0.00035459775,0.00071710185,0.0008965727,0.0010839723,0.0032166461],"category_scores_gemma":[0.0005210683,0.00011842357,0.0004967315,0.0009438647,0.00028211583,0.00068004895,0.000588399,0.0011749924,0.0029397572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004034457,0.000027878095,0.00033626586,0.0040838053,0.00004825731,0.0014644956,0.00004803897,0.00022864081,0.0008622283,0.0013928576,0.04467915,0.946788],"study_design_scores_gemma":[0.00006331145,0.00014927275,0.0032986808,0.0054987343,0.00015040547,0.030797372,0.00018286506,0.00025776378,0.0014771323,0.004307073,0.9537844,0.000033060813],"about_ca_topic_score_codex":0.0021968274,"about_ca_topic_score_gemma":0.0052382504,"teacher_disagreement_score":0.0032166461,"about_ca_system_score_codex":0.0007809079,"about_ca_system_score_gemma":0.001159904,"threshold_uncertainty_score":0.010760784},"labels":[],"label_agreement":null},{"id":"W1971210903","doi":"10.1517/14656566.3.10.1421","title":"Pharmacotherapy of postpartum depression","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Diathesis; Medicine; Bipolar disorder; Depression (economics); Postpartum depression; Psychiatry; Postpartum period; Pharmacotherapy; Major depressive disorder; Psychological intervention; Pregnancy; Lithium (medication); Mood","score_opus":0.11404874451524291,"score_gpt":0.45700835935035866,"score_spread":0.3429596148351157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971210903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028949036,0.99787843,0.000102103775,0.00035462284,0.0001651719,0.00001055214,0.000014065797,0.000007979855,0.0011775682],"genre_scores_gemma":[0.0014428775,0.99710685,0.00022116293,0.0003968496,0.0001657464,0.000015323023,0.000023648487,0.0000013421695,0.0006261498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997074,0.00008864596,0.00003967333,0.000041656433,0.00010051516,0.000022172186],"domain_scores_gemma":[0.9997296,0.00013064122,0.00005947075,0.000011961172,0.000052989908,0.00001533471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004563444,0.0007016319,0.001532212,0.0015095867,0.00022875867,0.0005744014,0.00074543065,0.0012944438,0.0034588252],"category_scores_gemma":[0.000778459,0.000174375,0.0005287588,0.0015371375,0.00024379844,0.00054526364,0.00037186302,0.0009957236,0.0017706546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007846827,0.000102965525,0.00014090344,0.014516203,0.000126833,0.00028448028,0.000044074677,0.00013096024,0.0011116212,0.00045600178,0.016034426,0.966973],"study_design_scores_gemma":[0.00023250401,0.0006216561,0.0071423594,0.018169124,0.00054480194,0.0077961166,0.00017029785,0.00032041367,0.0014198358,0.0021274234,0.9614209,0.000034494067],"about_ca_topic_score_codex":0.0013159397,"about_ca_topic_score_gemma":0.0031202487,"teacher_disagreement_score":0.0034588252,"about_ca_system_score_codex":0.0004422988,"about_ca_system_score_gemma":0.0007396392,"threshold_uncertainty_score":0.0115709305},"labels":[],"label_agreement":null},{"id":"W1971893169","doi":"10.1517/14656566.7.2.119","title":"Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institutes of Health","keywords":"Medicine; Tardive dyskinesia; Pharmacogenetics; Cognitive reframing; Psychiatry; Pharmacology; Intensive care medicine; Schizophrenia (object-oriented programming); Genotype; Genetics; Psychotherapist; Gene","score_opus":0.22415024684781412,"score_gpt":0.5288736713795347,"score_spread":0.3047234245317205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971893169","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060909394,0.023164475,0.03448479,0.814822,0.0029624586,0.00016119078,0.0006313993,0.0004990282,0.062365223],"genre_scores_gemma":[0.68077815,0.021696964,0.025122115,0.25064728,0.007407242,0.00022013056,0.00043980728,0.00034494244,0.013343417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98582304,0.008456716,0.0009216424,0.00097386446,0.0030052597,0.00081961777],"domain_scores_gemma":[0.9400184,0.043720376,0.007224419,0.0035248804,0.0030486102,0.0024632544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019695476,0.00037461898,0.0009177523,0.001509512,0.0013297912,0.006933131,0.0011999684,0.0052284696,0.005335244],"category_scores_gemma":[0.055012923,0.00036460205,0.0010917578,0.0012326298,0.005417724,0.005838148,0.0031725878,0.005693339,0.0011283262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019325603,0.0004072143,0.052536532,0.0011083895,0.00042197513,0.0022113363,0.004387952,0.0023105291,0.006613817,0.2865076,0.10913159,0.5324305],"study_design_scores_gemma":[0.00047817818,0.00090327923,0.043900352,0.003197139,0.0007340237,0.003412515,0.0028187195,0.004897219,0.0064870156,0.44044074,0.49241647,0.00031426336],"about_ca_topic_score_codex":0.0019531557,"about_ca_topic_score_gemma":0.0039329426,"teacher_disagreement_score":0.019695476,"about_ca_system_score_codex":0.0026247844,"about_ca_system_score_gemma":0.0060683205,"threshold_uncertainty_score":0.104160905},"labels":[],"label_agreement":null},{"id":"W1972631406","doi":"10.1517/14656566.5.7.1555","title":"Pharmacological management of metastatic boney pain","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Quality of life (healthcare); Population; Cancer; Internal medicine; Environmental health","score_opus":0.15312277648835515,"score_gpt":0.49526205442915183,"score_spread":0.3421392779407967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972631406","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031135423,0.9962012,0.00017262851,0.0004079758,0.00019564657,0.000010578884,0.000015313268,0.000009274264,0.002676057],"genre_scores_gemma":[0.0017251982,0.9961941,0.00024187655,0.00044224752,0.00025192113,0.000011570028,0.000026717244,0.0000014451058,0.0011049506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985266,0.000032018703,0.00001497764,0.000021036543,0.00006631602,0.000012922595],"domain_scores_gemma":[0.9999069,0.000037173068,0.000023196162,0.0000034814836,0.000020178635,0.000008992314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023964254,0.0006086279,0.0012433076,0.0013429986,0.00026079195,0.0005355679,0.00058364467,0.0009766974,0.004158603],"category_scores_gemma":[0.00038099248,0.000121976,0.00040724044,0.0009505153,0.000244678,0.00053614326,0.00036612156,0.0009868141,0.0022417766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078315825,0.000117348325,0.0001317498,0.011699975,0.00009479821,0.000549234,0.000041744144,0.0001639365,0.0023570233,0.0010418773,0.018370882,0.965353],"study_design_scores_gemma":[0.00015707639,0.0004114277,0.0038910755,0.007463256,0.00022612052,0.009739766,0.00014056219,0.00019218803,0.0015245846,0.0023825988,0.9738448,0.000026515285],"about_ca_topic_score_codex":0.0008344142,"about_ca_topic_score_gemma":0.002161278,"teacher_disagreement_score":0.004158603,"about_ca_system_score_codex":0.00031659112,"about_ca_system_score_gemma":0.00042535167,"threshold_uncertainty_score":0.0139119625},"labels":[],"label_agreement":null},{"id":"W1972663496","doi":"10.1517/14656566.6.10.1693","title":"Combination therapy versus single agent chemotherapy in non-small cell lung cancer","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Vinorelbine; Docetaxel; Gemcitabine; Oncology; Chemotherapy; Lung cancer; Internal medicine; Cisplatin; Combination chemotherapy; Quality of life (healthcare); Performance status; Intensive care medicine","score_opus":0.08944024370707172,"score_gpt":0.4632380360425038,"score_spread":0.3737977923354321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972663496","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001153126,0.99910176,0.000037179885,0.00012835277,0.00009407547,0.000004755876,0.000006428609,0.0000018221775,0.00051030255],"genre_scores_gemma":[0.0009269474,0.99830234,0.00012195636,0.00019173205,0.00009311945,0.0000071974537,0.000013302344,7.0156375e-7,0.00034275037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996885,0.00010337123,0.000045073277,0.000039608087,0.00010621622,0.000017327997],"domain_scores_gemma":[0.9995957,0.00025358197,0.00007990154,0.000007770063,0.000049414903,0.000013500795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082349207,0.0004856831,0.0023179373,0.0014641993,0.0001555856,0.00065767276,0.0008870837,0.00096943695,0.0047240695],"category_scores_gemma":[0.00092515483,0.00019231843,0.0007155914,0.0022263646,0.00034557775,0.0009116434,0.00030852482,0.00082427514,0.0013539282],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021907405,0.000054031414,0.00013148737,0.05652232,0.00037910655,0.00021221198,0.000037818805,0.00020750021,0.00082559173,0.001103534,0.022295881,0.91801137],"study_design_scores_gemma":[0.00031176145,0.00046891457,0.0030442355,0.034024164,0.001358116,0.003278677,0.00012830479,0.00023582038,0.000689459,0.0024764945,0.9539571,0.000027108388],"about_ca_topic_score_codex":0.0009480114,"about_ca_topic_score_gemma":0.0031962956,"teacher_disagreement_score":0.0047240695,"about_ca_system_score_codex":0.0005090774,"about_ca_system_score_gemma":0.0006342448,"threshold_uncertainty_score":0.015803516},"labels":[],"label_agreement":null},{"id":"W1974384804","doi":"10.1517/14656566.4.4.475","title":"Assessment and management of acute pain in high-risk neonates","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Neonatal intensive care unit; Acute pain; Intensive care medicine; Pain assessment; Psychological intervention; Pain management; Reliability (semiconductor); Physical therapy; Pediatrics; Anesthesia; Psychiatry","score_opus":0.04282670808845209,"score_gpt":0.4325960528435088,"score_spread":0.38976934475505676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974384804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081064785,0.9972101,0.00027693645,0.0004588841,0.000095598036,0.00001535514,0.00001036989,0.0000065387735,0.0011156128],"genre_scores_gemma":[0.003932608,0.99459755,0.0007450174,0.00024129622,0.00017145828,0.000022698887,0.000013350453,9.702658e-7,0.00027510128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996619,0.00012031962,0.000053719,0.00003105591,0.000111348905,0.000021688753],"domain_scores_gemma":[0.9995975,0.0001942966,0.00010218022,0.000007235826,0.000081206956,0.00001767582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006880807,0.0005326576,0.0012061651,0.0011320404,0.00017535122,0.0005604404,0.0008954736,0.0010716945,0.0018879565],"category_scores_gemma":[0.0012076095,0.00014075928,0.0003656965,0.00090761535,0.00033914202,0.00062895304,0.00028305096,0.0008229269,0.0008747577],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009046236,0.000113041286,0.0006809192,0.014363738,0.00007891968,0.00052652997,0.00007317897,0.00018941761,0.0015734595,0.00041551774,0.0053283134,0.97656655],"study_design_scores_gemma":[0.00047194902,0.002311349,0.067119494,0.062545724,0.00096797117,0.04118341,0.0015450789,0.0014268995,0.007858619,0.006583861,0.8078565,0.00012917636],"about_ca_topic_score_codex":0.0010779343,"about_ca_topic_score_gemma":0.0018192017,"teacher_disagreement_score":0.0018879565,"about_ca_system_score_codex":0.0003498566,"about_ca_system_score_gemma":0.00073753716,"threshold_uncertainty_score":0.0063158274},"labels":[],"label_agreement":null},{"id":"W1976895177","doi":"10.1517/14656560903078428","title":"Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity; University of Calgary","funders":"","keywords":"Mometasone furoate; Fluticasone propionate; Medicine; Asthma; Glucocorticoid; Drug; Fluticasone; Dry-powder inhaler; Bioavailability; Corticosteroid; Dosing; Clinical trial; Pharmacology; Inhaler; Internal medicine","score_opus":0.04175288918043532,"score_gpt":0.40529818003224005,"score_spread":0.36354529085180476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976895177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014294582,0.9975452,0.00013278729,0.00036603064,0.00020508465,0.000012895845,0.000033113796,0.000011824643,0.0015502047],"genre_scores_gemma":[0.00080866925,0.9974617,0.00023421342,0.0002747306,0.0001623149,0.000011378442,0.0000689276,0.0000017746806,0.00097627926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974066,0.00003854622,0.000036025645,0.000034073022,0.00012629108,0.000024385192],"domain_scores_gemma":[0.99979955,0.000064706845,0.000053886695,0.0000061268383,0.00005212607,0.000023678047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047643756,0.00088713644,0.0018124034,0.0023731512,0.0002233529,0.000660829,0.0009812214,0.001210623,0.005180322],"category_scores_gemma":[0.00054081465,0.00023477536,0.0006283497,0.002313544,0.00030375196,0.0007439329,0.00040475457,0.0012052291,0.0050426787],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008403642,0.00006836395,0.0001559677,0.01587466,0.00013730592,0.0003154567,0.000029165418,0.00013971658,0.0018790327,0.0005443964,0.034048617,0.9467232],"study_design_scores_gemma":[0.0001031338,0.00012493848,0.0017266638,0.003988566,0.00020886539,0.0033633106,0.000043755685,0.000065618064,0.00083650986,0.0005515121,0.9889692,0.000017880124],"about_ca_topic_score_codex":0.0014400075,"about_ca_topic_score_gemma":0.0033537082,"teacher_disagreement_score":0.005180322,"about_ca_system_score_codex":0.0005448641,"about_ca_system_score_gemma":0.00095677684,"threshold_uncertainty_score":0.017329931},"labels":[],"label_agreement":null},{"id":"W1977389467","doi":"10.1517/14656560903222281","title":"Dapagliflozin: where does it fit in the treatment of type 2 diabetes?","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"","keywords":"Dapagliflozin; Medicine; Hypoglycemia; Type 2 diabetes; Glycemic; Diabetes mellitus; Regimen; Pharmacotherapy; Drug class; Intensive care medicine; Concomitant; Clinical trial; Drug; Pharmacology; Internal medicine; Endocrinology","score_opus":0.09096050532522067,"score_gpt":0.42677421191226106,"score_spread":0.3358137065870404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977389467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016835962,0.9911143,0.00020036126,0.006726724,0.00085143547,0.000010451925,0.000023644163,0.000015311016,0.00088947295],"genre_scores_gemma":[0.0010138722,0.99278414,0.0005929855,0.0037045213,0.0009921833,0.000014942667,0.00003599454,0.0000041058606,0.00085738214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997024,0.0000646448,0.00004194268,0.000043437325,0.00011874757,0.000028828155],"domain_scores_gemma":[0.9995092,0.00018426648,0.00009235893,0.000013587521,0.00013816594,0.00006242271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014756444,0.0006723323,0.0029300817,0.0012438868,0.00029793402,0.001335635,0.0011109113,0.0023334334,0.003893437],"category_scores_gemma":[0.0014889813,0.0002981821,0.0007000887,0.0019730371,0.00061160285,0.0030663759,0.0005249822,0.0028686735,0.0028730116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021186944,0.00006151139,0.00019646119,0.0082480535,0.00011258645,0.0002189853,0.000035625504,0.0001826117,0.0004958786,0.0021435746,0.06774445,0.92034847],"study_design_scores_gemma":[0.0003067793,0.0003109896,0.0017012466,0.0136151835,0.00028797792,0.0014978152,0.00013722427,0.00035605862,0.00022299137,0.0061435373,0.9753794,0.000040892555],"about_ca_topic_score_codex":0.0013548371,"about_ca_topic_score_gemma":0.00397018,"teacher_disagreement_score":0.003893437,"about_ca_system_score_codex":0.0006748613,"about_ca_system_score_gemma":0.0011553201,"threshold_uncertainty_score":0.013024867},"labels":[],"label_agreement":null},{"id":"W1977936853","doi":"10.1517/14656566.9.8.1291","title":"Antidepressant therapy in post-stroke depression","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Sertraline; Post-stroke depression; Depression (economics); Nortriptyline; Stroke (engine); Citalopram; Antidepressant; Randomized controlled trial; Fluoxetine; Internal medicine; Psychiatry; Physical therapy; Activities of daily living; Anxiety; Amitriptyline","score_opus":0.06869704480743827,"score_gpt":0.4222142348065993,"score_spread":0.35351718999916104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977936853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000113212496,0.99914086,0.000025577134,0.00013475766,0.000062748986,0.000006862335,0.000006368109,0.0000020498883,0.00050741126],"genre_scores_gemma":[0.001057375,0.99839586,0.00008460387,0.00016606122,0.000071116665,0.000010019463,0.000011173266,3.861681e-7,0.0002033383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962676,0.00012100258,0.00007141706,0.00004005294,0.00012111965,0.000019671934],"domain_scores_gemma":[0.9996358,0.00020853516,0.00008606129,0.000007860681,0.000049363614,0.000012399783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007364801,0.00057746505,0.0017054934,0.0013121014,0.00016421865,0.00060890004,0.0006102898,0.0010092205,0.0031227667],"category_scores_gemma":[0.0010801655,0.00019306196,0.0005767365,0.0017249254,0.00023227918,0.00047441138,0.0002950882,0.00060713774,0.0009994659],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012211772,0.00006262214,0.0002826031,0.061345816,0.00029343006,0.00025609366,0.000073417345,0.00016273864,0.0006573521,0.0009837374,0.02000221,0.91575783],"study_design_scores_gemma":[0.00047380055,0.0006704274,0.009152101,0.10635997,0.0022064147,0.007942825,0.000331822,0.00037295834,0.000940534,0.0036257461,0.8678827,0.000040656127],"about_ca_topic_score_codex":0.0013026226,"about_ca_topic_score_gemma":0.0030854237,"teacher_disagreement_score":0.0031227667,"about_ca_system_score_codex":0.00044031694,"about_ca_system_score_gemma":0.0008696147,"threshold_uncertainty_score":0.010446727},"labels":[],"label_agreement":null},{"id":"W1982242297","doi":"10.1517/14656566.2011.600689","title":"Montelukast for the treatment of asthma in the adult population","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St Joseph's Health Care; McMaster University","funders":"","keywords":"Montelukast; Medicine; Asthma; Intensive care medicine; Population; Concomitant; Leukotriene; Bronchoconstriction; Clinical trial; Inhaler; Randomized controlled trial; Leukotriene receptor; Internal medicine","score_opus":0.11549415947633151,"score_gpt":0.4459149460032207,"score_spread":0.33042078652688917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982242297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005658481,0.98981255,0.00020127321,0.0050224313,0.00080557825,0.00002339541,0.00009654552,0.000012212501,0.0034601921],"genre_scores_gemma":[0.014875028,0.9744683,0.000766142,0.005373252,0.0021255708,0.000064066815,0.00018646364,0.000005765963,0.0021352845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939907,0.00022459876,0.000089046865,0.000083458,0.0001652968,0.00003865621],"domain_scores_gemma":[0.9992397,0.0003952223,0.00019245202,0.000011876423,0.00012608727,0.000034550812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092552556,0.0002691038,0.0006549379,0.0006207396,0.00013273692,0.00062437,0.00044720565,0.0012367212,0.008391175],"category_scores_gemma":[0.0022413107,0.00006807474,0.00061340525,0.00040946557,0.00027558082,0.0005774956,0.00033738432,0.0011264172,0.0017678947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004758308,0.000056592624,0.0005371765,0.037668124,0.00029371752,0.0004525981,0.00012101138,0.00020660348,0.0019572785,0.004076443,0.09066848,0.8634861],"study_design_scores_gemma":[0.00041636304,0.00034952714,0.0028667236,0.031774182,0.00052747736,0.0024539523,0.00012125709,0.00015531888,0.0006046676,0.0026714064,0.9580307,0.000028413308],"about_ca_topic_score_codex":0.00074204494,"about_ca_topic_score_gemma":0.001729887,"teacher_disagreement_score":0.008391175,"about_ca_system_score_codex":0.00039617732,"about_ca_system_score_gemma":0.0008932154,"threshold_uncertainty_score":0.028071284},"labels":[],"label_agreement":null},{"id":"W1986388359","doi":"10.1517/14656560802653206","title":"Economic evaluation of docetaxel for breast cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Docetaxel; Medicine; Taxane; Breast cancer; Oncology; Cancer; Internal medicine; Prostate cancer; Adjuvant; Chemotherapy; Intensive care medicine","score_opus":0.19665257186682186,"score_gpt":0.5538454632338995,"score_spread":0.35719289136707766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986388359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008945161,0.9935942,0.00041672718,0.0010720035,0.0001610199,0.000046653986,0.00006006508,0.0000034050447,0.0037513978],"genre_scores_gemma":[0.03006237,0.9670943,0.00078904605,0.0005606228,0.0003464377,0.00012494496,0.00010501983,0.0000044206854,0.0009128089],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9977028,0.001488262,0.00013905663,0.00006595499,0.00053668604,0.00006737756],"domain_scores_gemma":[0.9973525,0.0019099537,0.0004293928,0.000030984113,0.00021630962,0.000060837283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035703697,0.00076299155,0.0022433044,0.0015804832,0.00017713623,0.0012860456,0.000963978,0.0011140656,0.004557111],"category_scores_gemma":[0.009244252,0.00020925127,0.0017301027,0.0017117384,0.00033820182,0.00070276525,0.0003776723,0.0013264846,0.00043792409],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021844348,0.00020098666,0.00058702164,0.029324645,0.0019645265,0.00036095304,0.00003149581,0.0077631464,0.0004243104,0.01320363,0.022181733,0.9217731],"study_design_scores_gemma":[0.00444196,0.003983131,0.012772212,0.08364501,0.0075315065,0.005338593,0.00024321981,0.012943598,0.0026163063,0.045131065,0.8211846,0.00016888347],"about_ca_topic_score_codex":0.002874606,"about_ca_topic_score_gemma":0.0041068993,"teacher_disagreement_score":0.004557111,"about_ca_system_score_codex":0.0031690747,"about_ca_system_score_gemma":0.0026213587,"threshold_uncertainty_score":0.022993326},"labels":[],"label_agreement":null},{"id":"W1986471715","doi":"10.1517/14656566.9.15.2575","title":"Pharmacological treatment in moderate-to-severe Alzheimer's disease","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Donepezil; Memantine; Disease; Randomized controlled trial; Population; Clinical trial; Alzheimer's disease; Stage (stratigraphy); Caregiver burden; Intensive care medicine; Internal medicine; Pediatrics; Dementia","score_opus":0.1559657550852251,"score_gpt":0.4879294005533507,"score_spread":0.3319636454681256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986471715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015853958,0.9993782,0.000028955477,0.00008873762,0.00004862513,0.000010619342,0.000009011779,0.0000018432578,0.00027550716],"genre_scores_gemma":[0.0017815877,0.99775666,0.00013098822,0.00013919192,0.00005244641,0.00001653537,0.000013624681,4.7458713e-7,0.00010850932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993826,0.00022912356,0.00013690247,0.000060487182,0.0001632173,0.000027650824],"domain_scores_gemma":[0.99922085,0.0004936371,0.00018663965,0.0000112969765,0.00006877243,0.00001885486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011056272,0.0006662275,0.0027194526,0.0021261799,0.00018793804,0.0006887311,0.000852862,0.0011328841,0.0030543997],"category_scores_gemma":[0.0019418907,0.0002137263,0.0009926732,0.002119848,0.00029759223,0.0005370442,0.0002572359,0.00058547966,0.0006103927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030769705,0.000087631786,0.0002875031,0.2039747,0.00093788933,0.0002789898,0.00006453735,0.00020893617,0.00083318696,0.0006798783,0.011060732,0.7812784],"study_design_scores_gemma":[0.0013071464,0.0016482642,0.011572754,0.25394878,0.009571822,0.009071166,0.0004333056,0.0005776356,0.0022817873,0.0029416208,0.70656735,0.00007837225],"about_ca_topic_score_codex":0.0012174671,"about_ca_topic_score_gemma":0.0030278552,"teacher_disagreement_score":0.0030543997,"about_ca_system_score_codex":0.00058325403,"about_ca_system_score_gemma":0.0010588237,"threshold_uncertainty_score":0.010218024},"labels":[],"label_agreement":null},{"id":"W1986801377","doi":"10.1517/14656566.7.4.489","title":"Multidisciplinary Symposium on Head and Neck Cancer","year":2006,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Head and neck cancer; Head and neck squamous-cell carcinoma; Head and neck; Oncology; Chemoradiotherapy; Cancer; Disease; Chemotherapy; Multidisciplinary approach; Carcinogenesis; Internal medicine; Surgery","score_opus":0.03996260949890074,"score_gpt":0.4031644089716113,"score_spread":0.3632017994727106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986801377","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013884059,0.25350112,0.0018564203,0.17399539,0.46918806,0.00027761867,0.00045892785,0.00012615438,0.09920792],"genre_scores_gemma":[0.012818696,0.18114628,0.0024601698,0.07824629,0.27507693,0.0003968472,0.0007492647,0.00009853714,0.44900703],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900025,0.00021758533,0.00007365216,0.00019973113,0.00038298874,0.00012587087],"domain_scores_gemma":[0.9985177,0.00018549775,0.000077180055,0.000046430727,0.0005703297,0.0006029229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019255549,0.001240497,0.00082722306,0.0012176457,0.00083547155,0.0019239335,0.0009754309,0.004089685,0.059003633],"category_scores_gemma":[0.0019548296,0.00024897722,0.0007646126,0.000587825,0.00052963395,0.0012512602,0.0016492263,0.0036139952,0.022000205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082306506,0.00004431845,0.00015679772,0.0004452111,0.000014892265,0.00017697448,0.000055610697,0.000057783414,0.0009653444,0.0022826495,0.89097327,0.10474481],"study_design_scores_gemma":[0.0000087484905,0.000035871923,0.00034942623,0.00015933963,0.000005843428,0.0002592447,0.000024478628,0.000017796881,0.00008760919,0.00043854836,0.99860865,0.0000044317735],"about_ca_topic_score_codex":0.0010948527,"about_ca_topic_score_gemma":0.0037728962,"teacher_disagreement_score":0.059003633,"about_ca_system_score_codex":0.0017368518,"about_ca_system_score_gemma":0.0030095878,"threshold_uncertainty_score":0.1973868},"labels":[],"label_agreement":null},{"id":"W1987019231","doi":"10.1517/14656566.2014.972936","title":"Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; TRIUMF","funders":"National Institute of Mental Health; Foundation for the National Institutes of Health","keywords":"Pharmacotherapy; Olanzapine; Medicine; Psychiatry; Sertraline; Body dysmorphic disorder; Psychotherapist; Schizophrenia (object-oriented programming); Psychology; Anxiety; Antidepressant","score_opus":0.04438572038806491,"score_gpt":0.44008674423094163,"score_spread":0.3957010238428767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987019231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017373454,0.99926585,0.000024680872,0.00016178357,0.000060314513,0.0000286408,0.00012720563,0.000002817772,0.00015504066],"genre_scores_gemma":[0.0017018408,0.9976901,0.00009773725,0.0002709559,0.000043697633,0.000044877892,0.00008413329,9.4129433e-7,0.000065797285],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987562,0.00034292086,0.0003999156,0.0001370069,0.00029752383,0.0000664592],"domain_scores_gemma":[0.9963414,0.0022503606,0.0008167298,0.000040983065,0.00048133367,0.00006914603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017735283,0.0011172519,0.004382445,0.004363552,0.00033632058,0.0012665277,0.0012053513,0.0013352756,0.006498926],"category_scores_gemma":[0.007536412,0.00048508114,0.003458861,0.005891189,0.0003823597,0.0013329992,0.00076137733,0.0008888155,0.0004144194],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016230198,0.000019689633,0.00040717583,0.84795314,0.0036143789,0.00009132238,0.000090317684,0.000095786025,0.00015030475,0.0002298105,0.009870096,0.1373156],"study_design_scores_gemma":[0.00036156722,0.00021645066,0.0069984337,0.86199033,0.044594735,0.0008863879,0.00022338757,0.00011874892,0.00019050947,0.0004352081,0.08393935,0.00004483912],"about_ca_topic_score_codex":0.008831705,"about_ca_topic_score_gemma":0.023834899,"teacher_disagreement_score":0.008831705,"about_ca_system_score_codex":0.0016941613,"about_ca_system_score_gemma":0.0051807035,"threshold_uncertainty_score":0.021741092},"labels":[],"label_agreement":null},{"id":"W1987774319","doi":"10.1517/14656560903004184","title":"Pharmacotherapy for women's sexual dysfunction","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Sexual dysfunction; Pharmacology; Internal medicine","score_opus":0.15962365311473006,"score_gpt":0.47600544174443155,"score_spread":0.31638178862970145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987774319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010761939,0.9991304,0.00002194777,0.0001358668,0.000060466897,0.000007924553,0.000011804215,0.0000024681046,0.00052151777],"genre_scores_gemma":[0.000983048,0.9984047,0.000092942675,0.00017990707,0.00006556588,0.000013257088,0.000017010656,6.203238e-7,0.0002430121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961215,0.00012717606,0.000074043455,0.000042439246,0.00011788511,0.000026431213],"domain_scores_gemma":[0.999408,0.00036581792,0.00013087275,0.000011726049,0.00006388308,0.000019788095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073077733,0.0007392703,0.0022856123,0.0026276107,0.0002494762,0.00067501987,0.0008261392,0.0011355473,0.00933485],"category_scores_gemma":[0.0014138934,0.00019805913,0.0008398904,0.0029608137,0.00032402104,0.0006127917,0.00038482583,0.00073819887,0.0013106881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001628251,0.00009174386,0.00022655753,0.108180106,0.00051030266,0.00032455917,0.00006365344,0.0001235552,0.0005673757,0.00068372645,0.019729424,0.86933625],"study_design_scores_gemma":[0.0005976571,0.0006418232,0.008199147,0.14736387,0.0036313902,0.00623468,0.0003317451,0.0002483075,0.0011605835,0.0019925402,0.82954925,0.000048923186],"about_ca_topic_score_codex":0.0018297561,"about_ca_topic_score_gemma":0.0041665863,"teacher_disagreement_score":0.00933485,"about_ca_system_score_codex":0.00067405275,"about_ca_system_score_gemma":0.0012253958,"threshold_uncertainty_score":0.031228244},"labels":[],"label_agreement":null},{"id":"W1988876914","doi":"10.1517/14656566.6.5.707","title":"Duloxetine: pharmacoeconomic implications of an antidepressant that alleviates painful physical symptoms","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Duloxetine; Medicine; Antidepressant; Major depressive disorder; Venlafaxine; Reuptake inhibitor; Vortioxetine; Psychiatry; Fluoxetine; Agomelatine; Duloxetine Hydrochloride; Internal medicine; Serotonin; Mood; Alternative medicine; Anxiety","score_opus":0.09491935300903415,"score_gpt":0.46409916664202505,"score_spread":0.3691798136329909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988876914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059946254,0.99422175,0.0003092568,0.0021345904,0.00017227302,0.000020768271,0.00008516973,0.000008747034,0.0024480575],"genre_scores_gemma":[0.0072673075,0.98951346,0.0007271748,0.0011972745,0.00020970902,0.000026890282,0.000086824664,0.0000024408564,0.0009689443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995796,0.00015422123,0.000047987334,0.000040668416,0.00015494728,0.0000225302],"domain_scores_gemma":[0.99961275,0.00020927886,0.000100242105,0.000008013256,0.000057387264,0.000012292988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077949715,0.0007704198,0.002278373,0.0008830004,0.0001968846,0.0011370963,0.0009547071,0.0017763595,0.005976556],"category_scores_gemma":[0.0011777787,0.00022361989,0.0010527907,0.0017469532,0.00020914176,0.0006579066,0.00027081746,0.000867766,0.00097409805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027567887,0.00006860364,0.00033176783,0.04624809,0.00090460526,0.0006898765,0.000039083658,0.0020149776,0.0015985005,0.0050946274,0.027710278,0.9150238],"study_design_scores_gemma":[0.0008975243,0.00087054865,0.0072711124,0.060160656,0.0045846156,0.005665608,0.00022129605,0.0037072734,0.001821873,0.014399337,0.9003102,0.00008992675],"about_ca_topic_score_codex":0.003195296,"about_ca_topic_score_gemma":0.009745363,"teacher_disagreement_score":0.005976556,"about_ca_system_score_codex":0.001091097,"about_ca_system_score_gemma":0.001595581,"threshold_uncertainty_score":0.019993603},"labels":[],"label_agreement":null},{"id":"W1989418652","doi":"10.1517/14656566.8.7.1001","title":"Aripiprazole: pharmacology and evidence in bipolar disorder","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Aripiprazole; Bipolar disorder; Medicine; Mania; Tardive dyskinesia; Psychiatry; Tolerability; Bipolar I disorder; Akathisia; Treatment of bipolar disorder; Mood; Antipsychotic; Adverse effect; Pharmacology; Schizophrenia (object-oriented programming)","score_opus":0.13076910169560088,"score_gpt":0.4762390120830116,"score_spread":0.3454699103874107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989418652","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041493044,0.9996284,0.000014203646,0.000076732285,0.000029174438,0.0000030108013,0.000007673641,0.0000014382131,0.00019789657],"genre_scores_gemma":[0.00049457734,0.99917066,0.00008943029,0.000100887766,0.000041105402,0.0000062081067,0.000011310662,5.155196e-7,0.00008535663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995511,0.00009988267,0.00013171467,0.000063689964,0.00013307818,0.000020580212],"domain_scores_gemma":[0.99908745,0.00050108094,0.00021713645,0.000013355202,0.00015017657,0.00003076371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001042166,0.0008379866,0.0024251358,0.0038902464,0.0002660679,0.0012001742,0.0009034726,0.0011735024,0.005332481],"category_scores_gemma":[0.0018707179,0.00036393234,0.0008654922,0.005668897,0.00039045326,0.0011138391,0.00053308735,0.0008737256,0.0015055478],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017684716,0.00004594358,0.0002735422,0.17317861,0.00037480445,0.0003241566,0.00008583358,0.00012709454,0.0009591504,0.0008030539,0.01260667,0.81104416],"study_design_scores_gemma":[0.00024666858,0.0004688636,0.007451908,0.15648703,0.0040783253,0.0045672096,0.0002816004,0.00018244419,0.0008944938,0.0025369648,0.82273823,0.000066255474],"about_ca_topic_score_codex":0.0022256265,"about_ca_topic_score_gemma":0.004689973,"teacher_disagreement_score":0.005332481,"about_ca_system_score_codex":0.00077738595,"about_ca_system_score_gemma":0.0014836842,"threshold_uncertainty_score":0.017838895},"labels":[],"label_agreement":null},{"id":"W1997303941","doi":"10.1517/14656566.6.2.165","title":"Pityriasis versicolor: a review of pharmacological treatment options","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mediprobe Research (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Pityriasis; Medicine; Dermatology; Malassezia; Tinea versicolor; Etiology; Topical agents; Pathology","score_opus":0.18231492790249207,"score_gpt":0.5175295203484694,"score_spread":0.3352145924459774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997303941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001331279,0.99837434,0.00009416023,0.00023458336,0.0001528835,0.00000736269,0.00002101163,0.000007512124,0.0009750162],"genre_scores_gemma":[0.0005222838,0.99855274,0.00021566781,0.00015725296,0.0001488286,0.000007925109,0.000031364474,0.0000010304601,0.0003628613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979824,0.00003643364,0.000035837533,0.000031115116,0.00008386288,0.0000144734195],"domain_scores_gemma":[0.99971586,0.00013292163,0.000053227177,0.0000072627067,0.00006495776,0.00002572438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004193638,0.0009373905,0.0018726661,0.002838497,0.00029742092,0.00075351726,0.000985104,0.00088727847,0.0055829054],"category_scores_gemma":[0.0005757863,0.00027864557,0.0004985537,0.0026789873,0.00029308628,0.00095689174,0.00038010208,0.0011462201,0.0027203579],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008539903,0.0001170833,0.00013335687,0.019869423,0.00011981801,0.0005967121,0.00004627275,0.00029186768,0.0012356275,0.0009553458,0.04030063,0.93624854],"study_design_scores_gemma":[0.00007461468,0.00019553346,0.0016461447,0.012086709,0.0003244606,0.0063653896,0.0001252559,0.00017314666,0.00053247926,0.0012691218,0.9771739,0.000033293494],"about_ca_topic_score_codex":0.001271307,"about_ca_topic_score_gemma":0.0029598132,"teacher_disagreement_score":0.0055829054,"about_ca_system_score_codex":0.00050734705,"about_ca_system_score_gemma":0.00066709606,"threshold_uncertainty_score":0.018676639},"labels":[],"label_agreement":null},{"id":"W1999259854","doi":"10.1517/14656566.6.5.819","title":"An evaluation of paroxetine in generalised social anxiety disorder","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Paroxetine; Social anxiety; Anxiety; Psychiatry; Medicine; Pharmacotherapy; Anxiety disorder; Placebo; Clinical psychology; Psychology; Antidepressant; Alternative medicine","score_opus":0.22232938192537394,"score_gpt":0.5528664276615541,"score_spread":0.3305370457361802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999259854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018534089,0.9989473,0.00004371591,0.00009580924,0.00006192508,0.000008686177,0.000011332413,0.0000031423776,0.0006427799],"genre_scores_gemma":[0.0015434026,0.99726295,0.00020339621,0.00027487427,0.000083493054,0.000016800777,0.000031763368,0.0000014547164,0.0005819726],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99975365,0.00006101249,0.000043878055,0.000041129228,0.000086623746,0.00001365225],"domain_scores_gemma":[0.9997249,0.00014240426,0.000048971637,0.0000071809723,0.000059849513,0.000016721151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008060479,0.0006949738,0.0017046137,0.0016775867,0.00020207741,0.0006333306,0.0008559496,0.0010124587,0.0038370225],"category_scores_gemma":[0.0008432311,0.00021482568,0.000727954,0.0015902581,0.00019876669,0.00064401206,0.00038308065,0.0010509433,0.001416572],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021886142,0.00008026002,0.00009828835,0.02695184,0.00021845293,0.0002461683,0.000057936893,0.00010610672,0.0011242897,0.0007508295,0.011629015,0.95851785],"study_design_scores_gemma":[0.0005019656,0.0010513793,0.0047751646,0.018843,0.001188908,0.00508885,0.0001390895,0.00022134533,0.0016228724,0.0011317333,0.9653931,0.00004257253],"about_ca_topic_score_codex":0.0014009591,"about_ca_topic_score_gemma":0.0033826432,"teacher_disagreement_score":0.0038370225,"about_ca_system_score_codex":0.00053059956,"about_ca_system_score_gemma":0.00068871933,"threshold_uncertainty_score":0.012836099},"labels":[],"label_agreement":null},{"id":"W2000257366","doi":"10.1517/14656566.1.4.683","title":"Pharmacotherapy of hypercholesterolaemia: statins in clinical practice","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Gemfibrozil; Pharmacology; Statin; Cerivastatin; Lovastatin; Atorvastatin; Bezafibrate; Clinical trial; Internal medicine; Cholesterol; Pravastatin","score_opus":0.1386396925910737,"score_gpt":0.5305010941545557,"score_spread":0.39186140156348204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000257366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014416547,0.92628187,0.0010368561,0.06201675,0.0017463907,0.0000494015,0.000029260516,0.000049975344,0.0073478613],"genre_scores_gemma":[0.013444826,0.9474389,0.0047308933,0.025691304,0.0061498457,0.000095144445,0.000076499135,0.000021935939,0.0023506114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700147,0.0012871842,0.0005342776,0.00020317112,0.0008839494,0.000090025445],"domain_scores_gemma":[0.99701905,0.001067594,0.00078106404,0.00008365465,0.0006841538,0.00036452606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031335813,0.00056066667,0.0013277302,0.0019328514,0.00044916084,0.002106525,0.0006847431,0.0026762865,0.0036617003],"category_scores_gemma":[0.006661553,0.00024331473,0.00042470518,0.0019314776,0.0009508922,0.0025133467,0.001521686,0.0029751218,0.0019752805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021375982,0.00017215885,0.0017040225,0.010038984,0.000110342655,0.0005111061,0.00036362343,0.00023406079,0.0009339156,0.0050766845,0.058870442,0.9217709],"study_design_scores_gemma":[0.00034513438,0.00072703994,0.011827935,0.043245956,0.00023398772,0.0038356073,0.0009710798,0.00045356978,0.00038456285,0.015961546,0.9219332,0.000080343125],"about_ca_topic_score_codex":0.0009649456,"about_ca_topic_score_gemma":0.002037368,"teacher_disagreement_score":0.0036617003,"about_ca_system_score_codex":0.0015544572,"about_ca_system_score_gemma":0.002627652,"threshold_uncertainty_score":0.016572177},"labels":[],"label_agreement":null},{"id":"W2001996774","doi":"10.1517/14656566.2015.1022531","title":"Transdermal contraception methods: today’s patches and new options on the horizon","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Estrogen; Family planning; Intensive care medicine; Progestin; Popularity; Dosing; Transdermal; Gynecology; Population; Internal medicine; Pharmacology; Adverse effect; Environmental health","score_opus":0.26223119611235746,"score_gpt":0.5186390858378908,"score_spread":0.2564078897255333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001996774","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000097038435,0.9975472,0.00009727063,0.001147966,0.00026742654,0.0000033637525,0.000009858316,0.000004567998,0.000825339],"genre_scores_gemma":[0.00064247014,0.997399,0.0002001764,0.0006715901,0.0004317487,0.000004342277,0.000017032671,0.0000018522401,0.0006317349],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994777,0.00010732628,0.00006141457,0.00008054114,0.00023954049,0.00003365218],"domain_scores_gemma":[0.9992219,0.000448054,0.00010651145,0.000019734436,0.00016649527,0.000037221504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008919133,0.0005801973,0.0010004544,0.001643587,0.00021594139,0.000971971,0.00066014886,0.001589878,0.006466433],"category_scores_gemma":[0.0011981889,0.00024880446,0.000763762,0.0012398621,0.00062873727,0.0024067345,0.00047389566,0.002474294,0.0018993764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060930848,0.000039394126,0.00013548404,0.014611619,0.000063420084,0.00020669687,0.000080961036,0.00016649031,0.0011489058,0.004654081,0.032544278,0.94628775],"study_design_scores_gemma":[0.00001725885,0.00008779089,0.00062730105,0.0065264986,0.00006966363,0.0019284115,0.00009986556,0.00008339235,0.00025064428,0.0018520089,0.9884388,0.000018325509],"about_ca_topic_score_codex":0.0009983957,"about_ca_topic_score_gemma":0.0021156631,"teacher_disagreement_score":0.006466433,"about_ca_system_score_codex":0.0005481134,"about_ca_system_score_gemma":0.0006776685,"threshold_uncertainty_score":0.021632314},"labels":[],"label_agreement":null},{"id":"W2004568544","doi":"10.1517/14656566.2013.825606","title":"New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Osteoarthritis; Personalized medicine; Intensive care medicine; Psychological intervention; Disease; Alternative medicine; Bioinformatics; Internal medicine; Pathology; Psychiatry","score_opus":0.05105887081883347,"score_gpt":0.3860866797604262,"score_spread":0.33502780894159273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004568544","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005036232,0.996619,0.000118604505,0.0022289855,0.00035751832,0.0000057870975,0.000013246458,0.000005399212,0.00060105894],"genre_scores_gemma":[0.0004228901,0.9975684,0.0003223923,0.0010038947,0.00031770056,0.0000093201315,0.000013815412,0.0000014798786,0.0003401211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994375,0.00016608046,0.00008041587,0.000070449016,0.00019875483,0.00004680526],"domain_scores_gemma":[0.9990777,0.00045435745,0.00013698055,0.000024844825,0.00026020236,0.00004589543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013870583,0.0008551903,0.0021809672,0.0015569971,0.00036209112,0.0013666943,0.0009143662,0.002130429,0.0069937143],"category_scores_gemma":[0.0017755345,0.00024351849,0.0011657214,0.0023747152,0.0007932766,0.0028054696,0.0006128133,0.0030057116,0.0031555372],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112088055,0.000086063344,0.00013961921,0.048025124,0.00023919305,0.00020862547,0.00012729738,0.0002733841,0.0015688734,0.0076181437,0.06469207,0.87690955],"study_design_scores_gemma":[0.000067493245,0.00011958688,0.00084341574,0.031450164,0.0003157571,0.0010115956,0.00024421889,0.00014066718,0.00032362278,0.0065660267,0.95887923,0.00003825698],"about_ca_topic_score_codex":0.0015914259,"about_ca_topic_score_gemma":0.0032109926,"teacher_disagreement_score":0.0069937143,"about_ca_system_score_codex":0.0010302553,"about_ca_system_score_gemma":0.0026937337,"threshold_uncertainty_score":0.023396313},"labels":[],"label_agreement":null},{"id":"W2005776181","doi":"10.1517/14656566.7.5.607","title":"Sativex<sup>®</sup>: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neuropathic pain; Tolerability; Multiple sclerosis; Cannabidiol; Dosing; Spasticity; Placebo; Clinical trial; Chronic pain; Gabapentin; Anesthesia; Pharmacology; Physical therapy; Internal medicine; Cannabis; Adverse effect; Alternative medicine; Psychiatry","score_opus":0.14919064783503377,"score_gpt":0.4493601433132434,"score_spread":0.30016949547820965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005776181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082455395,0.99671006,0.00010539348,0.00027113286,0.00008610591,0.000015664986,0.000040165854,0.000015712803,0.0019311878],"genre_scores_gemma":[0.005336777,0.99105656,0.0003894883,0.00039275616,0.00015015711,0.000021664886,0.00008907611,0.000005346641,0.0025581724],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997745,0.000042318654,0.000030725267,0.000030008307,0.00010291503,0.0000194454],"domain_scores_gemma":[0.99978524,0.00007579707,0.000051541883,0.0000064037117,0.00005895543,0.000022136937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067809806,0.0007026289,0.001872093,0.0011318728,0.00019812355,0.0006981116,0.0007038024,0.0011557257,0.009632883],"category_scores_gemma":[0.0006069616,0.00020652583,0.0005515337,0.0015971465,0.000286148,0.00074376026,0.00032917183,0.00082945876,0.0036578474],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003697532,0.00008058722,0.000102506616,0.012475804,0.000102637205,0.00020115887,0.000038867776,0.00013989805,0.0040950207,0.0003716304,0.011578229,0.97044396],"study_design_scores_gemma":[0.00075008674,0.0019658515,0.009698715,0.0072989105,0.0009780504,0.0067147696,0.00022342119,0.0004196557,0.00633344,0.0012618381,0.96427256,0.00008272026],"about_ca_topic_score_codex":0.0016183178,"about_ca_topic_score_gemma":0.0042662486,"teacher_disagreement_score":0.009632883,"about_ca_system_score_codex":0.0005275609,"about_ca_system_score_gemma":0.00075147283,"threshold_uncertainty_score":0.03222519},"labels":[],"label_agreement":null},{"id":"W2006569343","doi":"10.1517/14656566.4.12.2355","title":"Tinzaparin in the treatment of venous thromboembolism","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Heparin; Warfarin; Deep vein; Venous thromboembolism; Low molecular weight heparin; Clinical trial; Thrombosis; Venous thrombosis; Anticoagulant; Internal medicine","score_opus":0.05540608515966367,"score_gpt":0.3817815458490013,"score_spread":0.32637546068933765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006569343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011677043,0.94689435,0.0019872375,0.0131875295,0.0025310677,0.000037512997,0.000054611704,0.000065320404,0.023565385],"genre_scores_gemma":[0.14029528,0.82273865,0.0053191623,0.0096988985,0.0060574575,0.00007479548,0.00018246428,0.000020199064,0.015613113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997718,0.00008195539,0.000021878739,0.000021549835,0.000086054286,0.000016699894],"domain_scores_gemma":[0.9998105,0.000069108435,0.000046683574,0.0000067116885,0.000032696516,0.000034272547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005083832,0.0003005685,0.0006897982,0.00047693352,0.00018435832,0.00040036542,0.0003796436,0.00095119205,0.002400455],"category_scores_gemma":[0.0008089484,0.000070547314,0.00017457214,0.0005391265,0.0002697691,0.00023388503,0.00017825431,0.0011324919,0.0011964297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010117324,0.0002470341,0.0020646106,0.0022624203,0.00012658947,0.0034604585,0.00010824074,0.00050315814,0.0073686964,0.005147875,0.04529575,0.93240345],"study_design_scores_gemma":[0.0011849897,0.0019636587,0.019236319,0.0014302868,0.00028127135,0.024067858,0.0001317204,0.0008631872,0.0043685124,0.0067632133,0.93967,0.00003895668],"about_ca_topic_score_codex":0.00068785704,"about_ca_topic_score_gemma":0.0015411782,"teacher_disagreement_score":0.002400455,"about_ca_system_score_codex":0.00035305822,"about_ca_system_score_gemma":0.00044478444,"threshold_uncertainty_score":0.008030355},"labels":[],"label_agreement":null},{"id":"W2008546357","doi":"10.1517/14656566.7.10.1305","title":"Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Mood disorders; Psychiatry; Disease; Neuroprotection; Anxiety; Psychological intervention; Mood; Bipolar disorder; Neuroscience; Bioinformatics; Psychology; Pharmacology; Internal medicine","score_opus":0.22770844625025552,"score_gpt":0.4688431981785058,"score_spread":0.24113475192825026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008546357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012912236,0.99828017,0.00009241936,0.00076024706,0.000110902176,0.00000775955,0.000005510931,0.0000032841058,0.0006106421],"genre_scores_gemma":[0.00083892175,0.99807405,0.00039349217,0.00032347342,0.00021488585,0.000013689772,0.000013444206,9.0151684e-7,0.00012717598],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991516,0.00034041275,0.00018125382,0.000068497015,0.00020082995,0.000057377256],"domain_scores_gemma":[0.99768853,0.0014526465,0.00034164358,0.000057864207,0.0003644085,0.00009481953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028629384,0.00096442905,0.0024001342,0.0029614542,0.00038944697,0.0019187398,0.0013309853,0.0022144176,0.0067792675],"category_scores_gemma":[0.002899403,0.0003066173,0.0007829444,0.0035485397,0.0007606851,0.0028295654,0.0007383145,0.0017562287,0.0017745374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013493684,0.00018017156,0.00028007894,0.03415085,0.00011523129,0.00052554737,0.00014757815,0.00022785355,0.0006547214,0.002273836,0.011089007,0.95022017],"study_design_scores_gemma":[0.0004719557,0.0010962676,0.0053427513,0.068788834,0.0009735548,0.0062875324,0.0013502543,0.00036388647,0.0008476799,0.00893518,0.90546566,0.000076567725],"about_ca_topic_score_codex":0.0014045321,"about_ca_topic_score_gemma":0.004558366,"teacher_disagreement_score":0.0067792675,"about_ca_system_score_codex":0.0012385495,"about_ca_system_score_gemma":0.0027374667,"threshold_uncertainty_score":0.022678852},"labels":[],"label_agreement":null},{"id":"W2009031791","doi":"10.1517/14656566.2013.781154","title":"Pharmacotherapy of fever control among hospitalized adult patients","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Thermal Regulation in Medicine","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Inland Hospital; University of Calgary","funders":"","keywords":"Medicine; Antipyretic; Pharmacotherapy; Intensive care medicine; Clinical trial; Hyperthermia; Internal medicine; Pharmacology; Analgesic","score_opus":0.038530625930422564,"score_gpt":0.4100111238548252,"score_spread":0.37148049792440263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009031791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019243825,0.99880433,0.00006244756,0.00030221508,0.000119860495,0.000007748726,0.000018850886,0.0000044367775,0.0004876983],"genre_scores_gemma":[0.0022480467,0.99688244,0.0001503953,0.00033091495,0.00016191755,0.000013522945,0.0000310474,0.0000010062139,0.00018066309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996486,0.00011341715,0.000054546792,0.000050115323,0.000107349246,0.000025989744],"domain_scores_gemma":[0.9995472,0.00022072175,0.00013721756,0.0000073416277,0.000070118636,0.000017407863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049497065,0.0005373258,0.001349068,0.00089031324,0.00015395723,0.0005020538,0.00057016406,0.00082677347,0.0030576496],"category_scores_gemma":[0.0013688443,0.00013241355,0.0007588088,0.00094413414,0.00021939623,0.00041196708,0.00032358113,0.00092892814,0.0006628828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001595587,0.00005903199,0.00027562567,0.053965364,0.00039235922,0.00014497591,0.000039388415,0.00023808116,0.0007771669,0.0010853442,0.022074407,0.9207887],"study_design_scores_gemma":[0.00039997094,0.000636946,0.010386887,0.09003236,0.0018997297,0.005469568,0.0001731355,0.0006011572,0.00193219,0.0027609752,0.8856418,0.00006525344],"about_ca_topic_score_codex":0.0010283388,"about_ca_topic_score_gemma":0.0019088365,"teacher_disagreement_score":0.0030576496,"about_ca_system_score_codex":0.0004535632,"about_ca_system_score_gemma":0.00079093064,"threshold_uncertainty_score":0.010228872},"labels":[],"label_agreement":null},{"id":"W2009126972","doi":"10.1517/14656566.2011.633511","title":"Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Pneumonia; Intensive care medicine; Hospital-acquired pneumonia; Antibiotics; Staphylococcus aureus; Dosing; Methicillin-resistant Staphylococcus aureus; Internal medicine; Microbiology","score_opus":0.11693127733150879,"score_gpt":0.4578364837173711,"score_spread":0.3409052063858623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009126972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009971361,0.99915814,0.0000499331,0.0001236125,0.00007831031,0.0000068667678,0.0000098930595,0.000003597488,0.00046994342],"genre_scores_gemma":[0.0009902,0.99827003,0.00013391236,0.00014178902,0.000097853685,0.000007869347,0.000022996428,8.2363897e-7,0.0003345286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997702,0.00005257115,0.000038552877,0.000035543817,0.000084134896,0.000018995737],"domain_scores_gemma":[0.999728,0.00012676477,0.00007209131,0.0000054277048,0.000050347866,0.000017410646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041185552,0.0007115656,0.0013235909,0.0018867025,0.00018061965,0.0005556335,0.00063604634,0.00085194013,0.005425039],"category_scores_gemma":[0.0007021807,0.00014603,0.0006202056,0.0017508735,0.00023597982,0.00065185595,0.0003502534,0.0009373816,0.0017841009],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012412827,0.00006947093,0.00013465378,0.050805245,0.0002366583,0.00037333748,0.000049775314,0.00015721947,0.001982354,0.000654481,0.019783814,0.9256289],"study_design_scores_gemma":[0.00022529243,0.00048122508,0.0027377927,0.029856509,0.0011556685,0.007438502,0.0001383298,0.00017517235,0.0016801332,0.0013646263,0.95470923,0.000037633054],"about_ca_topic_score_codex":0.0008301949,"about_ca_topic_score_gemma":0.0016591263,"teacher_disagreement_score":0.005425039,"about_ca_system_score_codex":0.0003488739,"about_ca_system_score_gemma":0.0007409677,"threshold_uncertainty_score":0.018148541},"labels":[],"label_agreement":null},{"id":"W2012833937","doi":"10.1517/14656566.5.6.1373","title":"Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Hamilton Health Sciences","funders":"","keywords":"Fondaparinux; Medicine; Antithrombotic; Dosing; Venous thrombosis; Heparin; Anesthesia; Thrombosis; Surgery; Internal medicine; Venous thromboembolism","score_opus":0.16283385619060706,"score_gpt":0.46512690406083856,"score_spread":0.3022930478702315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012833937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14489561,0.76667804,0.036183596,0.0078911055,0.0039428705,0.000731887,0.0010848251,0.0023668415,0.036225293],"genre_scores_gemma":[0.703825,0.20512092,0.044354673,0.0049452353,0.0038062113,0.0007150708,0.0026332818,0.00024481578,0.03435469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951184,0.00011281515,0.000043003634,0.000055404274,0.0002234294,0.000053481435],"domain_scores_gemma":[0.99980885,0.000040171253,0.000039575625,0.000013270834,0.00003909419,0.000059086564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005858791,0.0004700598,0.0006967557,0.00074295205,0.00028332826,0.0007843232,0.0003178798,0.0006584018,0.0034503741],"category_scores_gemma":[0.0005885541,0.00010820092,0.00037451938,0.00045549776,0.00022873949,0.00028988268,0.00034025364,0.001025866,0.0016111487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022691656,0.00061486714,0.002781594,0.001609787,0.00017197937,0.0010003787,0.00007310628,0.00029754319,0.09249995,0.0020206778,0.02557961,0.8710814],"study_design_scores_gemma":[0.0023401424,0.004662916,0.020802902,0.0005318274,0.0004908862,0.032531735,0.000042125554,0.0017041117,0.089995444,0.001486527,0.8453422,0.000069181595],"about_ca_topic_score_codex":0.00028049483,"about_ca_topic_score_gemma":0.00024471973,"teacher_disagreement_score":0.0034503741,"about_ca_system_score_codex":0.00038426256,"about_ca_system_score_gemma":0.0005502184,"threshold_uncertainty_score":0.011542618},"labels":[],"label_agreement":null},{"id":"W2015895269","doi":"10.1517/14656566.2011.555398","title":"Lipid modification in the elderly using the combination of a statin and a cholesterol absorption inhibitor","year":2011,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Ezetimibe; Medicine; Atorvastatin; Simvastatin; Tolerability; Statin; Combination therapy; Internal medicine; Pharmacology; Randomized controlled trial; Adverse effect","score_opus":0.07858964624462204,"score_gpt":0.3646761405947508,"score_spread":0.28608649435012873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015895269","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92288417,0.072000824,0.00081335986,0.0009793511,0.0003164333,0.00010585418,0.00017317447,0.00004863739,0.002678273],"genre_scores_gemma":[0.97957706,0.016976897,0.0011719438,0.0007820828,0.0003842363,0.00005186225,0.00015557748,0.0000032841,0.000897182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984753,0.00006269105,0.000025011324,0.000018954588,0.000028016137,0.000017752202],"domain_scores_gemma":[0.99988425,0.000023332592,0.000034940225,0.000010496472,0.000014179262,0.000032781074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004482968,0.00029519456,0.0008014655,0.00031710765,0.00013785547,0.00021452825,0.00013025533,0.0002995298,0.0007397502],"category_scores_gemma":[0.00047751077,0.00010446744,0.00089294143,0.00030888885,0.000107715015,0.00012346637,0.00015373132,0.00036775536,0.00019355521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19538157,0.005420819,0.0987728,0.0030578491,0.00791042,0.0018953448,0.00015525892,0.0010387044,0.05920621,0.00044873805,0.0048635816,0.62184864],"study_design_scores_gemma":[0.07119168,0.23471406,0.6203167,0.0008234016,0.015302124,0.0064129797,0.00028702684,0.00412176,0.014746202,0.00093679695,0.031059643,0.00008765068],"about_ca_topic_score_codex":0.00053457974,"about_ca_topic_score_gemma":0.0014569465,"teacher_disagreement_score":0.0008014655,"about_ca_system_score_codex":0.00015687612,"about_ca_system_score_gemma":0.00019366782,"threshold_uncertainty_score":0.0024747252},"labels":[],"label_agreement":null},{"id":"W2015914873","doi":"10.1517/14656566.8.2.203","title":"Memantine in the treatment of mild-to-moderate Alzheimer’s disease","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Memantine; Medicine; Donepezil; Disease; Rivastigmine; Alzheimer's disease; Dementia; Internal medicine; Pharmacology; Intensive care medicine; Psychiatry","score_opus":0.24913044926921502,"score_gpt":0.5180378012549213,"score_spread":0.26890735198570626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015914873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001722626,0.9971433,0.00012598989,0.00032489176,0.00027061356,0.000012559011,0.000020903966,0.000012843334,0.0019165397],"genre_scores_gemma":[0.00079240714,0.9972535,0.00023494632,0.000366311,0.00020702407,0.000011202346,0.000036892143,0.0000018151244,0.0010959408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997842,0.000043519576,0.00002616116,0.00003464637,0.000093786475,0.000017613911],"domain_scores_gemma":[0.9998559,0.000049323513,0.000029608915,0.000005197203,0.000040803443,0.000019239582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054259,0.0009625977,0.0017371104,0.0019008478,0.00023765773,0.0006491739,0.0009848145,0.0010675291,0.005540645],"category_scores_gemma":[0.00044929938,0.0001948512,0.00048506173,0.0019326231,0.00038549557,0.00090835424,0.0004107475,0.0013880163,0.004368583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012150007,0.0001003792,0.00010171723,0.013783436,0.000089610585,0.0003063269,0.000041835334,0.00024883045,0.0022307923,0.0014506404,0.045150507,0.9363745],"study_design_scores_gemma":[0.00010674013,0.00019065596,0.0010573901,0.0037627625,0.00013497929,0.0023814572,0.000047679176,0.000090324684,0.0005898245,0.0017226714,0.9898964,0.000019056552],"about_ca_topic_score_codex":0.0010484193,"about_ca_topic_score_gemma":0.0029425651,"teacher_disagreement_score":0.005540645,"about_ca_system_score_codex":0.0004951615,"about_ca_system_score_gemma":0.0006723817,"threshold_uncertainty_score":0.018535256},"labels":[],"label_agreement":null},{"id":"W2019255097","doi":"10.1517/14656561003601994","title":"Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Travoprost; Dosing; Glaucoma; Intraocular pressure; Timolol; Latanoprost; Internal medicine; Combination therapy; Ophthalmology; Cohort; Medical record","score_opus":0.0339769156539539,"score_gpt":0.356040220446425,"score_spread":0.32206330479247114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019255097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996729,0.000094345385,0.000026943184,0.0000085472175,0.000002927458,0.000014470101,0.000079037345,0.0000014130189,0.00009941423],"genre_scores_gemma":[0.9994912,0.000051339888,0.00009989879,0.00001655183,0.000008695723,0.00001636065,0.00018440309,9.726343e-7,0.0001306128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925286,0.000222282,0.00009776403,0.0001235852,0.00020707188,0.00009641268],"domain_scores_gemma":[0.99771345,0.00032555967,0.0011116351,0.00014990653,0.0002294293,0.0004701208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012970861,0.00028255134,0.00053664454,0.0007058148,0.00044507883,0.00047836246,0.0002708745,0.0005943708,0.0010036305],"category_scores_gemma":[0.0026017716,0.00028528718,0.0005870132,0.00064116885,0.00017948913,0.00042895303,0.00031273148,0.00063190196,0.0002879666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016613989,0.00040896083,0.99356985,0.000020353185,0.00007383427,0.00006419949,0.00020186718,0.000029418527,0.00066957535,0.0000044481712,0.000045814148,0.0032502469],"study_design_scores_gemma":[0.00007959939,0.002807014,0.99634105,0.0000052758523,0.000036950532,0.00019126853,0.0001181265,0.00018065574,0.00013237252,0.0000043675245,0.00009725063,0.000005925717],"about_ca_topic_score_codex":0.0020047752,"about_ca_topic_score_gemma":0.0018870448,"teacher_disagreement_score":0.0020047752,"about_ca_system_score_codex":0.00026907967,"about_ca_system_score_gemma":0.00019273533,"threshold_uncertainty_score":0.0068597198},"labels":[],"label_agreement":null},{"id":"W2021118758","doi":"10.1517/14656566.4.3.385","title":"Pharmacological management of Cronkhite–Canada syndrome","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Antibiotics; Intensive care medicine; Disease; Prednisone; Regimen; Internal medicine","score_opus":0.09786737015325622,"score_gpt":0.43601168627034376,"score_spread":0.3381443161170875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021118758","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028490422,0.9905093,0.00049114274,0.00086482975,0.00028639828,0.000019334197,0.000027088025,0.00002138501,0.004931544],"genre_scores_gemma":[0.016899565,0.97879183,0.0009121945,0.0010113533,0.00051201106,0.000029773868,0.00007791754,0.0000037549805,0.0017616149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998845,0.000027440365,0.000013015647,0.000012201954,0.00005193618,0.000010941974],"domain_scores_gemma":[0.99992573,0.000024998757,0.00002068144,0.0000022221009,0.00001561483,0.000010702134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014277683,0.00044479678,0.00090207526,0.0008575766,0.0002036587,0.00029330683,0.00058770145,0.00074080453,0.0018845326],"category_scores_gemma":[0.00029445504,0.0000662338,0.00023594114,0.0005716297,0.00015154772,0.00023966584,0.00019087705,0.0006041578,0.001029038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012769488,0.00015967357,0.0007350194,0.009924432,0.0001575144,0.00608082,0.00005127182,0.00026669007,0.005552182,0.0008131137,0.024205174,0.9519264],"study_design_scores_gemma":[0.00034907422,0.0006834994,0.015663568,0.005986799,0.00042304985,0.08422923,0.00021080808,0.000499405,0.0045575667,0.002031751,0.8853184,0.00004690433],"about_ca_topic_score_codex":0.00072139606,"about_ca_topic_score_gemma":0.0020146086,"teacher_disagreement_score":0.0018845326,"about_ca_system_score_codex":0.00028286534,"about_ca_system_score_gemma":0.00033812397,"threshold_uncertainty_score":0.0063043237},"labels":[],"label_agreement":null},{"id":"W2023312941","doi":"10.1517/14656566.1.5.1021","title":"Current treatment of asthma - focus on leukotrienes","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Asthma; Bronchoconstriction; Leukotriene; Immunology; Leukotriene C4; Zileuton; Pathogenesis; Arachidonate 5-lipoxygenase; Arachidonic acid","score_opus":0.09749648728149901,"score_gpt":0.4545223206043935,"score_spread":0.3570258333228945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023312941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012128728,0.9828896,0.0012058651,0.0065268697,0.0014613764,0.00004362822,0.00009941207,0.00008565951,0.0064747096],"genre_scores_gemma":[0.012704583,0.95848215,0.0028345105,0.009028043,0.004381129,0.000091286885,0.00039946198,0.000035871166,0.012042994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996031,0.00007712879,0.00004324817,0.00008580573,0.0001474155,0.000043362772],"domain_scores_gemma":[0.99952793,0.00012680085,0.00007524137,0.000031346848,0.00016714117,0.00007155105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071593927,0.0006385977,0.00114503,0.0006932284,0.0003242698,0.0010132157,0.0009890622,0.001413336,0.011859059],"category_scores_gemma":[0.00048361713,0.00014296279,0.0007975032,0.0006809855,0.00040326486,0.0010636932,0.0006791749,0.003417393,0.0056735976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047313262,0.00056678586,0.0005900096,0.006612809,0.00015605218,0.00023333807,0.00004967481,0.00018507245,0.0061094537,0.004392703,0.04845679,0.93217427],"study_design_scores_gemma":[0.0002517776,0.0010099154,0.0035445704,0.00379163,0.0002250871,0.0013099031,0.00007788786,0.00021000644,0.0015852337,0.004111754,0.9838554,0.000026772677],"about_ca_topic_score_codex":0.00051706244,"about_ca_topic_score_gemma":0.001382985,"teacher_disagreement_score":0.011859059,"about_ca_system_score_codex":0.0004497973,"about_ca_system_score_gemma":0.00048634788,"threshold_uncertainty_score":0.039672494},"labels":[],"label_agreement":null},{"id":"W2024553259","doi":"10.1517/14656566.3.5.575","title":"Review of enoxaparin and its clinical applications in venous and arterial thromboembolism","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Heparin; Thrombosis; Deep vein; Low molecular weight heparin; Dosing; Venous thrombosis; Enoxaparin sodium; Anticoagulant; Venous thromboembolism; Unstable angina; Anesthesia; Intensive care medicine; Surgery; Internal medicine; Myocardial infarction","score_opus":0.1385871125054735,"score_gpt":0.4784858908469179,"score_spread":0.3398987783414444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024553259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011983073,0.9969111,0.000117740485,0.00045870605,0.0008020529,0.000010279634,0.000044708897,0.000009674936,0.001526052],"genre_scores_gemma":[0.0005370014,0.9970325,0.0002126641,0.00041808453,0.00095235667,0.000012877939,0.00008423378,0.0000030132385,0.00074723177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995529,0.00008435367,0.00013117664,0.00005832575,0.00014697995,0.000026192201],"domain_scores_gemma":[0.99899,0.00045862704,0.00016434454,0.000025033165,0.0002726354,0.000089343026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006939162,0.00072775077,0.0014850243,0.004425434,0.000336926,0.0012821247,0.00097308884,0.0010299687,0.009426868],"category_scores_gemma":[0.0017574915,0.00027650906,0.0008213843,0.004915133,0.0003675897,0.0016626646,0.0006561755,0.0012681336,0.0031763932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012338375,0.00008395781,0.0002804231,0.046463393,0.00014515867,0.0003521724,0.0001263496,0.00026607665,0.001245071,0.0020799874,0.099940464,0.8488935],"study_design_scores_gemma":[0.000014552985,0.00008164664,0.00088952977,0.008016614,0.00015808683,0.0015067519,0.000050838036,0.00005248699,0.00014990201,0.00071030034,0.98835343,0.000015898951],"about_ca_topic_score_codex":0.0011890426,"about_ca_topic_score_gemma":0.0017035349,"teacher_disagreement_score":0.009426868,"about_ca_system_score_codex":0.00056268094,"about_ca_system_score_gemma":0.0018273985,"threshold_uncertainty_score":0.031535983},"labels":[],"label_agreement":null},{"id":"W2025227391","doi":"10.1517/14656566.3.3.237","title":"Pharmacoeconomic evidence and considerations for triptan treatment of migraine","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GLS Industries (Canada)","funders":"","keywords":"Triptans; Sumatriptan; Medicine; Migraine; Intensive care medicine; Acute migraine; Pharmacoeconomics; Quality of life (healthcare); Perspective (graphical); Health care; Psychiatry; Alternative medicine; Internal medicine; Nursing","score_opus":0.41565463300259353,"score_gpt":0.516647603710804,"score_spread":0.10099297070821045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025227391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016207118,0.9972709,0.000058511454,0.0015003873,0.00012619265,0.000021095304,0.000049676593,0.0000024949568,0.00080868765],"genre_scores_gemma":[0.003802946,0.99366283,0.00034812663,0.0016901151,0.0002075255,0.00005362003,0.000058433525,0.0000018112542,0.00017454996],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99340796,0.0029353513,0.0015678306,0.00027629393,0.0017000667,0.000112528774],"domain_scores_gemma":[0.980601,0.01492713,0.0025657294,0.00023676456,0.0015393238,0.00013001659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007554116,0.0009902663,0.005761981,0.0055060773,0.00036811523,0.002284636,0.0019985114,0.00325102,0.010289345],"category_scores_gemma":[0.022134509,0.00051987416,0.0035260448,0.006825303,0.00086532155,0.0018332998,0.0007380044,0.0015741595,0.0013146776],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009192756,0.00008854433,0.00053353666,0.30489793,0.0037879248,0.00057948363,0.00008030164,0.0005477676,0.00057810254,0.0038753443,0.0154047515,0.6687071],"study_design_scores_gemma":[0.0015505436,0.0011383718,0.008692211,0.43993735,0.026522817,0.003173692,0.00047479832,0.0005062123,0.0010831561,0.01312437,0.50370747,0.000089039844],"about_ca_topic_score_codex":0.0033619408,"about_ca_topic_score_gemma":0.0098585095,"teacher_disagreement_score":0.010289345,"about_ca_system_score_codex":0.0024298192,"about_ca_system_score_gemma":0.0043067,"threshold_uncertainty_score":0.03995043},"labels":[],"label_agreement":null},{"id":"W2026243499","doi":"10.1517/14656566.2013.823158","title":"Tolterodine for the treatment of urge urinary incontinence","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital; University of Toronto","funders":"","keywords":"Tolterodine; Medicine; Overactive bladder; Tolerability; Urinary incontinence; Urology; Population; Intensive care medicine; Adverse effect; Internal medicine; Alternative medicine","score_opus":0.21334229011155487,"score_gpt":0.5056500709038634,"score_spread":0.2923077807923085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026243499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119795906,0.99830234,0.000049708913,0.000245186,0.0001677919,0.000008750012,0.000030583793,0.000005256728,0.001070569],"genre_scores_gemma":[0.0012265547,0.9974922,0.00011426992,0.00033285265,0.00019358992,0.000008140682,0.000053337903,0.0000013959485,0.00057774276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972564,0.00005380846,0.000047704307,0.00004416684,0.000109386354,0.000019348614],"domain_scores_gemma":[0.99968207,0.00013689479,0.00009360437,0.000007214869,0.00006191144,0.0000183709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034846668,0.00050929096,0.0011076038,0.0022320386,0.00019926234,0.00059687014,0.0007088201,0.00082097313,0.008701837],"category_scores_gemma":[0.0008656028,0.00013869417,0.0007842331,0.0018969165,0.00025176487,0.0006010517,0.000376867,0.0009980472,0.0026339616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011321091,0.00005361866,0.00019178996,0.050668612,0.00022087945,0.00035947675,0.000054717297,0.00011867039,0.0012794725,0.0007891154,0.03751452,0.90863585],"study_design_scores_gemma":[0.000152716,0.0002193562,0.0028767402,0.042083792,0.00089553295,0.0061592357,0.00012200574,0.0001222241,0.000987086,0.0013635999,0.9449874,0.000030165722],"about_ca_topic_score_codex":0.0010618636,"about_ca_topic_score_gemma":0.0022262014,"teacher_disagreement_score":0.008701837,"about_ca_system_score_codex":0.0003949542,"about_ca_system_score_gemma":0.00078304997,"threshold_uncertainty_score":0.02911055},"labels":[],"label_agreement":null},{"id":"W2026296457","doi":"10.1517/14656566.2014.868884","title":"Raltegravir as antiretroviral therapy in HIV/AIDS","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Raltegravir; Medicine; Tolerability; Integrase inhibitor; Antiretroviral therapy; Dosing; Pharmacology; Drug; Drug resistance; Dolutegravir; Nucleoside Reverse Transcriptase Inhibitor; Lamivudine; Human immunodeficiency virus (HIV); Adverse effect; Intensive care medicine; Virology; Viral load; Virus; Chronic hepatitis","score_opus":0.08558497252242242,"score_gpt":0.42983217118888994,"score_spread":0.3442471986664675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026296457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043143846,0.9991061,0.000025865787,0.00015492484,0.00010075759,0.00000499092,0.000009609292,0.0000021781163,0.0005524458],"genre_scores_gemma":[0.00070274837,0.9984309,0.00011403415,0.00021989757,0.000119766555,0.0000076852275,0.000022049826,8.1088734e-7,0.00038212087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996433,0.00009834517,0.00006663143,0.00004647531,0.00012204171,0.000023217131],"domain_scores_gemma":[0.9996382,0.00017159402,0.00008715406,0.000007178419,0.000078366764,0.000017550577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066431944,0.0007482593,0.0014234397,0.0020853132,0.00020342639,0.00090587715,0.00075453543,0.0010892822,0.005530421],"category_scores_gemma":[0.00087786134,0.00020634376,0.00063989084,0.0028209772,0.0003281419,0.00082684326,0.00048681677,0.0011945376,0.0022650557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090254216,0.000038473554,0.00012715242,0.06884034,0.00018093387,0.00024252463,0.00006272067,0.00021792388,0.00094877917,0.0019413945,0.028818922,0.89849055],"study_design_scores_gemma":[0.00006257989,0.00011533049,0.0009987234,0.029526364,0.0005045227,0.0019892328,0.00007558784,0.000106955194,0.00043929732,0.0013692209,0.96479213,0.000020131734],"about_ca_topic_score_codex":0.0015040153,"about_ca_topic_score_gemma":0.002660237,"teacher_disagreement_score":0.005530421,"about_ca_system_score_codex":0.0006081524,"about_ca_system_score_gemma":0.001340674,"threshold_uncertainty_score":0.018501103},"labels":[],"label_agreement":null},{"id":"W2026753414","doi":"10.1517/14656566.2015.993380","title":"New pharmacotherapy for the treatment of onychomycosis: an update","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Antifungal; Intensive care medicine; Itraconazole; Dermatology; Terbinafine; Incidence (geometry); Gold standard (test); Antifungal drugs; Internal medicine","score_opus":0.12563433544611194,"score_gpt":0.5021458872599551,"score_spread":0.3765115518138432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026753414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010458346,0.99812526,0.000109956905,0.00040309058,0.00029828135,0.000007000456,0.000027387801,0.000007534268,0.00091693655],"genre_scores_gemma":[0.00040521423,0.9984883,0.00018096362,0.0002877743,0.00021384611,0.0000062663257,0.000038095244,0.0000014383754,0.00037804895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976724,0.000038781465,0.00004098769,0.000037337122,0.00009626667,0.000019362376],"domain_scores_gemma":[0.9995764,0.00018595633,0.00007005432,0.000009465652,0.00012802916,0.000030161465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004450536,0.00076847785,0.0011953412,0.0021965986,0.0002519613,0.0009328888,0.0007900319,0.0011885274,0.0069935555],"category_scores_gemma":[0.00075826456,0.00021682441,0.0006969559,0.0021422878,0.00034175493,0.0012025412,0.00056665204,0.0018841577,0.0025418256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051953717,0.00007530964,0.000116201736,0.02257428,0.00010216366,0.00021815083,0.00004220127,0.00018617553,0.00091436354,0.0012931144,0.038474802,0.93595135],"study_design_scores_gemma":[0.000029676561,0.00009985045,0.00078192324,0.008796109,0.00023983758,0.0021800308,0.00005517116,0.00011830628,0.0003189545,0.0009730797,0.98638713,0.000019859533],"about_ca_topic_score_codex":0.0011612175,"about_ca_topic_score_gemma":0.0025264733,"teacher_disagreement_score":0.0069935555,"about_ca_system_score_codex":0.0005214961,"about_ca_system_score_gemma":0.0009631577,"threshold_uncertainty_score":0.023395777},"labels":[],"label_agreement":null},{"id":"W2026785814","doi":"10.1517/14656566.2013.838218","title":"Therapy of <i>Clostridium difficile</i> infection: perspectives on a changing paradigm","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. John’s Health Sciences Centre","funders":"","keywords":"Fidaxomicin; Medicine; Tigecycline; Vancomycin; Clostridium difficile; Metronidazole; Rifaximin; Internal medicine; Intensive care medicine; Hypoalbuminemia; Concomitant; Antibiotics","score_opus":0.12227620196616962,"score_gpt":0.435092986422962,"score_spread":0.3128167844567924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026785814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004943931,0.8123168,0.0010897405,0.16979028,0.010760965,0.000018586992,0.00008607129,0.000046780708,0.005396336],"genre_scores_gemma":[0.0063625462,0.8827682,0.0018562239,0.084666446,0.021097323,0.000039980914,0.00014350127,0.000030336705,0.0030354806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985018,0.0006254016,0.00012873673,0.00016219681,0.00043669398,0.00014514595],"domain_scores_gemma":[0.9959,0.0016877041,0.00045683645,0.000078707286,0.0015002015,0.00037655435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002447338,0.0004986114,0.0013173511,0.0005142843,0.0003427199,0.002034819,0.0010689613,0.0034616746,0.0058649713],"category_scores_gemma":[0.004052001,0.00012638175,0.00091251027,0.0005137691,0.0013108454,0.002298664,0.0009207329,0.0060840473,0.0032587734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002354154,0.00008305753,0.00028712378,0.010272599,0.0001345665,0.0004739429,0.0001327215,0.00044650567,0.001094227,0.013012261,0.45674047,0.5170871],"study_design_scores_gemma":[0.00007378718,0.00018897463,0.0005595493,0.008765416,0.000088442845,0.00095473643,0.00019512456,0.00022541269,0.00016756856,0.008077324,0.9806748,0.00002896702],"about_ca_topic_score_codex":0.0016634475,"about_ca_topic_score_gemma":0.0033006573,"teacher_disagreement_score":0.0058649713,"about_ca_system_score_codex":0.00141002,"about_ca_system_score_gemma":0.0022750327,"threshold_uncertainty_score":0.0196203},"labels":[],"label_agreement":null},{"id":"W2027255665","doi":"10.1517/14656566.2012.687721","title":"Pharmacogenomics of third-generation aromatase inhibitors","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"King Saud University","keywords":"Aromatase; Pharmacogenomics; Letrozole; Exemestane; Medicine; Aromatase inhibitor; Anastrozole; Breast cancer; Adverse effect; Oncology; Internal medicine; Pharmacogenetics; Pharmacology; Bioinformatics; Cancer; Genotype; Biology; Genetics","score_opus":0.07384711940890466,"score_gpt":0.3928769917480633,"score_spread":0.31902987233915864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027255665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026123846,0.99740785,0.00034700384,0.000685638,0.00019547412,0.000005965721,0.000051727606,0.000008851668,0.0010362891],"genre_scores_gemma":[0.0019095113,0.99647176,0.00030046332,0.00031016546,0.00023338795,0.000007732555,0.000074308984,0.0000018027101,0.0006909866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997948,0.0000485396,0.000019967536,0.000037978767,0.00008274088,0.0000160291],"domain_scores_gemma":[0.99964666,0.00016527911,0.00006461137,0.000010238204,0.0000946652,0.000018603798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055759057,0.0006096767,0.0013646868,0.0011090207,0.00011588586,0.0007423296,0.0006072911,0.00085238187,0.003066503],"category_scores_gemma":[0.0007977943,0.00017591173,0.0006194072,0.0014079933,0.00022056431,0.0005258261,0.0003443773,0.0009373575,0.0015356642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011198654,0.00005932605,0.00040556924,0.01357546,0.0002818659,0.00032455893,0.00002364964,0.0006547376,0.0026473436,0.0028265314,0.028446445,0.95064247],"study_design_scores_gemma":[0.000055200355,0.00019531706,0.0027465022,0.0044493675,0.0004295453,0.003064073,0.000048855905,0.00049429096,0.0022075279,0.004137773,0.9821347,0.000036930353],"about_ca_topic_score_codex":0.0008172947,"about_ca_topic_score_gemma":0.0013754744,"teacher_disagreement_score":0.003066503,"about_ca_system_score_codex":0.00054099585,"about_ca_system_score_gemma":0.0008597772,"threshold_uncertainty_score":0.010258496},"labels":[],"label_agreement":null},{"id":"W2027642737","doi":"10.1517/14656560903176446","title":"New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Windsor Regional Hospital; Toronto General Hospital; University of Alberta","funders":"","keywords":"Darunavir; Etravirine; Raltegravir; Maraviroc; Rilpivirine; Medicine; Pharmacology; Drug; Intensive care medicine; Virology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","score_opus":0.02840759937183873,"score_gpt":0.37771341237789124,"score_spread":0.3493058130060525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027642737","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091662594,0.99864346,0.00008668415,0.00022130233,0.00013500167,0.0000053924236,0.000017098284,0.0000043793502,0.0007950409],"genre_scores_gemma":[0.00044339432,0.99859744,0.00024609585,0.00015196427,0.00010424956,0.0000050992144,0.000024110206,8.6324263e-7,0.00042677228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967146,0.00006768295,0.000053901073,0.00003837674,0.00014873581,0.000019859925],"domain_scores_gemma":[0.9995902,0.0001904963,0.0000589883,0.000009143735,0.00012820921,0.000023003267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065712206,0.0009001983,0.0016493849,0.002402852,0.00027735476,0.0008906098,0.0008623712,0.0008584445,0.003815614],"category_scores_gemma":[0.0009010681,0.0002682303,0.00052168575,0.0031096884,0.000354258,0.0011559206,0.00030349928,0.0010432816,0.0022273657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074864445,0.0000679954,0.00013211215,0.022229405,0.00011962871,0.00023928286,0.000071205985,0.0003048127,0.0012943284,0.0015105895,0.04305366,0.9309022],"study_design_scores_gemma":[0.000028915465,0.0001075451,0.001128571,0.0075785695,0.00018641802,0.0019144947,0.00007751467,0.000105821135,0.00036523145,0.0008644653,0.9876249,0.000017643417],"about_ca_topic_score_codex":0.002460087,"about_ca_topic_score_gemma":0.005807629,"teacher_disagreement_score":0.003815614,"about_ca_system_score_codex":0.00078739686,"about_ca_system_score_gemma":0.0014929409,"threshold_uncertainty_score":0.0127645135},"labels":[],"label_agreement":null},{"id":"W2027808292","doi":"10.1517/14656566.7.1.s1","title":"Disease-modifying drugs for multiple sclerosis: current and future aspects","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Medicine; Disease; Demyelinating disease; Relapsing remitting; Pharmacology; Immunology; Internal medicine","score_opus":0.21579428419351418,"score_gpt":0.4665057666203509,"score_spread":0.2507114824268367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027808292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000410341,0.9983931,0.00006727831,0.00073912763,0.00022900413,0.0000052435867,0.000009337012,0.00000522412,0.0005106796],"genre_scores_gemma":[0.0003438546,0.99808747,0.00023492875,0.00045347033,0.00038956327,0.000009784404,0.000018777466,0.0000013937238,0.00046070173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993579,0.00018533788,0.00009783923,0.00007106343,0.00025186653,0.00003606805],"domain_scores_gemma":[0.99880457,0.00052015553,0.00020989745,0.000046241777,0.00030091262,0.00011825269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002178615,0.0013233697,0.0029305916,0.0022848286,0.00033932817,0.0013043669,0.0014919597,0.0025909683,0.008923116],"category_scores_gemma":[0.0016299008,0.00035363509,0.00077109924,0.0031601547,0.000735192,0.0027608317,0.0006141429,0.0022725868,0.0054162005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016639571,0.00012087607,0.00011096878,0.014230646,0.00010418737,0.0002357776,0.000042350475,0.00015028084,0.00090461486,0.0016803343,0.0461587,0.9360948],"study_design_scores_gemma":[0.00014417958,0.00023564552,0.0008727067,0.006377188,0.00021728297,0.0014857231,0.00008926482,0.00011848222,0.00028559074,0.002011495,0.98814046,0.000021940825],"about_ca_topic_score_codex":0.0011761015,"about_ca_topic_score_gemma":0.0031293703,"teacher_disagreement_score":0.008923116,"about_ca_system_score_codex":0.0008877732,"about_ca_system_score_gemma":0.0015025052,"threshold_uncertainty_score":0.029850781},"labels":[],"label_agreement":null},{"id":"W2027877088","doi":"10.1517/14656566.2015.1041504","title":"Ezetimibe plus simvastatin for the treatment of hypercholesterolemia","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Ezetimibe; Simvastatin; Medicine; Pharmacology; Clinical trial; Pharmacodynamics; Combination therapy; Statin; Internal medicine; Pharmacokinetics","score_opus":0.19812055944903947,"score_gpt":0.48447515919048406,"score_spread":0.2863545997414446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027877088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051893465,0.9990602,0.000042426655,0.00030553163,0.00013684707,0.000004856404,0.000014432491,0.0000031652921,0.00038058238],"genre_scores_gemma":[0.0006824757,0.998409,0.000113676484,0.00034479034,0.00015377245,0.0000060203192,0.000028970408,0.000001023723,0.0002602751],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996464,0.00009122617,0.00006636447,0.00004649088,0.0001282196,0.000021267588],"domain_scores_gemma":[0.9996137,0.0001925784,0.000092696064,0.000008257152,0.000073764044,0.000019071664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007491301,0.00057732634,0.0015381975,0.0018318057,0.00016175804,0.0007073919,0.0007993486,0.0009749477,0.004575799],"category_scores_gemma":[0.001172599,0.00016807338,0.000925798,0.0015030361,0.00031209708,0.0007015373,0.0004803126,0.0013746403,0.0020497746],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015624723,0.000037868525,0.00014895572,0.062407292,0.0006021332,0.00016004148,0.00004332606,0.00016005996,0.0008958326,0.0019182125,0.040151,0.8933191],"study_design_scores_gemma":[0.00017208852,0.00013079861,0.0013796813,0.030105166,0.0013105659,0.001556988,0.000058731366,0.00013501638,0.00046051128,0.0022085586,0.9624558,0.000026065416],"about_ca_topic_score_codex":0.001079101,"about_ca_topic_score_gemma":0.0021534695,"teacher_disagreement_score":0.004575799,"about_ca_system_score_codex":0.00045786967,"about_ca_system_score_gemma":0.00094366196,"threshold_uncertainty_score":0.015307546},"labels":[],"label_agreement":null},{"id":"W2030886922","doi":"10.1517/14656566.3.9.1235","title":"The pharmacoeconomic impact of generics: an evolutionary tale","year":2002,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pride; Human immunodeficiency virus (HIV); Medicine; Position (finance); Law and economics; Economics; Law; Political science; Virology; Finance","score_opus":0.06265118156813454,"score_gpt":0.38548996348098574,"score_spread":0.3228387819128512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030886922","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032573368,0.09720034,0.0009566954,0.46167776,0.43433154,0.000012830111,0.00005555274,0.000038484184,0.005401135],"genre_scores_gemma":[0.0102268085,0.09163238,0.0006436691,0.09409799,0.79102594,0.000019940388,0.000024419078,0.000045338144,0.012283416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771476,0.0007109678,0.00019066111,0.00027247542,0.001017171,0.000094003124],"domain_scores_gemma":[0.97762614,0.017623963,0.0007018181,0.00033100456,0.0031605815,0.00055641035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055393344,0.0013245833,0.0016160305,0.0014547062,0.0012000827,0.0049694055,0.0016418323,0.012312483,0.003969782],"category_scores_gemma":[0.023432348,0.00037807322,0.0009437528,0.0011541222,0.0034942082,0.0048240386,0.0007096343,0.013350971,0.0011390483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052026597,0.000013981193,0.00006337699,0.000634712,0.00004572585,0.00032603604,0.0001095499,0.0003806963,0.00011382548,0.018226912,0.94974345,0.030289566],"study_design_scores_gemma":[0.00005698907,0.000043373067,0.0004678229,0.0011698653,0.000074420605,0.00043839225,0.00015140594,0.0009314569,0.0001576882,0.03455121,0.96192515,0.00003224043],"about_ca_topic_score_codex":0.0012482282,"about_ca_topic_score_gemma":0.002256066,"teacher_disagreement_score":0.012312483,"about_ca_system_score_codex":0.0021038214,"about_ca_system_score_gemma":0.001891881,"threshold_uncertainty_score":0.029295087},"labels":[],"label_agreement":null},{"id":"W2031383197","doi":"10.1517/14656566.8.12.1851","title":"Stroke prevention in the high-risk patient","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Stroke (engine); Carotid endarterectomy; Smoking cessation; Pharmacotherapy; Intensive care medicine; Carotid stenting; Population; Internal medicine; Physical therapy; Carotid arteries","score_opus":0.06920898370513931,"score_gpt":0.42585726233295307,"score_spread":0.3566482786278138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031383197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020236344,0.9945933,0.00029526546,0.0015721576,0.00040603225,0.000013759834,0.000015914475,0.0000139786125,0.002887153],"genre_scores_gemma":[0.0012440889,0.99586946,0.00045177122,0.0010654472,0.00038484615,0.000015785141,0.000025632737,0.0000017223182,0.00094120984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999635,0.0001128637,0.00003695176,0.000046473768,0.00013700117,0.00003165979],"domain_scores_gemma":[0.9997073,0.0001233132,0.000047706297,0.000012730108,0.000084137064,0.000024896783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000782117,0.00085597776,0.0023297179,0.0010516855,0.00023598007,0.00082219363,0.0007397918,0.0016602601,0.005076599],"category_scores_gemma":[0.001141278,0.00015853718,0.00054279977,0.0012132493,0.00030242626,0.00080414186,0.00045212227,0.001203792,0.0038757059],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007613775,0.00007987771,0.00026628468,0.016549107,0.00020306054,0.0004134348,0.000059706403,0.00015720015,0.0011742525,0.0017290863,0.050042737,0.92924917],"study_design_scores_gemma":[0.00012552828,0.00025215012,0.003072837,0.016164348,0.00040970807,0.004441117,0.00014059867,0.0001407017,0.00053432025,0.0038420723,0.9708553,0.000021289181],"about_ca_topic_score_codex":0.00097427214,"about_ca_topic_score_gemma":0.0019126193,"teacher_disagreement_score":0.005076599,"about_ca_system_score_codex":0.00041095118,"about_ca_system_score_gemma":0.0010926682,"threshold_uncertainty_score":0.016982853},"labels":[],"label_agreement":null},{"id":"W2031892788","doi":"10.1517/14656566.2013.767331","title":"Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain","year":2013,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Medicine; Buprenorphine; Quality of life (healthcare); Opioid; Anesthesia; Internal medicine; Nursing","score_opus":0.0190341332925148,"score_gpt":0.30789375709569794,"score_spread":0.28885962380318314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031892788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970741,0.002329034,0.00008189318,0.000057696747,0.00001540664,0.000160338,0.0000757305,0.0000045127495,0.00020117834],"genre_scores_gemma":[0.9983071,0.000692701,0.0003491522,0.00009710949,0.000031862375,0.00018444055,0.000108660744,9.228771e-7,0.0002280073],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99947876,0.00027925143,0.000057054684,0.00004694202,0.00007595935,0.000062045896],"domain_scores_gemma":[0.99937385,0.00015771911,0.00027565478,0.000023557333,0.000043505657,0.00012569656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000892972,0.00031745067,0.00070910656,0.00013220223,0.00013185313,0.0002693135,0.00022019155,0.0003816663,0.0017718906],"category_scores_gemma":[0.0012176074,0.00013883099,0.00051910913,0.00019487388,0.0001818653,0.00022743878,0.00019885409,0.00043927977,0.00013054367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57149315,0.030779218,0.07386611,0.0035551793,0.0027939167,0.00015812479,0.0003156343,0.00170219,0.051005576,0.00010666697,0.0007258748,0.26349843],"study_design_scores_gemma":[0.16748868,0.54126567,0.2829606,0.00018793048,0.0010361215,0.0002754008,0.0001496142,0.0014120544,0.003844619,0.00006429527,0.0012857276,0.000029357432],"about_ca_topic_score_codex":0.0004670314,"about_ca_topic_score_gemma":0.0010143796,"teacher_disagreement_score":0.0017718906,"about_ca_system_score_codex":0.00020529171,"about_ca_system_score_gemma":0.00029804284,"threshold_uncertainty_score":0.0059275627},"labels":[],"label_agreement":null},{"id":"W2033596403","doi":"10.1517/14656566.2010.490831","title":"Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Risperidone; Adjunctive treatment; Maintenance therapy; Bipolar disorder; Pharmacotherapy; Psychotherapist; Schizophrenia (object-oriented programming); Psychiatry; Pharmacology; Internal medicine; Lithium (medication); Chemotherapy; Psychology","score_opus":0.059465392711306096,"score_gpt":0.40747267229704104,"score_spread":0.34800727958573496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033596403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014631098,0.9988979,0.000038376897,0.00022764107,0.00012992806,0.0000041580947,0.0000071703807,0.0000028052098,0.00054568483],"genre_scores_gemma":[0.0018649253,0.9969408,0.0002017089,0.0003230075,0.00018359484,0.000009600435,0.000016361008,0.0000011455012,0.00045871735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963117,0.00012784608,0.00006396161,0.000036354842,0.00012147694,0.000019135216],"domain_scores_gemma":[0.9996044,0.00020419754,0.00010324678,0.000007232854,0.0000639876,0.00001706179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000751601,0.00040532064,0.0013506989,0.0010536867,0.00014017477,0.0004716217,0.0006036728,0.00094289664,0.0020519882],"category_scores_gemma":[0.0010051635,0.00016987127,0.0005993022,0.0014715301,0.00021370755,0.000497585,0.00024266024,0.0007906533,0.00094762805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018036604,0.00004355669,0.00018400048,0.041761868,0.0002950949,0.00034795824,0.00008778243,0.00012846038,0.0011392573,0.00071923534,0.031226832,0.9238857],"study_design_scores_gemma":[0.0002556823,0.00046732905,0.0059596957,0.03326125,0.0014205569,0.0058806934,0.00018975671,0.00030139415,0.0012397504,0.0016549943,0.9493281,0.00004072691],"about_ca_topic_score_codex":0.0013116417,"about_ca_topic_score_gemma":0.00410839,"teacher_disagreement_score":0.0020519882,"about_ca_system_score_codex":0.00039332802,"about_ca_system_score_gemma":0.00084110897,"threshold_uncertainty_score":0.0068645477},"labels":[],"label_agreement":null},{"id":"W2034556516","doi":"10.1517/14656566.6.6.955","title":"Use of medications in Wolff-Parkinson-White syndrome","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; White (mutation); Internal medicine","score_opus":0.12960523073126573,"score_gpt":0.4496644906192648,"score_spread":0.32005925988799905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034556516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002463655,0.99733764,0.00012786029,0.0003064805,0.000177728,0.000009164192,0.000024942306,0.000007985532,0.0017618051],"genre_scores_gemma":[0.0018513517,0.99636453,0.0002751509,0.00039885752,0.0002550841,0.00001535793,0.00004630476,0.0000015983699,0.0007917733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997217,0.000064220956,0.000053063322,0.000036006797,0.000105376654,0.00001963798],"domain_scores_gemma":[0.9997291,0.00013076904,0.0000755329,0.0000061835485,0.000045029436,0.000013309457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003564529,0.0007623659,0.001990312,0.0017035811,0.00020702444,0.0005242727,0.0008045757,0.0012394926,0.004490518],"category_scores_gemma":[0.0007006994,0.00018869145,0.00084114505,0.0016103605,0.00018391378,0.00062005315,0.00033692952,0.0008552949,0.0025232094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012693949,0.00009046676,0.00040049796,0.019431727,0.00024000139,0.0013332966,0.00004686421,0.00020962162,0.0011049628,0.0007099023,0.031018974,0.94528675],"study_design_scores_gemma":[0.00020108903,0.00036707908,0.006308059,0.01843268,0.0010368843,0.018519027,0.000117241296,0.00030242046,0.0014362287,0.0019420715,0.9512963,0.000040924257],"about_ca_topic_score_codex":0.0010983616,"about_ca_topic_score_gemma":0.0025356635,"teacher_disagreement_score":0.004490518,"about_ca_system_score_codex":0.00035694172,"about_ca_system_score_gemma":0.00046599002,"threshold_uncertainty_score":0.015022278},"labels":[],"label_agreement":null},{"id":"W2037298403","doi":"10.1517/14656566.2013.786701","title":"Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Entecavir; Medicine; Cirrhosis; Lamivudine; Hepatocellular carcinoma; Decompensation; Hepatitis B; Internal medicine; Gastroenterology; Hepatitis B virus; Virology; Virus","score_opus":0.07463972994596137,"score_gpt":0.4024981323189573,"score_spread":0.32785840237299596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037298403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000084323256,0.9990658,0.000029723327,0.00019921234,0.00010726211,0.000005509038,0.00001593757,0.0000026978603,0.00048962183],"genre_scores_gemma":[0.000987351,0.9982266,0.00009778086,0.00025727847,0.0001064222,0.0000075868484,0.000030758663,8.251747e-7,0.0002854224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997638,0.000070500784,0.00004320132,0.0000306718,0.00007599275,0.000015912214],"domain_scores_gemma":[0.9996544,0.0001400324,0.00010423855,0.000006410792,0.00007428155,0.00002064009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005009534,0.00057503907,0.0013375366,0.0015501184,0.00019418963,0.00056428276,0.0006599293,0.0008525915,0.0059957984],"category_scores_gemma":[0.00092200533,0.00015431143,0.0007470182,0.0015726486,0.00021088125,0.00056839763,0.00038579135,0.000992816,0.001496134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001622276,0.00004015863,0.00016444917,0.05461356,0.00036526876,0.0001913958,0.000034901066,0.00010867696,0.00087898946,0.00059948984,0.029833267,0.9130075],"study_design_scores_gemma":[0.0002946566,0.0002473015,0.0027569486,0.044167217,0.0015413032,0.003275235,0.00009951344,0.00014488348,0.00079867407,0.001157247,0.9454833,0.000033727614],"about_ca_topic_score_codex":0.0010522357,"about_ca_topic_score_gemma":0.002607207,"teacher_disagreement_score":0.0059957984,"about_ca_system_score_codex":0.0004183171,"about_ca_system_score_gemma":0.0007764931,"threshold_uncertainty_score":0.020057976},"labels":[],"label_agreement":null},{"id":"W2040234260","doi":"10.1517/14656566.8.14.2329","title":"Update on the use of letrozole in breast cancer","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Letrozole; Medicine; Tamoxifen; Breast cancer; Oncology; Adjuvant; Internal medicine; Aromatase inhibitor; Aromatase; Anastrozole; Adjuvant therapy; Clinical trial; Gynecology; Cancer","score_opus":0.10468364443771466,"score_gpt":0.421482655112988,"score_spread":0.31679901067527333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040234260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009174917,0.99521697,0.00014859023,0.0014891424,0.0011694054,0.000010081679,0.000037693128,0.000014524831,0.001821916],"genre_scores_gemma":[0.00045613124,0.9955069,0.00030083954,0.0014537472,0.0009327328,0.000013783102,0.00006546061,0.0000026976727,0.0012677333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973494,0.00006220271,0.00003894228,0.000033274522,0.000111155765,0.000019461273],"domain_scores_gemma":[0.999548,0.00017419212,0.00006982162,0.000009110135,0.00015303431,0.00004577935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008129059,0.00090695283,0.001617442,0.00175359,0.0003029795,0.0009328848,0.0016005633,0.0019734108,0.006149004],"category_scores_gemma":[0.0009774454,0.0002904531,0.0006051868,0.0017857958,0.0003915236,0.0013251525,0.00058771746,0.0023137939,0.0053219525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009570196,0.00006225432,0.00008677266,0.010326762,0.00008019391,0.00043473497,0.000038887712,0.00022102478,0.0010319353,0.0015737935,0.16293137,0.8231165],"study_design_scores_gemma":[0.00002709201,0.000058997175,0.00027483123,0.0021860371,0.0000882373,0.0008933848,0.000019173498,0.000048950456,0.00013707746,0.0005738626,0.99568343,0.000008861167],"about_ca_topic_score_codex":0.0013609929,"about_ca_topic_score_gemma":0.0037369148,"teacher_disagreement_score":0.006149004,"about_ca_system_score_codex":0.0008997152,"about_ca_system_score_gemma":0.0011402495,"threshold_uncertainty_score":0.020570457},"labels":[],"label_agreement":null},{"id":"W2040605051","doi":"10.1517/14656566.2014.903925","title":"Pharmacotherapy of bone metastases in breast cancer patients – an update","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Denosumab; Breast cancer; Oncology; Pharmacotherapy; Incidence (geometry); Randomized controlled trial; Internal medicine; Cancer; Clinical trial; Quality of life (healthcare); Osteoporosis","score_opus":0.06639185486588313,"score_gpt":0.46925771456642085,"score_spread":0.40286585970053773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040605051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005242304,0.9990369,0.00004488952,0.00034143534,0.00016412498,0.0000034270056,0.000011070669,0.00000291869,0.00034289705],"genre_scores_gemma":[0.0003173855,0.9989905,0.0000892517,0.00024956034,0.00017609053,0.000004106443,0.000016879147,7.298432e-7,0.00015553115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969614,0.00006446832,0.00004952593,0.000043958462,0.00012725711,0.000018605268],"domain_scores_gemma":[0.99940896,0.0002932108,0.00010314255,0.000010433154,0.00015657248,0.00002764106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006238543,0.0007544937,0.0014994409,0.0017364962,0.00021454053,0.0008619,0.0008405637,0.0014086973,0.0032349175],"category_scores_gemma":[0.0010724723,0.00025629756,0.00066657015,0.0021170618,0.0004005822,0.001034718,0.00049107336,0.0017474397,0.0014652293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000571652,0.000054810967,0.00013286543,0.026760358,0.000121488796,0.00013302633,0.000036076377,0.000211205,0.00055205333,0.0010943491,0.03963301,0.9312136],"study_design_scores_gemma":[0.00004728674,0.00013893656,0.0013594109,0.017312244,0.0003354861,0.0023506195,0.00006477666,0.00017372023,0.0002948257,0.001174712,0.9767228,0.000025273335],"about_ca_topic_score_codex":0.0016736161,"about_ca_topic_score_gemma":0.0031769988,"teacher_disagreement_score":0.0032349175,"about_ca_system_score_codex":0.0006238576,"about_ca_system_score_gemma":0.0010127949,"threshold_uncertainty_score":0.010821879},"labels":[],"label_agreement":null},{"id":"W2041310270","doi":"10.1517/14656566.2012.689130","title":"Sunitinib malate for the treatment of renal cell carcinoma","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Sunitinib; Sunitinib malate; Medicine; Renal cell carcinoma; Tolerability; Tyrosine-kinase inhibitor; Vascular endothelial growth factor; Pazopanib; Oncology; Clinical trial; Dosing; Internal medicine; Pharmacology; Adverse effect; Cancer; VEGF receptors","score_opus":0.19213255162905601,"score_gpt":0.4298720621045542,"score_spread":0.23773951047549818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041310270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013509474,0.91228545,0.0022493147,0.02363568,0.0051847915,0.000109851775,0.00063687266,0.00024019889,0.042148426],"genre_scores_gemma":[0.2760404,0.63269687,0.003957581,0.021886801,0.011919938,0.00016924739,0.0019797396,0.00009176118,0.05125753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998325,0.0000438162,0.000019525862,0.00002594811,0.000058142883,0.000019994739],"domain_scores_gemma":[0.9998436,0.00003811153,0.000038800263,0.0000055886467,0.000047689737,0.000026176369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032607777,0.0001905012,0.00044617755,0.00040408876,0.00019174058,0.00033510887,0.00025504362,0.00051325717,0.0076379767],"category_scores_gemma":[0.00055439747,0.000048297577,0.00039540645,0.00024306269,0.00015431069,0.00029635016,0.00024062635,0.00093073765,0.0025925126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009016437,0.000082599654,0.0009618418,0.00418226,0.00018042025,0.0012377047,0.00006154763,0.0003217434,0.0076060165,0.0032049974,0.116378725,0.86488044],"study_design_scores_gemma":[0.0004597264,0.00079820195,0.0037187568,0.0010741324,0.00019985007,0.00748531,0.000040091945,0.00041723892,0.004980962,0.0022704615,0.97853136,0.000023875971],"about_ca_topic_score_codex":0.00039868674,"about_ca_topic_score_gemma":0.0012890938,"teacher_disagreement_score":0.0076379767,"about_ca_system_score_codex":0.00043339096,"about_ca_system_score_gemma":0.00035273543,"threshold_uncertainty_score":0.025551558},"labels":[],"label_agreement":null},{"id":"W2043626423","doi":"10.1517/14656566.2011.563506","title":"Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Fenofibrate; Fibrate; Medicine; Dyslipidemia; Metabolic syndrome; Internal medicine; Statin; Type 2 Diabetes Mellitus; Insulin resistance; Combination therapy; Type 2 diabetes; Simvastatin; Diabetes mellitus; Population; Endocrinology; Insulin; Obesity","score_opus":0.03170774920635816,"score_gpt":0.31567765092331695,"score_spread":0.2839699017169588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043626423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056181895,0.98919475,0.00017026575,0.0020968367,0.00048750173,0.000026358239,0.00008949711,0.000009274504,0.002307275],"genre_scores_gemma":[0.07590706,0.9161874,0.0010690561,0.0033849974,0.0018016812,0.00010347807,0.00029014473,0.000006109147,0.0012501132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995503,0.00017432812,0.000105995634,0.00004565846,0.00009125472,0.000032338743],"domain_scores_gemma":[0.9994349,0.00026202336,0.00017621674,0.000011444492,0.00008116224,0.000034327306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006454309,0.00021779013,0.0011849231,0.0005661549,0.00015338883,0.0004545661,0.00029801842,0.0006334758,0.0034851744],"category_scores_gemma":[0.0013422641,0.000092263515,0.0009839657,0.00061038055,0.00010996209,0.00039111488,0.0002290234,0.0007049983,0.0003761137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003711212,0.00021983046,0.010756633,0.047649466,0.0029769149,0.0013000156,0.0001440838,0.0002452374,0.00172882,0.00092581473,0.030464176,0.8998779],"study_design_scores_gemma":[0.005795959,0.0052514197,0.088961594,0.082534656,0.020645326,0.02157763,0.0006174816,0.0013807269,0.002775869,0.0041415747,0.7661535,0.0001642589],"about_ca_topic_score_codex":0.0007812927,"about_ca_topic_score_gemma":0.002612363,"teacher_disagreement_score":0.0034851744,"about_ca_system_score_codex":0.00020871765,"about_ca_system_score_gemma":0.0005351015,"threshold_uncertainty_score":0.011659086},"labels":[],"label_agreement":null},{"id":"W2044618179","doi":"10.1517/14656566.4.10.1651","title":"Pharmacotherapy of postpartum psychosis","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Psychosis; Pharmacotherapy; Pregnancy; Postpartum period; Psychiatry; Lithium (medication); Postpartum psychosis; Mood; Bipolar disorder; Pediatrics; Intensive care medicine","score_opus":0.11321007406628959,"score_gpt":0.47673522707884464,"score_spread":0.36352515301255506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044618179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023113113,0.9982534,0.000060838604,0.0002351301,0.00014597944,0.00000954561,0.000017526298,0.000006864444,0.001039516],"genre_scores_gemma":[0.0012911253,0.9976693,0.00013529831,0.00031395702,0.000107998305,0.000012084622,0.000027977667,0.000001299912,0.0004409151],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997409,0.00006927221,0.000040417606,0.00003918014,0.00008796795,0.000022242715],"domain_scores_gemma":[0.99965096,0.00018780383,0.00007241477,0.000011413751,0.0000580963,0.000019185221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046161376,0.00076850125,0.0017302311,0.0017455327,0.00026419252,0.0006944269,0.0009789487,0.0014120357,0.004881756],"category_scores_gemma":[0.0009057162,0.00020488419,0.0007074478,0.0018486689,0.0002704405,0.00062017044,0.0004685701,0.0011745408,0.0016121193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010774347,0.000105663756,0.00013831673,0.026177099,0.0001840092,0.0003034655,0.00005246883,0.00018330492,0.00068680535,0.00068588933,0.020008918,0.95136636],"study_design_scores_gemma":[0.00032952265,0.00045386475,0.004745703,0.02784073,0.00065973925,0.0061295736,0.00017952334,0.00030853902,0.0009954129,0.0018691979,0.95645046,0.000037726582],"about_ca_topic_score_codex":0.0015478721,"about_ca_topic_score_gemma":0.0044333087,"teacher_disagreement_score":0.004881756,"about_ca_system_score_codex":0.0005568049,"about_ca_system_score_gemma":0.00075920194,"threshold_uncertainty_score":0.016331136},"labels":[],"label_agreement":null},{"id":"W2049793729","doi":"10.1517/14656560903061291","title":"Pharmacotherapy of endometrial cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Endometrial cancer; Oncology; Hormonal therapy; Disease; Adjuvant therapy; Malignancy; Internal medicine; Stage (stratigraphy); Cancer; Randomized controlled trial; Hormone therapy; Adjuvant; Gynecology; Intensive care medicine; Pharmacotherapy; Breast cancer","score_opus":0.1585372305893636,"score_gpt":0.5072554839571248,"score_spread":0.34871825336776124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049793729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024177939,0.99887174,0.000046238365,0.00019217705,0.0000735121,0.000011892469,0.000011257363,0.000002332158,0.0005489709],"genre_scores_gemma":[0.0030376455,0.99624276,0.00017449036,0.00024545423,0.00008788272,0.000020198244,0.000018004774,7.4222356e-7,0.00017286355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935085,0.00025606173,0.000109883294,0.000060338112,0.00019010481,0.000032748874],"domain_scores_gemma":[0.9991109,0.00054837984,0.00021183128,0.000021833854,0.00008539834,0.000021637927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008555949,0.00062587793,0.0018686071,0.0022150308,0.00023332132,0.0007930895,0.000606154,0.0010165777,0.0046307156],"category_scores_gemma":[0.0023568247,0.00020386929,0.0012219697,0.0020346602,0.00033713452,0.0005791255,0.00047858004,0.0008468279,0.00067485264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027800843,0.00011764245,0.00041461707,0.17943658,0.0012647447,0.00039098927,0.00009776666,0.00038628562,0.00135142,0.0016530018,0.013354067,0.80125487],"study_design_scores_gemma":[0.00080032385,0.0009948428,0.009098445,0.16602686,0.006333399,0.007591165,0.0002684612,0.0004994119,0.0030538393,0.003851003,0.80141807,0.000064248394],"about_ca_topic_score_codex":0.0012233263,"about_ca_topic_score_gemma":0.0026693095,"teacher_disagreement_score":0.0046307156,"about_ca_system_score_codex":0.00062867824,"about_ca_system_score_gemma":0.0014518629,"threshold_uncertainty_score":0.015491307},"labels":[],"label_agreement":null},{"id":"W2050289111","doi":"10.1517/14656566.2011.549126","title":"Medical management of ascites","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Ascites; Medicine; Cirrhosis; Spontaneous bacterial peritonitis; Paracentesis; Intensive care medicine; Complication; Gastroenterology; Internal medicine","score_opus":0.11192836970319525,"score_gpt":0.4566000810284927,"score_spread":0.34467171132529745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050289111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040532433,0.99395776,0.0003543955,0.001056643,0.0007423704,0.000012169021,0.000032445958,0.000021216047,0.0034175394],"genre_scores_gemma":[0.004157519,0.99143326,0.0005400071,0.001106244,0.001194338,0.000014312454,0.00008986463,0.00000368768,0.00146085],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974793,0.000058664395,0.00003258987,0.000040549276,0.00009769333,0.000022571974],"domain_scores_gemma":[0.99979705,0.00007531656,0.000052638934,0.000007121582,0.000049534992,0.000018229232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002770432,0.0005654786,0.0009451056,0.001184579,0.0002278957,0.000501984,0.00052086345,0.00080215005,0.003984349],"category_scores_gemma":[0.0006944934,0.000110971014,0.00043258388,0.00089866854,0.00034705913,0.0006361733,0.00043059874,0.0010471272,0.0022689837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006598089,0.00004070539,0.00034199093,0.01328152,0.00008123167,0.0007402901,0.000051637442,0.0001986955,0.0014586861,0.0013473489,0.05396589,0.9284261],"study_design_scores_gemma":[0.0000426607,0.00013864064,0.0030879404,0.009905204,0.00015481502,0.01496184,0.00008808938,0.00019285073,0.0011505331,0.0019461935,0.9683044,0.000026840158],"about_ca_topic_score_codex":0.0006367092,"about_ca_topic_score_gemma":0.0009315024,"teacher_disagreement_score":0.003984349,"about_ca_system_score_codex":0.00037457846,"about_ca_system_score_gemma":0.00065987307,"threshold_uncertainty_score":0.013329029},"labels":[],"label_agreement":null},{"id":"W2051609830","doi":"10.1517/14656566.6.2.255","title":"Current pharmacological options in the treatment of croup","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Otolaryngology and Infectious Diseases","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Child, Adolescent and Family Mental Health; University of Alberta","funders":"Canada Research Chairs","keywords":"Medicine; Croup; Heliox; Intensive care medicine; Stridor; Asthma; Respiratory distress; Quality of life (healthcare); Pediatrics; Anesthesia; Airway; Internal medicine","score_opus":0.15101432333198458,"score_gpt":0.5096861022355341,"score_spread":0.3586717789035495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051609830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000191621,0.997493,0.00011362279,0.00055801094,0.00015659544,0.000010333182,0.000017136814,0.00001027682,0.001449434],"genre_scores_gemma":[0.001021694,0.997285,0.00029031155,0.00047824153,0.0002455864,0.00001528371,0.00003640835,0.0000015788602,0.00062583806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976045,0.000044173015,0.000039047583,0.000037586306,0.00009857192,0.000020182666],"domain_scores_gemma":[0.99970406,0.00013686673,0.00006709736,0.000010054277,0.000055018725,0.000026832506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006196497,0.0007003299,0.0016293754,0.0018513314,0.00029176063,0.0007531526,0.0011132386,0.0013555855,0.007270548],"category_scores_gemma":[0.00063277164,0.00022433764,0.0006492071,0.0014120814,0.00043075578,0.00096584106,0.00043996895,0.0017229699,0.0042117266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013567417,0.00014195498,0.00015364165,0.016717598,0.00010529237,0.0003405836,0.000045346616,0.00016309773,0.0013670601,0.001075377,0.019529043,0.9602253],"study_design_scores_gemma":[0.00018461174,0.00031610872,0.0027308578,0.010012501,0.00026592356,0.0036566358,0.00014418288,0.0001430472,0.00073889573,0.002655718,0.97911835,0.000033264216],"about_ca_topic_score_codex":0.0007878127,"about_ca_topic_score_gemma":0.002134117,"teacher_disagreement_score":0.007270548,"about_ca_system_score_codex":0.0004203722,"about_ca_system_score_gemma":0.000538599,"threshold_uncertainty_score":0.02432239},"labels":[],"label_agreement":null},{"id":"W2054589128","doi":"10.1517/14656560903448837","title":"Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Quetiapine; Tolerability; Medicine; Quetiapine Fumarate; Major depressive disorder; Atypical antipsychotic; Psychiatry; Antidepressant; Extrapyramidal symptoms; Antipsychotic; Pharmacology; Adverse effect; Mood; Schizophrenia (object-oriented programming); Anxiety","score_opus":0.09731983139226451,"score_gpt":0.47648122177821134,"score_spread":0.3791613903859468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054589128","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022367368,0.99932766,0.000052594907,0.00013378805,0.000030662017,0.000018169729,0.00003334675,0.000003353579,0.00017672963],"genre_scores_gemma":[0.0024968034,0.99693394,0.0002065482,0.00017672952,0.000051404106,0.000024070114,0.000039319977,0.0000020800303,0.00006895916],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99848384,0.0003561791,0.0005644627,0.0001852899,0.00036911253,0.000041210707],"domain_scores_gemma":[0.9953219,0.0031634502,0.0008641351,0.00006711768,0.0005168443,0.00006649091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038351493,0.0006626984,0.003908241,0.0029292197,0.00025509542,0.0013648494,0.00144759,0.001026192,0.0018379373],"category_scores_gemma":[0.006190419,0.00043153233,0.0024493414,0.003952194,0.00055290776,0.0013465476,0.0005189006,0.00097322755,0.00032167384],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078272657,0.00005805956,0.00057948043,0.21175635,0.0014167577,0.00012759218,0.00013698517,0.00020103874,0.0008596107,0.0009996986,0.006695788,0.77638596],"study_design_scores_gemma":[0.0013074797,0.0030474106,0.017391711,0.35104188,0.033920027,0.0035254667,0.0006887789,0.0008688144,0.0021219547,0.0029000167,0.58302337,0.00016313349],"about_ca_topic_score_codex":0.001860134,"about_ca_topic_score_gemma":0.0043217386,"teacher_disagreement_score":0.003908241,"about_ca_system_score_codex":0.0011192295,"about_ca_system_score_gemma":0.0023819176,"threshold_uncertainty_score":0.020282507},"labels":[],"label_agreement":null},{"id":"W2056471646","doi":"10.1517/14656566.9.15.2707","title":"Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"GlaxoSmithKline","keywords":"Medicine; Fluticasone propionate; Nasal spray; Dermatology; Fluticasone; Nasal administration; Mometasone furoate; Anesthesia; Pharmacology; Internal medicine; Corticosteroid; Inhalation","score_opus":0.11570090677066157,"score_gpt":0.4234541966747482,"score_spread":0.3077532899040866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056471646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012914925,0.999498,0.00003348655,0.00008548048,0.0000359847,0.0000062421327,0.00001796059,0.0000025818388,0.00019119323],"genre_scores_gemma":[0.0013218692,0.9982457,0.00012834276,0.000118994256,0.000034289893,0.000010213975,0.000026551104,9.941668e-7,0.0001130261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953735,0.00008434029,0.00012178579,0.0000752004,0.00016069564,0.000020573336],"domain_scores_gemma":[0.99894994,0.00065437827,0.00018066815,0.00001745433,0.00016767322,0.0000299222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011735864,0.0007948277,0.0028904288,0.002305156,0.00020395019,0.00073155883,0.0011295258,0.00086580904,0.0023657952],"category_scores_gemma":[0.0018747993,0.00034225133,0.0009573162,0.0032027634,0.0003562039,0.00084004644,0.0003283444,0.00063249277,0.00079182157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025777094,0.00004129203,0.0003288547,0.1219555,0.0006993072,0.00024517797,0.00007836239,0.00022964347,0.000995222,0.00061772345,0.016601333,0.85794985],"study_design_scores_gemma":[0.00041233862,0.00071550114,0.0076939585,0.08972436,0.006314607,0.0058089397,0.0003433377,0.00040689897,0.0016525332,0.0014879772,0.88535905,0.00008042287],"about_ca_topic_score_codex":0.0015391074,"about_ca_topic_score_gemma":0.0032956193,"teacher_disagreement_score":0.0028904288,"about_ca_system_score_codex":0.000582272,"about_ca_system_score_gemma":0.0012423435,"threshold_uncertainty_score":0.007914364},"labels":[],"label_agreement":null},{"id":"W2057355671","doi":"10.1517/14656566.2014.855197","title":"The latest pharmacotherapy options for type 1 diabetes","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"LG Display; University of Guelph","keywords":"Medicine; Insulin; Metformin; Amylin; Pharmacotherapy; Insulin resistance; Type 2 diabetes; Diabetes mellitus; Intensive care medicine; Bioinformatics; Internal medicine; Endocrinology; Islet","score_opus":0.2283835522687489,"score_gpt":0.5191175320316764,"score_spread":0.29073397976292753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057355671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057868994,0.99742573,0.000100306126,0.00065107027,0.00036491532,0.000009606021,0.00003712987,0.000009899981,0.0013434609],"genre_scores_gemma":[0.00038469542,0.99824345,0.00017337449,0.00039010338,0.0002115606,0.000008155209,0.00005329196,0.0000016626656,0.00053370435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970263,0.00005943541,0.000052874497,0.000042559575,0.000118860116,0.000023571869],"domain_scores_gemma":[0.99961334,0.00016777561,0.000076474185,0.000012623665,0.00010339885,0.00002635709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048672376,0.0009795924,0.0014617827,0.0022856242,0.00024668756,0.0009027593,0.00084301335,0.0011445693,0.010313628],"category_scores_gemma":[0.00091412716,0.00024819578,0.00094348035,0.0023295118,0.00028663562,0.0012228342,0.0006339399,0.0021008432,0.0046260697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055779306,0.000049733975,0.00006906091,0.025791813,0.00011482024,0.00013007301,0.000033908284,0.00013237589,0.0004615792,0.0016143334,0.05054761,0.9209989],"study_design_scores_gemma":[0.00003255621,0.000055569802,0.00060442503,0.015060848,0.00021415007,0.0010922956,0.00004292083,0.00007615721,0.00019071678,0.0015747766,0.98103905,0.000016620459],"about_ca_topic_score_codex":0.0012017568,"about_ca_topic_score_gemma":0.0021227247,"teacher_disagreement_score":0.010313628,"about_ca_system_score_codex":0.00056803075,"about_ca_system_score_gemma":0.0008842671,"threshold_uncertainty_score":0.034502506},"labels":[],"label_agreement":null},{"id":"W2058093970","doi":"10.1517/14656560802532640","title":"Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada","keywords":"Rosuvastatin; Medicine; Pharmacokinetics; Cmax; Crossover study; Pharmacology; Bioequivalence; Concomitant; Dosing; Statin; Adverse effect; Rosuvastatin Calcium; Area under the curve; Internal medicine","score_opus":0.02710743316397679,"score_gpt":0.34600241506513363,"score_spread":0.31889498190115684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058093970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939334,0.0003525294,0.00008992921,0.000020263571,0.000005845946,0.000023643275,0.000032156226,0.000007551643,0.000074669704],"genre_scores_gemma":[0.99933475,0.00013779497,0.0003155416,0.000041416344,0.000012970534,0.000024642122,0.00005448917,0.0000024477733,0.00007583809],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99920064,0.00040668063,0.00008219434,0.00011164739,0.00012756832,0.00007133449],"domain_scores_gemma":[0.998459,0.0005951708,0.0005916437,0.00009454354,0.00006088573,0.0001987004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010340642,0.00036385152,0.000771845,0.00014054886,0.0001516654,0.00032111464,0.00018361799,0.0005393444,0.00088804093],"category_scores_gemma":[0.0020388549,0.00025001436,0.0007151033,0.00015313542,0.00030252573,0.00026301254,0.00022098974,0.0005943287,0.00013987807],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7019849,0.0118811745,0.09434136,0.00040081798,0.002606975,0.0002283241,0.00021539832,0.0009722254,0.09777758,0.000051895546,0.00023827828,0.08930099],"study_design_scores_gemma":[0.025030663,0.5438919,0.38765028,0.000034459947,0.0020243456,0.00057318393,0.00012832665,0.0029568176,0.036391333,0.000132408,0.0011424602,0.000043955395],"about_ca_topic_score_codex":0.0003835771,"about_ca_topic_score_gemma":0.00059665454,"teacher_disagreement_score":0.0010340642,"about_ca_system_score_codex":0.00027595946,"about_ca_system_score_gemma":0.000312457,"threshold_uncertainty_score":0.005468726},"labels":[],"label_agreement":null},{"id":"W2058489875","doi":"10.1517/14656566.2.7.1061","title":"Vagus nerve stimulation in depression","year":2001,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vagus nerve stimulation; Depression (economics); Stimulation; Anesthesia; Vagus nerve; Internal medicine","score_opus":0.12033227087873925,"score_gpt":0.44541677962254334,"score_spread":0.32508450874380407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058489875","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028985469,0.9799672,0.0005760515,0.0049916846,0.0014956719,0.000018047682,0.000033303117,0.00001742367,0.010002228],"genre_scores_gemma":[0.036651026,0.94681406,0.001228012,0.006120825,0.0036014835,0.000047959456,0.00009326871,0.000008761379,0.0054345313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998454,0.00005616213,0.000014347487,0.000026800417,0.000039588544,0.000017798578],"domain_scores_gemma":[0.99982315,0.00010222356,0.000031109954,0.0000065170593,0.000022233135,0.000014718038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053796946,0.00033949126,0.00066358724,0.00030833922,0.00014128708,0.0006904635,0.0004263566,0.0016146132,0.0036646414],"category_scores_gemma":[0.00050415617,0.000082775885,0.00028830668,0.00032248723,0.00038641796,0.0003242361,0.0002717118,0.0016185659,0.0017926516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006021544,0.00018188736,0.00080653623,0.0045787,0.000119164804,0.0007918591,0.00009079683,0.00028717853,0.00962063,0.0067677414,0.030957755,0.9451955],"study_design_scores_gemma":[0.0009051134,0.0024953738,0.014320388,0.0068537267,0.00028396933,0.009134272,0.00023916927,0.00068416743,0.004595776,0.017246658,0.9431761,0.000065198125],"about_ca_topic_score_codex":0.00058660295,"about_ca_topic_score_gemma":0.0014347128,"teacher_disagreement_score":0.0036646414,"about_ca_system_score_codex":0.00037648118,"about_ca_system_score_gemma":0.000303409,"threshold_uncertainty_score":0.012259424},"labels":[],"label_agreement":null},{"id":"W2059539152","doi":"10.1517/14656566.1.2.187","title":"Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Breast cancer; Natural history; Oncology; Chemotherapy; Cancer; Internal medicine","score_opus":0.08829158977714896,"score_gpt":0.42387209305990864,"score_spread":0.3355805032827597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059539152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003757171,0.9146664,0.00059244747,0.07578415,0.0019588717,0.000012713235,0.00006671094,0.000024432667,0.00313704],"genre_scores_gemma":[0.030581243,0.93293446,0.0006451923,0.02597846,0.0060193334,0.00003197998,0.00009907564,0.000022845841,0.0036874416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990658,0.0004097071,0.00007090235,0.00012226726,0.00025568006,0.00007565099],"domain_scores_gemma":[0.99780077,0.001079837,0.0003055929,0.00010485441,0.00047107082,0.00023790274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024737641,0.00033450781,0.00087233767,0.0005049586,0.0004130554,0.0018751213,0.0006190711,0.0017163769,0.004762919],"category_scores_gemma":[0.005069367,0.00018401183,0.0003367285,0.0008455834,0.0017146416,0.0035274106,0.0006953935,0.003434908,0.0015477623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000712673,0.00023024954,0.0050644856,0.003878921,0.00012617525,0.00031415184,0.00045058425,0.0005023911,0.003675726,0.0198584,0.069504976,0.8956813],"study_design_scores_gemma":[0.00019011687,0.0012833839,0.011964701,0.003695444,0.00013102566,0.0017115938,0.0008943184,0.00029003547,0.0015169855,0.028785102,0.9494788,0.000058446945],"about_ca_topic_score_codex":0.0011606474,"about_ca_topic_score_gemma":0.0023818281,"teacher_disagreement_score":0.004762919,"about_ca_system_score_codex":0.0011645344,"about_ca_system_score_gemma":0.0014484064,"threshold_uncertainty_score":0.015933573},"labels":[],"label_agreement":null},{"id":"W2060056173","doi":"10.1517/14656566.9.8.1375","title":"Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Sugammadex; Rocuronium; Medicine; Neuromuscular Blockade; Blockade; Anesthesia; Neuromuscular monitoring; Neuromuscular Blocking Agents; Paralysis; Surgery; Internal medicine; Intubation; Receptor","score_opus":0.10687992274177124,"score_gpt":0.4326943480920112,"score_spread":0.32581442535023997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060056173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004404638,0.99723285,0.00025252698,0.00026090434,0.00029675997,0.000014540892,0.000018864714,0.0000123969385,0.0014707576],"genre_scores_gemma":[0.0020436142,0.9950222,0.00044699875,0.00032040343,0.0003436242,0.000018176566,0.00006918447,0.000002090033,0.001733791],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981064,0.00003164323,0.000036434052,0.000028640952,0.000077023724,0.000015608897],"domain_scores_gemma":[0.9997694,0.00008445446,0.00006611525,0.000006542165,0.000053300988,0.000020172456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003618311,0.0008647606,0.0010690332,0.001958146,0.00017549557,0.00052706053,0.0006180227,0.0009368892,0.003732357],"category_scores_gemma":[0.00048975606,0.00017537027,0.00041107598,0.0015712566,0.000322865,0.0008153505,0.00031635608,0.00091852207,0.0030770793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015539506,0.0001569474,0.00036814838,0.0120557565,0.00014259797,0.0006972278,0.000039145245,0.0002746921,0.0043315464,0.0009961373,0.018210968,0.96257144],"study_design_scores_gemma":[0.00014774664,0.00033189144,0.0028375746,0.003067611,0.0002778727,0.007854356,0.00006627404,0.00022048391,0.0032426193,0.00095213443,0.9809796,0.000021763346],"about_ca_topic_score_codex":0.00066448597,"about_ca_topic_score_gemma":0.0011462638,"teacher_disagreement_score":0.003732357,"about_ca_system_score_codex":0.00036950738,"about_ca_system_score_gemma":0.00056822156,"threshold_uncertainty_score":0.012485981},"labels":[],"label_agreement":null},{"id":"W2061084001","doi":"10.1517/14656566.5.5.1045","title":"Pharmacotherapy for sexual dysfunction in women","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia Hospital","funders":"","keywords":"Biopsychosocial model; Sexual dysfunction; Sexual arousal; Medicine; Pharmacotherapy; Normative; Clinical psychology; Sexual desire; Arousal; Female sexual dysfunction; Human sexuality; Psychotherapist; Psychiatry; Psychology; Sexual behavior; Neuroscience","score_opus":0.13898182507787002,"score_gpt":0.46663726688432966,"score_spread":0.32765544180645967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061084001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015355596,0.9987087,0.00004640273,0.00020313277,0.00007850953,0.000010418033,0.00000963868,0.000004154992,0.00078543683],"genre_scores_gemma":[0.0012991849,0.997757,0.00012435392,0.00031402713,0.00008728855,0.000014070967,0.000015864198,8.500345e-7,0.00038743057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969447,0.00010371311,0.00004865476,0.00003726106,0.000095800104,0.000020200263],"domain_scores_gemma":[0.9996019,0.00022817329,0.00009586608,0.000011608301,0.0000475216,0.000014847158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061903667,0.0006455853,0.0020551553,0.0018467773,0.00022701154,0.0007986565,0.00069953577,0.0012299311,0.0075751045],"category_scores_gemma":[0.0010883885,0.00017569633,0.0007795046,0.0022613874,0.0003114755,0.0006785141,0.00045250647,0.0007262366,0.0015590762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010786651,0.000090716705,0.00019914414,0.058278218,0.00034895414,0.0003665005,0.000062690975,0.00011980796,0.00075800443,0.0007415123,0.015443204,0.9234835],"study_design_scores_gemma":[0.00041815886,0.00058003725,0.0062372345,0.07104001,0.0018913861,0.008637973,0.00037355264,0.00023924725,0.0013428773,0.0024573184,0.90674067,0.00004154774],"about_ca_topic_score_codex":0.0014111365,"about_ca_topic_score_gemma":0.0036277252,"teacher_disagreement_score":0.0075751045,"about_ca_system_score_codex":0.0005053094,"about_ca_system_score_gemma":0.00089299964,"threshold_uncertainty_score":0.025341213},"labels":[],"label_agreement":null},{"id":"W2062935202","doi":"10.1517/14656566.7.11.1457","title":"Treating osteoporosis: economic aspects of bisphosphonate therapy","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; Osteoporosis; Intensive care medicine; Quality of life (healthcare); Bisphosphonate; Health economics; Disease; Economic evaluation; Cost effectiveness; Health care; Physical therapy; Public health; Nursing; Internal medicine; Risk analysis (engineering)","score_opus":0.09325188495053834,"score_gpt":0.4552114200073096,"score_spread":0.36195953505677125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062935202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077484416,0.993309,0.00013947567,0.004423792,0.00031863578,0.0000069983607,0.000007565149,0.000002433371,0.0017145898],"genre_scores_gemma":[0.0012544788,0.9956275,0.00033515212,0.001656078,0.00059578876,0.000010606745,0.000007569448,0.0000010756883,0.00051181903],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99850035,0.0005091241,0.0001306837,0.000088797264,0.00071634137,0.000054695138],"domain_scores_gemma":[0.9986657,0.000804698,0.00021668099,0.000024537221,0.00023261002,0.00005574772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020312404,0.0008664601,0.0027895176,0.00223271,0.00035097203,0.0020526093,0.0011750343,0.0034209138,0.005982907],"category_scores_gemma":[0.003017087,0.00029820713,0.0008399596,0.0040649744,0.000803025,0.0019638164,0.00055952236,0.0020545716,0.0017542762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094415875,0.0001023476,0.00021723326,0.020695373,0.00031702133,0.000248526,0.00007405947,0.00052188383,0.00037675502,0.011719202,0.06477485,0.90085834],"study_design_scores_gemma":[0.00012420963,0.00016287637,0.0025405472,0.031779915,0.00039760745,0.0015538061,0.00020787177,0.00038395927,0.0003107455,0.019298539,0.9431977,0.00004212596],"about_ca_topic_score_codex":0.0034103913,"about_ca_topic_score_gemma":0.0064970325,"teacher_disagreement_score":0.005982907,"about_ca_system_score_codex":0.0018362391,"about_ca_system_score_gemma":0.0024590585,"threshold_uncertainty_score":0.020014822},"labels":[],"label_agreement":null},{"id":"W2066802629","doi":"10.1517/14656566.2010.524927","title":"Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Substance Abuse Treatment and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal College of Physicians and Surgeons of Canada; AstraZeneca (Canada); Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Quetiapine; Medicine; Craving; Psychiatry; Detoxification (alternative medicine); Quetiapine Fumarate; Atypical antipsychotic; Bipolar disorder; Open label; Olanzapine; Clinical trial; Mood; Antipsychotic; Schizophrenia (object-oriented programming); Addiction; Internal medicine; Alternative medicine","score_opus":0.09185294993188911,"score_gpt":0.41300813000778197,"score_spread":0.32115518007589283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066802629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99490744,0.0009647663,0.00022994028,0.00022027938,0.000099421384,0.0025145302,0.00033613812,0.000042806143,0.0006846341],"genre_scores_gemma":[0.99267286,0.0010334145,0.0007705357,0.0003203653,0.00026190034,0.0033960966,0.00048858824,0.0000094482,0.0010468058],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990758,0.0005242515,0.00006824275,0.00014162535,0.000075035256,0.00011500363],"domain_scores_gemma":[0.9981425,0.0004847323,0.00043873594,0.00016160078,0.00013484736,0.0006377199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019009735,0.0014059339,0.0024840706,0.0005015764,0.00072106684,0.00096251187,0.00087234593,0.0021156338,0.004311803],"category_scores_gemma":[0.0025281515,0.0005040397,0.001228429,0.00050522725,0.0012351496,0.0010479704,0.00046368255,0.0024175064,0.0008060548],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94255275,0.033429064,0.0019504383,0.0003306685,0.00046364358,0.000065882145,0.00013061882,0.00019866152,0.0026556142,0.00003508725,0.00031473147,0.017872876],"study_design_scores_gemma":[0.7406396,0.25218078,0.0058217905,0.00002065127,0.0001944793,0.000044605764,0.00003539091,0.0003465681,0.00034061196,0.00006393814,0.00029392968,0.00001751075],"about_ca_topic_score_codex":0.001007295,"about_ca_topic_score_gemma":0.0019586447,"teacher_disagreement_score":0.004311803,"about_ca_system_score_codex":0.00072326843,"about_ca_system_score_gemma":0.0010632839,"threshold_uncertainty_score":0.014424384},"labels":[],"label_agreement":null},{"id":"W2067204192","doi":"10.1517/14656566.6.13.2353","title":"A review of exemestane in the management of breast cancer","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Exemestane; Medicine; Aromatase; Tamoxifen; Breast cancer; Oncology; Internal medicine; Cancer; Endocrine system; Gynecology; Hormone","score_opus":0.03468283152236592,"score_gpt":0.4263808611344898,"score_spread":0.3916980296121239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067204192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007544417,0.9981091,0.00009903047,0.00031489288,0.00048447115,0.000007083935,0.000014466257,0.000005242675,0.0008901326],"genre_scores_gemma":[0.00027214622,0.99832314,0.00019410404,0.00030647893,0.00034564498,0.0000075167914,0.000022251836,0.0000010016139,0.000527621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967885,0.00007616099,0.00006093408,0.00004581076,0.00012143895,0.000016889137],"domain_scores_gemma":[0.9995902,0.00018004206,0.00007300579,0.000009665743,0.00010665736,0.000040412593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063928065,0.0010019233,0.0017488786,0.0026803024,0.00031910196,0.0008116571,0.0012445137,0.001199345,0.0046787104],"category_scores_gemma":[0.0010437459,0.0002835447,0.0005514593,0.0031597968,0.00037739766,0.0013399273,0.00044579915,0.0015719532,0.0033615353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094958086,0.000089002715,0.00011236865,0.024098247,0.0001102481,0.00050450506,0.00005411519,0.00030840185,0.0011409716,0.001361428,0.07734349,0.8947822],"study_design_scores_gemma":[0.00003945312,0.00011554388,0.0008327117,0.007977134,0.000126519,0.0025345802,0.000052009324,0.0000715698,0.00021940998,0.0010807479,0.9869337,0.000016521082],"about_ca_topic_score_codex":0.0011465258,"about_ca_topic_score_gemma":0.0028519984,"teacher_disagreement_score":0.0046787104,"about_ca_system_score_codex":0.0007471524,"about_ca_system_score_gemma":0.0008803957,"threshold_uncertainty_score":0.015651822},"labels":[],"label_agreement":null},{"id":"W2067463954","doi":"10.1517/14656566.4.10.1789","title":"The epidemiology of severe sepsis syndrome and its treatment with recombinant human activated protein C","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Drotrecogin alfa; Medicine; Intensive care medicine; Sepsis; Epidemiology; Intensive care unit; Protein C; Incidence (geometry); Severe sepsis; Septic shock; Internal medicine","score_opus":0.2697773719650954,"score_gpt":0.4863797149737627,"score_spread":0.21660234300866732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067463954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005714322,0.9990946,0.000041416308,0.00031207278,0.00008203496,0.0000030176598,0.000005538207,0.0000018011829,0.00040244503],"genre_scores_gemma":[0.00044424675,0.99902606,0.00010142039,0.00018347756,0.00010161469,0.0000046361,0.00000768945,2.6168908e-7,0.00013052327],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993561,0.00019447674,0.00009894761,0.000058740472,0.0002667975,0.000024856156],"domain_scores_gemma":[0.99909997,0.00040861176,0.00022736487,0.000018682586,0.0002114848,0.00003386045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009717817,0.00066784606,0.0019782647,0.0020665417,0.00022296607,0.0008884332,0.0006939496,0.0013833895,0.0023386956],"category_scores_gemma":[0.0018919682,0.0002534341,0.00053078495,0.0036154275,0.0005162127,0.0010621379,0.00037026464,0.0010584621,0.0013272738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011238462,0.00006839628,0.0005733866,0.03802839,0.00026171535,0.000429613,0.000051774066,0.00031572746,0.0009568764,0.0020928783,0.029452084,0.92765677],"study_design_scores_gemma":[0.00007780438,0.00026023143,0.0070636845,0.01891701,0.00053974584,0.006610633,0.00016980592,0.0001290184,0.0005879719,0.0023818938,0.9632258,0.00003639978],"about_ca_topic_score_codex":0.0023391852,"about_ca_topic_score_gemma":0.0033631523,"teacher_disagreement_score":0.0023391852,"about_ca_system_score_codex":0.0008294042,"about_ca_system_score_gemma":0.0020690341,"threshold_uncertainty_score":0.007823765},"labels":[],"label_agreement":null},{"id":"W2072750281","doi":"10.1517/14656560903025189","title":"Treatment options for epileptic myoclonus and epilepsy syndromes associated with myoclonus","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Glycogen Storage Diseases and Myoclonus","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Myoclonus; Medicine; Irritability; Etiology; Epilepsy; Epilepsy syndromes; Progressive myoclonus epilepsy; Intensive care medicine; Psychiatry; Neuroscience; Pediatrics; Psychology; Cognition","score_opus":0.09827733634555261,"score_gpt":0.4208378990022289,"score_spread":0.3225605626566763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072750281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002635854,0.9977754,0.00008703364,0.00042791848,0.00015386374,0.000008679603,0.00001565607,0.0000065849704,0.0012612826],"genre_scores_gemma":[0.002225295,0.9960829,0.00033102877,0.0004908388,0.00019151845,0.000019578709,0.00004122351,0.0000014004601,0.0006162815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976486,0.00007285015,0.000048160557,0.000026924215,0.00006605193,0.000021150276],"domain_scores_gemma":[0.9997149,0.00015297376,0.00007950788,0.0000061671717,0.00003217836,0.000014301915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042524486,0.00075818185,0.0017880201,0.0027342597,0.00027551147,0.0005382015,0.00084667426,0.0013473666,0.0060907346],"category_scores_gemma":[0.00084637007,0.0001980078,0.0008252092,0.0019462494,0.0002617617,0.0008366777,0.000334504,0.00089606625,0.0018248837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001489483,0.0001351035,0.0003236134,0.046834446,0.00034259591,0.0018152756,0.000084742336,0.00031138788,0.0014812619,0.0013007524,0.030753424,0.91646856],"study_design_scores_gemma":[0.0004142968,0.0004453467,0.006333729,0.04330519,0.001440241,0.028741244,0.00043966217,0.00033933477,0.001505662,0.0033870111,0.91358006,0.000068186724],"about_ca_topic_score_codex":0.0010363518,"about_ca_topic_score_gemma":0.0028716787,"teacher_disagreement_score":0.0060907346,"about_ca_system_score_codex":0.0004407949,"about_ca_system_score_gemma":0.00073046854,"threshold_uncertainty_score":0.02037555},"labels":[],"label_agreement":null},{"id":"W2073384113","doi":"10.1517/14656566.8.11.1651","title":"Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Acute gastroenteritis; Intensive care medicine; Rotavirus; Ondansetron; Clinical trial; Diarrhea; Pediatrics; Vomiting; Surgery; Internal medicine","score_opus":0.13517698774905557,"score_gpt":0.4957563572399178,"score_spread":0.3605793694908622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073384113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006590989,0.99871147,0.00004079536,0.0006064371,0.000118391734,0.0000029670807,0.000006437139,0.0000028030818,0.00044487242],"genre_scores_gemma":[0.00037850704,0.99877435,0.000092263304,0.00034212696,0.00017058883,0.0000049714085,0.000009870773,5.088164e-7,0.00022668918],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964845,0.00010755931,0.00005887062,0.00004399461,0.00011635448,0.000024801619],"domain_scores_gemma":[0.9993643,0.0003049355,0.0001432509,0.000016782573,0.00012756561,0.00004323705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008577887,0.0008087261,0.0027560296,0.0018086736,0.00021335128,0.000998372,0.00092436135,0.0013998483,0.0045242356],"category_scores_gemma":[0.0011589725,0.0001940708,0.0007068999,0.0026813683,0.00048470672,0.0014883095,0.00042861848,0.0015415311,0.002248398],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110805595,0.00007517679,0.00021104755,0.023535026,0.00015767601,0.000254034,0.000040666808,0.00017121593,0.0005505717,0.0014330021,0.030267933,0.94319284],"study_design_scores_gemma":[0.00014737385,0.00025216793,0.0030783731,0.0207489,0.00035524715,0.0028902993,0.00013506536,0.00013527305,0.0003558804,0.0025842467,0.9692918,0.000025404548],"about_ca_topic_score_codex":0.0013450967,"about_ca_topic_score_gemma":0.003594332,"teacher_disagreement_score":0.0045242356,"about_ca_system_score_codex":0.00084369007,"about_ca_system_score_gemma":0.0013809938,"threshold_uncertainty_score":0.01513505},"labels":[],"label_agreement":null},{"id":"W2074772519","doi":"10.1517/14656566.8.11.1769","title":"The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Etonogestrel; Vaginal ring; Medicine; Desogestrel; Dosing; Ethinylestradiol; Gynecology; Family planning; Sterilization (economics); Population; Obstetrics; Intravaginal administration; Hormonal contraception; Research methodology; Vagina; Pharmacology; Surgery","score_opus":0.1280559089278602,"score_gpt":0.48001780177774095,"score_spread":0.3519618928498808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074772519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002828995,0.99682546,0.00017489941,0.00019082062,0.00011621161,0.000012947025,0.000030367954,0.000009719603,0.0023566077],"genre_scores_gemma":[0.0021059697,0.99528474,0.00041187747,0.00024733928,0.00016940084,0.00001535134,0.000060659007,0.0000017240752,0.0017030316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996804,0.000056749683,0.00003746392,0.000055181106,0.0001475449,0.000022682247],"domain_scores_gemma":[0.99984026,0.00006465575,0.00004752459,0.000005260239,0.000027561313,0.000014757419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049863616,0.0006471524,0.0015734701,0.0020000546,0.00016448271,0.00057473604,0.00080448284,0.0008420023,0.0075264215],"category_scores_gemma":[0.0004923405,0.00018647968,0.00049447315,0.0016095266,0.00027589418,0.00075067516,0.0003570804,0.00073281233,0.0040319245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011768817,0.00006505442,0.00019462655,0.014517154,0.00013122655,0.0006358547,0.000022791253,0.00012323773,0.0030638408,0.00091602694,0.015628405,0.964584],"study_design_scores_gemma":[0.0001565521,0.00034221524,0.0022765112,0.0037905087,0.00026117146,0.009795407,0.00005442038,0.000082321196,0.0016054234,0.00065917993,0.9809534,0.000022906448],"about_ca_topic_score_codex":0.00072793773,"about_ca_topic_score_gemma":0.0016926691,"teacher_disagreement_score":0.0075264215,"about_ca_system_score_codex":0.0003306974,"about_ca_system_score_gemma":0.00049880275,"threshold_uncertainty_score":0.025178432},"labels":[],"label_agreement":null},{"id":"W2075154501","doi":"10.1517/14656566.2014.902936","title":"Teriflunomide: a novel oral treatment for relapsing multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Teriflunomide; Medicine; Tolerability; Multiple sclerosis; Intensive care medicine; Adverse effect; Oncology; Internal medicine; Fingolimod; Immunology","score_opus":0.42314524665065556,"score_gpt":0.5018911586860166,"score_spread":0.07874591203536108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075154501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017893374,0.99849,0.00009122515,0.00022556854,0.0001371569,0.00000998315,0.000017833843,0.0000066539924,0.00084263127],"genre_scores_gemma":[0.0012198549,0.99762976,0.00020665492,0.00022626622,0.00012259859,0.000011266185,0.00003066178,0.0000014328976,0.0005514541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998323,0.000032870463,0.000026767293,0.000029080293,0.000065954024,0.000013018182],"domain_scores_gemma":[0.99984884,0.00006686917,0.00003794107,0.00000395944,0.000029816494,0.000012608565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035162747,0.00059401465,0.0010513033,0.0018488888,0.00026415574,0.0006581421,0.00053302635,0.0008661357,0.005208891],"category_scores_gemma":[0.00044365515,0.00017522952,0.0005663729,0.0014612303,0.00030940876,0.00075968396,0.0004366947,0.0014022266,0.0018457068],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009669457,0.00006392126,0.00010217132,0.02276949,0.00012856063,0.00021166775,0.00005893107,0.0001441729,0.0020551025,0.0013185592,0.017118549,0.9559322],"study_design_scores_gemma":[0.000097813645,0.00021161081,0.0014149487,0.00974037,0.00039045615,0.0034016867,0.000085180116,0.00011829528,0.0012172351,0.0011790936,0.9821186,0.00002461394],"about_ca_topic_score_codex":0.0008243101,"about_ca_topic_score_gemma":0.0018657794,"teacher_disagreement_score":0.005208891,"about_ca_system_score_codex":0.00035923425,"about_ca_system_score_gemma":0.0006529522,"threshold_uncertainty_score":0.017425418},"labels":[],"label_agreement":null},{"id":"W2075399197","doi":"10.1517/14656566.9.13.2259","title":"Pharmacotherapy of relapsed metastatic testicular cancer","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy; Testicular cancer; Radiation therapy; Cisplatin; Oncology; Internal medicine; Cancer; Disease; Pharmacotherapy","score_opus":0.13829468147737287,"score_gpt":0.490619097376913,"score_spread":0.3523244158995401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075399197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019078863,0.99908686,0.00004168484,0.000106542466,0.000072077244,0.0000036832291,0.000008229726,0.000003195178,0.00048702626],"genre_scores_gemma":[0.001541373,0.99786395,0.0000960561,0.00016059713,0.00010048301,0.0000056697236,0.000016438966,8.148405e-7,0.00021461044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998041,0.000057902518,0.000027921113,0.000030800988,0.00006584414,0.000013551304],"domain_scores_gemma":[0.99974126,0.00012357863,0.00006965559,0.000006893044,0.000043638476,0.000015009428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003863705,0.00056983077,0.0016439493,0.0014180877,0.00017713233,0.00046734608,0.0008389785,0.00070827757,0.0026057765],"category_scores_gemma":[0.0006420546,0.00014727257,0.0004377586,0.0015877654,0.0003140823,0.00046063864,0.00026770835,0.00060361304,0.0010879858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010192082,0.00006712506,0.00034043827,0.03226689,0.00022831545,0.0006029853,0.000042419106,0.0002650542,0.0011122369,0.00067843846,0.020784637,0.9435095],"study_design_scores_gemma":[0.00018226013,0.00045695697,0.0068217516,0.022126662,0.00095880945,0.015166526,0.0001679096,0.00043454874,0.0019479925,0.001769151,0.94992703,0.00004040463],"about_ca_topic_score_codex":0.0010939852,"about_ca_topic_score_gemma":0.0022120671,"teacher_disagreement_score":0.0026057765,"about_ca_system_score_codex":0.00038616298,"about_ca_system_score_gemma":0.00070107315,"threshold_uncertainty_score":0.008717179},"labels":[],"label_agreement":null},{"id":"W2075578129","doi":"10.1517/14656566.7.16.2271","title":"Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Famciclovir; Medicine; Penciclovir; Viral shedding; Herpes simplex virus; Asymptomatic; Valaciclovir; Transmission (telecommunications); Adverse effect; Immunology; Dosing; Virus; Virology; Internal medicine; Herpesviridae; Viral disease","score_opus":0.21743447602998886,"score_gpt":0.5453714211799782,"score_spread":0.3279369451499893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075578129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017113207,0.99803334,0.000087344044,0.00037954908,0.0001701527,0.000005542241,0.000009894068,0.0000048593674,0.0011380919],"genre_scores_gemma":[0.0011096274,0.99748033,0.00022046478,0.0003372712,0.0002719359,0.000007185851,0.00001975294,0.0000011082716,0.0005523785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998203,0.00005005634,0.000020312538,0.000029346786,0.000064512926,0.000015593707],"domain_scores_gemma":[0.99979573,0.00009168656,0.00003829869,0.0000061991777,0.000046470646,0.000021625352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057428813,0.0008534384,0.0015108227,0.0021329944,0.0002045775,0.0007033458,0.0009092795,0.0013116515,0.004778083],"category_scores_gemma":[0.00047320433,0.0001925487,0.00051749096,0.0017958849,0.00037126016,0.0010618217,0.00031087652,0.0014037738,0.0021907997],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017911992,0.00012491224,0.00012412101,0.008907927,0.00009129332,0.00047417847,0.000037068643,0.00023777511,0.0015772235,0.0012391694,0.020628069,0.96637917],"study_design_scores_gemma":[0.00023850713,0.00060241995,0.0024768012,0.006438081,0.00024675284,0.0077857855,0.000100753234,0.00027829717,0.00080753164,0.0019118512,0.97907704,0.000036218073],"about_ca_topic_score_codex":0.0009026083,"about_ca_topic_score_gemma":0.002205521,"teacher_disagreement_score":0.004778083,"about_ca_system_score_codex":0.0004484184,"about_ca_system_score_gemma":0.0004777896,"threshold_uncertainty_score":0.015984297},"labels":[],"label_agreement":null},{"id":"W2076137665","doi":"10.1517/14656566.2010.510835","title":"Atypical antipsychotic tolerability and switching strategies in bipolar disorder","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; University Health Network","funders":"","keywords":"Tolerability; Medicine; Bipolar disorder; Atypical antipsychotic; Discontinuation; Tardive dyskinesia; Treatment of bipolar disorder; Quetiapine; Adverse effect; Extrapyramidal symptoms; Antipsychotic; Psychiatry; Risperidone; Mania; Schizophrenia (object-oriented programming); Internal medicine; Lithium (medication)","score_opus":0.0556380966803749,"score_gpt":0.4287480617266722,"score_spread":0.3731099650462973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076137665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014048409,0.9685327,0.001139034,0.0052563297,0.0007617771,0.000038528866,0.00012039243,0.000062122126,0.010040648],"genre_scores_gemma":[0.13335414,0.84830856,0.0023742225,0.008151388,0.0030282957,0.00006890091,0.00025573687,0.000039889455,0.0044189286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999524,0.00014393403,0.00008564819,0.00004397957,0.00017102486,0.000031472653],"domain_scores_gemma":[0.9994215,0.00023507184,0.00018519524,0.000015121893,0.00011337678,0.000029731329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097065174,0.00021900916,0.00043375365,0.00032529997,0.0001620934,0.00069378794,0.0002696935,0.0005083634,0.002369167],"category_scores_gemma":[0.0019661281,0.00008201577,0.00052706455,0.0003648188,0.0002208347,0.00048375592,0.0002451901,0.0010648851,0.0005285542],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056123565,0.00005742001,0.0029768692,0.003823761,0.00015100067,0.0012598902,0.00033763517,0.00028386703,0.002389487,0.0022809901,0.018497813,0.9673799],"study_design_scores_gemma":[0.0004926192,0.0036918262,0.05168563,0.016370885,0.0020402984,0.027627956,0.0011767534,0.0013958522,0.006169826,0.01865515,0.87054527,0.00014794976],"about_ca_topic_score_codex":0.0009172261,"about_ca_topic_score_gemma":0.0017915376,"teacher_disagreement_score":0.002369167,"about_ca_system_score_codex":0.00043986892,"about_ca_system_score_gemma":0.0004983513,"threshold_uncertainty_score":0.00792563},"labels":[],"label_agreement":null},{"id":"W2078654246","doi":"10.1517/14656566.2010.508071","title":"Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Medicine; Tranexamic acid; QT interval; Anesthesia; Internal medicine; Cardiology; Pharmacology; Surgery; Blood loss","score_opus":0.09651605985712917,"score_gpt":0.4475528035186238,"score_spread":0.3510367436614946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078654246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985044,0.00079896674,0.00022708008,0.00004841998,0.000019147872,0.00018674895,0.0000466543,0.000009353204,0.00015911816],"genre_scores_gemma":[0.9983652,0.0005055621,0.00054652523,0.00007011519,0.00006165748,0.00015580229,0.000054690503,0.000002047871,0.00023834013],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995802,0.00020969535,0.00003845244,0.000069356254,0.00006535518,0.00003690807],"domain_scores_gemma":[0.9994153,0.0001414719,0.00025462147,0.000047202902,0.00003841941,0.00010304636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072323706,0.0003683111,0.0011790218,0.000118201766,0.00013720698,0.00023270393,0.00032911848,0.0004890409,0.0013746762],"category_scores_gemma":[0.0012545813,0.00022347814,0.00038215963,0.000112357135,0.00034971736,0.00024041698,0.00015056667,0.0007931167,0.00012335976],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68856406,0.020347148,0.015012629,0.0010320075,0.00093528884,0.00020700511,0.00017428669,0.00044490682,0.12866038,0.00007329403,0.000342166,0.14420687],"study_design_scores_gemma":[0.11365076,0.7616408,0.10075945,0.00006359183,0.0011362252,0.00047978433,0.00006396029,0.0011629243,0.01966702,0.000054601704,0.001298227,0.000022734996],"about_ca_topic_score_codex":0.0003160817,"about_ca_topic_score_gemma":0.00072178664,"teacher_disagreement_score":0.0013746762,"about_ca_system_score_codex":0.00025526085,"about_ca_system_score_gemma":0.00043760944,"threshold_uncertainty_score":0.004598677},"labels":[],"label_agreement":null},{"id":"W2078959212","doi":"10.1517/14656566.8.11.1693","title":"Novel uses for risperidone: focus on depressive, anxiety and behavioral disorders","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Risperidone; Anxiety; Medicine; Tolerability; Psychiatry; Mood disorders; Mood; Atypical antipsychotic; Bipolar disorder; Schizophrenia (object-oriented programming); Randomized controlled trial; Antipsychotic; Clinical psychology; Adverse effect; Pharmacology","score_opus":0.18192137894730873,"score_gpt":0.5018738249233845,"score_spread":0.31995244597607575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078959212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007266542,0.9981944,0.00010359443,0.0005179685,0.0002435966,0.0000061089563,0.000012247726,0.0000074960367,0.00084202405],"genre_scores_gemma":[0.0005498794,0.99770784,0.0003215941,0.000610786,0.00027767013,0.000008612509,0.000021331052,0.0000016361537,0.0005007278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996152,0.00008807272,0.00007995249,0.000058270227,0.00013596474,0.000022559962],"domain_scores_gemma":[0.9994578,0.00024599003,0.00011409288,0.000014317271,0.00013781535,0.000029971463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008070501,0.0010687179,0.002372527,0.0024954397,0.0002612242,0.0008534043,0.00090178393,0.0012509002,0.0039957194],"category_scores_gemma":[0.000994466,0.00024574337,0.0009790686,0.002960203,0.00044343824,0.0013165496,0.0005090279,0.0016809722,0.0022734487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007782792,0.000064665204,0.00016005067,0.031605307,0.00024141383,0.0005145071,0.00005565958,0.0002574527,0.0010209328,0.0016363207,0.046643678,0.9177222],"study_design_scores_gemma":[0.00010406859,0.00016745622,0.0019545862,0.020622227,0.0005559124,0.0042767175,0.000115728464,0.0002357218,0.0004998466,0.0022833536,0.9691486,0.000035805082],"about_ca_topic_score_codex":0.0014098281,"about_ca_topic_score_gemma":0.005132414,"teacher_disagreement_score":0.0039957194,"about_ca_system_score_codex":0.0007215016,"about_ca_system_score_gemma":0.0010850442,"threshold_uncertainty_score":0.013366997},"labels":[],"label_agreement":null},{"id":"W2081943145","doi":"10.1517/14656566.9.8.1387","title":"Co-administration of opioid agonists and antagonists in addiction and pain medicine","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Medicine; Opioid; Addiction; Pharmacology; Opioid addiction; Chronic pain; Addiction medicine; Buprenorphine; Anesthesia; Internal medicine; Physical therapy; Psychiatry; Receptor","score_opus":0.05378495400292248,"score_gpt":0.42652186129092456,"score_spread":0.3727369072880021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081943145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000087668486,0.9991855,0.000035660734,0.000120440636,0.00007243395,0.0000035037442,0.0000043786613,0.0000012772816,0.00048920134],"genre_scores_gemma":[0.0010575022,0.99819857,0.00018838419,0.00015912935,0.000122149,0.0000075784574,0.000008792698,5.8972444e-7,0.00025734166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911076,0.00026927894,0.00018098923,0.00010206231,0.00029480451,0.000042054315],"domain_scores_gemma":[0.99880517,0.00071854383,0.0002732966,0.000019078092,0.0001546823,0.000029271536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010670807,0.0007369484,0.0022684247,0.0029112203,0.00029373358,0.0011052607,0.0008841008,0.001490309,0.004733985],"category_scores_gemma":[0.0016148823,0.00030995024,0.0008278366,0.0040940302,0.00046604307,0.0012988497,0.00049878925,0.0009219719,0.0016952495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014677395,0.00009661418,0.0005874867,0.106410265,0.00054408103,0.00095787714,0.000117053096,0.00019438808,0.0019234089,0.0014985455,0.013440621,0.87408274],"study_design_scores_gemma":[0.00013326448,0.00037299283,0.0069044265,0.06562013,0.0022719123,0.016272504,0.0004275599,0.00023897528,0.00167068,0.002233426,0.90379107,0.000063162806],"about_ca_topic_score_codex":0.0014275754,"about_ca_topic_score_gemma":0.004074073,"teacher_disagreement_score":0.004733985,"about_ca_system_score_codex":0.00069720304,"about_ca_system_score_gemma":0.0016396209,"threshold_uncertainty_score":0.015836716},"labels":[],"label_agreement":null},{"id":"W2085923488","doi":"10.1517/14656561003614773","title":"Pharmacokinetic comparison of an oral diclofenac potassium liquid-filled soft gelatin capsule with a diclofenac potassium tablet","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Diclofenac; Medicine; Pharmacokinetics; Potassium; Capsule; Gelatin; Pharmacology; Chromatography; Biochemistry","score_opus":0.02238942418740035,"score_gpt":0.36776019453908965,"score_spread":0.3453707703516893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085923488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970054,0.0017952402,0.0006215576,0.00003061499,0.000021737742,0.000150624,0.00008014004,0.000017854769,0.00027679856],"genre_scores_gemma":[0.99721694,0.0005974548,0.0015777516,0.00006632014,0.00001781921,0.00008522386,0.0001591443,0.000005964039,0.00027330237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992816,0.00024410951,0.00005725779,0.00016775272,0.00020092542,0.000048367918],"domain_scores_gemma":[0.99947363,0.0001547054,0.00015605814,0.000043884094,0.00005124194,0.00012049089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006490564,0.00042346027,0.0007164894,0.0002558383,0.00013019795,0.00045782735,0.000340169,0.00063467264,0.0012096022],"category_scores_gemma":[0.0016430003,0.00030928254,0.00036462134,0.00026004235,0.00046222605,0.0004547988,0.0001904086,0.00047051505,0.00024639795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11464347,0.0029461982,0.0045655877,0.0012025997,0.00058662816,0.00019912797,0.000253867,0.0006597531,0.80701137,0.0001249635,0.00022568356,0.0675808],"study_design_scores_gemma":[0.025536919,0.58535403,0.09740676,0.00010775192,0.0014933252,0.0014387611,0.00021127223,0.005121841,0.2784266,0.00009493885,0.0046582352,0.00014952353],"about_ca_topic_score_codex":0.00064957095,"about_ca_topic_score_gemma":0.0007704481,"teacher_disagreement_score":0.0012096022,"about_ca_system_score_codex":0.00029827308,"about_ca_system_score_gemma":0.00043732132,"threshold_uncertainty_score":0.0040465593},"labels":[],"label_agreement":null},{"id":"W2088817500","doi":"10.1517/14656566.6.2.157","title":"Hepatitis A vaccines: the growing case for universal immunisation of children","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hepatitis Viruses Studies and Epidemiology","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Herd immunity; Hepatitis A vaccine; Hepatitis A; Hepatitis a virus; Vaccination; Immunization; Hepatitis B; Pediatrics; Environmental health; Immunology; Hepatitis; Virus; Immune system","score_opus":0.11681724765628905,"score_gpt":0.4527021299099891,"score_spread":0.33588488225370006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088817500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010483239,0.9964978,0.0000844609,0.0024625564,0.00018925537,0.0000063956095,0.00002004044,0.0000050765157,0.0006295098],"genre_scores_gemma":[0.0006872575,0.9974795,0.00024295575,0.0011571156,0.00018503328,0.000014481362,0.000019225405,0.0000017578159,0.0002126631],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998073,0.00090418814,0.00029361856,0.00017497088,0.00048685554,0.000067340305],"domain_scores_gemma":[0.99382013,0.0041036303,0.0011019022,0.00014891244,0.0006278129,0.00019767013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042236983,0.0007386978,0.0033396976,0.0021463383,0.00020735711,0.0015015389,0.0011603368,0.0028362048,0.007210003],"category_scores_gemma":[0.0076594786,0.0003215886,0.0014968885,0.0035142358,0.00079707586,0.0021300714,0.0006892341,0.0020331,0.0023904275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014209334,0.000051977884,0.00038578035,0.048787378,0.0005013063,0.00017073654,0.00006438853,0.00020313945,0.00042733445,0.0025175828,0.03628776,0.91046053],"study_design_scores_gemma":[0.00025250606,0.0003683874,0.0037303427,0.06489975,0.00096392265,0.001832731,0.000186812,0.00011480104,0.00038567424,0.004380689,0.9228467,0.000037695463],"about_ca_topic_score_codex":0.0023154786,"about_ca_topic_score_gemma":0.004560984,"teacher_disagreement_score":0.007210003,"about_ca_system_score_codex":0.0013657777,"about_ca_system_score_gemma":0.0033205824,"threshold_uncertainty_score":0.024119914},"labels":[],"label_agreement":null},{"id":"W2090011342","doi":"10.1517/14656566.3.7.875","title":"Pharmacotherapy of acute respiratory distress syndrome","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; ARDS; Intensive care medicine; Magic bullet; Pharmacotherapy; Acute respiratory distress; Disease; Bioinformatics; Lung; Internal medicine","score_opus":0.12810905781096021,"score_gpt":0.44900790018194026,"score_spread":0.32089884237098004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090011342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004077823,0.9955108,0.00024388674,0.0006290105,0.00038166734,0.0000134412,0.000016702386,0.000014735771,0.0027820528],"genre_scores_gemma":[0.0021023927,0.99488384,0.000389736,0.00060483586,0.00044537825,0.000020671332,0.000032457207,0.0000022357124,0.0015184805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998287,0.000045065717,0.000022011629,0.00002148976,0.00006796444,0.000014675777],"domain_scores_gemma":[0.99986446,0.000049660084,0.000029697627,0.0000060431653,0.000039129154,0.00001104376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034488988,0.0006701413,0.0013608703,0.0011614636,0.00021277086,0.00057386,0.00059356954,0.0010370782,0.0048738676],"category_scores_gemma":[0.0003693515,0.00011836667,0.00030460808,0.0010455786,0.00025305984,0.00055563747,0.0003321559,0.0009219316,0.0032260888],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009876882,0.00013747,0.0001314063,0.009044592,0.00008479367,0.00051803305,0.00003226727,0.00015492205,0.003023368,0.0013138931,0.020775089,0.9646854],"study_design_scores_gemma":[0.00015112062,0.00038281802,0.0031636027,0.0034230344,0.0001560175,0.0069320616,0.000074789656,0.00023135204,0.0021258797,0.0022354412,0.98110044,0.000023469194],"about_ca_topic_score_codex":0.00052673055,"about_ca_topic_score_gemma":0.0011908017,"teacher_disagreement_score":0.0048738676,"about_ca_system_score_codex":0.00034762954,"about_ca_system_score_gemma":0.0005747722,"threshold_uncertainty_score":0.016304731},"labels":[],"label_agreement":null},{"id":"W2090189145","doi":"10.1517/14656560903140525","title":"The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Food and drug administration; Bioequivalence; Generic drug; MEDLINE; Drug; Substitution (logic); Drug approval; Antiepileptic drug; Alternative medicine; Epilepsy; Family medicine; Psychiatry; Pharmacology","score_opus":0.2535574849152221,"score_gpt":0.45538050080739784,"score_spread":0.20182301589217572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090189145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016554337,0.9992494,0.000026782653,0.00028047682,0.000040842875,0.000005066844,0.00002188187,6.8498224e-7,0.00020929516],"genre_scores_gemma":[0.0017438818,0.99800605,0.00006253037,0.00009522084,0.000046919184,0.000006491222,0.000012525506,3.712611e-7,0.000026027563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998247,0.0005294502,0.0004077874,0.00016958691,0.0005703317,0.0000757242],"domain_scores_gemma":[0.9816627,0.015014603,0.002199535,0.00009587019,0.0009215312,0.000105720734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041407463,0.0008694056,0.0031967408,0.00636269,0.00023092337,0.0019257959,0.0011302739,0.0018572578,0.0046501593],"category_scores_gemma":[0.017043399,0.00061255076,0.0021856981,0.010351207,0.0005934083,0.0015744308,0.0005366694,0.0009477788,0.0003914883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048285417,0.00007827051,0.0013706575,0.42177033,0.0033646205,0.0003816563,0.0000764767,0.0010540754,0.00020053527,0.004006936,0.011234561,0.55597895],"study_design_scores_gemma":[0.0004915568,0.00059615925,0.018733893,0.6177686,0.021204224,0.003121912,0.0005632339,0.0012616493,0.00061375496,0.0066616633,0.32888943,0.00009387756],"about_ca_topic_score_codex":0.0052607176,"about_ca_topic_score_gemma":0.007942998,"teacher_disagreement_score":0.00636269,"about_ca_system_score_codex":0.0032416093,"about_ca_system_score_gemma":0.0048460076,"threshold_uncertainty_score":0.023519635},"labels":[],"label_agreement":null},{"id":"W2090657901","doi":"10.1517/14656566.9.1.83","title":"Clinical management of chronic obstructive pulmonary disease and asthma in an obese patient","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Asthma; COPD; Obesity; Pulmonary disease; Concomitant; Intensive care medicine; Management of obesity; Disease; Respiratory system; Internal medicine; Weight loss; Physical therapy","score_opus":0.08568150894631833,"score_gpt":0.4675737346072304,"score_spread":0.3818922256609121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090657901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019011348,0.99676645,0.00017672527,0.001006489,0.0004329012,0.000009763723,0.00000864406,0.0000075518888,0.0014013244],"genre_scores_gemma":[0.0012997423,0.9959657,0.0005394616,0.0008016733,0.0006492337,0.000015561405,0.00002222645,0.0000010868021,0.00070538744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996544,0.000105989384,0.000043115804,0.0000339404,0.00014172778,0.000020859543],"domain_scores_gemma":[0.99974054,0.00010214613,0.00005536022,0.0000064095843,0.000069334776,0.000026118016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006099647,0.0006966783,0.0017931481,0.0011997547,0.00029810195,0.00072318705,0.00084066385,0.00160286,0.002380333],"category_scores_gemma":[0.0009299191,0.00014588538,0.0004474617,0.0011447612,0.00031431566,0.0007488332,0.00044630858,0.0013594539,0.0023153827],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058845642,0.00010317966,0.00036159434,0.013846649,0.00012444964,0.0011942739,0.00007823286,0.00019748218,0.0014833787,0.0011451152,0.044909693,0.9364972],"study_design_scores_gemma":[0.000099723635,0.00028942173,0.0042998525,0.011332227,0.00024421496,0.016015138,0.00021819462,0.00019609997,0.0005242285,0.002283155,0.9644619,0.00003585124],"about_ca_topic_score_codex":0.000743732,"about_ca_topic_score_gemma":0.00203531,"teacher_disagreement_score":0.002380333,"about_ca_system_score_codex":0.0003796217,"about_ca_system_score_gemma":0.00076873234,"threshold_uncertainty_score":0.007963061},"labels":[],"label_agreement":null},{"id":"W2091638536","doi":"10.1517/14656566.8.18.3147","title":"Prevention of Type 2 diabetes: fact or fiction?","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Prediabetes; Orlistat; Diabetes mellitus; Acarbose; Impaired glucose tolerance; Type 2 diabetes; Metformin; Internal medicine; Impaired fasting glucose; Weight loss; Obesity; Endocrinology","score_opus":0.1900839952381679,"score_gpt":0.5176337641156915,"score_spread":0.32754976887752363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091638536","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017590952,0.38544,0.00026471444,0.58957845,0.022862725,0.000005747068,0.000042493608,0.000023216435,0.0016068425],"genre_scores_gemma":[0.0075544366,0.53236824,0.0009424408,0.36757788,0.08992495,0.00004313021,0.00007366794,0.00003163244,0.0014836293],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938846,0.0031569847,0.00061969797,0.0007415257,0.0013022146,0.00029499625],"domain_scores_gemma":[0.9519575,0.035407685,0.0019426533,0.0017827146,0.0065328563,0.0023765583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0153696835,0.0014539632,0.0033960312,0.0021107884,0.0021816315,0.005388681,0.0029811433,0.010789059,0.005463144],"category_scores_gemma":[0.033837844,0.00047912137,0.0013738876,0.0027960234,0.012789382,0.012071145,0.0024912723,0.028785447,0.0027467848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034077105,0.00019329769,0.00088537094,0.005505576,0.0002747618,0.00032557294,0.00059814285,0.0002518177,0.00018033297,0.04509706,0.64459467,0.3017527],"study_design_scores_gemma":[0.00016664395,0.00022708987,0.0015514116,0.008474573,0.00018276442,0.0006448455,0.0012013398,0.00020401215,0.00010219971,0.07553681,0.9116327,0.000075540884],"about_ca_topic_score_codex":0.0045962953,"about_ca_topic_score_gemma":0.0043170177,"teacher_disagreement_score":0.0153696835,"about_ca_system_score_codex":0.0026035642,"about_ca_system_score_gemma":0.0042355936,"threshold_uncertainty_score":0.08128363},"labels":[],"label_agreement":null},{"id":"W2092235705","doi":"10.1517/14656566.8.18.3097","title":"Therapeutic management of acute intracerebral haemorrhage","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Intracerebral and Subarachnoid Hemorrhage Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta","funders":"","keywords":"Medicine; Intensive care medicine; Neurointensive care; Stroke (engine); Coagulopathy; Intracerebral hemorrhage; Natural history; Surgery; Internal medicine; Subarachnoid hemorrhage","score_opus":0.1372593060256154,"score_gpt":0.4886392771859018,"score_spread":0.3513799711602864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092235705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013706936,0.9985286,0.00009393205,0.00021941066,0.00011859967,0.000008304987,0.000009236899,0.000005685714,0.0008790796],"genre_scores_gemma":[0.001246462,0.9979499,0.00022417921,0.00021065536,0.00012887704,0.000012747226,0.000021313308,9.3589597e-7,0.00020493634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995353,0.0001317474,0.00007400521,0.00005238965,0.00017705082,0.000029473085],"domain_scores_gemma":[0.99971074,0.00013714346,0.00007025033,0.000007442454,0.000057678437,0.000016728203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071418285,0.00090654456,0.002359729,0.0028594772,0.00027801533,0.0007174043,0.0013739668,0.0011697481,0.0031251248],"category_scores_gemma":[0.0013855657,0.00018335364,0.0006838565,0.002139185,0.0004629781,0.000743559,0.0004012595,0.001188708,0.0017242965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011086533,0.00007813134,0.00019853805,0.035236686,0.00021368529,0.00058256544,0.00006172875,0.00024316643,0.0008698373,0.0012418088,0.02519488,0.93596816],"study_design_scores_gemma":[0.00022487252,0.0003213219,0.004447992,0.03711007,0.0007681407,0.0114185205,0.00021365922,0.00027748273,0.0012578798,0.0033316002,0.9405837,0.000044735632],"about_ca_topic_score_codex":0.0009486069,"about_ca_topic_score_gemma":0.0015057657,"teacher_disagreement_score":0.0031251248,"about_ca_system_score_codex":0.0007733053,"about_ca_system_score_gemma":0.000926515,"threshold_uncertainty_score":0.010454595},"labels":[],"label_agreement":null},{"id":"W2093145231","doi":"10.1517/14656566.2014.931373","title":"Pityriasis versicolor: an update on pharmacological treatment options","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Pityriasis; Dosing; Dermatology; Tinea versicolor; Antifungal; Expert opinion; Malassezia; Adverse effect; Intensive care medicine; Clinical trial; Pharmacology; Internal medicine","score_opus":0.16159978007492787,"score_gpt":0.5005085718537026,"score_spread":0.3389087917787747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093145231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007475994,0.99913627,0.000043226362,0.00025840936,0.00011306395,0.0000041994613,0.00001690926,0.0000026883265,0.00035055837],"genre_scores_gemma":[0.00053037406,0.99889576,0.00011606347,0.00018678705,0.00011378712,0.0000045927854,0.000023561315,6.7769827e-7,0.00012839033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960655,0.00008571345,0.000094399606,0.00005728127,0.00013064705,0.000025505973],"domain_scores_gemma":[0.9992512,0.0004265852,0.00013266208,0.0000124697435,0.00014721244,0.000029846507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006601841,0.00081737066,0.0016169323,0.002966021,0.00025915107,0.00096332986,0.0008062099,0.0009275516,0.005428194],"category_scores_gemma":[0.0014073384,0.00025218888,0.0010231853,0.0025476618,0.00034461278,0.001132795,0.00048521522,0.0013912016,0.0010476266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009338244,0.000067881796,0.0002233658,0.08829436,0.00026694866,0.0003135862,0.00009491824,0.000245125,0.0007289418,0.0013709799,0.032200485,0.87609994],"study_design_scores_gemma":[0.000067113666,0.00018378597,0.0023433673,0.0762508,0.0012662574,0.0041302326,0.0002018494,0.00019136614,0.00039772876,0.0016361407,0.9132901,0.00004121328],"about_ca_topic_score_codex":0.0017798601,"about_ca_topic_score_gemma":0.0038618057,"teacher_disagreement_score":0.005428194,"about_ca_system_score_codex":0.00067947624,"about_ca_system_score_gemma":0.0013068116,"threshold_uncertainty_score":0.018159151},"labels":[],"label_agreement":null},{"id":"W2096607288","doi":"10.1517/14656566.3.12.1739","title":"Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Doxorubicin; Therapeutic index; Metastatic breast cancer; Breast cancer; Pharmacology; Cumulative dose; Anthracycline; Cancer; Cardiotoxicity; Liposome; Therapeutic effect; Chemotherapy; Oncology; Internal medicine; Drug","score_opus":0.1480815675914475,"score_gpt":0.45383212290448716,"score_spread":0.30575055531303963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096607288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004682148,0.9951939,0.00066045596,0.0008514324,0.00038960326,0.000018768418,0.000015346572,0.000016186734,0.0023861413],"genre_scores_gemma":[0.0013392871,0.9956702,0.00070355285,0.00051772676,0.00029604186,0.0000152402745,0.000029365108,0.000002288147,0.0014263885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981755,0.000033458975,0.000016734424,0.0000325734,0.00008448616,0.0000152291395],"domain_scores_gemma":[0.9999006,0.00003311894,0.00001818708,0.0000047907324,0.000027826936,0.00001545792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062000647,0.0008736453,0.0014411027,0.0018372255,0.00029256562,0.0009491841,0.0007590536,0.0012686586,0.0034919558],"category_scores_gemma":[0.0002834139,0.00027839278,0.00040039403,0.0018420744,0.0006464201,0.0016541572,0.00055887504,0.0017156091,0.0036014565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116638614,0.00019632853,0.00011271919,0.0057876445,0.000052549232,0.0005539943,0.000070105576,0.00045630493,0.008590809,0.0045038685,0.019648062,0.9599109],"study_design_scores_gemma":[0.000105173596,0.00034961107,0.0008144065,0.0012436148,0.000074592266,0.0029725302,0.000052396445,0.0002567913,0.0022899962,0.0024176112,0.98939323,0.000030107001],"about_ca_topic_score_codex":0.0008350211,"about_ca_topic_score_gemma":0.0018835193,"teacher_disagreement_score":0.0034919558,"about_ca_system_score_codex":0.00081071095,"about_ca_system_score_gemma":0.00080067007,"threshold_uncertainty_score":0.011681795},"labels":[],"label_agreement":null},{"id":"W2098097322","doi":"10.1517/14656566.2014.923403","title":"Desvenlafaxine for the treatment of major depressive disorder","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); University of Toronto","funders":"","keywords":"Tolerability; Major depressive disorder; Antidepressant; Medicine; Psychiatry; Placebo; Population; Reuptake inhibitor; Clinical trial; Internal medicine; Oncology; Pharmacology; Adverse effect; Mood; Alternative medicine","score_opus":0.08784260984736643,"score_gpt":0.4567015111206201,"score_spread":0.36885890127325366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098097322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015972136,0.99863917,0.000059312195,0.00027349676,0.00014420117,0.000007618906,0.00002124713,0.000003787672,0.00069143466],"genre_scores_gemma":[0.0018354829,0.9968843,0.00015361114,0.0003571549,0.00013643148,0.000009971346,0.000043542917,9.967396e-7,0.0005784787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998332,0.000040674,0.000029400559,0.000027527707,0.000057517955,0.00001157585],"domain_scores_gemma":[0.99981374,0.000086629865,0.000050734423,0.0000034276925,0.000033849505,0.000011589188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003686042,0.0004098934,0.0008223311,0.0012214762,0.00014098562,0.00041938174,0.0005227221,0.00067467743,0.0053232424],"category_scores_gemma":[0.00067136774,0.000111391484,0.00051090936,0.0010839708,0.00017399996,0.00038865214,0.000259718,0.00078905385,0.001700848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001357783,0.0000378556,0.0001496721,0.04310316,0.00027182826,0.00020412987,0.000040642808,0.00015085319,0.0012892383,0.00094223575,0.027630184,0.92604434],"study_design_scores_gemma":[0.00023679085,0.00023833528,0.0025328621,0.028692165,0.0009823642,0.0032264434,0.00007986888,0.00015145166,0.0007809759,0.0014769553,0.9615761,0.00002565023],"about_ca_topic_score_codex":0.000861052,"about_ca_topic_score_gemma":0.0023763087,"teacher_disagreement_score":0.0053232424,"about_ca_system_score_codex":0.0003146818,"about_ca_system_score_gemma":0.00060388865,"threshold_uncertainty_score":0.01780796},"labels":[],"label_agreement":null},{"id":"W2098445432","doi":"10.1517/14656566.3.4.363","title":"Synthetic dopamine agonists","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Expert opinion; Dopamine; Dopamine agonist; Pharmacology; Pharmacotherapy; Pramipexole; Endogenous agonist; Dopamine receptor; Internal medicine; Dopamine receptor D1; Dopaminergic; Intensive care medicine; Disease; Parkinson's disease","score_opus":0.16680712516147878,"score_gpt":0.46492068759023286,"score_spread":0.2981135624287541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098445432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022808879,0.9919304,0.00033073456,0.00055581436,0.0009248161,0.0000347613,0.00025245608,0.000043229466,0.005699635],"genre_scores_gemma":[0.0020353857,0.9841658,0.00064774236,0.0013066905,0.0006914376,0.00006965427,0.00073265814,0.000010588407,0.010340016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997044,0.00003468824,0.000036329155,0.000040042338,0.00016152597,0.00002295343],"domain_scores_gemma":[0.9997991,0.000047705627,0.000062919804,0.000007394463,0.000056979643,0.000025886911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003988365,0.0013666969,0.0012484441,0.0023584228,0.00025144726,0.0008115237,0.0009299775,0.0017625977,0.01222228],"category_scores_gemma":[0.00051301334,0.0004982518,0.000686091,0.0020759848,0.0003719743,0.0010764971,0.00074448856,0.0018520288,0.016769174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023389679,0.00009284183,0.00010216674,0.010640867,0.00008022494,0.00042720544,0.000032625067,0.00019634533,0.006071573,0.0013290528,0.17095035,0.8098428],"study_design_scores_gemma":[0.00009851284,0.00018194367,0.00048502162,0.0012822084,0.00006164136,0.0016547844,0.00001768667,0.000052603453,0.0014720546,0.00058367907,0.9940935,0.000016458298],"about_ca_topic_score_codex":0.0018511676,"about_ca_topic_score_gemma":0.0054639215,"teacher_disagreement_score":0.01222228,"about_ca_system_score_codex":0.0005023877,"about_ca_system_score_gemma":0.0007139001,"threshold_uncertainty_score":0.040887654},"labels":[],"label_agreement":null},{"id":"W2099168269","doi":"10.1517/14656566.3.3.341","title":"Seretide for obstructive lung disease","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital","funders":"","keywords":"Salmeterol; Fluticasone propionate; Medicine; Inhaler; Asthma; Bronchodilator; COPD; Fluticasone; Exacerbation; Salbutamol; Maintenance therapy; Corticosteroid; Dry-powder inhaler; Intensive care medicine; Internal medicine; Chemotherapy","score_opus":0.08973338735497513,"score_gpt":0.4491465449872883,"score_spread":0.3594131576323132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099168269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03265516,0.7015838,0.004026874,0.025556173,0.009967788,0.00093466457,0.0026174623,0.0021155253,0.22054267],"genre_scores_gemma":[0.23929913,0.27098382,0.00884353,0.04753384,0.011751677,0.0013095516,0.009238007,0.00025326724,0.4107871],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997861,0.00004132771,0.000014409052,0.000034981174,0.00007511954,0.0000480898],"domain_scores_gemma":[0.9997243,0.000045008866,0.00004615407,0.000013078756,0.000034893048,0.0001364928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042322904,0.00063868903,0.00073114334,0.00050219597,0.00039650695,0.0006931535,0.0005600538,0.0014097227,0.036279295],"category_scores_gemma":[0.00045021987,0.00010721381,0.0008789653,0.00035775744,0.00023585906,0.0003546393,0.0005580973,0.0022721868,0.016416924],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030514267,0.0010706089,0.0020909293,0.0024564017,0.0001658525,0.002592919,0.000072512,0.00011659169,0.019253498,0.0027763005,0.24886955,0.7174833],"study_design_scores_gemma":[0.0030853862,0.0038082122,0.010470069,0.0009085893,0.0001777006,0.006423794,0.000028545363,0.00031106008,0.0038971875,0.0009849287,0.9698694,0.000035098878],"about_ca_topic_score_codex":0.00037693314,"about_ca_topic_score_gemma":0.0011923511,"teacher_disagreement_score":0.036279295,"about_ca_system_score_codex":0.00040376335,"about_ca_system_score_gemma":0.00065158424,"threshold_uncertainty_score":0.12136632},"labels":[],"label_agreement":null},{"id":"W2101110309","doi":"10.1517/14656566.9.3.491","title":"Alendronate for the treatment of osteoporosis in men","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada; University of Saskatchewan","funders":"","keywords":"Medicine; Osteoporosis; Bisphosphonate; Bone mineral; Regimen; Fragility fracture; Dosing; Internal medicine; Bone density; Surgery","score_opus":0.15894291898413984,"score_gpt":0.49535711169654223,"score_spread":0.33641419271240236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101110309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010970248,0.99870217,0.000048847083,0.00023246683,0.000104266954,0.000009769846,0.000016204125,0.000005326819,0.00077129743],"genre_scores_gemma":[0.0011782245,0.99735343,0.00016017305,0.00041585823,0.00016082649,0.0000135798255,0.000035456982,0.0000013303755,0.00068116403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965644,0.00008728699,0.000055034212,0.000044412893,0.00013620344,0.000020633695],"domain_scores_gemma":[0.9997315,0.00011324983,0.00008500629,0.000007828498,0.000045400724,0.000017098493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071941374,0.00063285034,0.0018979452,0.0027051575,0.00021601429,0.00059996796,0.0007659343,0.0010623377,0.0061261915],"category_scores_gemma":[0.0008997529,0.00021778414,0.0007011045,0.0026521524,0.00033348505,0.0005676348,0.00038721415,0.0008956131,0.0030455014],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021496802,0.00007421929,0.00027005517,0.034158584,0.0003568793,0.00035681346,0.00004233266,0.00015874437,0.0016264899,0.0011000617,0.03700514,0.92463577],"study_design_scores_gemma":[0.0003629491,0.000260824,0.0027981878,0.014877861,0.0008138025,0.004678293,0.00006753775,0.000116665506,0.0007790755,0.0017435666,0.97347736,0.000023962748],"about_ca_topic_score_codex":0.0012891699,"about_ca_topic_score_gemma":0.0028963925,"teacher_disagreement_score":0.0061261915,"about_ca_system_score_codex":0.00047110612,"about_ca_system_score_gemma":0.00087425153,"threshold_uncertainty_score":0.020494163},"labels":[],"label_agreement":null},{"id":"W2102096093","doi":"10.1517/14656566.2014.873790","title":"Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Dopamine; Dopamine receptor D2; Antipsychotic; Schizophrenia (object-oriented programming); Clinical trial; Dopamine receptor; Pharmacology; Dopamine receptor D3; Psychiatry; Internal medicine","score_opus":0.1437235222958871,"score_gpt":0.46804408064761527,"score_spread":0.3243205583517281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102096093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012458008,0.9987704,0.000079777885,0.0003099641,0.00012189259,0.000049182177,0.00003462633,0.000005493325,0.0005039356],"genre_scores_gemma":[0.0014400465,0.99714833,0.00034166317,0.000534535,0.000109794826,0.00008988719,0.00005367619,0.0000028150903,0.00027922273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989624,0.00041410018,0.0002032615,0.00008975861,0.00027159968,0.000058852103],"domain_scores_gemma":[0.9970943,0.0016330522,0.0007135114,0.000059417365,0.00038308828,0.00011667688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003595283,0.00090779184,0.0028639447,0.0017683863,0.00021793306,0.001179069,0.0015205649,0.0017189976,0.0061421487],"category_scores_gemma":[0.004575871,0.00029229937,0.0018358382,0.002790445,0.00046049332,0.0011558512,0.00054442004,0.0014498685,0.001316734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061869196,0.000114122275,0.00015302372,0.17862329,0.0005889458,0.00016253881,0.000076695556,0.0002804824,0.001198678,0.0017818926,0.026546134,0.7898555],"study_design_scores_gemma":[0.0021506143,0.0013881035,0.0024676016,0.28596985,0.0046625654,0.0012975982,0.00019017833,0.0003665409,0.0012770635,0.003634799,0.6965274,0.00006769193],"about_ca_topic_score_codex":0.0010203962,"about_ca_topic_score_gemma":0.00293976,"teacher_disagreement_score":0.0061421487,"about_ca_system_score_codex":0.0011190728,"about_ca_system_score_gemma":0.0029077688,"threshold_uncertainty_score":0.02054751},"labels":[],"label_agreement":null},{"id":"W2102201050","doi":"10.1517/14656566.4.12.2213","title":"Anti-thrombotic therapy in cancer patients","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Intensive care medicine; Cancer; Low molecular weight heparin; Thrombosis; Heparin; Venous thromboembolism; Clinical trial; Anticoagulant; Surgery; Internal medicine","score_opus":0.11896333985239967,"score_gpt":0.4575935634708984,"score_spread":0.33863022361849876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102201050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000393596,0.99745053,0.000055359393,0.0003703303,0.00011067567,0.0000076135107,0.000018113247,0.0000036909482,0.0015900648],"genre_scores_gemma":[0.0035912942,0.9950454,0.00015196565,0.0004820212,0.00015899746,0.000016212187,0.000036686044,7.5377676e-7,0.0005166477],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997335,0.00009231378,0.000032338132,0.000026985783,0.00009668728,0.000018218845],"domain_scores_gemma":[0.9997408,0.00011719281,0.000070552764,0.000006885564,0.000046697816,0.00001790263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044544108,0.00043891626,0.0012441373,0.0011019659,0.0001407723,0.00046230468,0.00056630594,0.0008091284,0.0044694026],"category_scores_gemma":[0.0009648858,0.00012223449,0.00044457483,0.0017337217,0.00013500899,0.0003913726,0.0002076628,0.00057536556,0.0015090759],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013116021,0.000090632915,0.0010879835,0.015681133,0.00020312652,0.00044957115,0.000044547032,0.00015444006,0.000520971,0.0005835414,0.029987046,0.95106584],"study_design_scores_gemma":[0.00035389067,0.00053376175,0.016733041,0.023010895,0.0009330924,0.009081208,0.00011505303,0.00028127187,0.0008714983,0.001314637,0.9467473,0.000024448293],"about_ca_topic_score_codex":0.0012451872,"about_ca_topic_score_gemma":0.0023060893,"teacher_disagreement_score":0.0044694026,"about_ca_system_score_codex":0.00040573988,"about_ca_system_score_gemma":0.0007223678,"threshold_uncertainty_score":0.014951587},"labels":[],"label_agreement":null},{"id":"W2103061944","doi":"10.1517/14656566.3.8.1131","title":"The evolution and role of macrolides in infectious diseases","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; St. Paul's Hospital; Royal University Hospital","funders":"","keywords":"Azithromycin; Clarithromycin; Erythromycin; Medicine; Antibiotics; Intensive care medicine; Macrolide Antibiotics; Antibiotic resistance; Antimicrobial; Infectious disease (medical specialty); Adverse effect; Pharmacology; Disease; Internal medicine; Microbiology; Biology","score_opus":0.03350763329633764,"score_gpt":0.3894406921246051,"score_spread":0.3559330588282674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103061944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000069937654,0.99884593,0.000074437885,0.00031314752,0.00012139704,0.000001759056,0.0000031466227,0.000003352461,0.000566832],"genre_scores_gemma":[0.00054512435,0.9985026,0.00015000894,0.00025175395,0.00021433491,0.0000033565962,0.000006189884,8.109387e-7,0.00032577646],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943346,0.00016145295,0.00008386563,0.00007806535,0.0002105153,0.000032572414],"domain_scores_gemma":[0.99936193,0.00028070432,0.000101988706,0.000029567316,0.00017687245,0.000048972997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010833973,0.0008601746,0.001695516,0.0021177197,0.0003717471,0.0012387194,0.000953039,0.0016547274,0.0025227137],"category_scores_gemma":[0.0012064811,0.00031026424,0.00043461437,0.0026780816,0.0010497415,0.0020667808,0.0007109393,0.0017331864,0.0022625616],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008554844,0.00006216651,0.00025992666,0.011313932,0.00008563317,0.00036483075,0.0001111057,0.00038577596,0.0018504853,0.0048912275,0.021518605,0.95907086],"study_design_scores_gemma":[0.000025809893,0.00011271524,0.001305012,0.0036757411,0.0000596995,0.001911277,0.00006387961,0.000075800985,0.00039336385,0.0027823509,0.9895795,0.000014788731],"about_ca_topic_score_codex":0.0012337732,"about_ca_topic_score_gemma":0.0018697771,"teacher_disagreement_score":0.0025227137,"about_ca_system_score_codex":0.0009750326,"about_ca_system_score_gemma":0.0012413658,"threshold_uncertainty_score":0.008439302},"labels":[],"label_agreement":null},{"id":"W2103158417","doi":"10.1517/14656566.2014.865724","title":"Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Intracranial Aneurysms: Treatment and Complications","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Subarachnoid hemorrhage; Ischemia; Context (archaeology); Vasospasm; Pathogenesis; Anesthesia; Cardiology; Internal medicine","score_opus":0.04896894933888376,"score_gpt":0.36300927752500767,"score_spread":0.31404032818612393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103158417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014306931,0.9987974,0.00006882043,0.00027679012,0.00014258889,0.000006851509,0.000024815647,0.0000043165796,0.0005353031],"genre_scores_gemma":[0.00061430736,0.9988392,0.00010358763,0.00011764744,0.000087469525,0.0000077628065,0.000021716998,6.7548547e-7,0.00020763343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998385,0.00003408302,0.000028648523,0.000023906989,0.00005757665,0.000017321807],"domain_scores_gemma":[0.9997887,0.000084076855,0.00005168259,0.000005623384,0.000056635796,0.000013295205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004019206,0.0006223779,0.0012660862,0.0015151945,0.00021131741,0.0006657477,0.0007119282,0.00094010826,0.0036333222],"category_scores_gemma":[0.00063619245,0.00016225624,0.0005145709,0.0012357591,0.00031240607,0.0006565048,0.00045620915,0.0011001593,0.001770615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011094869,0.00009545985,0.0001345975,0.04044386,0.00018203593,0.00018944236,0.000056964567,0.00025887432,0.0019758595,0.0019421257,0.025343219,0.9292665],"study_design_scores_gemma":[0.00007998957,0.00031792765,0.0019078061,0.01967948,0.00044711545,0.0020821523,0.00011268908,0.00017693365,0.0014203738,0.0026111,0.97112864,0.000035827357],"about_ca_topic_score_codex":0.0007853666,"about_ca_topic_score_gemma":0.001466529,"teacher_disagreement_score":0.0036333222,"about_ca_system_score_codex":0.00041316997,"about_ca_system_score_gemma":0.000647046,"threshold_uncertainty_score":0.012154639},"labels":[],"label_agreement":null},{"id":"W2104836659","doi":"10.1517/14656566.3.3.277","title":"Ketolides in the treatment of respiratory infections","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Ketolide; Telithromycin; Streptococcus pneumoniae; Microbiology; Medicine; Chronic bronchitis; Erythromycin; Respiratory tract infections; Streptococcus pyogenes; Pharmacology; Antibiotics; Biology; Bacteria; Staphylococcus aureus; Respiratory system; Internal medicine","score_opus":0.18356362710583396,"score_gpt":0.47271462341288684,"score_spread":0.2891509963070529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104836659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004830653,0.97958344,0.0009538996,0.0022002885,0.0010020405,0.000034083947,0.00010215667,0.0000629967,0.011230357],"genre_scores_gemma":[0.072960496,0.90185666,0.002981851,0.0033962235,0.0020791835,0.000069369264,0.00046259453,0.000027836775,0.01616575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976546,0.000059785085,0.000026232648,0.000033485132,0.00008762907,0.000027505295],"domain_scores_gemma":[0.99981433,0.00003766577,0.00004038139,0.000006221153,0.000058255657,0.000043128992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040084007,0.00038628612,0.000554974,0.00069602137,0.00018007126,0.00047730756,0.00038961964,0.0006928873,0.004970207],"category_scores_gemma":[0.00047865303,0.000089988156,0.00028421375,0.0006059764,0.00023532221,0.0004212993,0.00042969134,0.001897291,0.0026519597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010055166,0.00033348872,0.00062638335,0.0029046072,0.00008615872,0.00086935767,0.00010864479,0.0006577798,0.012280229,0.0034879528,0.040130973,0.9375089],"study_design_scores_gemma":[0.0004471834,0.0019872622,0.00435526,0.0013521644,0.000081597915,0.004145372,0.000088265915,0.0004041767,0.0048702434,0.0020208634,0.9802066,0.000041063748],"about_ca_topic_score_codex":0.00066004193,"about_ca_topic_score_gemma":0.0011766814,"teacher_disagreement_score":0.004970207,"about_ca_system_score_codex":0.00032163458,"about_ca_system_score_gemma":0.00026663265,"threshold_uncertainty_score":0.016626954},"labels":[],"label_agreement":null},{"id":"W2105286456","doi":"10.1517/14656566.2012.681779","title":"New therapeutic options for onychomycosis","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Terbinafine; Azole; Dermatology; Pharmacotherapy; Dosing; Drug; Iontophoresis; Pharmacology; Itraconazole; Internal medicine; Antifungal","score_opus":0.22693141211679096,"score_gpt":0.5066414459557826,"score_spread":0.2797100338389917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105286456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013463537,0.93566966,0.003677104,0.024167825,0.004556894,0.00007934149,0.0002405574,0.00014192915,0.030120365],"genre_scores_gemma":[0.018449828,0.937776,0.003946563,0.016369121,0.005873317,0.00009638179,0.00054197776,0.000038144954,0.016908621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994574,0.00012685006,0.000043519296,0.000079185585,0.00024034177,0.000052727853],"domain_scores_gemma":[0.99962795,0.00011838042,0.00007275665,0.000013415045,0.00012175653,0.000045670724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005291157,0.0005100743,0.00072275026,0.0008115376,0.00027411914,0.0011285293,0.0006171783,0.0017292941,0.023561027],"category_scores_gemma":[0.0009809798,0.00010261778,0.0007293963,0.0004132535,0.000511855,0.0011305409,0.0006744759,0.0022599052,0.006651934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012132282,0.00008154315,0.0002597134,0.008650914,0.00009350402,0.0009055404,0.00007513827,0.00025843724,0.0041333027,0.009654701,0.13438629,0.8413796],"study_design_scores_gemma":[0.00004829939,0.00009991349,0.00043933166,0.002878365,0.00007712555,0.0029991048,0.000059135113,0.00013861856,0.0008279277,0.004648224,0.98776895,0.0000150605465],"about_ca_topic_score_codex":0.0004708363,"about_ca_topic_score_gemma":0.0013552131,"teacher_disagreement_score":0.023561027,"about_ca_system_score_codex":0.0005180402,"about_ca_system_score_gemma":0.00067057763,"threshold_uncertainty_score":0.07881951},"labels":[],"label_agreement":null},{"id":"W2106610960","doi":"10.1517/14656566.2013.797965","title":"Dutasteride for the treatment of benign prostatic hyperplasia","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dutasteride; Medicine; Hyperplasia; Urology; Finasteride; Tamsulosin; Prostatic Diseases; Prostate; Internal medicine; Cancer","score_opus":0.24295717235312522,"score_gpt":0.516529994349962,"score_spread":0.27357282199683686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106610960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080909325,0.9987274,0.000033246088,0.00016254955,0.0001099625,0.0000063167327,0.000018774856,0.0000038195076,0.000857134],"genre_scores_gemma":[0.0014512856,0.99736184,0.00010082582,0.00031075798,0.00017444415,0.000007876364,0.00004285036,0.0000014060493,0.0005486991],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997042,0.00006744534,0.00005059006,0.000046937475,0.0001114064,0.00001927444],"domain_scores_gemma":[0.9996512,0.0001664396,0.00009700839,0.000008274111,0.000056695444,0.000020396914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003845864,0.00054774183,0.0011726124,0.0024625782,0.00020578499,0.0006151273,0.0006028903,0.0007948516,0.008619145],"category_scores_gemma":[0.0009157045,0.00015799675,0.000715529,0.0021182932,0.00035154584,0.00061098847,0.0004113196,0.00097568735,0.0025547382],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015553633,0.00004426816,0.00021068624,0.07461049,0.00027470462,0.00040458623,0.000058980797,0.00012956986,0.001457171,0.001157572,0.031908475,0.88958794],"study_design_scores_gemma":[0.00015038649,0.00016641298,0.002202611,0.027733224,0.0008382362,0.005451759,0.000094356044,0.00007902968,0.0010113408,0.0012974261,0.96094745,0.00002769244],"about_ca_topic_score_codex":0.0015895466,"about_ca_topic_score_gemma":0.0034048948,"teacher_disagreement_score":0.008619145,"about_ca_system_score_codex":0.00051117264,"about_ca_system_score_gemma":0.00096975244,"threshold_uncertainty_score":0.028833985},"labels":[],"label_agreement":null},{"id":"W2106863992","doi":"10.1517/14656566.9.14.2545","title":"Mycophenolate mofetil in myasthenia gravis: the unanswered question","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Medicine; Myasthenia gravis; Mycophenolate; Immunosuppression; Clinical trial; Weakness; Mycophenolic acid; Disease; Intensive care medicine; Internal medicine; Transplantation; Surgery","score_opus":0.043270591970313375,"score_gpt":0.36029755492114884,"score_spread":0.3170269629508355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106863992","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035226878,0.8525682,0.00058441027,0.13282034,0.005581401,0.000017698208,0.000041835217,0.000026129352,0.0048373276],"genre_scores_gemma":[0.06697301,0.83651507,0.0023644047,0.052925594,0.036660828,0.00006874313,0.000062378065,0.000017952396,0.004412128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993944,0.00029737572,0.00009711,0.0000523248,0.00012033195,0.00003844368],"domain_scores_gemma":[0.9987809,0.00077062554,0.00015373382,0.000030879706,0.00017557706,0.00008826557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019268539,0.0002966212,0.0016366808,0.00047070818,0.00036936247,0.00092531485,0.0006601099,0.003283548,0.0029303157],"category_scores_gemma":[0.0032230709,0.00013823115,0.00035858393,0.0004903112,0.0010389036,0.0014256082,0.00031787588,0.002412671,0.0020007924],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009264778,0.00020746814,0.0025575722,0.0049530854,0.00023097797,0.004732888,0.00019413861,0.00027587952,0.0023446786,0.009079512,0.11563475,0.8588625],"study_design_scores_gemma":[0.001171385,0.0013410241,0.007264966,0.007409767,0.0005571,0.01841211,0.00074519427,0.0007053712,0.0018384072,0.020726992,0.93975234,0.00007531156],"about_ca_topic_score_codex":0.00060370535,"about_ca_topic_score_gemma":0.001483777,"teacher_disagreement_score":0.003283548,"about_ca_system_score_codex":0.000492547,"about_ca_system_score_gemma":0.0008909489,"threshold_uncertainty_score":0.010190308},"labels":[],"label_agreement":null},{"id":"W2107109865","doi":"10.1517/14656566.8.9.1221","title":"Latest medical treatment strategies for venous thromboembolism","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Fondaparinux; Warfarin; Intensive care medicine; Heparin; Anticoagulant; Low molecular weight heparin; Thrombosis; Venous thromboembolism; Coagulation cascade; Thrombus; Discovery and development of direct thrombin inhibitors; Bivalirudin; Surgery; Internal medicine; Thrombin; Myocardial infarction; Platelet; Atrial fibrillation; Percutaneous coronary intervention","score_opus":0.19151695133716443,"score_gpt":0.5131542746789183,"score_spread":0.3216373233417539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107109865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095279254,0.9954358,0.0001749523,0.0012564531,0.0005843555,0.00001395675,0.000027743901,0.000012337315,0.0023991393],"genre_scores_gemma":[0.0006682666,0.9963666,0.00040410453,0.0007594366,0.00054177776,0.00001817223,0.00006545483,0.0000018433412,0.0011743101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968886,0.00006436194,0.000046378733,0.000034025215,0.00014454436,0.000021916832],"domain_scores_gemma":[0.99973613,0.000096737254,0.000051301562,0.000009915751,0.00007878586,0.000027238106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005921481,0.0010009453,0.0016376146,0.0023713682,0.00028318027,0.0008685043,0.0011269335,0.0014212243,0.010737735],"category_scores_gemma":[0.0008434384,0.00025292236,0.00077290746,0.0017761252,0.00031986038,0.0011264383,0.00044661755,0.0017771001,0.006481274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059273756,0.00009663933,0.0001307838,0.012077486,0.00013191254,0.0003595797,0.00004097074,0.00020626202,0.0007086779,0.0026413146,0.08012987,0.90341717],"study_design_scores_gemma":[0.00006362741,0.000070507354,0.000902204,0.0055495678,0.00017381475,0.0020398507,0.000046520145,0.000096539996,0.00019210957,0.0018574574,0.9889936,0.000014292901],"about_ca_topic_score_codex":0.0010983156,"about_ca_topic_score_gemma":0.0022925602,"teacher_disagreement_score":0.010737735,"about_ca_system_score_codex":0.0006829594,"about_ca_system_score_gemma":0.00095739064,"threshold_uncertainty_score":0.035921335},"labels":[],"label_agreement":null},{"id":"W2107352701","doi":"10.1517/14656566.2010.499125","title":"Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Antipsychotic; Schizophrenia (object-oriented programming); Psychiatry; Intensive care medicine; Relapse prevention; Pharmacotherapy; Ziprasidone","score_opus":0.09113384902379,"score_gpt":0.44069307829564985,"score_spread":0.34955922927185984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107352701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017267525,0.9975387,0.00013000183,0.0013398651,0.00030548553,0.000005466719,0.000018617597,0.000004942138,0.0004842485],"genre_scores_gemma":[0.0017587398,0.9964953,0.00023592223,0.00073286734,0.00033560809,0.000009400706,0.00001732161,0.0000021378573,0.00041276208],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99939394,0.00022447108,0.00011140444,0.00006895807,0.00016699101,0.000034141864],"domain_scores_gemma":[0.9986494,0.00078506634,0.00029085157,0.000025732004,0.0002099179,0.000039081086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011798105,0.00034894358,0.0009513996,0.0006595722,0.00017020397,0.0009922145,0.00047271224,0.0010379095,0.004671284],"category_scores_gemma":[0.0022998366,0.00014207429,0.0009156552,0.0008934014,0.00041473814,0.0014500142,0.00048240073,0.0016452176,0.00090406334],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022652307,0.000053044354,0.00032592737,0.059064966,0.00028725405,0.00018484078,0.00026405073,0.00031414154,0.0012097942,0.00490138,0.028316967,0.90485114],"study_design_scores_gemma":[0.000095722506,0.00047613482,0.0035223681,0.054932434,0.00084287114,0.0016707649,0.00032382258,0.0002662813,0.0007257008,0.0066432743,0.930454,0.000046638746],"about_ca_topic_score_codex":0.001592869,"about_ca_topic_score_gemma":0.0029745703,"teacher_disagreement_score":0.004671284,"about_ca_system_score_codex":0.00051733875,"about_ca_system_score_gemma":0.0016154613,"threshold_uncertainty_score":0.015626967},"labels":[],"label_agreement":null},{"id":"W2110210123","doi":"10.1517/14656566.2014.873789","title":"Alprostadil for the treatment of impotence","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Erectile dysfunction; cGMP-specific phosphodiesterase type 5; Sildenafil; Tadalafil; First line; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.27678807213541823,"score_gpt":0.5035388989325601,"score_spread":0.22675082679714187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110210123","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007511485,0.99845266,0.000042809443,0.00039761,0.00022084957,0.0000067323367,0.000028735143,0.0000036050037,0.00077175844],"genre_scores_gemma":[0.001171404,0.9975822,0.00008181631,0.00042841354,0.00027992076,0.000008554749,0.000040722927,0.0000013819351,0.0004055709],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996854,0.000078260375,0.000055383356,0.00004783614,0.000115773684,0.0000173624],"domain_scores_gemma":[0.99947006,0.00027548126,0.00013320045,0.000009124831,0.00008954253,0.000022537419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005297314,0.00045274766,0.0010035569,0.0017739277,0.00018984372,0.0008575786,0.0006042839,0.0009015743,0.010659424],"category_scores_gemma":[0.0013114043,0.00012929,0.00074693275,0.0013762265,0.0002969231,0.0007060775,0.00035325735,0.0011430912,0.002220187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014819212,0.000044263626,0.00016470731,0.08079299,0.00030733497,0.00023847156,0.00006461334,0.00013469737,0.0009202841,0.0015620379,0.039697908,0.87592447],"study_design_scores_gemma":[0.00013376123,0.00019143189,0.0012459982,0.040091317,0.0008258496,0.0027472028,0.00009408558,0.00008185656,0.00050496706,0.0015929352,0.952466,0.000024554134],"about_ca_topic_score_codex":0.0011009523,"about_ca_topic_score_gemma":0.0018197942,"teacher_disagreement_score":0.010659424,"about_ca_system_score_codex":0.00039469052,"about_ca_system_score_gemma":0.0010835372,"threshold_uncertainty_score":0.035659313},"labels":[],"label_agreement":null},{"id":"W2111074312","doi":"10.1517/14656566.6.8.1299","title":"A pharmacogeneticist’s look at drug effects and the drug development process: an overview","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacogenomics; Medicine; Drug; Drug development; Personalized medicine; Pharmacogenetics; Identification (biology); Drug response; Pharmacology; Drug action; Intensive care medicine; Bioinformatics; Genetics","score_opus":0.21577903902343207,"score_gpt":0.5352320778405615,"score_spread":0.3194530388171294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111074312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010986319,0.99106723,0.0017042577,0.004016416,0.00069548935,0.000010291515,0.000010080666,0.000018561102,0.0023677957],"genre_scores_gemma":[0.0008391237,0.9936108,0.0015565231,0.0019517115,0.0009997542,0.00001667391,0.00001507594,0.0000040186305,0.0010063465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989072,0.00041606225,0.00012225553,0.00012447887,0.00037370934,0.000056271798],"domain_scores_gemma":[0.9982309,0.0012529152,0.00010364585,0.00005465087,0.00027733497,0.000080545295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024992514,0.001405365,0.002472315,0.0061495784,0.00052414625,0.001909747,0.0015208705,0.003800663,0.003374405],"category_scores_gemma":[0.0018412663,0.0006244637,0.0010567824,0.0046483343,0.002001459,0.0059065456,0.0011533211,0.0040580905,0.0032901824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009200986,0.00017404128,0.00052398123,0.011623586,0.00018510564,0.001252451,0.00037045355,0.0009813856,0.0016645278,0.026002543,0.049006384,0.90812355],"study_design_scores_gemma":[0.000029386694,0.00015052997,0.0010066432,0.0035050125,0.00007627644,0.0045849895,0.00019631667,0.00026483412,0.00035093553,0.018216975,0.9715788,0.000039421142],"about_ca_topic_score_codex":0.001968419,"about_ca_topic_score_gemma":0.0029764941,"teacher_disagreement_score":0.0061495784,"about_ca_system_score_codex":0.0019652066,"about_ca_system_score_gemma":0.0020292096,"threshold_uncertainty_score":0.014258683},"labels":[],"label_agreement":null},{"id":"W2111100080","doi":"10.1517/14656566.6.11.1911","title":"Ramipril in the treatment of vascular diseases","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Ramipril; Medicine; Heart failure; Diabetes mellitus; Cardiology; ACE inhibitor; Internal medicine; Myocardial infarction; Stroke (engine); Angiotensin-converting enzyme; Blood pressure; Endocrinology","score_opus":0.13024043692909668,"score_gpt":0.4500948359908155,"score_spread":0.31985439906171886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111100080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008342498,0.99868554,0.0000602446,0.00015923644,0.00013404911,0.000007111677,0.000010950137,0.0000069926796,0.000852463],"genre_scores_gemma":[0.0006576407,0.9980636,0.00016748227,0.00027620955,0.00016901831,0.0000080045465,0.000026444231,0.0000011066251,0.0006304717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970204,0.00007538708,0.000040160223,0.00004084513,0.000121829085,0.00001977088],"domain_scores_gemma":[0.99976176,0.00010796297,0.000051192033,0.000008916379,0.00004769721,0.0000224566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007002025,0.0008362835,0.0018764427,0.0022741486,0.00021357636,0.0007252445,0.0008156484,0.00097909,0.0056487713],"category_scores_gemma":[0.00062991463,0.00021127812,0.0005247211,0.0020681699,0.0003137522,0.0008242147,0.0004950742,0.0014069591,0.0030973828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012353595,0.00008436263,0.00009714571,0.020967307,0.00018662501,0.00018166474,0.000046451227,0.00019902633,0.0013260985,0.0012905544,0.03395275,0.94154453],"study_design_scores_gemma":[0.00016909066,0.00021450887,0.0014406733,0.009533996,0.00036653876,0.001909506,0.00005894265,0.000103848884,0.00042721006,0.0019456437,0.9838088,0.000021193202],"about_ca_topic_score_codex":0.0010586779,"about_ca_topic_score_gemma":0.0023979498,"teacher_disagreement_score":0.0056487713,"about_ca_system_score_codex":0.0004042188,"about_ca_system_score_gemma":0.00072123215,"threshold_uncertainty_score":0.018896997},"labels":[],"label_agreement":null},{"id":"W2111872404","doi":"10.1517/14656566.2012.732998","title":"Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Incyte; Massachusetts Medical Society","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Clinical trial; Janus kinase; Anemia; Internal medicine; Oncology; Tolerability; Adverse effect; Pharmacology; Bone marrow; Cytokine","score_opus":0.17150415643462785,"score_gpt":0.46996782130591475,"score_spread":0.2984636648712869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111872404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033945395,0.9766872,0.0009051587,0.009395297,0.0016399374,0.000035903246,0.00027021073,0.000047235804,0.0076246723],"genre_scores_gemma":[0.044469204,0.9354802,0.0012180741,0.008226523,0.0038306024,0.00007600903,0.00066233723,0.000012506477,0.006024493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998517,0.00004716734,0.000016914737,0.000021864553,0.000044984175,0.000017335586],"domain_scores_gemma":[0.9998253,0.00006399716,0.00004276584,0.0000028240427,0.000052043717,0.000013056062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030450386,0.00023287394,0.0005258344,0.00038911132,0.00010640351,0.0004601532,0.00036448825,0.0006851217,0.004129112],"category_scores_gemma":[0.0005972904,0.0000608446,0.00036651827,0.0003158127,0.00013394648,0.00034709787,0.00018751275,0.00075207104,0.0013588753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005268249,0.000071275426,0.00040449077,0.009807431,0.00021587967,0.0005017964,0.000046121684,0.0004940138,0.004188131,0.0018795659,0.1145222,0.86734223],"study_design_scores_gemma":[0.0005402513,0.0005223228,0.0026824432,0.0076509146,0.00061399804,0.0033624433,0.00006832846,0.0008078726,0.0025076133,0.0029507566,0.9782582,0.00003482595],"about_ca_topic_score_codex":0.00037414196,"about_ca_topic_score_gemma":0.0010731791,"teacher_disagreement_score":0.004129112,"about_ca_system_score_codex":0.00030296302,"about_ca_system_score_gemma":0.000307854,"threshold_uncertainty_score":0.013813257},"labels":[],"label_agreement":null},{"id":"W2114489138","doi":"10.1517/14656566.9.6.937","title":"Pharmacotherapy of bone metastases in breast cancer patients","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone health and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Denosumab; Bisphosphonate; Breast cancer; Osteoprotegerin; Osteoclast; Bone pain; Osteoporosis; Bone remodeling; Oncology; Bone Density Conservation Agents; Quality of life (healthcare); Bone metastasis; Cancer; Internal medicine; Zoledronic acid; Metastatic breast cancer; Bone density","score_opus":0.08076604072673427,"score_gpt":0.46234957995315107,"score_spread":0.3815835392264168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114489138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046021552,0.9973679,0.00013463071,0.00039731615,0.00013719471,0.000017384824,0.000021193062,0.000008207164,0.0014559113],"genre_scores_gemma":[0.002781688,0.9951141,0.00037220118,0.00061634043,0.00019517231,0.00002485001,0.00005375624,0.0000019547517,0.0008399786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998072,0.00005485349,0.000019723937,0.000022214108,0.00008205354,0.000014100472],"domain_scores_gemma":[0.9998741,0.00004900997,0.000035451598,0.0000036738763,0.000027258548,0.0000104326455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040542398,0.00046975477,0.0015239423,0.0010644671,0.00014700543,0.0004597908,0.00067327265,0.00088585436,0.003523899],"category_scores_gemma":[0.0004938191,0.00013831408,0.000521113,0.0010717354,0.00016789623,0.0003400223,0.00029764953,0.0007185031,0.0016582696],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013376026,0.00012675511,0.0001916718,0.014877048,0.00022456067,0.00032506642,0.000029903184,0.00020569483,0.0020784745,0.00064245285,0.020894734,0.9602699],"study_design_scores_gemma":[0.0005090846,0.0006684073,0.006262666,0.01143321,0.00064576603,0.006314205,0.00009563765,0.00037079703,0.0022146024,0.0019743422,0.9694773,0.00003392245],"about_ca_topic_score_codex":0.0008381595,"about_ca_topic_score_gemma":0.002355622,"teacher_disagreement_score":0.003523899,"about_ca_system_score_codex":0.00032014897,"about_ca_system_score_gemma":0.00044598788,"threshold_uncertainty_score":0.011788547},"labels":[],"label_agreement":null},{"id":"W2114606818","doi":"10.1517/14656566.2012.667073","title":"A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain","year":2012,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Medicine; Tolerability; Hydrocodone; Anesthesia; Acetaminophen; Osteoarthritis; Transdermal; Analgesic; Buprenorphine; Adverse effect; Opioid; Clinical endpoint; Randomized controlled trial; Surgery; Oxycodone; Internal medicine; Pharmacology","score_opus":0.04890670844190818,"score_gpt":0.3569356426387557,"score_spread":0.3080289341968475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114606818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184614,0.0021747348,0.00057920854,0.00022365646,0.00033317212,0.0034862205,0.00048861036,0.00005094039,0.0008173791],"genre_scores_gemma":[0.98871267,0.0019489765,0.0020645398,0.000672043,0.00045600513,0.0037098932,0.00055173464,0.000011317879,0.0018729107],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990638,0.0004907797,0.000073192525,0.00017711722,0.00010481476,0.0000902379],"domain_scores_gemma":[0.99869126,0.00047467012,0.00032749755,0.00010944777,0.000101646925,0.00029542446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017577602,0.0009113868,0.0025793884,0.00028262517,0.00031271897,0.00067149923,0.00096917374,0.0014519424,0.0052381908],"category_scores_gemma":[0.0020584948,0.0004853383,0.0011964423,0.00030932264,0.0011571528,0.00059504627,0.00027526388,0.0015739347,0.00084809616],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94431573,0.020667747,0.0007519014,0.0010269949,0.000693505,0.00004610006,0.0000777795,0.00021564617,0.007010962,0.00006860214,0.0004200944,0.02470493],"study_design_scores_gemma":[0.8489084,0.1483728,0.0015672629,0.000017475712,0.00020533112,0.000025151518,0.000014765086,0.00021491261,0.0003659831,0.000037984795,0.00026082416,0.000009131071],"about_ca_topic_score_codex":0.0005146303,"about_ca_topic_score_gemma":0.0015631953,"teacher_disagreement_score":0.0052381908,"about_ca_system_score_codex":0.0005426316,"about_ca_system_score_gemma":0.0011707792,"threshold_uncertainty_score":0.017523527},"labels":[],"label_agreement":null},{"id":"W2114843189","doi":"10.1517/14656566.2014.862233","title":"The mechanism, efficacy, and tolerability profile of agomelatine","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Agomelatine; Tolerability; Medicine; Antidepressant; Melatonin; Major depressive disorder; Pharmacology; Internal medicine; Psychiatry; Adverse effect; Mood; Hippocampus","score_opus":0.10513958353118176,"score_gpt":0.40294674886848725,"score_spread":0.2978071653373055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114843189","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040773398,0.9987219,0.00007004237,0.00022420743,0.000064572356,0.0000070612355,0.000026652842,0.0000032972418,0.00047456493],"genre_scores_gemma":[0.008222868,0.9904845,0.00024727546,0.0003054621,0.0001551847,0.000020898748,0.00005324126,0.0000018018673,0.0005088536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997819,0.00005198982,0.000049930262,0.00004366294,0.00005803009,0.000014427086],"domain_scores_gemma":[0.999688,0.00014887522,0.00009226417,0.000006937422,0.000053338248,0.000010568937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005197483,0.00040421667,0.0013539593,0.0008743452,0.00014169682,0.00062670826,0.00058665016,0.0008516038,0.0034750984],"category_scores_gemma":[0.0009369575,0.0001483853,0.0007247239,0.0008035922,0.00026147612,0.00057176675,0.00028887458,0.0007277386,0.0006762536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005232699,0.000057839905,0.0003241446,0.07564717,0.0003814243,0.0002786807,0.00004652024,0.0001967901,0.005418804,0.0010017911,0.0070533156,0.9090702],"study_design_scores_gemma":[0.0006389818,0.0017135742,0.013969756,0.05228043,0.0044068787,0.009822664,0.00023721102,0.00056764315,0.008871815,0.0033865538,0.9040083,0.00009612587],"about_ca_topic_score_codex":0.0008333407,"about_ca_topic_score_gemma":0.001850684,"teacher_disagreement_score":0.0034750984,"about_ca_system_score_codex":0.00045194777,"about_ca_system_score_gemma":0.00073958316,"threshold_uncertainty_score":0.0116253495},"labels":[],"label_agreement":null},{"id":"W2115343619","doi":"10.1517/14656566.2011.584064","title":"A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St Joseph's Health Care","funders":"","keywords":"Vardenafil; Erectile dysfunction; Medicine; Clinical trial; Intensive care medicine; Sexual function; Sexual medicine; Sexual dysfunction; Prostatectomy; Disease; Erectile function; Placebo; Efficacy; Drug; Pharmacology; Tadalafil; Alternative medicine; Internal medicine; Gynecology; Prostate cancer; Pathology","score_opus":0.1463684454376852,"score_gpt":0.4259670341956967,"score_spread":0.27959858875801147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115343619","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058713653,0.9995554,0.000020608466,0.00007983351,0.0000688301,0.0000077860095,0.000025802257,0.000001916246,0.00018111918],"genre_scores_gemma":[0.0004792754,0.999186,0.000082157865,0.0000905266,0.00005023005,0.000008974063,0.000025015379,5.13085e-7,0.00007742448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99934334,0.00015610509,0.00020086273,0.00007382721,0.00019324593,0.00003268089],"domain_scores_gemma":[0.9981456,0.0011613447,0.00039562443,0.000021844027,0.0002299888,0.000045549747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011727817,0.0009815121,0.0034276133,0.0031738412,0.00031755873,0.0011973566,0.0010653421,0.0011775572,0.008415285],"category_scores_gemma":[0.0028582106,0.0003789255,0.0017437888,0.00521769,0.00026732375,0.0009603835,0.00054418086,0.0007824901,0.00094235205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018380373,0.000053770156,0.00028946844,0.419194,0.0011990933,0.000207989,0.00010144257,0.00017072565,0.00048678505,0.0005643882,0.023070758,0.5544777],"study_design_scores_gemma":[0.00020272515,0.0003557506,0.0063217,0.36375716,0.012538726,0.0025424021,0.00021567623,0.00019908354,0.0005588268,0.000952374,0.61230403,0.000051567946],"about_ca_topic_score_codex":0.0024497502,"about_ca_topic_score_gemma":0.0059432858,"teacher_disagreement_score":0.008415285,"about_ca_system_score_codex":0.0006519054,"about_ca_system_score_gemma":0.0025244206,"threshold_uncertainty_score":0.02815193},"labels":[],"label_agreement":null},{"id":"W2115535897","doi":"10.1517/14656566.6.8.1349","title":"Bivalirudin: a review","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Bivalirudin; Hirudin; Medicine; Thrombin; Direct thrombin inhibitor; Discovery and development of direct thrombin inhibitors; Tetrapeptide; Pharmacology; Heparin; Anticoagulant; Cardiology; Internal medicine; Warfarin; Biochemistry; Myocardial infarction; Percutaneous coronary intervention; Atrial fibrillation; Chemistry; Platelet; Peptide","score_opus":0.2426197530651197,"score_gpt":0.5301296405093221,"score_spread":0.28750988744420236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115535897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095018055,0.9985501,0.00007620985,0.00028671607,0.00021017264,0.0000062324552,0.0000145407,0.000005790105,0.00075523416],"genre_scores_gemma":[0.000567933,0.99826485,0.00017831073,0.00026851267,0.00024895038,0.000010110558,0.000033017623,0.0000010138255,0.00042730584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983203,0.00002965243,0.000036149886,0.000030776362,0.000058364407,0.000013015063],"domain_scores_gemma":[0.99965966,0.00014626737,0.00006175249,0.0000079857855,0.00008394575,0.000040444782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050119817,0.0008983061,0.0017027167,0.0024639796,0.0002560748,0.0009459133,0.001078021,0.0011376851,0.005700853],"category_scores_gemma":[0.0007777346,0.00030342204,0.00043518667,0.002962971,0.00034623034,0.0012821546,0.00043827572,0.0012227509,0.0034872054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013361429,0.000103882325,0.00016057894,0.021243524,0.000108454995,0.00034983206,0.00004086572,0.00024897768,0.0010034231,0.0011647053,0.047200087,0.92824197],"study_design_scores_gemma":[0.0000674639,0.00012900743,0.0010358888,0.007170447,0.00022059679,0.0021669823,0.000052388088,0.00011723452,0.00032237143,0.00095938594,0.9877422,0.000016043701],"about_ca_topic_score_codex":0.0009960476,"about_ca_topic_score_gemma":0.0018170903,"teacher_disagreement_score":0.005700853,"about_ca_system_score_codex":0.0006322969,"about_ca_system_score_gemma":0.0008959055,"threshold_uncertainty_score":0.019071281},"labels":[],"label_agreement":null},{"id":"W2116030241","doi":"10.1517/14656566.2013.760543","title":"A 10-year perspective on donepezil","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Donepezil; Medicine; Dosing; Clinical trial; Cholinesterase; Intensive care medicine; Expert opinion; Disease; Rivastigmine; Pharmacology; Dementia; Internal medicine","score_opus":0.1443808273236295,"score_gpt":0.48460049836866304,"score_spread":0.34021967104503353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116030241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085527674,0.99255216,0.000053054366,0.0037613397,0.002178241,0.000004301498,0.000028092709,0.000006007643,0.0013313129],"genre_scores_gemma":[0.0005866518,0.99322164,0.00012213676,0.003331811,0.0014384064,0.000008088995,0.000050329116,0.0000017423317,0.0012392249],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995883,0.00006950898,0.000062234045,0.00006293354,0.00016668852,0.000050397415],"domain_scores_gemma":[0.99927706,0.00022834833,0.00011149312,0.000012763715,0.000281573,0.00008871273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012037514,0.0012128078,0.0014213348,0.0017583718,0.00030162602,0.0011187877,0.0010597435,0.0029766893,0.006334724],"category_scores_gemma":[0.0013147446,0.00033296438,0.0009194069,0.0018999026,0.00037561796,0.0028254006,0.00083425525,0.0035157423,0.0033111526],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002707457,0.00009772702,0.00014163816,0.02743929,0.0001323609,0.0004974825,0.00012996406,0.00030870203,0.001689874,0.0063922405,0.23933658,0.7235633],"study_design_scores_gemma":[0.000033799522,0.00012743357,0.00055486325,0.007620695,0.00011383691,0.0009004563,0.00007609209,0.00006193126,0.00012823328,0.0012311823,0.98913527,0.000016150236],"about_ca_topic_score_codex":0.0021588812,"about_ca_topic_score_gemma":0.006763425,"teacher_disagreement_score":0.006334724,"about_ca_system_score_codex":0.0012663902,"about_ca_system_score_gemma":0.0020781958,"threshold_uncertainty_score":0.021191776},"labels":[],"label_agreement":null},{"id":"W2116273754","doi":"10.1517/14656566.2011.608351","title":"Off-label use of atypical antipsychotics in personality disorders","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Personality Disorders and Psychopathology","field":"Psychology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Personality disorders; Borderline personality disorder; Impulsivity; Psychiatry; Sadistic personality disorder; Atypical antipsychotic; Olanzapine; Medicine; Schizotypal personality disorder; Antisocial personality disorder; Clinical psychology; Comorbidity; Personality; Antipsychotic; Psychology; Schizophrenia (object-oriented programming); Poison control; Psychosis; Injury prevention","score_opus":0.25951335745465576,"score_gpt":0.48830629687963023,"score_spread":0.22879293942497447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116273754","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061067665,0.997727,0.00007077628,0.00019476021,0.000114111004,0.000015585816,0.000048905193,0.0000045614897,0.0012136585],"genre_scores_gemma":[0.009239493,0.98903453,0.00028808645,0.0004957177,0.00015583812,0.00003143425,0.00010015702,0.0000026910081,0.0006520142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992218,0.00027594392,0.00014251487,0.00009291307,0.00023241107,0.000034458546],"domain_scores_gemma":[0.998618,0.0006750777,0.00049397827,0.000030295694,0.00013461652,0.000047890266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010279528,0.0005245301,0.0013986769,0.0011075985,0.0001867667,0.0006601479,0.00058742677,0.0009722938,0.004706297],"category_scores_gemma":[0.0025413637,0.00015885403,0.0011314012,0.0012102725,0.00028883986,0.00044681554,0.0004250037,0.0007476438,0.0007120941],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003395108,0.000057026817,0.00062511314,0.085702576,0.00061106053,0.0003501631,0.00006566758,0.00017862984,0.00095252076,0.00057492394,0.011963546,0.8985793],"study_design_scores_gemma":[0.0012759478,0.0013173964,0.02821689,0.20754746,0.006376315,0.011018944,0.00046569013,0.0006067729,0.0023485937,0.0031543593,0.73758966,0.000081954815],"about_ca_topic_score_codex":0.0017230862,"about_ca_topic_score_gemma":0.0045130714,"teacher_disagreement_score":0.004706297,"about_ca_system_score_codex":0.00060146407,"about_ca_system_score_gemma":0.0009789733,"threshold_uncertainty_score":0.01574409},"labels":[],"label_agreement":null},{"id":"W2116707979","doi":"10.1517/14656566.6.14.2443","title":"An update on the treatment options for gout and calcium pyrophosphate deposition","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Gout; Synovitis; Calcium pyrophosphate; Pathogenesis; Disease; Joint disorder; Intensive care medicine; Osteoarthritis; Rheumatoid arthritis; Bioinformatics; Calcium; Internal medicine; Pathology; Alternative medicine","score_opus":0.12859370029633976,"score_gpt":0.46575608593487183,"score_spread":0.33716238563853207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116707979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017537027,0.9940726,0.00024686375,0.0013702384,0.0011997774,0.000013962822,0.000045667468,0.000018603792,0.0028568248],"genre_scores_gemma":[0.0007818685,0.9933602,0.00095958606,0.0014020804,0.0012425891,0.000023267059,0.000096725744,0.0000032776302,0.002130463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996867,0.00007279362,0.000050633727,0.000032367407,0.00013587323,0.000021606298],"domain_scores_gemma":[0.99951756,0.00022999785,0.00006802278,0.000010470491,0.00012757813,0.000046332152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006950387,0.0011090825,0.0017534832,0.0022443028,0.00033534854,0.0009837165,0.001444967,0.0018486864,0.008462423],"category_scores_gemma":[0.0010876625,0.00031468627,0.00073431776,0.0018738653,0.00033443607,0.0013386862,0.00042298803,0.0024449204,0.005008264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007257664,0.00012992987,0.00014503946,0.008314569,0.0000990196,0.0007729859,0.000057025252,0.00023942815,0.00079793547,0.0011771031,0.13178612,0.85640824],"study_design_scores_gemma":[0.000046169127,0.00010528273,0.0006635445,0.0037646298,0.00013653758,0.004397235,0.000052779273,0.00009348273,0.00014685048,0.00067459897,0.9899042,0.000014582298],"about_ca_topic_score_codex":0.0016030493,"about_ca_topic_score_gemma":0.004735259,"teacher_disagreement_score":0.008462423,"about_ca_system_score_codex":0.00060125225,"about_ca_system_score_gemma":0.0008889676,"threshold_uncertainty_score":0.028309643},"labels":[],"label_agreement":null},{"id":"W2117294423","doi":"10.1517/14656566.7.5.583","title":"Alfuzosin: an α<sub>1</sub>-receptor blocker for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Alfuzosin; Medicine; Lower urinary tract symptoms; Hyperplasia; Urology; Urinary retention; Sexual function; Adverse effect; Urinary system; Internal medicine; Prostate","score_opus":0.0758192222938245,"score_gpt":0.41544174635158965,"score_spread":0.33962252405776516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117294423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058480824,0.99518305,0.0002875782,0.00064477365,0.00029565446,0.000022078326,0.000031876825,0.000021357315,0.0029288614],"genre_scores_gemma":[0.0021181633,0.9934002,0.00048985914,0.000728552,0.00041452303,0.00002297057,0.000083782805,0.000003585578,0.002738417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998497,0.000030227255,0.000018736087,0.000020139954,0.00006473249,0.000016472872],"domain_scores_gemma":[0.9998468,0.000042324988,0.00004710984,0.0000043590735,0.00003713377,0.000022196373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037567396,0.0007848462,0.0014158606,0.001418439,0.0002322431,0.0006099592,0.00077350065,0.001283405,0.006323574],"category_scores_gemma":[0.00038170122,0.00016229911,0.00043706578,0.0013748537,0.00022458353,0.0007545455,0.00029575347,0.0008565444,0.0063427733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013976291,0.00013059331,0.00014939006,0.008865307,0.00009309445,0.00070129783,0.00003451634,0.0001450654,0.0039362623,0.0005694037,0.02892267,0.95631266],"study_design_scores_gemma":[0.00020089764,0.0004630264,0.0025695446,0.003336987,0.00023959333,0.0087368,0.0000806763,0.00013343862,0.0018200505,0.0007661245,0.981628,0.000024956293],"about_ca_topic_score_codex":0.00065879285,"about_ca_topic_score_gemma":0.0018516222,"teacher_disagreement_score":0.006323574,"about_ca_system_score_codex":0.0003265164,"about_ca_system_score_gemma":0.0006375834,"threshold_uncertainty_score":0.021154463},"labels":[],"label_agreement":null},{"id":"W2117353601","doi":"10.1517/14656566.1.4.623","title":"Replicating herpes simplex virus vectors for cancer gene therapy","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; World Health Organization","keywords":"Oncolytic virus; Herpes simplex virus; Medicine; Virus; Disease; Genetic enhancement; Cancer; Radiation therapy; Cancer cell; Virology; Chemotherapy; Vector (molecular biology); Cancer research; Immunology; HSL and HSV; Gene; Biology; Pathology; Internal medicine","score_opus":0.1294799134940627,"score_gpt":0.48552920033053004,"score_spread":0.3560492868364673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117353601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030642803,0.9893785,0.0022497596,0.0005444709,0.0010139042,0.00004049654,0.000039924205,0.000057806206,0.006368655],"genre_scores_gemma":[0.0016537171,0.98961043,0.0019754379,0.0004421027,0.00029330942,0.00005496912,0.000104833045,0.000009209831,0.0058559794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996493,0.000053099568,0.000022126962,0.00004670753,0.0002009064,0.00002776942],"domain_scores_gemma":[0.9998534,0.000044375112,0.00002719175,0.000011738033,0.000042149517,0.000021153523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084605324,0.0012524113,0.0013831458,0.0019188484,0.00031133657,0.0009322899,0.0013211941,0.0014932838,0.005983069],"category_scores_gemma":[0.00039277496,0.00034907204,0.00048911036,0.0019951037,0.00069811125,0.0013752799,0.0005415089,0.0022953968,0.0088733975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078478486,0.00011346918,0.00010505338,0.005813482,0.000053754564,0.00036627933,0.00006836594,0.0005499194,0.018803215,0.008409158,0.055026475,0.91061234],"study_design_scores_gemma":[0.000028356535,0.00005474525,0.00018597477,0.00050226384,0.000021030786,0.0009341759,0.0000144813885,0.00010759987,0.0025755938,0.0016690405,0.9938929,0.000013817236],"about_ca_topic_score_codex":0.0009136503,"about_ca_topic_score_gemma":0.001326076,"teacher_disagreement_score":0.005983069,"about_ca_system_score_codex":0.0010104371,"about_ca_system_score_gemma":0.00076431857,"threshold_uncertainty_score":0.0200153},"labels":[],"label_agreement":null},{"id":"W2118731850","doi":"10.1517/14656566.2.10.1671","title":"Oseltamivir: a clinical and pharmacological perspective","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Oseltamivir; Prodrug; Medicine; Neuraminidase inhibitor; Pharmacology; Renal function; Neuraminidase; Antiviral drug; Metabolite; Pharmacokinetics; Virology; Drug; Internal medicine; Virus","score_opus":0.4206725464578862,"score_gpt":0.6191239929573048,"score_spread":0.1984514464994186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118731850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001447294,0.9522065,0.00070662156,0.03701686,0.0025625245,0.00001279156,0.0000822392,0.000032929598,0.005932112],"genre_scores_gemma":[0.013455811,0.9527456,0.0016602338,0.015536456,0.011858115,0.000032739943,0.00017174066,0.000015733402,0.0045235986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994873,0.00013349907,0.00006229212,0.0000719397,0.00016695565,0.00007799038],"domain_scores_gemma":[0.99871373,0.00029465958,0.000100287674,0.00004168263,0.0005714146,0.0002782726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019072283,0.00096407445,0.0012788964,0.001087114,0.00039901867,0.0025025143,0.0010753492,0.0027509597,0.004620748],"category_scores_gemma":[0.0012975489,0.00028652174,0.0006071479,0.0008966509,0.0010578587,0.003204752,0.0009367736,0.004282592,0.00209393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088916766,0.0006149119,0.0013257962,0.0052465973,0.00011141238,0.0012897548,0.00023526134,0.0006002964,0.011385168,0.030355712,0.11748992,0.8304559],"study_design_scores_gemma":[0.00009188253,0.0010140039,0.0022288703,0.0017136362,0.00006149946,0.0021608754,0.00020233126,0.0002934932,0.00070299825,0.0063308263,0.9851666,0.000032957018],"about_ca_topic_score_codex":0.000822596,"about_ca_topic_score_gemma":0.002079454,"teacher_disagreement_score":0.004620748,"about_ca_system_score_codex":0.001030921,"about_ca_system_score_gemma":0.0017936955,"threshold_uncertainty_score":0.015457988},"labels":[],"label_agreement":null},{"id":"W2118820814","doi":"10.1517/14656566.7.2.229","title":"6th International Workshop on Clinical Pharmacology of HIV Therapy","year":2006,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical pharmacology; Antiretroviral therapy; Pharmacology; Pharmacokinetics; Pharmacodynamics; Human immunodeficiency virus (HIV); Antiretroviral drug; ANTIRETROVIRAL AGENTS; Drug; Family medicine; Viral load","score_opus":0.06906413491715782,"score_gpt":0.43962418552232163,"score_spread":0.37056005060516384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118820814","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032851526,0.37856117,0.008440623,0.19524032,0.1618892,0.0005093997,0.0006390522,0.000425649,0.25100943],"genre_scores_gemma":[0.026680874,0.18733811,0.008529435,0.04373737,0.074545994,0.00047052692,0.00097247836,0.00023742703,0.6574878],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998288,0.00048907247,0.00007702775,0.00016291511,0.00069538254,0.00028766223],"domain_scores_gemma":[0.99840087,0.00015189046,0.000084434214,0.00007022268,0.00058899546,0.0007036604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003553078,0.0013763078,0.0008516869,0.0010976179,0.0010864473,0.0035773488,0.001520473,0.0042993044,0.057399347],"category_scores_gemma":[0.0023563674,0.0003629046,0.0010137178,0.0005002498,0.0009840524,0.0015141605,0.0024872418,0.0065994994,0.029167015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001460463,0.0001125874,0.00015921386,0.00031056153,0.000020961013,0.00036167857,0.00017285056,0.00010387965,0.0016284393,0.0040781223,0.8562962,0.1366095],"study_design_scores_gemma":[0.000014597132,0.0000612231,0.00031076866,0.00028109207,0.0000058739797,0.0004228405,0.000045903867,0.0000338844,0.00031004427,0.0008874272,0.9976197,0.000006634746],"about_ca_topic_score_codex":0.0020676276,"about_ca_topic_score_gemma":0.006414935,"teacher_disagreement_score":0.057399347,"about_ca_system_score_codex":0.0024869922,"about_ca_system_score_gemma":0.004420363,"threshold_uncertainty_score":0.19201994},"labels":[],"label_agreement":null},{"id":"W2119194124","doi":"10.1517/14656566.7.13.1835","title":"Lamivudine treatment in patients with chronic hepatitis B and cirrhosis","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Lamivudine; Medicine; Cirrhosis; Entecavir; Hepatocellular carcinoma; Adefovir; Gastroenterology; Hepatitis B virus; Internal medicine; Liver function; Hepatitis B; Liver disease; Nucleoside analogue; Immunology; Virus; Nucleoside","score_opus":0.04641000150982292,"score_gpt":0.38473039694472144,"score_spread":0.3383203954348985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119194124","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41667128,0.5353704,0.00056606776,0.01814413,0.0012849071,0.0005712504,0.0005020116,0.000109268774,0.026780665],"genre_scores_gemma":[0.8963834,0.08403151,0.0011072461,0.010251413,0.0019462884,0.00047368865,0.0005755191,0.000012705236,0.0052181813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996456,0.00018862958,0.000038254435,0.000020358477,0.000052776068,0.000054410193],"domain_scores_gemma":[0.9996506,0.00009605058,0.00007133558,0.0000086848095,0.00003358112,0.00013966535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004796656,0.0002247487,0.00086851546,0.00029002642,0.0004349368,0.00031862652,0.0001835606,0.00084475835,0.002597604],"category_scores_gemma":[0.001056555,0.00009751667,0.00039526325,0.00049764686,0.000136784,0.0002686034,0.00022654925,0.00058181374,0.0004967549],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025668338,0.0023307232,0.13640818,0.0057303836,0.00065537286,0.0056835883,0.0006322197,0.00023452955,0.007457625,0.00091057864,0.030549062,0.7837394],"study_design_scores_gemma":[0.023785727,0.038285766,0.63561577,0.0041449266,0.0015101861,0.017420443,0.0009084366,0.00066035386,0.0017811353,0.0014019017,0.27438357,0.00010188426],"about_ca_topic_score_codex":0.0010250185,"about_ca_topic_score_gemma":0.0023827087,"teacher_disagreement_score":0.002597604,"about_ca_system_score_codex":0.0003324778,"about_ca_system_score_gemma":0.0007198211,"threshold_uncertainty_score":0.008689821},"labels":[],"label_agreement":null},{"id":"W2119624606","doi":"10.1517/14656566.9.3.459","title":"Clozapine use in children and adolescents","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Clozapine; Medicine; Schizophrenia (object-oriented programming); Adverse effect; Psychiatry; Pediatrics; Incidence (geometry); Population; Refractory (planetary science); Pharmacology","score_opus":0.08732462987944417,"score_gpt":0.43155449005393426,"score_spread":0.3442298601744901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119624606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008802908,0.997919,0.000030193034,0.00020043878,0.00007008331,0.0000043519885,0.00002748352,0.0000044568164,0.000863714],"genre_scores_gemma":[0.004740413,0.9946662,0.0000742852,0.00012700041,0.00006616306,0.000006263485,0.000031105672,6.492085e-7,0.00028781395],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998154,0.000042334515,0.000037386097,0.000026889396,0.000060694623,0.000017333885],"domain_scores_gemma":[0.99976224,0.000084031104,0.00009079839,0.0000035023445,0.000037945454,0.000021560545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002660425,0.00050564884,0.0010358641,0.0010068183,0.00018376285,0.0004424065,0.0003933657,0.00062298117,0.0018430391],"category_scores_gemma":[0.0006601193,0.00014814496,0.0003739118,0.0011741985,0.00019357994,0.00024081476,0.00025541327,0.00048399257,0.0005391347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002441236,0.000069544636,0.0064367307,0.030571474,0.00034053938,0.0033933148,0.0001963046,0.0002210554,0.0018057999,0.0008452515,0.026260896,0.929615],"study_design_scores_gemma":[0.00023116193,0.0004287117,0.047248602,0.035648122,0.0018253281,0.039680332,0.00067971816,0.00022185747,0.0023411897,0.00082641386,0.8708205,0.00004802339],"about_ca_topic_score_codex":0.006251829,"about_ca_topic_score_gemma":0.010310188,"teacher_disagreement_score":0.006251829,"about_ca_system_score_codex":0.00053221,"about_ca_system_score_gemma":0.001382478,"threshold_uncertainty_score":0.012430906},"labels":[],"label_agreement":null},{"id":"W2121005224","doi":"10.1517/14656566.6.11.1851","title":"Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; McGill University; McGill Genome Centre","funders":"","keywords":"Angioedema; Medicine; Bradykinin; Angiotensin-converting enzyme; Adverse effect; Enzyme; Pharmacology; Bioinformatics; Internal medicine; Biochemistry; Blood pressure; Biology; Receptor","score_opus":0.07191002089388304,"score_gpt":0.38432926286412744,"score_spread":0.3124192419702444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121005224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002739858,0.99757713,0.0001853863,0.0005187673,0.00014088443,0.000006313779,0.000013145235,0.000007770896,0.0012766122],"genre_scores_gemma":[0.0017378974,0.9965042,0.00023190258,0.00040603345,0.00029799636,0.000010267955,0.00002852223,0.0000012373104,0.0007821146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997266,0.0000799881,0.000037742935,0.000034538916,0.000097538476,0.000023552773],"domain_scores_gemma":[0.99953127,0.00021641965,0.00011914318,0.000008501516,0.00009116348,0.00003348169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063374237,0.0009264192,0.0019763617,0.0009461435,0.0002005103,0.00072182453,0.0007925244,0.0013538961,0.0050734812],"category_scores_gemma":[0.00074617617,0.0001684366,0.0005948319,0.0010609743,0.00029413713,0.0007573979,0.0002944623,0.0009827039,0.0024758172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011064105,0.00009349193,0.00043928012,0.011641187,0.00015216164,0.0012926937,0.000039978127,0.00028563736,0.0015468951,0.0008400631,0.027960517,0.95559746],"study_design_scores_gemma":[0.000267147,0.0005832762,0.007550855,0.01017588,0.00068012637,0.029399568,0.0002260983,0.00039349447,0.0014851169,0.0034152055,0.9457632,0.000060182436],"about_ca_topic_score_codex":0.00061983865,"about_ca_topic_score_gemma":0.001557189,"teacher_disagreement_score":0.0050734812,"about_ca_system_score_codex":0.00039610083,"about_ca_system_score_gemma":0.0005290598,"threshold_uncertainty_score":0.016972482},"labels":[],"label_agreement":null},{"id":"W2121769821","doi":"10.1517/14656566.3.2.81","title":"Salvage antiretroviral therapy in HIV infection","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Salvage therapy; Discontinuation; Regimen; Intensive care medicine; Drug resistance; Antiretroviral therapy; Combination therapy; Drug; Protease inhibitor (pharmacology); Internal medicine; Viral load; Human immunodeficiency virus (HIV); Pharmacology; Immunology; Chemotherapy","score_opus":0.10216402638026828,"score_gpt":0.42054423431703697,"score_spread":0.3183802079367687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121769821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016935063,0.99614054,0.0001754648,0.0002887088,0.0004173117,0.000011248069,0.0000126928935,0.000009144703,0.0027755906],"genre_scores_gemma":[0.0015664336,0.9941322,0.00049856195,0.00075164647,0.00045207364,0.000018425158,0.000047651825,0.0000030877043,0.0025299322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996706,0.00010291357,0.000037205416,0.000040712635,0.00012584006,0.000022782377],"domain_scores_gemma":[0.9998338,0.00006980829,0.00003285005,0.000010871234,0.000036591424,0.000016002174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005414441,0.00091634603,0.0014041562,0.0014963341,0.00030169822,0.0007537248,0.0009711647,0.0012345774,0.0057446905],"category_scores_gemma":[0.0005899559,0.00014422274,0.00045273555,0.0016561577,0.00041458162,0.00088190817,0.00050697237,0.0015805486,0.004037704],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057959995,0.00006904549,0.00010516489,0.007579589,0.000057595225,0.0003761993,0.000055576624,0.00014850173,0.00096864934,0.0013909006,0.02916531,0.9600254],"study_design_scores_gemma":[0.000040348827,0.0001036765,0.0008040356,0.003284348,0.00007549556,0.003239131,0.00003717934,0.00007752964,0.00037003486,0.0014176271,0.99054015,0.000010441091],"about_ca_topic_score_codex":0.0007181146,"about_ca_topic_score_gemma":0.0014308344,"teacher_disagreement_score":0.0057446905,"about_ca_system_score_codex":0.00047757447,"about_ca_system_score_gemma":0.00065661967,"threshold_uncertainty_score":0.019217908},"labels":[],"label_agreement":null},{"id":"W2123938163","doi":"10.1517/14656566.6.4.609","title":"Pharmacotherapy of onychomycosis","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Pharmacotherapy; Itraconazole; Terbinafine; Dermatology; Pharmacology; Intensive care medicine; Internal medicine; Antifungal","score_opus":0.14596244719312867,"score_gpt":0.5199113413738277,"score_spread":0.373948894180699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123938163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003585709,0.99544454,0.00028651263,0.000392971,0.0002829074,0.000013077103,0.000022362356,0.000018243705,0.0031809125],"genre_scores_gemma":[0.0015972164,0.99584997,0.00048040602,0.00036909326,0.00023904577,0.000015501995,0.000048574126,0.0000024728251,0.0013976933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976796,0.000048622576,0.000025296873,0.000032936663,0.00010590503,0.000019243398],"domain_scores_gemma":[0.9998803,0.000039254537,0.00002773235,0.0000058207884,0.000033746775,0.000013124532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030193446,0.00075205206,0.0015702037,0.001590667,0.00022584919,0.00056256,0.0008505041,0.0010662748,0.0047533],"category_scores_gemma":[0.00033579065,0.00014668058,0.0004113743,0.0014319037,0.00022863831,0.00052389374,0.0004225502,0.0010808407,0.003579384],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005719736,0.00010620355,0.000094258445,0.009791735,0.000101076446,0.0005001875,0.000030514513,0.00017160461,0.0023510137,0.00082261564,0.020933792,0.9650396],"study_design_scores_gemma":[0.00009838814,0.0002440887,0.002221391,0.004646304,0.00017800422,0.006629348,0.00006874379,0.00021634815,0.0014976427,0.0016490071,0.9825277,0.000023013465],"about_ca_topic_score_codex":0.00081203185,"about_ca_topic_score_gemma":0.0019392588,"teacher_disagreement_score":0.0047533,"about_ca_system_score_codex":0.00038544816,"about_ca_system_score_gemma":0.0005810952,"threshold_uncertainty_score":0.015901327},"labels":[],"label_agreement":null},{"id":"W2125073267","doi":"10.1517/14656566.8.9.1211","title":"A preclinical and clinical rationale for quetiapine in mood syndromes","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Quetiapine; Quetiapine Fumarate; Antidepressant; Serotonergic; Medicine; Pharmacology; Neuroscience; Dopamine receptor D2; Dopamine receptor D3; Atypical antipsychotic; Dopamine; Antipsychotic; Serotonin; Internal medicine; Psychology; Psychiatry; Receptor; Schizophrenia (object-oriented programming); Hippocampus","score_opus":0.28780102376129496,"score_gpt":0.5640704639575373,"score_spread":0.2762694401962424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125073267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019447423,0.98059237,0.0016661031,0.0060894135,0.0014028837,0.0001087992,0.00008367029,0.000037080234,0.008074863],"genre_scores_gemma":[0.05048046,0.9205261,0.005395716,0.011527322,0.0047140094,0.000471043,0.00015028154,0.00002284728,0.00671218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954575,0.00018244657,0.00006902704,0.000071259434,0.00009810374,0.000033507924],"domain_scores_gemma":[0.99914,0.00059483456,0.00008671758,0.00003082765,0.00011626713,0.000031311858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001329484,0.00069868733,0.0009969481,0.0013555773,0.00034210345,0.00096791924,0.0011530943,0.0020366313,0.0041904775],"category_scores_gemma":[0.002112609,0.00022645315,0.0009197626,0.0006319252,0.0011893916,0.0011082813,0.0005684361,0.0020890695,0.0013299324],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002201858,0.0005102445,0.0008386864,0.03263419,0.00036196352,0.00423603,0.00042663675,0.0006315056,0.026522093,0.09825967,0.030697452,0.8026796],"study_design_scores_gemma":[0.0015503631,0.00331548,0.0052265283,0.010687466,0.0007728453,0.009047605,0.00023342905,0.0002997231,0.011189191,0.021286756,0.93629014,0.00010048355],"about_ca_topic_score_codex":0.0007740319,"about_ca_topic_score_gemma":0.0017873419,"teacher_disagreement_score":0.0041904775,"about_ca_system_score_codex":0.0010391308,"about_ca_system_score_gemma":0.0010623225,"threshold_uncertainty_score":0.014018536},"labels":[],"label_agreement":null},{"id":"W2125741987","doi":"10.1517/14656566.4.4.533","title":"Bupropion SR for smoking cessation","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bupropion; Medicine; Smoking cessation; Nicotine replacement therapy; Placebo; Varenicline; Anesthesia; Psychiatry; Pediatrics","score_opus":0.1723569181062473,"score_gpt":0.48105230155989487,"score_spread":0.30869538345364755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125741987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06176252,0.5583508,0.0080906935,0.019500291,0.0047669513,0.0010505416,0.00385778,0.0038594874,0.3387609],"genre_scores_gemma":[0.3385236,0.22413895,0.011151999,0.031482086,0.0057344455,0.0013649062,0.007516125,0.00044447728,0.37964344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976367,0.00004604114,0.000018225563,0.000036317695,0.00010936851,0.000026344565],"domain_scores_gemma":[0.9998981,0.000027951128,0.000028247074,0.000007853795,0.000014509071,0.00002334509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028786037,0.00041607267,0.0005963592,0.0003771824,0.00018784292,0.00033361095,0.00027463265,0.00080897735,0.052046813],"category_scores_gemma":[0.00039758816,0.00010559015,0.0006280683,0.00027718663,0.00012342753,0.00026638745,0.00038851696,0.0011912624,0.018072767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014263942,0.00051516964,0.00041689302,0.0028392407,0.00018590289,0.0010003797,0.00006766164,0.00012665693,0.025769902,0.0023374143,0.10903599,0.85627836],"study_design_scores_gemma":[0.0046325717,0.0061255703,0.017040776,0.0022236502,0.00017993795,0.015096051,0.000068894005,0.0005904731,0.006505704,0.0028384721,0.94463605,0.00006187233],"about_ca_topic_score_codex":0.00021918758,"about_ca_topic_score_gemma":0.00046276546,"teacher_disagreement_score":0.052046813,"about_ca_system_score_codex":0.00015525275,"about_ca_system_score_gemma":0.00018839465,"threshold_uncertainty_score":0.17411393},"labels":[],"label_agreement":null},{"id":"W2127370803","doi":"10.1517/14656566.2011.558006","title":"Memantine in dementia: a review of the current evidence","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Memantine; Dementia; Current (fluid); Psychiatry; Intensive care medicine; Internal medicine; Disease","score_opus":0.3722309154406039,"score_gpt":0.5328991881366025,"score_spread":0.16066827269599865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127370803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051314793,0.9993685,0.00002821123,0.0001491735,0.000108030996,0.0000043810714,0.000015239062,0.000002860941,0.000272307],"genre_scores_gemma":[0.00030435887,0.99927586,0.00007437766,0.00013029172,0.00008412282,0.0000051061447,0.000014224713,6.062468e-7,0.000111048364],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997421,0.00004771656,0.00006347194,0.000042806878,0.00008754633,0.000016303304],"domain_scores_gemma":[0.999363,0.00034774005,0.00012129782,0.000010446971,0.00012255594,0.000034903933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070776884,0.00095982605,0.0020664237,0.002658599,0.00026593043,0.00096251466,0.0012283489,0.0011502008,0.005178425],"category_scores_gemma":[0.0013269831,0.0002897263,0.00080730347,0.003386193,0.00036240762,0.0011963882,0.00043786273,0.0011688109,0.0016794357],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014590388,0.000051431514,0.00016371079,0.076894306,0.00022925486,0.0002801457,0.000053360793,0.0002024987,0.00050625816,0.00091076375,0.038405374,0.88215697],"study_design_scores_gemma":[0.00010814072,0.00026063639,0.0024746966,0.082279176,0.001372192,0.003481767,0.00019452118,0.00017803581,0.00043492482,0.0019279051,0.9072505,0.000037328944],"about_ca_topic_score_codex":0.0015688624,"about_ca_topic_score_gemma":0.0030867574,"teacher_disagreement_score":0.005178425,"about_ca_system_score_codex":0.00065715273,"about_ca_system_score_gemma":0.0011879693,"threshold_uncertainty_score":0.017323554},"labels":[],"label_agreement":null},{"id":"W2130847374","doi":"10.1517/14656566.2012.651461","title":"3rd Pavia international symposium on advanced kidney cancer","year":2012,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Kidney cancer; Cancer; Viewpoints; Kidney disease; Natural history; Disease; Intensive care medicine; Oncology; Internal medicine","score_opus":0.04326929366883678,"score_gpt":0.39209366209510604,"score_spread":0.3488243684262693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130847374","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044151503,0.5621527,0.0053313863,0.07648752,0.2530487,0.00022134151,0.00051908795,0.00025094752,0.09757316],"genre_scores_gemma":[0.043483306,0.41427222,0.0070443656,0.018319558,0.2729746,0.00029011146,0.0012530108,0.00018130489,0.24218157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993767,0.0001726473,0.000055128792,0.00011810645,0.00017674742,0.000100561374],"domain_scores_gemma":[0.9993413,0.000102831014,0.00006351484,0.000024231127,0.00024112698,0.00022700161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011017355,0.0009831318,0.0007023782,0.0014335999,0.0004280976,0.0014147958,0.00079498073,0.0019211557,0.02264408],"category_scores_gemma":[0.0010432453,0.00025154965,0.00076873676,0.00048548126,0.0004336991,0.0006974516,0.0010635752,0.0027659198,0.00953447],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026858432,0.00009082794,0.000644497,0.0013295908,0.000081612765,0.0007737674,0.00009985701,0.0004135139,0.0031857789,0.0048379498,0.712365,0.27590913],"study_design_scores_gemma":[0.000014018916,0.00006121663,0.00084298727,0.00030955035,0.00002752548,0.0009533622,0.000021428772,0.00009880019,0.00055240764,0.0008281185,0.99628216,0.000008525565],"about_ca_topic_score_codex":0.00065044075,"about_ca_topic_score_gemma":0.0018057576,"teacher_disagreement_score":0.02264408,"about_ca_system_score_codex":0.0012421813,"about_ca_system_score_gemma":0.0015580404,"threshold_uncertainty_score":0.07575196},"labels":[],"label_agreement":null},{"id":"W2130914578","doi":"10.1517/14656566.2013.763030","title":"Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum β-lactamases and carbapenemases)","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Enterobacteriaceae; Medicine; Antimicrobial; Microbiology; Antibiotic resistance; Antibiotics; Escherichia coli; Biology; Genetics; Gene","score_opus":0.021928291009944197,"score_gpt":0.3304190644713412,"score_spread":0.30849077346139697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130914578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015730589,0.99122417,0.00028400953,0.004611893,0.00058724603,0.000012111471,0.00018238547,0.000010315039,0.0015149096],"genre_scores_gemma":[0.014295676,0.9794496,0.000600621,0.00382968,0.0008108952,0.00001700527,0.00023905911,0.0000069995917,0.00075038394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877065,0.00030441338,0.00023174277,0.00026284475,0.00035265854,0.000077717144],"domain_scores_gemma":[0.99462646,0.0026089496,0.0013067877,0.00007698854,0.0012467244,0.0001341452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020303736,0.00040361908,0.0007712855,0.001943323,0.00017618583,0.0013879886,0.00058758387,0.0012979357,0.004281348],"category_scores_gemma":[0.0054773884,0.00017408626,0.0009619926,0.0021656342,0.0005882947,0.0017833012,0.00056319684,0.0008666959,0.00088124623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024555836,0.000035588168,0.006664899,0.11490819,0.0007755781,0.0010174288,0.000596092,0.00048414146,0.0031924387,0.003179406,0.059300214,0.8096005],"study_design_scores_gemma":[0.00006800866,0.00041886518,0.0347759,0.1370424,0.0019518009,0.010095421,0.0013224201,0.00023170968,0.0017310649,0.0034577397,0.80882084,0.00008379901],"about_ca_topic_score_codex":0.002194427,"about_ca_topic_score_gemma":0.0031879763,"teacher_disagreement_score":0.004281348,"about_ca_system_score_codex":0.0009582375,"about_ca_system_score_gemma":0.0021407737,"threshold_uncertainty_score":0.014322519},"labels":[],"label_agreement":null},{"id":"W2131349644","doi":"10.1517/14656560903329102","title":"Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Mecamylamine; Medicine; Nicotinic agonist; Pharmacology; Antagonist; Neuroscience; Internal medicine; Psychology; Receptor","score_opus":0.026188795957031805,"score_gpt":0.3739305931689614,"score_spread":0.34774179721192955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131349644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022596601,0.99643624,0.00018056,0.00059106713,0.00041926888,0.000009467301,0.000025035435,0.000012725743,0.0020996078],"genre_scores_gemma":[0.0010652664,0.99620193,0.00030975192,0.000498351,0.00029607682,0.000012798798,0.000047169025,0.0000018927045,0.0015667492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999,0.000018827415,0.000013260961,0.000018891731,0.000039358732,0.000009673488],"domain_scores_gemma":[0.9998752,0.000041354775,0.000022612296,0.000004270894,0.000038390273,0.000018086714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003452479,0.0007144534,0.0010806384,0.0010927338,0.00019446312,0.00045595696,0.0009151294,0.000957133,0.004591941],"category_scores_gemma":[0.00036495502,0.00016343042,0.00032774176,0.0012016412,0.00026693736,0.00073549297,0.00030686386,0.0012895813,0.0041445685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120968434,0.00011267296,0.00012106919,0.008359645,0.000081882026,0.00038603283,0.000030092679,0.00024851452,0.0035385555,0.0017349897,0.055826314,0.9294392],"study_design_scores_gemma":[0.00006971303,0.00016728694,0.001015944,0.0015860645,0.00009604245,0.0019994406,0.000035600293,0.00010087168,0.0006367163,0.001150366,0.9931248,0.000017212617],"about_ca_topic_score_codex":0.00078675343,"about_ca_topic_score_gemma":0.002397447,"teacher_disagreement_score":0.004591941,"about_ca_system_score_codex":0.00044073103,"about_ca_system_score_gemma":0.00052167656,"threshold_uncertainty_score":0.0153615475},"labels":[],"label_agreement":null},{"id":"W2132185981","doi":"10.1517/14656566.3.4.411","title":"Treatment options for renovascular hypertension","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Renal and Vascular Pathologies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Renovascular hypertension; Renal artery stenosis; Cardiology; Internal medicine; Angioplasty; Blood pressure; Renal artery; Pathophysiology of hypertension; Stenosis; Kidney","score_opus":0.28366608676769955,"score_gpt":0.46428817736092054,"score_spread":0.18062209059322099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132185981","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008561765,0.6048634,0.013416526,0.108402684,0.0132814525,0.0003324525,0.0017953643,0.00073382165,0.2486125],"genre_scores_gemma":[0.1367917,0.5508681,0.026479708,0.10838631,0.024560206,0.000819851,0.006136732,0.00035531266,0.14560214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953294,0.000117473115,0.00004625119,0.00006525941,0.00016865772,0.00006947286],"domain_scores_gemma":[0.9992976,0.00023958735,0.00010352621,0.000048726208,0.00014743989,0.00016305111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006439108,0.00047199114,0.0006972293,0.0007046269,0.000659317,0.0009434359,0.0008256225,0.0014713606,0.06618585],"category_scores_gemma":[0.0025738094,0.00009672078,0.0012725142,0.00052023353,0.00027191342,0.0012371052,0.00095508556,0.0024992218,0.011956799],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000264454,0.00031560217,0.0015975349,0.0024267237,0.00016094572,0.0017135631,0.00012511524,0.00023440458,0.0007880845,0.0114025185,0.23787212,0.7430989],"study_design_scores_gemma":[0.00022916349,0.00020765365,0.0020189933,0.002676574,0.00015810646,0.006147103,0.00010671799,0.00022104237,0.00030160113,0.011811046,0.9760902,0.00003184727],"about_ca_topic_score_codex":0.0006718811,"about_ca_topic_score_gemma":0.0015499805,"teacher_disagreement_score":0.06618585,"about_ca_system_score_codex":0.0004098481,"about_ca_system_score_gemma":0.0009903838,"threshold_uncertainty_score":0.22141373},"labels":[],"label_agreement":null},{"id":"W2132239648","doi":"10.1517/14656566.2014.853039","title":"An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds","year":2013,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aspirin; Primary prevention; Disease; Secondary prevention; Intensive care medicine; Context (archaeology); Adverse effect; Platelet aggregation inhibitor; Population; Internal medicine; Environmental health","score_opus":0.02116803437083587,"score_gpt":0.33934537443845597,"score_spread":0.3181773400676201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132239648","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054577707,0.04212116,0.00016999763,0.061544333,0.89355683,0.000030432542,0.000046712983,0.000064145825,0.0024119313],"genre_scores_gemma":[0.0005129386,0.032511998,0.000196108,0.035468727,0.9256917,0.000025365278,0.00003572714,0.000021882424,0.0055355513],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978229,0.00051490485,0.00036387864,0.00023201334,0.0009421018,0.0001242674],"domain_scores_gemma":[0.9920757,0.0035924562,0.00063584297,0.0001936275,0.0027210363,0.00078144635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034679705,0.0026684273,0.0035639328,0.0019263532,0.0016753592,0.00401794,0.002967636,0.014079406,0.008575811],"category_scores_gemma":[0.014447187,0.0008766551,0.0018649944,0.00138454,0.0021090815,0.003536629,0.0008798799,0.015484677,0.010560703],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029707999,0.000015319782,0.000025129842,0.0004727989,0.000025195352,0.00014907999,0.000019022731,0.000018369698,0.000056147197,0.0002673187,0.9845472,0.014374739],"study_design_scores_gemma":[0.00007247729,0.000040478375,0.00030090375,0.0011128121,0.000079796824,0.00073387974,0.000055040724,0.00012208313,0.00009780874,0.0010743989,0.9962921,0.000018139204],"about_ca_topic_score_codex":0.0014655615,"about_ca_topic_score_gemma":0.0033431437,"teacher_disagreement_score":0.014079406,"about_ca_system_score_codex":0.0020607577,"about_ca_system_score_gemma":0.0016267566,"threshold_uncertainty_score":0.028688908},"labels":[],"label_agreement":null},{"id":"W2133353215","doi":"10.1517/14656566.7.2.177","title":"A review of erlotinib and its clinical use","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Erlotinib; Medicine; Rash; Epidermal growth factor receptor; Gemcitabine; Clinical trial; Oncology; Erlotinib Hydrochloride; Internal medicine; Gefitinib; Lung cancer; Tyrosine-kinase inhibitor; Pancreatic cancer; Pharmacology; Cancer","score_opus":0.22250994714479316,"score_gpt":0.5773877545529791,"score_spread":0.3548778074081859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133353215","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008913797,0.9981705,0.00007661803,0.00028282206,0.00029784776,0.000006240665,0.000017384615,0.000006250451,0.0010533362],"genre_scores_gemma":[0.0003741683,0.99807644,0.00016901773,0.00027887424,0.00033598836,0.000009314798,0.000029675264,0.0000013759416,0.0007251772],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967563,0.00006802906,0.00006003973,0.000049158352,0.00012813778,0.000019052155],"domain_scores_gemma":[0.9996973,0.0001228242,0.000058644422,0.000008426627,0.00007648099,0.000036352467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006754687,0.0010198224,0.001849138,0.0028085902,0.00034947158,0.001183522,0.0011971097,0.0013681112,0.0061129257],"category_scores_gemma":[0.00095812697,0.00036946245,0.0005500176,0.003372858,0.00037446473,0.0015768493,0.000551292,0.0015342839,0.00442813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113019625,0.00010006484,0.00010231333,0.018249353,0.00008285657,0.00044277258,0.000057441193,0.0003043674,0.0010024273,0.00133896,0.070841864,0.90736455],"study_design_scores_gemma":[0.000031779422,0.000109331144,0.000582882,0.004681282,0.000085670916,0.0019625619,0.00004479583,0.00006485989,0.00020864174,0.0007144887,0.9914989,0.00001488621],"about_ca_topic_score_codex":0.0010691432,"about_ca_topic_score_gemma":0.0025091507,"teacher_disagreement_score":0.0061129257,"about_ca_system_score_codex":0.0008241389,"about_ca_system_score_gemma":0.0010837369,"threshold_uncertainty_score":0.020449817},"labels":[],"label_agreement":null},{"id":"W2134373304","doi":"10.1517/14656566.1.3.575","title":"The Sixth International Conference on Endothelin","year":2000,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Cardiovascular, Neuropeptides, and Oxidative Stress Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endothelin receptor; Clinical trial; Pharmacology; Disease; Internal medicine; Receptor","score_opus":0.07739156945634294,"score_gpt":0.4179388430665808,"score_spread":0.34054727361023784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134373304","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022498195,0.30210435,0.004430413,0.08970322,0.41933572,0.00023591625,0.0007342005,0.0003779993,0.18082833],"genre_scores_gemma":[0.010277578,0.16372862,0.0027930494,0.024158109,0.12829295,0.00022475809,0.0012623408,0.00016653599,0.66909605],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900836,0.000158568,0.000085914886,0.00017192181,0.0004240878,0.00015123436],"domain_scores_gemma":[0.9987206,0.0001104903,0.00010780838,0.00005986299,0.00048829196,0.00051295344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015282808,0.0011444554,0.000802001,0.0013617546,0.0007084058,0.0032605615,0.0010635894,0.0030657097,0.090731904],"category_scores_gemma":[0.0023111932,0.00025862877,0.0007440226,0.0007914806,0.0006398677,0.0018279282,0.0018120412,0.00331004,0.05396382],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018231822,0.00006933654,0.0003660704,0.00061655464,0.00003117714,0.00035683,0.000069651745,0.000100501304,0.002861195,0.004568134,0.7199362,0.27084202],"study_design_scores_gemma":[0.0000060609113,0.00003046907,0.00025744134,0.00012412076,0.0000064287497,0.00024570242,0.000015531312,0.000021737791,0.0002105281,0.00058882515,0.99848914,0.000003943733],"about_ca_topic_score_codex":0.00069357466,"about_ca_topic_score_gemma":0.0019023446,"teacher_disagreement_score":0.090731904,"about_ca_system_score_codex":0.0010203351,"about_ca_system_score_gemma":0.0020473865,"threshold_uncertainty_score":0.30352843},"labels":[],"label_agreement":null},{"id":"W2135344776","doi":"10.1517/14656566.8.11.1615","title":"Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; McMaster University; University of Toronto; University Health Network","funders":"GlaxoSmithKline; AstraZeneca; Eli Lilly and Company","keywords":"Mood disorders; Mood; Medicine; Cognition; Disease; Bioinformatics; Neuroscience; Psychiatry; Psychology; Clinical psychology; Anxiety; Internal medicine; Biology","score_opus":0.18067765430314467,"score_gpt":0.45982508818113105,"score_spread":0.27914743387798635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135344776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024093439,0.998069,0.00006956084,0.00073380384,0.0003146074,0.000010348954,0.0000116917245,0.0000030958693,0.00054687855],"genre_scores_gemma":[0.0014545924,0.99593854,0.00025669072,0.0011299013,0.00065750396,0.000033660475,0.000017491877,0.0000012168163,0.00051032467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963653,0.00010489485,0.00008904441,0.000050177892,0.00008587099,0.000033442615],"domain_scores_gemma":[0.9993943,0.00031586117,0.00013406214,0.000012076367,0.000115300616,0.000028360568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010006936,0.0008501294,0.0021635776,0.0021121788,0.0003344322,0.0015924036,0.0009717089,0.0017260507,0.0037636166],"category_scores_gemma":[0.0016138064,0.00030494775,0.00068198267,0.0019665838,0.00059714465,0.0020429923,0.00046967017,0.0012928217,0.0014025511],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005173541,0.00014900666,0.00046365557,0.07181908,0.00026520935,0.00093555386,0.00027326343,0.0002864399,0.0029453898,0.0060207555,0.017392565,0.89893174],"study_design_scores_gemma":[0.00069166505,0.0016863286,0.0047928747,0.04756861,0.0011012338,0.004875746,0.00078094564,0.0003621055,0.0010913822,0.009390004,0.9275707,0.00008841019],"about_ca_topic_score_codex":0.0010594679,"about_ca_topic_score_gemma":0.004532206,"teacher_disagreement_score":0.0037636166,"about_ca_system_score_codex":0.00082801917,"about_ca_system_score_gemma":0.0012841638,"threshold_uncertainty_score":0.012590528},"labels":[],"label_agreement":null},{"id":"W2138218422","doi":"10.1517/14656566.2012.656590","title":"Treatment-emergent adverse events associated with atypical antipsychotics","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Extrapyramidal symptoms; Adverse effect; Atypical antipsychotic; Tolerability; Discontinuation; Olanzapine; Antipsychotic; Risperidone; Clozapine; Quetiapine; Atypical depression; Side effect (computer science); Psychiatry; Intensive care medicine; Pediatrics; Internal medicine; Schizophrenia (object-oriented programming); Cognition","score_opus":0.1710411252647439,"score_gpt":0.46703920134336746,"score_spread":0.29599807607862355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138218422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052589347,0.99674547,0.00024307628,0.0003487174,0.00017526488,0.000022922844,0.00006471283,0.0000107874575,0.0018631209],"genre_scores_gemma":[0.0055445237,0.99221075,0.00042833868,0.00048559564,0.00028595905,0.000025233208,0.00011306863,0.00000234494,0.0009042355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991165,0.0002209113,0.00017146619,0.000087081666,0.00034846054,0.00005551625],"domain_scores_gemma":[0.9989409,0.00034938304,0.0004459449,0.000017987903,0.000212301,0.000033425335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007430996,0.0006948383,0.001294495,0.00095535687,0.00017429702,0.00060656836,0.0005635279,0.0007802983,0.0039649433],"category_scores_gemma":[0.0015396168,0.00012638187,0.00097415654,0.0012386456,0.00017763009,0.0003897426,0.00037901945,0.00072860916,0.00087924465],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013713802,0.000047825597,0.00079216715,0.035702914,0.00038913728,0.0008641926,0.000060766823,0.00024482515,0.0016062389,0.0005849684,0.02332909,0.9362407],"study_design_scores_gemma":[0.0002849002,0.00046090604,0.014082,0.046073932,0.0024268248,0.022444507,0.00021729573,0.0004642557,0.0030719205,0.0024744147,0.9079321,0.00006687594],"about_ca_topic_score_codex":0.00096430496,"about_ca_topic_score_gemma":0.0023017083,"teacher_disagreement_score":0.0039649433,"about_ca_system_score_codex":0.00047527358,"about_ca_system_score_gemma":0.00097549683,"threshold_uncertainty_score":0.013264},"labels":[],"label_agreement":null},{"id":"W2138366034","doi":"10.1517/14656566.9.2.311","title":"Idursulfase for the treatment of mucopolysaccharidosis II","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Child and Family Research Institute","funders":"","keywords":"Hunter syndrome; Enzyme replacement therapy; Recombinant DNA; Medicine; Mucopolysaccharidosis; Mucopolysaccharidosis type II; Disease; Glycosylation; Genetic enhancement; Bioinformatics; Internal medicine; Biology; Genetics; Gene","score_opus":0.17781894602661114,"score_gpt":0.4863654061848031,"score_spread":0.308546460158192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138366034","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019462494,0.99567527,0.00028591297,0.0004246674,0.00035018142,0.000016339973,0.00002486177,0.000017559096,0.0030105445],"genre_scores_gemma":[0.0010766226,0.99580115,0.00048356666,0.00043830203,0.00024123736,0.000017682483,0.000073310446,0.0000032567925,0.0018647859],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998281,0.000032422347,0.000021988244,0.000026778262,0.00007705122,0.000013793762],"domain_scores_gemma":[0.99985576,0.00005243079,0.000030698237,0.0000067334445,0.000034785928,0.000019524603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041373438,0.0009841692,0.0015519962,0.0024859407,0.00026362913,0.00060267805,0.00086176896,0.0010741742,0.0055760792],"category_scores_gemma":[0.00040285528,0.0002006239,0.0005082476,0.001782725,0.00042614326,0.00088929926,0.0004746504,0.0017004595,0.006511231],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010953697,0.000109402405,0.00010774275,0.007918251,0.00010977342,0.00055952923,0.00004466296,0.00026661018,0.003680268,0.002109024,0.043152764,0.9418325],"study_design_scores_gemma":[0.000065236054,0.00011133503,0.00056145067,0.0013733704,0.00006721252,0.002712185,0.000025234998,0.000064879,0.0008041739,0.0010630606,0.9931379,0.000013974046],"about_ca_topic_score_codex":0.00088687794,"about_ca_topic_score_gemma":0.0018813681,"teacher_disagreement_score":0.0055760792,"about_ca_system_score_codex":0.0005078638,"about_ca_system_score_gemma":0.00065506296,"threshold_uncertainty_score":0.01865381},"labels":[],"label_agreement":null},{"id":"W2142447425","doi":"10.1517/14656566.2015.1067682","title":"A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lama; Bronchodilator; COPD; Asthma; Bronchodilation; Bronchodilator Agents; Muscarinic antagonist; Intensive care medicine; Population; Combination therapy; Internal medicine; Muscarinic acetylcholine receptor","score_opus":0.059781031924271165,"score_gpt":0.40154194020603706,"score_spread":0.3417609082817659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142447425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016553624,0.6945431,0.00077905395,0.27182898,0.019978074,0.000053580316,0.0003860168,0.00005178346,0.010723998],"genre_scores_gemma":[0.037683588,0.7258874,0.003414491,0.16574912,0.06235585,0.00013240112,0.00052428077,0.00006415856,0.004188738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99435943,0.002227973,0.00084258575,0.0005495059,0.0017233244,0.0002972254],"domain_scores_gemma":[0.9644947,0.016367301,0.0025822131,0.00069761684,0.014396118,0.0014619686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008481782,0.00053425477,0.0015529328,0.00063854415,0.00043331788,0.002092191,0.0015544188,0.004147906,0.007742657],"category_scores_gemma":[0.033440802,0.0001645478,0.0016083905,0.0006159874,0.000917754,0.0024992514,0.0008820103,0.00636846,0.0029414517],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048764932,0.00006325597,0.001797031,0.011057849,0.000411318,0.0002941506,0.00014232755,0.00034149512,0.00060100877,0.0042077308,0.3542827,0.6263134],"study_design_scores_gemma":[0.00036430778,0.00031814392,0.0061686276,0.041219205,0.00085420714,0.0013661692,0.00040993773,0.0004953956,0.00034555013,0.0068773236,0.9415131,0.00006804811],"about_ca_topic_score_codex":0.00320825,"about_ca_topic_score_gemma":0.0070368764,"teacher_disagreement_score":0.008481782,"about_ca_system_score_codex":0.0018798941,"about_ca_system_score_gemma":0.0039679483,"threshold_uncertainty_score":0.04485649},"labels":[],"label_agreement":null},{"id":"W2143239720","doi":"10.1517/14656566.5.10.2139","title":"Etanercept in psoriasis","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Etanercept; Medicine; Psoriatic arthritis; Psoriasis; Rheumatoid arthritis; Ankylosing spondylitis; Adverse effect; Clinical trial; Arthritis; Placebo; Dermatology; Internal medicine; Immunology; Pathology","score_opus":0.0893489166961888,"score_gpt":0.45685759399466197,"score_spread":0.36750867729847314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143239720","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014790866,0.99768794,0.00006756444,0.00016214376,0.00017359458,0.000011235693,0.000017660419,0.000008325175,0.0017237226],"genre_scores_gemma":[0.0011618239,0.99643457,0.00018343635,0.00048203656,0.00015996536,0.000016035247,0.000045109115,0.0000016984562,0.0015153639],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969566,0.000075448086,0.000042616586,0.000055681558,0.00010449148,0.000026110118],"domain_scores_gemma":[0.9998272,0.00007419725,0.000040764313,0.000005808319,0.00003428152,0.0000176711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060450076,0.00080903934,0.0017915982,0.0020596117,0.00028246516,0.0009854725,0.0008988497,0.0014003816,0.008425422],"category_scores_gemma":[0.0005428259,0.00026096133,0.0006252835,0.0023028266,0.00028833747,0.000954142,0.00050579756,0.0014603281,0.0040627937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017737837,0.00009454894,0.00009592619,0.023281738,0.00012643842,0.000339529,0.000042742395,0.00028861177,0.0013439658,0.0014947278,0.034223035,0.9384914],"study_design_scores_gemma":[0.00023434346,0.00018094332,0.00081394607,0.006956309,0.00022814645,0.002938842,0.000045205295,0.000091566,0.0005187815,0.0015017655,0.98647296,0.000017174349],"about_ca_topic_score_codex":0.0010283868,"about_ca_topic_score_gemma":0.0022801408,"teacher_disagreement_score":0.008425422,"about_ca_system_score_codex":0.0006447466,"about_ca_system_score_gemma":0.0007570404,"threshold_uncertainty_score":0.028185844},"labels":[],"label_agreement":null},{"id":"W2150426329","doi":"10.1517/14656566.2010.484020","title":"Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Heart and Stroke Foundation of Canada","keywords":"Olmesartan; Medicine; Valsartan; Blood pressure; Combination therapy; Risk factor; Internal medicine; Cardiology; Pharmacology","score_opus":0.04497177242538245,"score_gpt":0.3498153123478145,"score_spread":0.304843539922432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150426329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012647817,0.9958413,0.00013398999,0.0018966986,0.00076517224,0.000016931775,0.000025514923,0.000014041407,0.0011798278],"genre_scores_gemma":[0.0008585107,0.9948131,0.00040617405,0.0021519118,0.0005438914,0.000024631496,0.00003013373,0.0000036218644,0.0011680594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965477,0.00009262679,0.000056023262,0.00003480714,0.0001405064,0.00002127401],"domain_scores_gemma":[0.9996723,0.0001517123,0.0000821184,0.0000090828635,0.000065061504,0.000019764373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008102738,0.00071928377,0.0015728554,0.0014450118,0.00021938098,0.0008811401,0.00084220205,0.0014720093,0.0067832917],"category_scores_gemma":[0.0011710632,0.00020532265,0.00084516447,0.0015610936,0.00031149838,0.0017043062,0.00048659783,0.0017280952,0.0031710349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026214638,0.00008039994,0.00010200881,0.041841064,0.00025937706,0.0001545891,0.00008288829,0.000095510535,0.0014125636,0.0017590648,0.10335771,0.8505926],"study_design_scores_gemma":[0.00033898163,0.00022112022,0.0021508439,0.02873765,0.00073851016,0.0016325932,0.0001378765,0.00011812687,0.0007139816,0.0024008611,0.9627701,0.00003940505],"about_ca_topic_score_codex":0.00083775667,"about_ca_topic_score_gemma":0.0025182888,"teacher_disagreement_score":0.0067832917,"about_ca_system_score_codex":0.0004895747,"about_ca_system_score_gemma":0.001106711,"threshold_uncertainty_score":0.022692323},"labels":[],"label_agreement":null},{"id":"W2151114022","doi":"10.1517/14656566.2010.512004","title":"Probiotic strategies for the treatment and prevention of bacterial vaginosis","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Reproductive tract infections research","field":"Immunology and Microbiology","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Bacterial vaginosis; Medicine; Intensive care medicine; Probiotic; Disease; Genitourinary system; Population; Microbicide; Microbicides for sexually transmitted diseases; Vaginal disease; Clinical trial; Reproductive health; Vagina; Immunology; Gynecology; Human immunodeficiency virus (HIV); Internal medicine; Environmental health; Surgery; Health services","score_opus":0.12285491585598339,"score_gpt":0.4660475121725111,"score_spread":0.3431925963165277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151114022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008203995,0.9788461,0.0011335914,0.0102970945,0.0038279549,0.00002926526,0.000083045845,0.000041458803,0.004921151],"genre_scores_gemma":[0.007146552,0.97898865,0.0017816942,0.004459517,0.001926752,0.00003775935,0.00011822174,0.000020194824,0.0055206507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995277,0.00014217371,0.000048100534,0.000059471215,0.00017324642,0.00004931226],"domain_scores_gemma":[0.9996327,0.00013227414,0.00006864846,0.000015103856,0.00010769465,0.00004349307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066738157,0.0005723709,0.00082412787,0.0009701105,0.0002985018,0.0012307538,0.00064460223,0.0019589858,0.011140862],"category_scores_gemma":[0.001293631,0.00013699362,0.00065445044,0.00058733724,0.00050545175,0.0011508941,0.0010107842,0.0032536339,0.0034527148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003132665,0.00020610046,0.0006279963,0.016883269,0.00019439589,0.00046738138,0.0003866481,0.00027764493,0.010350985,0.016144903,0.10401518,0.85013217],"study_design_scores_gemma":[0.000039918013,0.00028008304,0.0012518596,0.00631937,0.000111473324,0.0009676702,0.00020878437,0.000095655385,0.0016083502,0.0050523267,0.98404247,0.000021956761],"about_ca_topic_score_codex":0.00074775325,"about_ca_topic_score_gemma":0.0010816292,"teacher_disagreement_score":0.011140862,"about_ca_system_score_codex":0.00037956543,"about_ca_system_score_gemma":0.0006936822,"threshold_uncertainty_score":0.03726989},"labels":[],"label_agreement":null},{"id":"W2151952082","doi":"10.1517/14656566.2010.485614","title":"Fidaxomicin (OPT-80) for the treatment of<i>Clostridium difficile</i>infection","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Fidaxomicin; Medicine; Clostridium difficile; Internal medicine; Vancomycin; Antibiotics; Diarrhea; Gastroenterology; Intensive care medicine; Surgery; Microbiology","score_opus":0.1285146787912159,"score_gpt":0.46083316786330575,"score_spread":0.33231848907208983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151952082","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026587108,0.99206007,0.0003254856,0.00067086454,0.00071994466,0.000022276678,0.00007255892,0.000027557991,0.003442567],"genre_scores_gemma":[0.033285912,0.95831037,0.00082730316,0.0017601665,0.0006831711,0.000045969526,0.00019956144,0.00001048878,0.004877029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998896,0.00002691661,0.00001616193,0.000019420635,0.000032954213,0.0000148893105],"domain_scores_gemma":[0.9999181,0.000021113128,0.00003332556,0.000001828384,0.000015814903,0.000009766071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017342636,0.0003081447,0.00041137743,0.00057703175,0.00012235262,0.00037847928,0.0002033564,0.00047408268,0.0031336187],"category_scores_gemma":[0.0003017975,0.000053571475,0.00040780436,0.00041808048,0.00015403226,0.00031180502,0.00020453069,0.0006125394,0.0009595115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055957166,0.0000903874,0.00035067933,0.01905512,0.00021456722,0.00033658728,0.00006818201,0.00035817997,0.013969901,0.002243071,0.04699354,0.9157603],"study_design_scores_gemma":[0.0002960515,0.0011025299,0.004083939,0.0054357057,0.0004228163,0.0037638173,0.00007807416,0.00024149429,0.0071153496,0.0010063448,0.97642344,0.000030343208],"about_ca_topic_score_codex":0.0006191541,"about_ca_topic_score_gemma":0.0010516479,"teacher_disagreement_score":0.0031336187,"about_ca_system_score_codex":0.00027984334,"about_ca_system_score_gemma":0.00045434927,"threshold_uncertainty_score":0.0104830265},"labels":[],"label_agreement":null},{"id":"W2152565098","doi":"10.1517/14656566.6.13.2327","title":"Alefacept: an expert review concerning the treatment of psoriasis","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Mediprobe Research (Canada); Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Psoriatic arthritis; Dermatology; Clinical trial; Plaque psoriasis; Topical agents; Intensive care medicine; Internal medicine","score_opus":0.12976649526910297,"score_gpt":0.4289530562968752,"score_spread":0.2991865610277722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152565098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009421781,0.99750924,0.00014633432,0.00042334947,0.00046922133,0.0000100651405,0.000021483336,0.000010657766,0.0013153653],"genre_scores_gemma":[0.00037656797,0.9976157,0.00027477043,0.00046277832,0.00038872648,0.000011869623,0.00004622102,0.0000019412732,0.0008214446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997155,0.0000472092,0.000043057702,0.000045797373,0.00012643792,0.0000219734],"domain_scores_gemma":[0.99969935,0.00011469677,0.00005265603,0.0000084649355,0.000089746216,0.000035110148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006033539,0.0011432645,0.0017579852,0.0024118205,0.00029429197,0.00086021883,0.0011489897,0.0013781413,0.004442378],"category_scores_gemma":[0.000685525,0.0003104092,0.00060723757,0.002655017,0.00030967023,0.0011347439,0.0005740066,0.0017493757,0.004198028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009157997,0.000076369724,0.00006595144,0.009682478,0.000074776544,0.00030938233,0.000033784338,0.00018520952,0.0012322821,0.0007101445,0.058408767,0.92912936],"study_design_scores_gemma":[0.00006280616,0.00010491564,0.0004645653,0.003510971,0.00013681829,0.0019033831,0.000026301124,0.00006929363,0.00039075818,0.00064755575,0.9926662,0.000016447777],"about_ca_topic_score_codex":0.001021712,"about_ca_topic_score_gemma":0.0023907083,"teacher_disagreement_score":0.004442378,"about_ca_system_score_codex":0.00061059144,"about_ca_system_score_gemma":0.00094723405,"threshold_uncertainty_score":0.0148611665},"labels":[],"label_agreement":null},{"id":"W2152716121","doi":"10.1517/14656566.2010.482100","title":"Pharmacotherapy of neuroblastoma","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Izaak Walton Killam Health Centre","funders":"","keywords":"Neuroblastoma; Medicine; Clinical trial; Oncology; Disease; Immunotherapy; Targeted therapy; Pharmacotherapy; Combination therapy; Drug; Drug development; Internal medicine; Pharmacology; Cancer","score_opus":0.11078687250440349,"score_gpt":0.4954936893576022,"score_spread":0.3847068168531987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152716121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002201604,0.99574417,0.000189249,0.0009593009,0.0005211338,0.000008738591,0.0000257218,0.000011213803,0.0023202547],"genre_scores_gemma":[0.0011597105,0.9958858,0.0002498621,0.0006506661,0.00033369046,0.000010515654,0.00004539218,0.0000024003853,0.0016619208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998235,0.000036300546,0.000019453235,0.000028734094,0.00007821031,0.000013899392],"domain_scores_gemma":[0.99988735,0.000041480762,0.000020461455,0.0000057194147,0.000035111294,0.000009800067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028057588,0.0006345233,0.0010148362,0.0011346028,0.00019792229,0.0005414202,0.0005064001,0.00093647686,0.0035489255],"category_scores_gemma":[0.0004066221,0.00013563687,0.0003914038,0.0010814376,0.0002773376,0.00082156906,0.00044574754,0.001439574,0.002309393],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056228768,0.00006110185,0.00010241675,0.008960132,0.000078352925,0.00021338035,0.000054686847,0.00025602712,0.0036247962,0.0028874064,0.05057006,0.9331354],"study_design_scores_gemma":[0.0000314388,0.000081345184,0.00083344383,0.0024766743,0.000057497233,0.0017622642,0.00003360344,0.00009420426,0.0009412758,0.0013906538,0.9922863,0.000011290144],"about_ca_topic_score_codex":0.0010590743,"about_ca_topic_score_gemma":0.002190042,"teacher_disagreement_score":0.0035489255,"about_ca_system_score_codex":0.00059101847,"about_ca_system_score_gemma":0.0008395051,"threshold_uncertainty_score":0.011872292},"labels":[],"label_agreement":null},{"id":"W2153837033","doi":"10.1517/14656566.4.6.911","title":"Androgen replacement therapy in the hypogonadal ageing man","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Ageing; Medicine; Climacteric; Androgen; Androgen deficiency; Testosterone (patch); Hormone; Menopause; Intensive care medicine; Internal medicine","score_opus":0.15872693761260623,"score_gpt":0.4507242243536365,"score_spread":0.2919972867410303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153837033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018697814,0.9987588,0.000037710855,0.00015981228,0.00011549673,0.0000023748682,0.0000056417566,0.0000029176242,0.0007302271],"genre_scores_gemma":[0.0018970908,0.9968945,0.00009917234,0.00033359963,0.00021713042,0.0000050537274,0.000012994247,7.953234e-7,0.00053959043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983406,0.00004626098,0.0000269097,0.000024477577,0.000058379002,0.000009808782],"domain_scores_gemma":[0.9998549,0.00007908001,0.000032977652,0.000004675446,0.000020092866,0.000008132153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039692922,0.00041344183,0.001479852,0.0012331047,0.0002055822,0.00046887237,0.00060300436,0.0008089831,0.0030251804],"category_scores_gemma":[0.00045917084,0.0001224837,0.00039572906,0.0015790925,0.00032560775,0.0004392572,0.000245997,0.0007521581,0.0016515134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012762031,0.000070378956,0.0003959664,0.016583871,0.00012020302,0.0016127205,0.00009418212,0.00019350697,0.0018201326,0.0012884684,0.021828057,0.95586497],"study_design_scores_gemma":[0.00010841344,0.00027762738,0.004459644,0.0063267346,0.0002811902,0.013658125,0.00016878294,0.00011070616,0.0007940037,0.0017936974,0.97200114,0.000019799745],"about_ca_topic_score_codex":0.0010989122,"about_ca_topic_score_gemma":0.003012584,"teacher_disagreement_score":0.0030251804,"about_ca_system_score_codex":0.00034306524,"about_ca_system_score_gemma":0.00053315563,"threshold_uncertainty_score":0.010120213},"labels":[],"label_agreement":null},{"id":"W2155797527","doi":"10.1517/14656566.5.5.1117","title":"Gemifloxacin: a new fluoroquinolone","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Medicine; Gemifloxacin; Pharmacology; Intensive care medicine; Antibiotics; Moxifloxacin; Microbiology","score_opus":0.046934078133935686,"score_gpt":0.38150362655071635,"score_spread":0.33456954841678066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155797527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3682852,0.554583,0.023659525,0.004110812,0.0023246808,0.000556625,0.0044268533,0.0040066876,0.038046695],"genre_scores_gemma":[0.82679075,0.117486924,0.018638523,0.002706575,0.00063101837,0.00021710464,0.0060192994,0.00006436694,0.02744558],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991477,0.000013131444,0.0000074410195,0.000021163274,0.000022167185,0.000021339882],"domain_scores_gemma":[0.999946,0.0000037823418,0.000011460057,0.0000022305455,0.00001094006,0.000025547139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001342078,0.00049647986,0.00028872312,0.000503066,0.00028613815,0.00035290694,0.00037882238,0.0006558198,0.00120228],"category_scores_gemma":[0.00007289255,0.000108593085,0.00023311206,0.00025756477,0.00022373014,0.0003015185,0.00026965857,0.0005550436,0.0009723957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00291823,0.0005698988,0.0033563434,0.0016679841,0.000060067065,0.0018285002,0.00008763745,0.0008415257,0.5339726,0.0011558114,0.025602031,0.42793936],"study_design_scores_gemma":[0.00075715064,0.0059082746,0.012975409,0.00025966958,0.00016932437,0.010464865,0.000062230814,0.0020919263,0.37558565,0.00032027677,0.5913044,0.000100764555],"about_ca_topic_score_codex":0.002021558,"about_ca_topic_score_gemma":0.0033116469,"teacher_disagreement_score":0.002021558,"about_ca_system_score_codex":0.00076832186,"about_ca_system_score_gemma":0.00039156873,"threshold_uncertainty_score":0.005574584},"labels":[],"label_agreement":null},{"id":"W2157257597","doi":"10.1517/14656566.2012.686169","title":"A review of olanzapine pamoate","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Alberta","funders":"","keywords":"Olanzapine; Medicine; Delirium; Sedation; Incidence (geometry); Side effect (computer science); Anesthesia; Schizophrenia (object-oriented programming); Intensive care medicine; Psychiatry","score_opus":0.2894159198900078,"score_gpt":0.5768339360212112,"score_spread":0.28741801613120344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157257597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060560076,0.99942076,0.000023090486,0.00011538034,0.000073470066,0.000006815615,0.000021116924,0.0000019498666,0.000276853],"genre_scores_gemma":[0.0006115595,0.9990031,0.00007966728,0.000099732555,0.00005849593,0.00001030493,0.00002485546,5.7647446e-7,0.000111678455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994568,0.000109125045,0.00017280082,0.00007967163,0.00015322582,0.0000283618],"domain_scores_gemma":[0.9988667,0.000605341,0.00027262905,0.000017255104,0.0001912081,0.000046883662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008465016,0.0011502473,0.0025344072,0.0049202945,0.00032381382,0.0011280134,0.0012609089,0.0011797801,0.0069451467],"category_scores_gemma":[0.0023628902,0.0003519467,0.0013243941,0.005816112,0.00033827114,0.0011143676,0.0005913664,0.000882841,0.0010153648],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015584237,0.000056730372,0.00018944999,0.30999416,0.0005312673,0.0004221283,0.00012391797,0.00018929827,0.0005730644,0.0009363356,0.023857461,0.6629703],"study_design_scores_gemma":[0.00011540702,0.00022634353,0.00286035,0.16318509,0.0033056578,0.003338907,0.00022203127,0.00011969649,0.00047415707,0.0010682697,0.82503575,0.00004830866],"about_ca_topic_score_codex":0.003184328,"about_ca_topic_score_gemma":0.005460479,"teacher_disagreement_score":0.0069451467,"about_ca_system_score_codex":0.0010008643,"about_ca_system_score_gemma":0.0028308642,"threshold_uncertainty_score":0.023233771},"labels":[],"label_agreement":null},{"id":"W2158903958","doi":"10.1517/14656566.9.13.2349","title":"Reassessment of enfuvirtide's role in the management of HIV-1 infection","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Enfuvirtide; Medicine; Human immunodeficiency virus (HIV); Salvage therapy; Protease inhibitor (pharmacology); Pharmacology; Intensive care medicine; Virology; Internal medicine; Viral load; Antiretroviral therapy; Immunology; Chemotherapy; Gp41","score_opus":0.06095669159787775,"score_gpt":0.4238646789794652,"score_spread":0.36290798738158747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158903958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013505656,0.9990219,0.000024360505,0.00044748138,0.00012329825,0.0000022381748,0.000003092991,0.000001625449,0.0002409389],"genre_scores_gemma":[0.00093231903,0.9981865,0.00013608542,0.00037749467,0.00018748097,0.0000063192992,0.0000072862363,5.524191e-7,0.00016591813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942577,0.00019165239,0.00011214009,0.000052903073,0.00018234622,0.000035242218],"domain_scores_gemma":[0.9991443,0.00043127761,0.00015610764,0.000013318377,0.00021789581,0.000037037393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018872423,0.00062318845,0.0021780615,0.0024287838,0.0002746188,0.0012277851,0.0010132673,0.0018319375,0.001693197],"category_scores_gemma":[0.0018957629,0.00028014474,0.0005584685,0.0029936773,0.00055808853,0.0022168632,0.0003686332,0.0012257402,0.00065410446],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020466541,0.00006865666,0.00037209783,0.059249517,0.00030060325,0.0014377034,0.0002817439,0.00026283172,0.0030520111,0.0023178142,0.02994813,0.9025042],"study_design_scores_gemma":[0.00011687617,0.00034060833,0.0030391954,0.022771848,0.0006840443,0.0070379623,0.0004405767,0.00019912444,0.0012958862,0.001729986,0.96229994,0.00004405208],"about_ca_topic_score_codex":0.0022042517,"about_ca_topic_score_gemma":0.003478766,"teacher_disagreement_score":0.0024287838,"about_ca_system_score_codex":0.0014409663,"about_ca_system_score_gemma":0.0021191693,"threshold_uncertainty_score":0.010455012},"labels":[],"label_agreement":null},{"id":"W2159480688","doi":"10.1517/14656566.2012.683174","title":"A review of published evidence reporting on the efficacy and pharmacology of lurasidone","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network","funders":"","keywords":"Lurasidone; Medicine; Pharmacology; Clinical pharmacology; Intensive care medicine; Antipsychotic; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.20422599979781877,"score_gpt":0.48899652151341544,"score_spread":0.2847705217155967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159480688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020419607,0.99850535,0.00005571347,0.00041142522,0.00012660782,0.000014098264,0.00016849316,0.0000054590687,0.00050880795],"genre_scores_gemma":[0.0019140996,0.9970483,0.000149613,0.00045303386,0.00018146905,0.00001759854,0.00013981872,0.0000022762665,0.000093745766],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983076,0.0003660527,0.00065264537,0.00020871937,0.00040281273,0.000062194034],"domain_scores_gemma":[0.99170965,0.005032293,0.001925119,0.000100349134,0.0011154918,0.000117071446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026888635,0.000829524,0.0027442586,0.0041414304,0.0003010704,0.0016998515,0.0014297509,0.0011869797,0.008943841],"category_scores_gemma":[0.009367746,0.00040360985,0.0022073803,0.0049820403,0.00054362457,0.0013289631,0.00076404004,0.001164393,0.001330766],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044931643,0.00004950507,0.00084451196,0.4293271,0.0016451274,0.00037379778,0.00015192576,0.00018095902,0.0006668294,0.0007236066,0.027261784,0.5383256],"study_design_scores_gemma":[0.00024028352,0.00060714094,0.008983443,0.4657279,0.015996465,0.003784983,0.0003699979,0.0001590246,0.0008045455,0.0014912104,0.50176275,0.0000722233],"about_ca_topic_score_codex":0.0019095377,"about_ca_topic_score_gemma":0.0035231942,"teacher_disagreement_score":0.008943841,"about_ca_system_score_codex":0.0009478483,"about_ca_system_score_gemma":0.0031688288,"threshold_uncertainty_score":0.029920101},"labels":[],"label_agreement":null},{"id":"W2162326198","doi":"10.1517/14656566.2.2.303","title":"Pharmacology and clinical experience with saquinavir","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria General Hospital; Ottawa Hospital","funders":"","keywords":"Saquinavir; Ritonavir; Medicine; Pharmacology; Nelfinavir; Protease inhibitor (pharmacology); Nucleoside Reverse Transcriptase Inhibitor; Virology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","score_opus":0.11299448764175786,"score_gpt":0.5016361084492189,"score_spread":0.38864162080746106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162326198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013051353,0.99000144,0.00046620428,0.0006283634,0.00025955145,0.000020932666,0.000044953707,0.000015745734,0.007257701],"genre_scores_gemma":[0.015323735,0.9758375,0.0010927458,0.0009848251,0.00054420205,0.000038912756,0.0001597009,0.000010320346,0.0060078846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956995,0.00011302977,0.000050684142,0.00007752185,0.0001621693,0.00002670887],"domain_scores_gemma":[0.99957055,0.00013833579,0.000054329837,0.000028590905,0.00015472644,0.000053533306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011200758,0.00082026026,0.0009971001,0.0011019222,0.00028784553,0.00076466135,0.0008225486,0.0008989118,0.0083296],"category_scores_gemma":[0.0015067919,0.00020187501,0.0005685057,0.001474692,0.00034833915,0.00078071444,0.00050573563,0.0015134476,0.005609784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002545842,0.00017258653,0.00054692494,0.0041332496,0.00007780679,0.00047956844,0.00011821259,0.0001999894,0.0035636735,0.001078415,0.0128659215,0.97650915],"study_design_scores_gemma":[0.00014727905,0.0010567607,0.0045980727,0.0018313738,0.00016945523,0.009398169,0.00009172487,0.00014761837,0.0026236072,0.0012936397,0.9786083,0.00003390896],"about_ca_topic_score_codex":0.00058649195,"about_ca_topic_score_gemma":0.0009398382,"teacher_disagreement_score":0.0083296,"about_ca_system_score_codex":0.0004376764,"about_ca_system_score_gemma":0.00052285386,"threshold_uncertainty_score":0.02786529},"labels":[],"label_agreement":null},{"id":"W2166669754","doi":"10.1517/14656560903413534","title":"Examining the roles of cannabinoids in pain and other therapeutic indications: a review","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Medicine; Dronabinol; Cannabidiol; Tolerability; Cannabis; Synthetic cannabinoids; Clinical trial; Randomized controlled trial; Intensive care medicine; Cannabinoid; Pharmacology; Adverse effect; Psychiatry; Surgery; Internal medicine","score_opus":0.11635039492108899,"score_gpt":0.44611785053375647,"score_spread":0.32976745561266746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166669754","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006367998,0.99942315,0.000020794008,0.00013166202,0.000060688228,0.000005834218,0.0000060768875,0.0000012088958,0.00028696534],"genre_scores_gemma":[0.0003815491,0.9992218,0.000082541155,0.000111224865,0.000062610365,0.000007317265,0.0000062460044,3.6856858e-7,0.00012638695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933547,0.00020058628,0.00013180274,0.00007920591,0.00021401448,0.000039009108],"domain_scores_gemma":[0.9982256,0.0011640048,0.0002616694,0.000023308621,0.0002632257,0.0000621364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013812305,0.0009907485,0.002934508,0.0064213723,0.0003905374,0.0015267398,0.0011547222,0.001893625,0.0056930934],"category_scores_gemma":[0.0026784865,0.00038685548,0.0010024217,0.0083214,0.00064064324,0.0020591316,0.00057917874,0.0009221055,0.0014148242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017771014,0.00010095776,0.00034878906,0.1762276,0.00045741946,0.00063318654,0.000232152,0.00028712285,0.0016526215,0.0016324109,0.020398444,0.79785156],"study_design_scores_gemma":[0.00016764038,0.0004174744,0.0061774114,0.165983,0.0024034283,0.004521696,0.00071414845,0.00019732682,0.00093754416,0.002758973,0.8156533,0.000067962275],"about_ca_topic_score_codex":0.0035098954,"about_ca_topic_score_gemma":0.007157142,"teacher_disagreement_score":0.0064213723,"about_ca_system_score_codex":0.0014283403,"about_ca_system_score_gemma":0.0036792972,"threshold_uncertainty_score":0.019045353},"labels":[],"label_agreement":null},{"id":"W2167079031","doi":"10.1517/14656566.8.12.1837","title":"Combined intravenous and intra-arterial approach in acute stroke treatment","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital; Foothills Medical Centre","funders":"","keywords":"Medicine; Stroke (engine); Intensive care medicine; Acute stroke; Tissue plasminogen activator; Thrombolysis; Modalities; Recombinant tissue plasminogen activator; Fibrinolytic agent; Ischemic stroke; Ischemia; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.07460703907512574,"score_gpt":0.4087784671248298,"score_spread":0.33417142804970407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167079031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017639161,0.9975485,0.000173781,0.00024254195,0.00015877993,0.000008217695,0.000005985353,0.0000054790335,0.0016802705],"genre_scores_gemma":[0.0013008307,0.9971439,0.000415248,0.00028438398,0.00023176438,0.000011832879,0.00001371004,0.0000011155335,0.0005971485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966073,0.00010516573,0.00004796241,0.000043792257,0.00011894085,0.000023440038],"domain_scores_gemma":[0.9998307,0.00008129053,0.000039603223,0.0000047708204,0.00003260892,0.000010981079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052262,0.0007233274,0.0017492556,0.0018297848,0.0002045541,0.00071651227,0.00080070406,0.0012085134,0.0035898346],"category_scores_gemma":[0.00051219977,0.00019715568,0.00050996494,0.0018635615,0.00041115907,0.0008922997,0.00039114006,0.0012329099,0.00252067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008355811,0.00013538795,0.00018127331,0.018366206,0.0001422425,0.0008065798,0.00005043177,0.00025951277,0.0017100007,0.00132955,0.019445289,0.95748985],"study_design_scores_gemma":[0.0001333232,0.00040064444,0.0035766666,0.013181646,0.00042656757,0.01569979,0.00014225111,0.0002530414,0.0013023126,0.0022960987,0.9625487,0.0000389554],"about_ca_topic_score_codex":0.0007997821,"about_ca_topic_score_gemma":0.00196023,"teacher_disagreement_score":0.0035898346,"about_ca_system_score_codex":0.00043614142,"about_ca_system_score_gemma":0.0006736,"threshold_uncertainty_score":0.012009203},"labels":[],"label_agreement":null},{"id":"W2169543120","doi":"10.1517/14656566.3.10.1405","title":"Major depressive episodes and diet pills","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Sibutramine; Medicine; Weight loss; Orlistat; Depression (economics); Serotonergic; Pill; Fenfluramine; Phenylpropanolamine; Etiology; Obesity; Caffeine; Psychiatry; Pharmacology; Internal medicine; Serotonin","score_opus":0.08915129555430716,"score_gpt":0.43682837926998763,"score_spread":0.34767708371568046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169543120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064009253,0.9907659,0.00011171373,0.0007748837,0.0003441619,0.000026774347,0.00006903058,0.00002362332,0.0072437287],"genre_scores_gemma":[0.0041705514,0.9886026,0.0002871916,0.0013184753,0.00037457992,0.000027226472,0.00012865431,0.00000226245,0.0050884574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985087,0.000035483954,0.000018346354,0.000019804644,0.000060924285,0.000014609297],"domain_scores_gemma":[0.9998653,0.000036536887,0.00004280379,0.000004575579,0.000030964333,0.000019743246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027808477,0.00053793204,0.0011717755,0.0009123143,0.00021386247,0.0004811374,0.0005661535,0.00075312884,0.007127723],"category_scores_gemma":[0.0004603509,0.00013657467,0.0003748044,0.001119148,0.00012222597,0.00032845928,0.0003021251,0.00048559348,0.003435561],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013342049,0.000151435,0.0006205686,0.011162514,0.00017532308,0.00043321986,0.00004116833,0.00007074221,0.00083366426,0.0007231167,0.05040117,0.9352537],"study_design_scores_gemma":[0.00017906907,0.0004032587,0.014509356,0.00631041,0.00030199974,0.005285214,0.000108023014,0.00010339162,0.00047082163,0.001051767,0.9712551,0.000021691827],"about_ca_topic_score_codex":0.0017405512,"about_ca_topic_score_gemma":0.004888854,"teacher_disagreement_score":0.007127723,"about_ca_system_score_codex":0.0003260389,"about_ca_system_score_gemma":0.00059361284,"threshold_uncertainty_score":0.02384466},"labels":[],"label_agreement":null},{"id":"W2171281019","doi":"10.1517/14656566.2011.596149","title":"Therapy for prevention of post-stroke depression","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Depression (economics); Stroke (engine); Post-stroke depression; Psychological intervention; Psychiatry; Activities of daily living","score_opus":0.10707253224869083,"score_gpt":0.4536675801635518,"score_spread":0.34659504791486095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171281019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011643497,0.9985404,0.00008270756,0.00033799995,0.00012299836,0.00001377249,0.000024212724,0.000006895514,0.0007545903],"genre_scores_gemma":[0.0011247818,0.9979101,0.00017194141,0.00027791556,0.00011105979,0.000015691772,0.00003287834,0.0000010706642,0.00035452755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997011,0.00008922315,0.000042404263,0.00004624534,0.00009994607,0.000020988868],"domain_scores_gemma":[0.9996426,0.00019022942,0.000079122125,0.000009653399,0.00006333278,0.000015053574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005051459,0.00065926864,0.0016731921,0.0014973219,0.00019078043,0.00061903783,0.00074948714,0.0011457697,0.0063027125],"category_scores_gemma":[0.0011356053,0.0001497153,0.0007841255,0.0013247927,0.00024556371,0.0005170558,0.00039571227,0.0010888511,0.002414678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008284464,0.00007054184,0.00012148873,0.039749347,0.00030990705,0.0001034341,0.000038138398,0.00014477436,0.0005885884,0.0009443869,0.021741677,0.9361049],"study_design_scores_gemma":[0.0002770997,0.0004348225,0.00488457,0.08763277,0.001382074,0.003894597,0.00016550813,0.0003082286,0.00090951385,0.0036015592,0.89646804,0.000041187504],"about_ca_topic_score_codex":0.0010980447,"about_ca_topic_score_gemma":0.002068212,"teacher_disagreement_score":0.0063027125,"about_ca_system_score_codex":0.00035428687,"about_ca_system_score_gemma":0.00065282214,"threshold_uncertainty_score":0.021084666},"labels":[],"label_agreement":null},{"id":"W2171837479","doi":"10.1517/14712598.2012.727618","title":"Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding","year":2012,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Ezetimibe; Medicine; Intensive care medicine; Internal medicine; Statin","score_opus":0.0470890939153772,"score_gpt":0.3500374663059719,"score_spread":0.3029483723905947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171837479","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021034892,0.0014190979,0.000054330056,0.95783603,0.039178208,0.000004775492,0.0000264652,0.000013110448,0.001257609],"genre_scores_gemma":[0.003485376,0.0010900866,0.0001203136,0.893212,0.09899078,0.0000148151685,0.000018347322,0.000021808375,0.0030464157],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99576306,0.0014632335,0.00052881514,0.0005615918,0.001198391,0.00048485983],"domain_scores_gemma":[0.9895257,0.005564752,0.0011256711,0.00025560593,0.0022922412,0.0012360349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004127695,0.0008889384,0.002198008,0.0008468295,0.0028573086,0.0041597467,0.0021886202,0.060502063,0.005188285],"category_scores_gemma":[0.03887413,0.00081453007,0.0011565732,0.00083328114,0.002890543,0.0036648537,0.0012879592,0.03931004,0.0061407625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053127882,0.00001546996,0.00020489434,0.000046161513,0.000016893468,0.0013186391,0.000075399344,0.000024188092,0.0000579871,0.00094362954,0.99364036,0.0036030894],"study_design_scores_gemma":[0.00022987266,0.0000733329,0.0010185125,0.00059597025,0.0001037465,0.004201357,0.000408583,0.00038636377,0.00032633936,0.0070463936,0.9855232,0.0000863422],"about_ca_topic_score_codex":0.0024752473,"about_ca_topic_score_gemma":0.0032042388,"teacher_disagreement_score":0.060502063,"about_ca_system_score_codex":0.003947525,"about_ca_system_score_gemma":0.0039135595,"threshold_uncertainty_score":0.028641462},"labels":[],"label_agreement":null},{"id":"W2191064608","doi":"10.1517/14656566.2015.1115014","title":"Beclomethasone HFA for the treatment of allergic rhinitis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dermatology","score_opus":0.19473610660336954,"score_gpt":0.4632658466981847,"score_spread":0.2685297400948152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2191064608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002042811,0.96330166,0.00086117175,0.015282959,0.0034991698,0.000051731637,0.00015446587,0.00006317666,0.014742913],"genre_scores_gemma":[0.042399656,0.91200167,0.002185089,0.018263143,0.009327306,0.000092762406,0.0005184244,0.000024068391,0.015187941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997003,0.000086921085,0.000028102291,0.00004306366,0.00011491016,0.000026707079],"domain_scores_gemma":[0.99965894,0.00011498038,0.000086142034,0.000007128221,0.00009935664,0.000033364584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043997628,0.00027710738,0.0004695417,0.00052629417,0.00016330877,0.00045211904,0.00037665962,0.0011490105,0.008128391],"category_scores_gemma":[0.00086587336,0.000059927977,0.00049997185,0.0002745968,0.00023868526,0.0003759081,0.00026501445,0.0013434547,0.003524554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031455111,0.00008219497,0.0003855097,0.00801382,0.0001521952,0.00077583326,0.0000459144,0.000121771605,0.005463851,0.0016576321,0.15830274,0.8246839],"study_design_scores_gemma":[0.00030912855,0.00044581742,0.002611645,0.0046838447,0.00025382938,0.004727487,0.00005630723,0.00022309502,0.0018995756,0.001568868,0.98319745,0.000023152075],"about_ca_topic_score_codex":0.00057793304,"about_ca_topic_score_gemma":0.0016078715,"teacher_disagreement_score":0.008128391,"about_ca_system_score_codex":0.00034673852,"about_ca_system_score_gemma":0.00035446946,"threshold_uncertainty_score":0.027192235},"labels":[],"label_agreement":null},{"id":"W2266600836","doi":"10.1517/14656566.2016.1146691","title":"Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Neuropathic pain; Gabapentin; Amitriptyline; Ketamine; Neuralgia; Postherpetic neuralgia; Adverse effect; Anesthesia; Peripheral neuropathy; Clinical trial; Pregabalin; Onset of action; Dosing; Pharmacology; Internal medicine; Diabetes mellitus","score_opus":0.03261861953782947,"score_gpt":0.34716190035916294,"score_spread":0.3145432808213335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266600836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038873315,0.918736,0.005186243,0.007314463,0.0014250906,0.00013708863,0.00019242924,0.00013381748,0.028001549],"genre_scores_gemma":[0.31843206,0.6515568,0.00658359,0.0064226477,0.0041187406,0.00015899912,0.0003591451,0.000037659,0.01233029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977773,0.00005904524,0.000028596722,0.00003231391,0.00007140387,0.000030955096],"domain_scores_gemma":[0.9997707,0.00005837218,0.000107113745,0.000008768333,0.000032910437,0.000022100123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000364172,0.00026415748,0.0005341618,0.00031519373,0.0001504599,0.00033135602,0.00032909494,0.0006460201,0.0062809046],"category_scores_gemma":[0.0004729182,0.000062002466,0.00039805955,0.00027766117,0.0002539246,0.00039531582,0.00020190966,0.00059435243,0.0019744113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001375386,0.00026827998,0.0021467682,0.0075394367,0.000287137,0.003493579,0.00008711196,0.00022681287,0.04453876,0.0021541007,0.027498173,0.9103844],"study_design_scores_gemma":[0.0014564137,0.007531922,0.038478576,0.007580397,0.00093559397,0.09431984,0.00045682455,0.0012706458,0.05327256,0.005325237,0.7892702,0.000101847334],"about_ca_topic_score_codex":0.0003199287,"about_ca_topic_score_gemma":0.0012275781,"teacher_disagreement_score":0.0062809046,"about_ca_system_score_codex":0.00025442356,"about_ca_system_score_gemma":0.0002697753,"threshold_uncertainty_score":0.02101171},"labels":[],"label_agreement":null},{"id":"W2282704344","doi":"10.1517/14656566.2016.1146687","title":"How effective is efinaconazole in the management of onychomycosis?","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mediprobe Research (Canada)","funders":"","keywords":"Medicine; Dermatology; Adverse effect; Broad spectrum; Antifungal; Cure rate; Combination therapy; Surgery; Internal medicine","score_opus":0.02648377841797236,"score_gpt":0.36761610883201246,"score_spread":0.3411323304140401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282704344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001994352,0.9588589,0.0008159592,0.029942427,0.0020761164,0.000032126107,0.00012423258,0.00003096738,0.0061249146],"genre_scores_gemma":[0.025002427,0.9456572,0.0013672342,0.018043492,0.0063990443,0.000048384216,0.0002187414,0.000015972975,0.003247593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949527,0.00013085797,0.00006219189,0.00009266573,0.00016871667,0.000050294977],"domain_scores_gemma":[0.9994142,0.0002040411,0.0001492764,0.0000080444715,0.00018269556,0.000041821564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006027036,0.00031145976,0.0011159638,0.0004724908,0.00021254641,0.0010382636,0.0006722852,0.0019341672,0.0047275503],"category_scores_gemma":[0.0016528347,0.000083830244,0.0005287114,0.00037693765,0.00043299145,0.0008562596,0.00024535286,0.001510005,0.002139353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003395868,0.000080172416,0.00083318236,0.008790527,0.00022398468,0.00052927976,0.000051362338,0.0002677378,0.0019212071,0.001676812,0.073805556,0.91148055],"study_design_scores_gemma":[0.00041634424,0.00075187575,0.006908304,0.029946769,0.0008803935,0.0059413756,0.00043216615,0.0008565467,0.0021651802,0.0070911585,0.94453216,0.000077794735],"about_ca_topic_score_codex":0.0009676062,"about_ca_topic_score_gemma":0.003195237,"teacher_disagreement_score":0.0047275503,"about_ca_system_score_codex":0.00058352784,"about_ca_system_score_gemma":0.0006360021,"threshold_uncertainty_score":0.015815198},"labels":[],"label_agreement":null},{"id":"W2295116138","doi":"10.1517/14656566.2015.1064897","title":"Odanacatib for the treatment of osteoporosis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bone Metabolism and Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Cathepsin K; Medicine; Osteoporosis; Bone resorption; Bone mineral; Pharmacology; Internal medicine; Osteoclast; Receptor","score_opus":0.11406651901762999,"score_gpt":0.44887797703472576,"score_spread":0.3348114580170958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295116138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002073725,0.99154586,0.00017253526,0.001427152,0.0009442362,0.00002198872,0.00011131685,0.000023428065,0.0055461107],"genre_scores_gemma":[0.0017868571,0.9916767,0.00023491266,0.0016208688,0.0006822245,0.000019350227,0.00021104398,0.000004398446,0.0037636906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982125,0.000029825793,0.000019445624,0.000030301666,0.000081292776,0.000017960096],"domain_scores_gemma":[0.99983764,0.00004906622,0.000039335715,0.0000041502344,0.000048383386,0.000021438245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034099,0.00052213,0.0007771038,0.001274614,0.0002245161,0.00074137095,0.0006643039,0.0009473645,0.011324875],"category_scores_gemma":[0.00055670616,0.00015306608,0.0006047923,0.0010397765,0.00025593126,0.00059397414,0.0005151859,0.0017168566,0.005445857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010769497,0.000044918437,0.00008432961,0.011780754,0.000106921,0.00017877863,0.00002747124,0.00017934489,0.0016826522,0.0027791723,0.107534155,0.87549394],"study_design_scores_gemma":[0.000059211194,0.00007600077,0.00033749623,0.002913271,0.00008298459,0.0009922418,0.00001526608,0.00005973042,0.0003132475,0.001376015,0.9937643,0.000010156839],"about_ca_topic_score_codex":0.00083226303,"about_ca_topic_score_gemma":0.002264641,"teacher_disagreement_score":0.011324875,"about_ca_system_score_codex":0.0004806036,"about_ca_system_score_gemma":0.00084656005,"threshold_uncertainty_score":0.037885487},"labels":[],"label_agreement":null},{"id":"W2345727571","doi":"10.1517/14656566.2016.1115481","title":"Overtreatment in cancer – is it a problem?","year":2016,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Overdiagnosis; Medicine; Disease; Cancer; Intensive care medicine; Precision medicine; Family medicine; Internal medicine; Pathology","score_opus":0.33262471852849523,"score_gpt":0.542635894490983,"score_spread":0.2100111759624878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345727571","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007402844,0.10145483,0.0002517664,0.20900616,0.6875263,0.000011859163,0.00005799105,0.000029328097,0.0015877761],"genre_scores_gemma":[0.0012581429,0.048153106,0.00017699123,0.048615374,0.89855427,0.000016388594,0.000022046448,0.000027359278,0.003176353],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99449253,0.0019003104,0.0006967602,0.0005241164,0.0021608558,0.00022548715],"domain_scores_gemma":[0.9565137,0.03453523,0.0016523509,0.00056171336,0.005271695,0.0014652308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0087858755,0.0022379851,0.0028436182,0.0018871839,0.0016750722,0.005315777,0.0029679593,0.014611887,0.0052543934],"category_scores_gemma":[0.04809722,0.0006133982,0.002081851,0.0015366662,0.0038469927,0.0053150756,0.0011786119,0.018645555,0.0031691603],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025139618,0.000009629472,0.000043676006,0.0004836829,0.00003360125,0.00008192563,0.000039265564,0.000056458673,0.000014880676,0.0018026219,0.9875337,0.009875411],"study_design_scores_gemma":[0.00007630795,0.00003884886,0.0005455281,0.0025173065,0.000105649895,0.00048131804,0.00011962834,0.00032835655,0.000055253397,0.011114173,0.9845834,0.000034312456],"about_ca_topic_score_codex":0.0030303085,"about_ca_topic_score_gemma":0.0054825577,"teacher_disagreement_score":0.014611887,"about_ca_system_score_codex":0.0036941937,"about_ca_system_score_gemma":0.0043604006,"threshold_uncertainty_score":0.04646468},"labels":[],"label_agreement":null},{"id":"W2489102976","doi":"10.1080/14656566.2016.1215432","title":"How can the new antipsychotic medications improve quality of life in patients with schizophrenia?","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Schizophrenia (object-oriented programming); Quality of life (healthcare); Antipsychotic; Psychiatry; Intensive care medicine","score_opus":0.03670641421594753,"score_gpt":0.36282109665944146,"score_spread":0.32611468244349395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2489102976","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41370878,0.46385756,0.0014215076,0.08296347,0.0027362152,0.00016441567,0.0022183529,0.000041089497,0.03288866],"genre_scores_gemma":[0.8560417,0.13123232,0.0011011012,0.0070978426,0.0014763514,0.00008259657,0.0006680998,0.000009454624,0.0022905746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992138,0.00037303343,0.00007153381,0.000047513204,0.000196279,0.000097761884],"domain_scores_gemma":[0.9980205,0.0008197065,0.00059667055,0.000044422493,0.00029450757,0.00022427122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017596637,0.0002356673,0.00084362854,0.0003210828,0.00018307343,0.00082043966,0.00022790112,0.0005468777,0.005782118],"category_scores_gemma":[0.0049136616,0.000059506277,0.0011030817,0.00048585533,0.0002573171,0.000705614,0.00045606063,0.0008743261,0.00022953779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025864902,0.00074023375,0.08509592,0.0050982474,0.0022578621,0.00015644057,0.0003114339,0.00096232793,0.0008744414,0.002166153,0.019391667,0.8803587],"study_design_scores_gemma":[0.0026748322,0.006491625,0.86648095,0.0077047735,0.0036063155,0.0016447174,0.0023740758,0.003008561,0.001479655,0.009932807,0.09446883,0.0001329086],"about_ca_topic_score_codex":0.0024824466,"about_ca_topic_score_gemma":0.009466258,"teacher_disagreement_score":0.005782118,"about_ca_system_score_codex":0.0010510279,"about_ca_system_score_gemma":0.0009624904,"threshold_uncertainty_score":0.019343138},"labels":[],"label_agreement":null},{"id":"W2512726512","doi":"10.1080/14656566.2016.1219339","title":"An update on adjuvant systemic therapy for elderly patients with early breast cancer","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Cancer; Trastuzumab; Oncology; Population; Life expectancy; Clinical trial; Geriatric oncology; Internal medicine; Adjuvant therapy; Intensive care medicine","score_opus":0.026059949225191698,"score_gpt":0.3776303086561885,"score_spread":0.3515703594309968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512726512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055272118,0.99825424,0.00006626496,0.00058728,0.00042859488,0.0000077784025,0.000038388138,0.000004717224,0.0005574865],"genre_scores_gemma":[0.00031026624,0.9986872,0.00011820858,0.0004057517,0.00021301462,0.000007831749,0.000041279138,0.0000010360218,0.00021532484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996158,0.00009805514,0.00009046729,0.000044763256,0.00013001858,0.000020876607],"domain_scores_gemma":[0.9991961,0.00044678603,0.00012420047,0.000012010727,0.00019014138,0.000030817977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000747062,0.0006808982,0.0014139027,0.0016672456,0.00020064857,0.000793419,0.0008975583,0.0012204993,0.0046043196],"category_scores_gemma":[0.0021071364,0.00024385609,0.0011060312,0.0016754175,0.0002757806,0.0010260239,0.000496775,0.0015787347,0.001436869],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077493234,0.000032378135,0.00013855656,0.054205313,0.0002293718,0.0001432932,0.0000603579,0.0002166132,0.00047718966,0.0013590006,0.076911926,0.86614853],"study_design_scores_gemma":[0.000043117332,0.000076186094,0.0008731719,0.03267618,0.00054711103,0.0012396334,0.0000460601,0.00008780431,0.00014285126,0.0009724317,0.9632784,0.000017002772],"about_ca_topic_score_codex":0.0016502205,"about_ca_topic_score_gemma":0.00345941,"teacher_disagreement_score":0.0046043196,"about_ca_system_score_codex":0.0006450649,"about_ca_system_score_gemma":0.0013449846,"threshold_uncertainty_score":0.015402973},"labels":[],"label_agreement":null},{"id":"W2549381486","doi":"10.1080/14656566.2016.1258060","title":"Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Memantine; Disease; Clinical trial; Rivastigmine; Biomarker; Alzheimer's disease; Oncology; Intensive care medicine; Donepezil; Internal medicine; Dementia","score_opus":0.25923119354640534,"score_gpt":0.4671612476598155,"score_spread":0.20793005411341015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549381486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032787746,0.99842393,0.00007237667,0.00056484237,0.00023797574,0.0000089938985,0.000013660447,0.000003487311,0.0006419095],"genre_scores_gemma":[0.00031747768,0.99847466,0.00017008872,0.00048300502,0.00018329482,0.000010844721,0.000016879396,0.0000013199674,0.00034244845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993649,0.00017147645,0.00010700493,0.00007972943,0.00023566704,0.00004128919],"domain_scores_gemma":[0.9991505,0.00045929782,0.00013868573,0.00002575592,0.00019046427,0.000035319143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012466949,0.0010430928,0.0020080446,0.002965935,0.0002899457,0.0014709661,0.0009603405,0.002105069,0.009426676],"category_scores_gemma":[0.0014997914,0.00027500498,0.001377345,0.0024939764,0.0006794585,0.0024976565,0.0007648668,0.0028497863,0.0035827954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008992237,0.000079766396,0.00007695827,0.08769731,0.0002501145,0.00015395845,0.00011474799,0.00020534283,0.0012415064,0.0062388266,0.039706215,0.86414534],"study_design_scores_gemma":[0.000055012206,0.00009418442,0.00049248355,0.03654974,0.00030711418,0.00073565025,0.00007808892,0.00006169223,0.00024914663,0.003365779,0.957991,0.000020069703],"about_ca_topic_score_codex":0.0012140856,"about_ca_topic_score_gemma":0.0026324412,"teacher_disagreement_score":0.009426676,"about_ca_system_score_codex":0.0008719948,"about_ca_system_score_gemma":0.0019644042,"threshold_uncertainty_score":0.031535387},"labels":[],"label_agreement":null},{"id":"W2626261656","doi":"10.1080/14656566.2017.1340938","title":"Novel therapy for childhood acute lymphoblastic leukemia","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Clinical trial; Intensive care medicine; Disease; Minimal residual disease; Oncology; Risk stratification; Lymphoblastic Leukemia; Expert opinion; Internal medicine; Leukemia","score_opus":0.17184688914497115,"score_gpt":0.48562954739914893,"score_spread":0.3137826582541778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626261656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016752505,0.9971777,0.00018516209,0.0005785838,0.00034884218,0.000010907547,0.000037846065,0.000010089738,0.0014833586],"genre_scores_gemma":[0.0012657105,0.9970099,0.00023044858,0.0004569349,0.00021272826,0.000011551829,0.000060787395,0.0000021281205,0.0007498993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981934,0.000042016367,0.000021591653,0.000034006298,0.00006669741,0.000016311173],"domain_scores_gemma":[0.9998313,0.00007863017,0.00002998455,0.0000048264524,0.00004309564,0.000012065137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003884979,0.00045083187,0.00080434565,0.0011891463,0.00017379982,0.0006250249,0.00056954654,0.00075631717,0.0055195903],"category_scores_gemma":[0.00056133856,0.00013254354,0.00051075715,0.0007787161,0.00025744445,0.0007122267,0.0004904124,0.0016192233,0.0023179462],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000762457,0.00005018029,0.00010249751,0.015189494,0.00009108991,0.00015857529,0.00004011909,0.00026317904,0.0017451394,0.0033421034,0.027913624,0.95102775],"study_design_scores_gemma":[0.00003473317,0.000096888674,0.0003896196,0.004453733,0.000110145826,0.0010225177,0.000029194645,0.00008529074,0.0005956301,0.0014626532,0.99170834,0.000011175639],"about_ca_topic_score_codex":0.0006343673,"about_ca_topic_score_gemma":0.0013878313,"teacher_disagreement_score":0.0055195903,"about_ca_system_score_codex":0.00045515076,"about_ca_system_score_gemma":0.0006513638,"threshold_uncertainty_score":0.018464923},"labels":[],"label_agreement":null},{"id":"W2753504277","doi":"10.1080/14656566.2017.1369957","title":"Time for new low density lipoprotein cholesterol (LDL-C) targets?","year":2017,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Kexin; Proprotein convertase; PCSK9; Subtilisin; Medicine; Cholesterol; Ldl cholesterol; Lipoprotein; Low-density lipoprotein; Internal medicine; Endocrinology; Pharmacology; LDL receptor; Biochemistry; Enzyme; Biology","score_opus":0.03531593968877128,"score_gpt":0.36188147889046013,"score_spread":0.32656553920168885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753504277","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022206489,0.38245568,0.0047310614,0.47638887,0.023624137,0.00019717118,0.001372347,0.0002570311,0.08876728],"genre_scores_gemma":[0.24247678,0.29049584,0.010078996,0.30237514,0.03589222,0.0006079265,0.0018163157,0.00019947375,0.11605738],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9995041,0.00013223846,0.000051825,0.00007653602,0.00014048508,0.0000948761],"domain_scores_gemma":[0.99893147,0.00039680494,0.00019726377,0.000041790678,0.00019808569,0.00023463214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011884177,0.0002981861,0.0007497682,0.00022636162,0.00039035725,0.0015686593,0.00034971704,0.0022338575,0.03892214],"category_scores_gemma":[0.002741153,0.00011640095,0.00057975046,0.00021715379,0.00048793806,0.0021813503,0.0006331731,0.003186166,0.006716971],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039017096,0.00041671057,0.002135719,0.0025223037,0.00024250743,0.00064673735,0.00013838064,0.00032437325,0.007212397,0.023151966,0.28528455,0.6740226],"study_design_scores_gemma":[0.0013424216,0.00095614564,0.0033375449,0.0017760873,0.00024363314,0.0010353633,0.0003334731,0.0002376995,0.0023925363,0.015397877,0.9729128,0.00003442835],"about_ca_topic_score_codex":0.00080375804,"about_ca_topic_score_gemma":0.0024904772,"teacher_disagreement_score":0.03892214,"about_ca_system_score_codex":0.00076402834,"about_ca_system_score_gemma":0.0017807913,"threshold_uncertainty_score":0.13020748},"labels":[],"label_agreement":null},{"id":"W2774490089","doi":"10.1080/14656566.2017.1410540","title":"Efficacy of levomilnacipran extended release in treating major depressive disorder","year":2017,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Milnacipran; Major depressive disorder; Medicine; Reuptake inhibitor; Psychiatry; Vortioxetine; Antidepressant; Cognition","score_opus":0.03819352289831413,"score_gpt":0.4015517016384805,"score_spread":0.36335817874016635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774490089","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008324668,0.9700754,0.0005757383,0.0097191855,0.0010630671,0.00008215737,0.00043202433,0.00003929155,0.009688566],"genre_scores_gemma":[0.13494532,0.84439695,0.0018949646,0.010881607,0.0028757458,0.00014750885,0.00084659935,0.000019763116,0.003991624],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995851,0.00016274206,0.00005639565,0.000060348055,0.00010918204,0.000026270922],"domain_scores_gemma":[0.9992501,0.00030651147,0.00020126908,0.000012036499,0.00019231532,0.00003779142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096248765,0.00023134713,0.0006950678,0.0002478855,0.00010141337,0.0005502451,0.0004826394,0.000676185,0.005472035],"category_scores_gemma":[0.0021091236,0.000073418974,0.00050886587,0.00022670957,0.00017646662,0.0003246537,0.0001910451,0.0009313031,0.0011576788],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025644456,0.00013234612,0.0010476462,0.017503183,0.00072729477,0.0002645253,0.00006612281,0.00040460523,0.0031535774,0.0012058447,0.049518056,0.9234123],"study_design_scores_gemma":[0.0071873963,0.0097812135,0.031186314,0.043280836,0.0051498557,0.0044718855,0.00033941772,0.00252214,0.00565388,0.0047299284,0.88557625,0.000120801495],"about_ca_topic_score_codex":0.00067601324,"about_ca_topic_score_gemma":0.0025735581,"teacher_disagreement_score":0.005472035,"about_ca_system_score_codex":0.00041175427,"about_ca_system_score_gemma":0.00038576397,"threshold_uncertainty_score":0.018305779},"labels":[],"label_agreement":null},{"id":"W2883176237","doi":"10.1080/14656566.2018.1499727","title":"A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer’s disease","year":2018,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; MEDLINE; Cochrane Library; Donepezil; Economic evaluation; Disease; Mood; Memantine; Rivastigmine; Cognition; Cognitive decline; Dementia; Quality of life (healthcare); Placebo; Psychiatry; Alternative medicine; Intensive care medicine; Pathology","score_opus":0.4774879761810773,"score_gpt":0.538269756086534,"score_spread":0.060781779905456745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883176237","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.087843716,0.8841027,0.0017912786,0.010695347,0.0015547234,0.0035578758,0.0016186689,0.000029704095,0.008806003],"genre_scores_gemma":[0.65833867,0.32652578,0.0041100527,0.004829552,0.001329287,0.0026757738,0.00080230436,0.000017226836,0.0013712746],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9811736,0.014352544,0.0018599549,0.0003291679,0.0019672094,0.00031749415],"domain_scores_gemma":[0.9578149,0.034115292,0.0050321263,0.0004096452,0.0021194401,0.0005086205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017860545,0.0009288445,0.0034640573,0.002531376,0.00034063292,0.0020667934,0.00068013516,0.002374216,0.006523621],"category_scores_gemma":[0.0668426,0.00038698883,0.007317872,0.0019777091,0.0005351168,0.0011753187,0.0007847348,0.0019802134,0.00024299875],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15690354,0.002497919,0.005731267,0.24477397,0.0632145,0.0009006309,0.0003380463,0.008680214,0.0015183239,0.009707837,0.011059909,0.4946739],"study_design_scores_gemma":[0.15402594,0.08214392,0.05660864,0.29476255,0.2912531,0.0018232918,0.0011347408,0.016244307,0.0029658633,0.015552599,0.083113246,0.00037177082],"about_ca_topic_score_codex":0.002319098,"about_ca_topic_score_gemma":0.0037461251,"teacher_disagreement_score":0.017860545,"about_ca_system_score_codex":0.0049509285,"about_ca_system_score_gemma":0.0037487135,"threshold_uncertainty_score":0.09445673},"labels":[],"label_agreement":null},{"id":"W2886451501","doi":"10.1080/14656566.2018.1502270","title":"Choosing oral drug therapy for overactive bladder in older people","year":2018,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; University of Alberta","funders":"","keywords":"Mirabegron; Medicine; Overactive bladder; Tolerability; Anticholinergic; Oxybutynin; Polypharmacy; Older people; Adverse effect; Clinical trial; Solifenacin; Urinary incontinence; Intensive care medicine; Tolterodine; Pharmacotherapy; Alternative medicine; Internal medicine; Urology; Gerontology","score_opus":0.05773820357586884,"score_gpt":0.4449890274900204,"score_spread":0.38725082391415155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886451501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009086518,0.8650669,0.0016931951,0.09819525,0.0049379882,0.00012114946,0.00057348487,0.00004982349,0.02027569],"genre_scores_gemma":[0.07931053,0.8395802,0.004989794,0.057769466,0.0091402335,0.00017481086,0.0006257344,0.000026605654,0.008382635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998847,0.00044447646,0.00018879173,0.00012987772,0.0003279856,0.00006176187],"domain_scores_gemma":[0.9977254,0.0010260949,0.00057302706,0.000039513947,0.0004372378,0.0001987452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001453527,0.00020370375,0.0009344296,0.0004101168,0.00030690362,0.0010503792,0.00045356216,0.0017309561,0.01045442],"category_scores_gemma":[0.006299912,0.00008833029,0.00077588804,0.00044064978,0.00039763137,0.0009926925,0.00052951806,0.001262956,0.0021632286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003932022,0.00013296184,0.0074043446,0.013450299,0.0003471305,0.00046873745,0.0002447269,0.000103016326,0.0008260624,0.0028894912,0.12127813,0.8524618],"study_design_scores_gemma":[0.0008872499,0.0008062947,0.022071162,0.039538525,0.0011411337,0.0037413887,0.0009885329,0.00037659923,0.0013416891,0.010866164,0.91814876,0.00009254379],"about_ca_topic_score_codex":0.0013087502,"about_ca_topic_score_gemma":0.003911586,"teacher_disagreement_score":0.01045442,"about_ca_system_score_codex":0.00048010473,"about_ca_system_score_gemma":0.0013220249,"threshold_uncertainty_score":0.034973502},"labels":[],"label_agreement":null},{"id":"W2911702342","doi":"10.1080/14656566.2019.1570132","title":"An evaluation of roflumilast and PDE4 inhibitors with a focus on the treatment of asthma","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Roflumilast; Medicine; Asthma; Intensive care medicine; Internal medicine; COPD","score_opus":0.07748991243654003,"score_gpt":0.4016291271319666,"score_spread":0.32413921469542656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911702342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020052449,0.99640346,0.00012536984,0.0008955284,0.00064086495,0.0000121476505,0.00004547376,0.0000075588064,0.0016691382],"genre_scores_gemma":[0.0015077689,0.99468696,0.0002330268,0.0013201389,0.0004858303,0.00002133409,0.000086239255,0.0000032717046,0.0016554068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998227,0.00003537757,0.000021245729,0.000034996967,0.00006252279,0.000023220322],"domain_scores_gemma":[0.99974245,0.00012098543,0.00004020385,0.0000046250057,0.000073271796,0.000018433839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005119816,0.0006567198,0.0011385867,0.0009404666,0.0001660931,0.0007216989,0.0006840204,0.0011747148,0.0060379594],"category_scores_gemma":[0.00066824845,0.00018141966,0.00074671395,0.000779294,0.00021195365,0.0007966088,0.0003857415,0.0018895746,0.002252038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021155641,0.00006585885,0.000066846806,0.020522973,0.00014067089,0.00018184385,0.000035395144,0.00024829357,0.0025265184,0.0028929617,0.04785888,0.92524827],"study_design_scores_gemma":[0.00015562566,0.00036323263,0.0006126988,0.0076922495,0.0002760669,0.00092918664,0.000037293063,0.00013637803,0.0007289511,0.0014135332,0.98763627,0.00001851347],"about_ca_topic_score_codex":0.0006200044,"about_ca_topic_score_gemma":0.0017558536,"teacher_disagreement_score":0.0060379594,"about_ca_system_score_codex":0.0005071667,"about_ca_system_score_gemma":0.000783503,"threshold_uncertainty_score":0.020198941},"labels":[],"label_agreement":null},{"id":"W3010618473","doi":"10.1080/14656566.2020.1735353","title":"Current and future pharmacological agents for the treatment of back pain","year":2020,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Women's College Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.04506430274158087,"score_gpt":0.4164827542350792,"score_spread":0.37141845149349834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010618473","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006825671,0.09268061,0.00017846741,0.030411605,0.87245756,0.00004775295,0.000083949664,0.000058210826,0.0040136175],"genre_scores_gemma":[0.0005251337,0.06651042,0.00022820961,0.021626912,0.8987399,0.000035908008,0.0000550015,0.000018863884,0.012259814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975823,0.00043599657,0.0003482774,0.00018852123,0.0012951976,0.00014962391],"domain_scores_gemma":[0.9927448,0.0029313562,0.0006193918,0.00014139489,0.0026570226,0.0009059439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037234256,0.0022247455,0.0029707684,0.0024712582,0.0013843785,0.003405453,0.0022204586,0.00854339,0.014444647],"category_scores_gemma":[0.009619796,0.0007457002,0.0020203018,0.0011754547,0.0012182705,0.0027995664,0.00086060463,0.011010429,0.00856799],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011146372,0.000032994743,0.00002440681,0.0014868968,0.00004783226,0.00011976115,0.000011588398,0.000028706023,0.00013674883,0.00035986933,0.9638493,0.033790395],"study_design_scores_gemma":[0.00023140966,0.000085487605,0.0003185596,0.0014911244,0.00015434875,0.00036243844,0.000030127143,0.00011726343,0.00011134395,0.0008944328,0.9961857,0.000017680253],"about_ca_topic_score_codex":0.0014800782,"about_ca_topic_score_gemma":0.0057452573,"teacher_disagreement_score":0.014444647,"about_ca_system_score_codex":0.0020721082,"about_ca_system_score_gemma":0.0026711228,"threshold_uncertainty_score":0.04832214},"labels":[],"label_agreement":null},{"id":"W3015809125","doi":"10.1080/14656566.2020.1721465","title":"Current pharmacotherapy for tic disorders","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tics; Medicine; Topiramate; Tourette syndrome; Ziprasidone; Comorbidity; Aripiprazole; Antipsychotic; Pharmacotherapy; Psychiatry; Tic disorder; Clozapine; Schizophrenia (object-oriented programming); Epilepsy","score_opus":0.0794798536636295,"score_gpt":0.48001872941399254,"score_spread":0.40053887575036307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015809125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089044566,0.9969848,0.000086741784,0.0005857115,0.0002989284,0.000008699815,0.00005060327,0.000011178786,0.001884402],"genre_scores_gemma":[0.001090287,0.99687886,0.00015584714,0.0006175023,0.00026542973,0.000010009392,0.00008563965,0.0000023592347,0.0008940485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997272,0.000052361043,0.000045948313,0.000048987626,0.000101824095,0.00002361099],"domain_scores_gemma":[0.9995734,0.00021523166,0.00009200372,0.000012189854,0.00008664737,0.000020555348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035289116,0.00068127917,0.0011121819,0.0017886669,0.00019299058,0.00083085854,0.0006771036,0.0010257673,0.013874651],"category_scores_gemma":[0.0010559447,0.00017726852,0.0008468635,0.0012897158,0.00030748383,0.0006989787,0.00056601834,0.0014968144,0.0032525267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057294335,0.00003501007,0.000089965826,0.03495582,0.00017023951,0.00012758146,0.000033897537,0.00014071394,0.00042787986,0.0015289407,0.043227546,0.919205],"study_design_scores_gemma":[0.000050202983,0.00007046225,0.0012426431,0.030076139,0.00041076285,0.0016753802,0.00005227947,0.00010440345,0.0002587317,0.0021258236,0.9639154,0.00001778431],"about_ca_topic_score_codex":0.001866569,"about_ca_topic_score_gemma":0.0035269158,"teacher_disagreement_score":0.013874651,"about_ca_system_score_codex":0.0005640951,"about_ca_system_score_gemma":0.0010784079,"threshold_uncertainty_score":0.04641533},"labels":[],"label_agreement":null},{"id":"W3133361374","doi":"10.1080/14656566.2021.1892073","title":"Important considerations with respect to reducing the transition from acute to persistent postoperative pain","year":2021,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Anesthesia; Intensive care medicine","score_opus":0.036262437718385804,"score_gpt":0.3394034596894778,"score_spread":0.30314102197109205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133361374","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024810894,0.182729,0.0030147596,0.7844977,0.009319102,0.00008969245,0.00012697611,0.00007605046,0.017665662],"genre_scores_gemma":[0.07335663,0.5202421,0.027936855,0.31497136,0.0434787,0.0003839917,0.00021097469,0.00008844847,0.019330973],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977418,0.00080073025,0.00024106454,0.00018401469,0.0007915796,0.00024084921],"domain_scores_gemma":[0.9849985,0.007693513,0.00123086,0.0003136022,0.0043884753,0.0013750098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004989378,0.00042190278,0.001240119,0.00047932623,0.0010697703,0.0033020237,0.0014815899,0.0069271675,0.012645472],"category_scores_gemma":[0.016988002,0.00015856288,0.0009123511,0.00033397152,0.001813337,0.0031595174,0.0009837591,0.008593891,0.0034308087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050257257,0.00057826773,0.0025889336,0.0068117008,0.0002324219,0.0021892178,0.0008217866,0.0007278339,0.0030848111,0.028551666,0.3369506,0.6169602],"study_design_scores_gemma":[0.00024276895,0.0009671157,0.010642697,0.012860261,0.00026591524,0.004457969,0.002639207,0.00052753947,0.0014009434,0.034384932,0.9314647,0.00014599535],"about_ca_topic_score_codex":0.002647262,"about_ca_topic_score_gemma":0.008716504,"teacher_disagreement_score":0.012645472,"about_ca_system_score_codex":0.0009605775,"about_ca_system_score_gemma":0.0062052016,"threshold_uncertainty_score":0.042303383},"labels":[],"label_agreement":null},{"id":"W3134513179","doi":"10.1080/14656566.2021.1902504","title":"Evaluating the combination of emtricitabine/ tenofovir alafenamide fumarate to reduce the risk of sexually acquired HIV-1-infection in at-risk adults","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Tenofovir alafenamide; Emtricitabine; Medicine; Pre-exposure prophylaxis; Human immunodeficiency virus (HIV); Cobicistat; Tenofovir; Microbicides for sexually transmitted diseases; Prodrug; Pharmacology; Men who have sex with men; Elvitegravir; Pill; Internal medicine; Virology; Viral load; Antiretroviral therapy; Population; Environmental health; Syphilis","score_opus":0.08268813015531437,"score_gpt":0.44715164221954157,"score_spread":0.3644635120642272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134513179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008845693,0.99664414,0.00011571376,0.00038069006,0.00023083841,0.00006094291,0.00006914238,0.000005135019,0.0016088578],"genre_scores_gemma":[0.008093817,0.98925346,0.00045646125,0.00068714924,0.0001761027,0.00006106655,0.00011661478,0.0000029796067,0.0011523892],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997569,0.000081044105,0.000039179344,0.000032703367,0.000070407244,0.000019744548],"domain_scores_gemma":[0.9996207,0.00017672617,0.000088024666,0.0000061909736,0.00009035643,0.000017988252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071297336,0.0004242233,0.001090871,0.0006787663,0.000112839116,0.00063969695,0.0006224583,0.00085823104,0.005981163],"category_scores_gemma":[0.0012725216,0.00012719649,0.0010397101,0.00055894005,0.00011743981,0.00047434258,0.00022918242,0.0007538591,0.0009047579],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086835644,0.00014122014,0.00021460149,0.09055747,0.0008793773,0.00014475879,0.000057112866,0.00022552241,0.0024013217,0.0010047868,0.012424707,0.8910808],"study_design_scores_gemma":[0.0018507402,0.004410225,0.004970729,0.09271342,0.007847061,0.0024574953,0.00020842561,0.0006560852,0.0050519416,0.0017446429,0.87802,0.000069306814],"about_ca_topic_score_codex":0.00089377945,"about_ca_topic_score_gemma":0.002073256,"teacher_disagreement_score":0.005981163,"about_ca_system_score_codex":0.00032720945,"about_ca_system_score_gemma":0.0009827178,"threshold_uncertainty_score":0.02000904},"labels":[],"label_agreement":null},{"id":"W3142645707","doi":"10.1080/14656566.2021.1904891","title":"Escalating antimicrobial resistance among Enterobacteriaceae: focus on carbapenemases","year":2021,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Enterobacteriaceae; Antibiotic resistance; Antimicrobial; Microbiology; Klebsiella pneumoniae; Citrobacter; Enterobacter; Carbapenem-resistant enterobacteriaceae; Multiple drug resistance; Medicine; Antibiotics; Biology; Escherichia coli; Genetics","score_opus":0.01587479053287727,"score_gpt":0.3082440871677065,"score_spread":0.29236929663482925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142645707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007700667,0.9625766,0.0003779458,0.029642042,0.0029189354,0.000022871285,0.00016649827,0.000020974945,0.0035040388],"genre_scores_gemma":[0.0050684838,0.97933793,0.0005974392,0.0102419155,0.0034976872,0.000020051355,0.00015217831,0.000007639331,0.0010767251],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990145,0.00026382873,0.00016103502,0.00015538826,0.00031127705,0.000093987444],"domain_scores_gemma":[0.9935487,0.0027373624,0.0012980895,0.0000861271,0.0020617375,0.0002680198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017629133,0.00048013174,0.001035993,0.0018688553,0.00026636358,0.0016063014,0.00092545367,0.0022966682,0.00886044],"category_scores_gemma":[0.005507618,0.00017381326,0.0010589205,0.0020915898,0.00070086773,0.0021059818,0.0007479973,0.0015241026,0.0021429525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020449083,0.000048904698,0.0014754568,0.0757744,0.00044563258,0.00079183915,0.00025336895,0.00023818512,0.0017873188,0.0026669556,0.21152933,0.7047841],"study_design_scores_gemma":[0.00008408384,0.00017154559,0.004258592,0.07573176,0.0009563593,0.0028937445,0.000560556,0.00016997523,0.0006801266,0.004126333,0.91032326,0.000043597876],"about_ca_topic_score_codex":0.0014346732,"about_ca_topic_score_gemma":0.00314698,"teacher_disagreement_score":0.00886044,"about_ca_system_score_codex":0.0010175534,"about_ca_system_score_gemma":0.0026554808,"threshold_uncertainty_score":0.029641092},"labels":[],"label_agreement":null},{"id":"W3155205222","doi":"10.1080/14656566.2021.1915988","title":"What impact does bipolar disorder staging have on the use of pharmacotherapy?","year":2021,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pharmacotherapy; Bipolar disorder; Psychiatry; Intensive care medicine; Mood","score_opus":0.07537272316824038,"score_gpt":0.3961063187687885,"score_spread":0.3207335956005481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155205222","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019622449,0.75310785,0.0008366451,0.17907733,0.0055576456,0.00004825155,0.0049147913,0.00007039868,0.036764618],"genre_scores_gemma":[0.23203923,0.699754,0.0015016937,0.039154846,0.020342585,0.00009557052,0.0036695842,0.00008843019,0.0033541005],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974105,0.0008450743,0.0003395902,0.00024179596,0.0009527367,0.00021038271],"domain_scores_gemma":[0.9759084,0.0132873515,0.003843107,0.0004405331,0.0050366605,0.0014838855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004284587,0.00029406365,0.001874825,0.00084080436,0.00037383946,0.0022083889,0.00090877624,0.0015730612,0.012650432],"category_scores_gemma":[0.035712205,0.00017452902,0.0016348291,0.0012538286,0.0006496762,0.0019802453,0.0005683229,0.0020672115,0.0025439225],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012879629,0.0001840022,0.07688525,0.008137339,0.0022165847,0.00035138056,0.00025037737,0.0004877454,0.00028598655,0.0040542283,0.12476278,0.7810964],"study_design_scores_gemma":[0.00076774653,0.001070699,0.45186082,0.054982197,0.0072873235,0.002885497,0.0016708577,0.001642465,0.00047114235,0.018402645,0.45871735,0.00024138387],"about_ca_topic_score_codex":0.011650464,"about_ca_topic_score_gemma":0.026103463,"teacher_disagreement_score":0.012650432,"about_ca_system_score_codex":0.0016271825,"about_ca_system_score_gemma":0.002685591,"threshold_uncertainty_score":0.042319894},"labels":[],"label_agreement":null},{"id":"W3155326873","doi":"10.1080/14656566.2021.1915989","title":"Pneumocystis jirovecii: a review with a focus on prevention and treatment","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Pneumocystis jirovecii; Intensive care medicine; Dapsone; Pentamidine; Pneumonia; Trimethoprim; Atovaquone; Pneumocystis pneumonia; Clindamycin; Immunology; Internal medicine; Antibiotics; Malaria","score_opus":0.0814376463522127,"score_gpt":0.4306934843465176,"score_spread":0.34925583799430493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155326873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040598523,0.9994055,0.000023500521,0.0001616897,0.0001333132,0.000003471928,0.000018023304,0.0000023217574,0.00021154644],"genre_scores_gemma":[0.00030114365,0.9992912,0.00005465854,0.00014027886,0.00008489207,0.0000038108371,0.000021548865,5.3581516e-7,0.00010195747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996915,0.000058675632,0.00007681906,0.00005042993,0.00010006643,0.000022433189],"domain_scores_gemma":[0.99927956,0.00039794898,0.00013540688,0.000012399585,0.00014580863,0.000028822173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000581816,0.00083139195,0.0017592736,0.0025700317,0.00023095154,0.0010540622,0.00083844026,0.000976964,0.0050854045],"category_scores_gemma":[0.0016742575,0.0002507513,0.0011911773,0.002442736,0.0003038244,0.0010935008,0.0005045283,0.001112718,0.0011914349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010098942,0.000047394446,0.00019904335,0.17299575,0.00041163445,0.00019782654,0.00008762055,0.00024610094,0.00077959395,0.0015299072,0.048526164,0.774878],"study_design_scores_gemma":[0.00005132494,0.00014205016,0.0017734718,0.09702842,0.0015875893,0.0020617987,0.00011481039,0.00011091421,0.0002653687,0.0013246702,0.8955047,0.00003492531],"about_ca_topic_score_codex":0.001887951,"about_ca_topic_score_gemma":0.0032244024,"teacher_disagreement_score":0.0050854045,"about_ca_system_score_codex":0.0005740066,"about_ca_system_score_gemma":0.0017227156,"threshold_uncertainty_score":0.017012358},"labels":[],"label_agreement":null},{"id":"W3158733857","doi":"10.1080/14656566.2021.1921736","title":"An update on antidepressant pharmacotherapy in late-life depression","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"","keywords":"Polypharmacy; Medicine; Pharmacotherapy; Adverse effect; Major depressive disorder; Depression (economics); Psychiatry; Antidepressant; Late life depression; Intensive care medicine; Mood; Cognition; Pharmacology; Anxiety","score_opus":0.09534354125489485,"score_gpt":0.47319554317915885,"score_spread":0.377852001924264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158733857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006271351,0.9976603,0.00007175111,0.00074738957,0.00074712135,0.000010065531,0.00004927743,0.0000069489824,0.0006444109],"genre_scores_gemma":[0.00034354927,0.9980718,0.00015137238,0.00063139986,0.00043351713,0.000010400909,0.000062032275,0.0000013775199,0.00029458926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994312,0.00013155752,0.00014816172,0.00006294964,0.00019731767,0.000028780865],"domain_scores_gemma":[0.99846953,0.0008772426,0.00024981966,0.00002322094,0.00032890638,0.000051320876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096127973,0.00086734403,0.0016592053,0.0025294083,0.00022329818,0.0010987655,0.00104283,0.0015943904,0.0063933805],"category_scores_gemma":[0.0027765725,0.0003143855,0.0013462079,0.0023969556,0.00026605822,0.001296986,0.0006288116,0.0018983867,0.001899503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008896052,0.000046268236,0.00015446488,0.0737422,0.00034931078,0.00014942436,0.000072021816,0.00020261432,0.00036739622,0.0011593892,0.087894805,0.8357731],"study_design_scores_gemma":[0.00006759363,0.00013470666,0.0017814734,0.071112305,0.0010596454,0.0015374414,0.000072662624,0.00015148842,0.00013645554,0.0011129894,0.9228055,0.000027743177],"about_ca_topic_score_codex":0.0022903397,"about_ca_topic_score_gemma":0.0052336035,"teacher_disagreement_score":0.0063933805,"about_ca_system_score_codex":0.0007687184,"about_ca_system_score_gemma":0.0017157358,"threshold_uncertainty_score":0.021387935},"labels":[],"label_agreement":null},{"id":"W3174714141","doi":"10.1080/14656566.2021.1940953","title":"What is the real value of metronomic chemotherapy in the treatment of gastrointestinal cancer?","year":2021,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Chemotherapy; Cancer; Drug; Gastrointestinal cancer; Intensive care medicine; Oncology; Internal medicine; Pharmacology; Colorectal cancer","score_opus":0.03143953758171897,"score_gpt":0.3911318410502958,"score_spread":0.35969230346857684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174714141","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075024036,0.0937501,0.00014196981,0.09267555,0.8109265,0.000033790322,0.00011279597,0.000057780453,0.0022266337],"genre_scores_gemma":[0.0006934062,0.07855518,0.00019132791,0.07417494,0.84035224,0.000036391215,0.00008468364,0.00003339914,0.005878443],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975331,0.00065977115,0.000342019,0.00023442572,0.0010688975,0.0001618217],"domain_scores_gemma":[0.98574716,0.006967275,0.00074215425,0.00022351003,0.0050738156,0.001246038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070987507,0.0014915236,0.003636208,0.0014062264,0.0012562703,0.0037262146,0.0035328248,0.011987664,0.007989053],"category_scores_gemma":[0.019557143,0.0006017685,0.00196415,0.00087617035,0.0014389299,0.0040347422,0.000756363,0.016573565,0.007947632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007983688,0.00001376668,0.00001959695,0.0012055641,0.000060856248,0.00006228432,0.000012387383,0.000027279691,0.00006523794,0.0004246162,0.9761077,0.021920932],"study_design_scores_gemma":[0.00016946658,0.00009885406,0.00030371879,0.0020431136,0.00020633965,0.0002138007,0.000041071937,0.00012296617,0.00009843046,0.0015947772,0.99507964,0.0000279277],"about_ca_topic_score_codex":0.0015713972,"about_ca_topic_score_gemma":0.0041185026,"teacher_disagreement_score":0.011987664,"about_ca_system_score_codex":0.0021578448,"about_ca_system_score_gemma":0.002744757,"threshold_uncertainty_score":0.037542224},"labels":[],"label_agreement":null},{"id":"W3192632021","doi":"10.1080/14656566.2021.1965574","title":"Medications to manage infant pain, distress and end-of-life symptoms in the immediate postpartum period","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Queen's University; Children's Hospital of Eastern Ontario; Kingston Health Sciences Centre; University of Ottawa","funders":"","keywords":"Medicine; Palliative care; Limiting; Distress; Pain management; Postpartum period; End-of-life care; Pain medicine; Health care; Nursing; Intensive care medicine; Pregnancy; Psychiatry; Anesthesiology; Physical therapy","score_opus":0.08817008056009416,"score_gpt":0.47728330813362,"score_spread":0.38911322757352584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192632021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013340826,0.99827135,0.00005576494,0.0004607664,0.00017334048,0.000011404153,0.0000309071,0.0000044461276,0.00085862516],"genre_scores_gemma":[0.001266539,0.9979108,0.00016742836,0.00029873816,0.00008588935,0.000014328358,0.00002832649,0.0000010803865,0.00022699725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948275,0.000154842,0.000103593295,0.000058179165,0.00016782635,0.000032766817],"domain_scores_gemma":[0.9986253,0.0009281984,0.0002212907,0.00002069587,0.00017806917,0.000026441254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000679991,0.0004887594,0.00094715145,0.0015618629,0.00021244083,0.000783854,0.00081439735,0.0011823812,0.0053629377],"category_scores_gemma":[0.0029366964,0.00016063954,0.0010286601,0.0011703466,0.00026958247,0.00066717615,0.0004429836,0.0010028147,0.0010706369],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074882395,0.000052812866,0.00025552337,0.09737256,0.0002520914,0.00017107256,0.000112513146,0.00013763526,0.00036369148,0.0009894375,0.023539681,0.87667805],"study_design_scores_gemma":[0.00012047466,0.00020584078,0.0038412912,0.16713631,0.0014403159,0.0033553531,0.0003204564,0.00018675931,0.00062438817,0.0013756277,0.8213584,0.00003489484],"about_ca_topic_score_codex":0.0017478092,"about_ca_topic_score_gemma":0.0036536409,"teacher_disagreement_score":0.0053629377,"about_ca_system_score_codex":0.00047088205,"about_ca_system_score_gemma":0.0012541536,"threshold_uncertainty_score":0.01794076},"labels":[],"label_agreement":null},{"id":"W4210486996","doi":"10.1080/14656566.2022.2029409","title":"An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Dolutegravir; Medicine; Abacavir; Lamivudine; Emtricitabine; Tolerability; Pharmacology; Fixed-dose combination; Integrase inhibitor; Human immunodeficiency virus (HIV); Virology; Viral load; Antiretroviral therapy; Adverse effect; Hepatitis B virus; Virus","score_opus":0.26138356818045766,"score_gpt":0.51806958953392,"score_spread":0.25668602135346236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210486996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021198006,0.99669856,0.00009757087,0.00060780905,0.0004061835,0.00001379864,0.00005545193,0.0000059702234,0.0019026768],"genre_scores_gemma":[0.0016804322,0.9957287,0.00024284892,0.000909779,0.00021660366,0.000013299887,0.00009432953,0.0000027780013,0.0011112626],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999703,0.00006627524,0.000034804998,0.00004276171,0.00012327963,0.00002996258],"domain_scores_gemma":[0.9995472,0.00018432972,0.00007160602,0.000010116606,0.0001632982,0.000023528186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007995386,0.00051634264,0.0010945257,0.0009786418,0.00017608424,0.0008170576,0.00069726555,0.0009670266,0.006336804],"category_scores_gemma":[0.0011957757,0.0001612837,0.0008718827,0.001002309,0.00018549015,0.0006863601,0.00036267357,0.001278215,0.0018445336],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015478807,0.000048702324,0.000069618705,0.033304676,0.00017823627,0.00012852074,0.000041773113,0.00019478794,0.0015228015,0.0020083832,0.04326934,0.9190784],"study_design_scores_gemma":[0.00009408609,0.00024085831,0.00058107026,0.014545841,0.00054311706,0.0008088741,0.000044857527,0.00012607989,0.0006431997,0.0010400059,0.9813141,0.000017922941],"about_ca_topic_score_codex":0.0011620002,"about_ca_topic_score_gemma":0.0024766144,"teacher_disagreement_score":0.006336804,"about_ca_system_score_codex":0.0004259664,"about_ca_system_score_gemma":0.0013484997,"threshold_uncertainty_score":0.02119875},"labels":[],"label_agreement":null},{"id":"W4225326877","doi":"10.1080/14656566.2022.2072212","title":"Comprehensive overview of the available pharmacotherapy for the treatment of non-neurogenic overactive bladder in children","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Overactive bladder; Oxybutynin; Intensive care medicine; Pharmacotherapy; Quality of life (healthcare); Tolterodine; Anticholinergic; Mirabegron; Pharmacology; Internal medicine; Alternative medicine","score_opus":0.24743543452977995,"score_gpt":0.4966767790766242,"score_spread":0.24924134454684427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225326877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001343471,0.9983563,0.000079475736,0.00032113996,0.00013391345,0.0000108334825,0.00007200929,0.000007147429,0.00088484504],"genre_scores_gemma":[0.0006918532,0.9985297,0.00017306286,0.0001980538,0.00008603069,0.000009873871,0.000065314394,0.0000012685394,0.0002448831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997551,0.000046216363,0.000057768964,0.000042539774,0.00007901015,0.000019328878],"domain_scores_gemma":[0.99943024,0.00035358558,0.00009821175,0.000008312138,0.000091960625,0.000017725055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044567892,0.00064428215,0.00093396136,0.0020649128,0.00021352568,0.00063811895,0.00063367805,0.00077904563,0.0068377936],"category_scores_gemma":[0.0013054818,0.00019355668,0.000990827,0.001519831,0.00016597184,0.0006361009,0.00033870325,0.0010199726,0.0011507039],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009016339,0.000051586427,0.00019239681,0.08379837,0.00028868907,0.00016022948,0.00007050853,0.00029854442,0.0007361884,0.0012334617,0.032686412,0.8803934],"study_design_scores_gemma":[0.00005778633,0.00019382514,0.0025492138,0.06567652,0.0010694965,0.002114069,0.00009498316,0.00019418036,0.00045046766,0.0011387793,0.9264284,0.000032298703],"about_ca_topic_score_codex":0.0018076039,"about_ca_topic_score_gemma":0.0037320768,"teacher_disagreement_score":0.0068377936,"about_ca_system_score_codex":0.0004849191,"about_ca_system_score_gemma":0.001146356,"threshold_uncertainty_score":0.022874653},"labels":[],"label_agreement":null},{"id":"W4230738500","doi":"10.1517/14656566.2.8.1325","title":"Dalteparin sodium","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Vancouver Coastal Health","funders":"","keywords":"Medicine; Antithrombotic; Low molecular weight heparin; Enoxaparin sodium; Thrombosis; Heparin; Warfarin Sodium; Deep vein; Anticoagulant; Warfarin; Venous thrombosis; Anesthesia; Clinical trial; Surgery; Internal medicine","score_opus":0.12945234621695814,"score_gpt":0.46550829278913325,"score_spread":0.3360559465721751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230738500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009177427,0.8703778,0.009588798,0.03189296,0.005885171,0.000301077,0.0014761303,0.00087670865,0.07042385],"genre_scores_gemma":[0.14918429,0.7062687,0.011397581,0.03863047,0.0056097377,0.00069964415,0.0059201703,0.00013924499,0.08215009],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996381,0.00008652728,0.00003228562,0.00005448534,0.00014380048,0.000044710574],"domain_scores_gemma":[0.9997842,0.000049769693,0.000052925472,0.000011210056,0.000060856808,0.00004106863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034416723,0.00044424253,0.00077837636,0.00046327253,0.00016740849,0.00078117586,0.0008255249,0.0014529162,0.01610616],"category_scores_gemma":[0.00084217516,0.00012019079,0.00039775344,0.0003631399,0.0002310621,0.00045972486,0.00039098048,0.0016881701,0.009290444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001260715,0.00025860345,0.00046211315,0.0044895345,0.0002087294,0.0009850845,0.000035024117,0.0002961532,0.011888195,0.0048132176,0.18384416,0.7914584],"study_design_scores_gemma":[0.00092484197,0.0004662547,0.0011509043,0.0005726085,0.000100505735,0.0025141682,0.00001833448,0.00029535155,0.005507573,0.001610678,0.98682004,0.000018703837],"about_ca_topic_score_codex":0.00075697363,"about_ca_topic_score_gemma":0.00094884494,"teacher_disagreement_score":0.01610616,"about_ca_system_score_codex":0.00046939802,"about_ca_system_score_gemma":0.00048572847,"threshold_uncertainty_score":0.053880453},"labels":[],"label_agreement":null},{"id":"W4230819912","doi":"10.1517/14656566.3.9.1341","title":"Quinupristin/dalfopristin","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Health Authority; Royal University Hospital","funders":"","keywords":"Quinupristin; Dalfopristin; Medicine; Antimicrobial; Antibiotic resistance; Penicillin; Methicillin-resistant Staphylococcus aureus; Staphylococcus aureus; Drug resistance; Streptococcus pneumoniae; Enterococcus; Microbiology; Antibiotics; Vancomycin; Biology; Bacteria","score_opus":0.12594548311954487,"score_gpt":0.44880702804811207,"score_spread":0.3228615449285672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230819912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013127225,0.99703574,0.00012368635,0.00059266796,0.0003102975,0.000008046715,0.00004333005,0.000010013192,0.0017448219],"genre_scores_gemma":[0.0010000938,0.99733955,0.00017573028,0.0003963999,0.00017775019,0.000008431619,0.000059159644,0.0000016583125,0.00084128167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998129,0.000035598732,0.00003042796,0.000034849112,0.000071037575,0.000015249793],"domain_scores_gemma":[0.9997267,0.00011353099,0.00006446082,0.000007199953,0.00007168112,0.000016408025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002478127,0.00052750256,0.000824534,0.0012394647,0.00014440561,0.000780514,0.0005876096,0.00077546824,0.0068869237],"category_scores_gemma":[0.0007124823,0.00013907505,0.0005321195,0.0010018584,0.00021410384,0.00066772866,0.0004062707,0.0010992085,0.002603184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007253812,0.000038879843,0.00010258579,0.024552424,0.000112322574,0.00014041313,0.000035127523,0.00018099984,0.001104101,0.001422043,0.035305142,0.93693346],"study_design_scores_gemma":[0.000032535474,0.00007993204,0.0005039354,0.007682889,0.00014291165,0.0009880691,0.000031929227,0.0000699626,0.00040793905,0.00093057205,0.9891182,0.000010991552],"about_ca_topic_score_codex":0.0008439264,"about_ca_topic_score_gemma":0.0018187187,"teacher_disagreement_score":0.0068869237,"about_ca_system_score_codex":0.00039648826,"about_ca_system_score_gemma":0.0007693421,"threshold_uncertainty_score":0.023039103},"labels":[],"label_agreement":null},{"id":"W4233171052","doi":"10.1517/eoph.4.12.2355.22419","title":"Tinzaparin in the treatment of venous thromboembolism","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre","funders":"","keywords":"Medicine; Venous thromboembolism; Internal medicine; Venous thrombosis; Intensive care medicine; Thrombosis","score_opus":0.05540608515966367,"score_gpt":0.3817815458490013,"score_spread":0.32637546068933765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233171052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009780504,0.9467588,0.0019305082,0.015384089,0.0027819287,0.00003236423,0.00005418433,0.00005222627,0.023225302],"genre_scores_gemma":[0.121083386,0.83726174,0.00471014,0.01116452,0.0071128216,0.000058158585,0.00016496825,0.000017985496,0.018426243],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997911,0.00007039595,0.00001915502,0.000021173317,0.00008236292,0.000015867141],"domain_scores_gemma":[0.9998192,0.00007106329,0.00004075062,0.0000060050556,0.00003393198,0.000029016917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005390777,0.00029290386,0.00056743034,0.00046856003,0.0001605628,0.00035649093,0.00036196737,0.00093532394,0.0023559616],"category_scores_gemma":[0.0007115961,0.00006378776,0.00016170823,0.0004584031,0.00024301195,0.00024017549,0.00016386811,0.0011648928,0.001184439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000852961,0.00021822217,0.0017367494,0.0023909602,0.000120953206,0.0036978452,0.00009511471,0.0005239635,0.0085850265,0.0050950283,0.052401725,0.92428154],"study_design_scores_gemma":[0.00073179614,0.0015573524,0.013660635,0.001267277,0.00021042732,0.018584276,0.00009754741,0.0007112733,0.00373365,0.0055766413,0.95383674,0.00003237963],"about_ca_topic_score_codex":0.0007736908,"about_ca_topic_score_gemma":0.0018317247,"teacher_disagreement_score":0.0023559616,"about_ca_system_score_codex":0.0003706395,"about_ca_system_score_gemma":0.0004092137,"threshold_uncertainty_score":0.007881463},"labels":[],"label_agreement":null},{"id":"W4233763517","doi":"10.1517/eoph.4.5.693.22210","title":"Best pharmacological practice: urinary tract infections","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Medicine; Urinary system; Nitrofurantoin; Genitourinary system; Trimethoprim; Fosfomycin; Bacteriuria; Intensive care medicine; Acute Cystitis; Internal medicine; Antimicrobial; Antibiotic resistance; Antibiotics","score_opus":0.06248632098873857,"score_gpt":0.42927523277062724,"score_spread":0.36678891178188866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233763517","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006445266,0.27817833,0.013125346,0.19852704,0.015895033,0.0007923425,0.0009797281,0.001516061,0.48454082],"genre_scores_gemma":[0.077993326,0.4485472,0.040312894,0.15765636,0.03413991,0.0015943157,0.00229344,0.00032721672,0.2371353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991454,0.00029197783,0.00008465931,0.00007224243,0.00033166233,0.00007402271],"domain_scores_gemma":[0.998533,0.00031300794,0.00017661689,0.00009749089,0.00060317345,0.00027673927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007920095,0.0007870072,0.0009622285,0.0010020384,0.00058828626,0.001027332,0.00085988204,0.003008529,0.05518166],"category_scores_gemma":[0.0050155595,0.00011757293,0.0003998983,0.000753575,0.00033421104,0.0009371592,0.000791925,0.0018283388,0.030521952],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088592664,0.00029396408,0.0006285412,0.0016614753,0.000028550525,0.0009365554,0.00007505644,0.00011107327,0.00046064897,0.001609572,0.3921636,0.60194236],"study_design_scores_gemma":[0.0001423962,0.00020935776,0.0040760487,0.0036745132,0.000044060234,0.0041675293,0.00010573654,0.00017143547,0.0003795577,0.0049830796,0.9820248,0.00002156144],"about_ca_topic_score_codex":0.0009976227,"about_ca_topic_score_gemma":0.0020380917,"teacher_disagreement_score":0.05518166,"about_ca_system_score_codex":0.00063914084,"about_ca_system_score_gemma":0.0013383005,"threshold_uncertainty_score":0.18460101},"labels":[],"label_agreement":null},{"id":"W4238121547","doi":"10.1517/eoph.5.5.1117.31079","title":"Gemifloxacin: a new fluoroquinolone","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Gemifloxacin; Moraxella catarrhalis; Microbiology; Streptococcus pneumoniae; Topoisomerase IV; Quinolone; Medicine; DNA gyrase; Trovafloxacin; Chronic bronchitis; Haemophilus influenzae; Pharmacology; Biology; Antibiotics; Escherichia coli","score_opus":0.046934078133935686,"score_gpt":0.38150362655071635,"score_spread":0.33456954841678066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238121547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2735958,0.64922994,0.020193338,0.004675201,0.0023428902,0.000522682,0.0043097055,0.0032705814,0.041859847],"genre_scores_gemma":[0.7611131,0.17476052,0.0176238,0.0036350256,0.0007712051,0.00025900244,0.007350668,0.000066688,0.03441998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999008,0.000014771451,0.000008751645,0.000022618355,0.000028814115,0.000024241643],"domain_scores_gemma":[0.9999515,0.00000363646,0.0000099106255,0.0000020954171,0.000010700786,0.000022149656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014522072,0.00046495217,0.00031893866,0.00062679814,0.0002540711,0.00032496054,0.00038331863,0.0005746905,0.0013666612],"category_scores_gemma":[0.00007788418,0.00012038922,0.00027260958,0.00026761164,0.00019935926,0.00028196283,0.00026744252,0.00070273306,0.0010143844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002740156,0.0007642752,0.0025330037,0.0023418558,0.000076466706,0.0021054293,0.00009945831,0.0009171408,0.41542944,0.0015942616,0.03559734,0.5358012],"study_design_scores_gemma":[0.00084586936,0.005588501,0.00965729,0.0003345283,0.00014232883,0.010135047,0.00004590934,0.0017299859,0.21713142,0.00034338876,0.75394326,0.00010246617],"about_ca_topic_score_codex":0.001933639,"about_ca_topic_score_gemma":0.003557771,"teacher_disagreement_score":0.001933639,"about_ca_system_score_codex":0.0007099769,"about_ca_system_score_gemma":0.00036654816,"threshold_uncertainty_score":0.005151272},"labels":[],"label_agreement":null},{"id":"W4247691111","doi":"10.1517/14656566.6.6.1019","title":"Intranasal zolmitriptan","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Zolmitriptan; Medicine; Nasal administration; Systemic circulation; Pharmacokinetics; Pharmacology; Onset of action; Drug; Internal medicine; Sumatriptan; Receptor","score_opus":0.1793706590767419,"score_gpt":0.5145638946286409,"score_spread":0.33519323555189906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247691111","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037730226,0.996789,0.00015104335,0.00018327528,0.00013633585,0.000013415862,0.00002380822,0.000010775929,0.0023150882],"genre_scores_gemma":[0.0027419569,0.99486417,0.0002601226,0.00022690502,0.00018365025,0.000011663811,0.000036382644,0.0000014905152,0.001673704],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977165,0.000042657317,0.000029245732,0.000041005736,0.00009862277,0.000016975968],"domain_scores_gemma":[0.99986506,0.00004672037,0.000037724192,0.000004138838,0.00003479408,0.000011548685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003704618,0.0005479366,0.0013037974,0.0013816956,0.00016412769,0.00061926205,0.0005852225,0.0005996321,0.0061939526],"category_scores_gemma":[0.00039481831,0.00014527736,0.00038048925,0.0011463134,0.00023066721,0.0006395281,0.00037370494,0.0006301936,0.0033877415],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013575409,0.00006732908,0.0001384852,0.014193225,0.000092945855,0.00041494681,0.000039799994,0.00007257576,0.003862617,0.0008856796,0.011624216,0.9684724],"study_design_scores_gemma":[0.00011982166,0.0004201215,0.0034039405,0.004360069,0.0002880566,0.008906735,0.00010709242,0.00011666854,0.0035857277,0.0009736608,0.9776969,0.000021130367],"about_ca_topic_score_codex":0.0010737123,"about_ca_topic_score_gemma":0.0027402423,"teacher_disagreement_score":0.0061939526,"about_ca_system_score_codex":0.00041995785,"about_ca_system_score_gemma":0.0005395665,"threshold_uncertainty_score":0.0207209},"labels":[],"label_agreement":null},{"id":"W4253846085","doi":"10.1517/14656560802233827","title":"Effect of omega-3-acid ethyl esters on steady-state plasma pharmacokinetics of atorvastatin in healthy adults","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"American College of Clinical Pharmacy","keywords":"Medicine; Pharmacokinetics; Atorvastatin; Plasma levels; Pharmacology; Plasma concentration; Traditional medicine; Internal medicine","score_opus":0.024148094478118772,"score_gpt":0.35244344519124926,"score_spread":0.3282953507131305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253846085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991673,0.00049811846,0.00009502122,0.000022595857,0.000006156215,0.000027725844,0.000051402316,0.000008502588,0.00012319478],"genre_scores_gemma":[0.99929607,0.00014337081,0.00028875185,0.00004485575,0.000014296346,0.000026535634,0.00007590274,0.0000022795625,0.00010793142],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9993224,0.0003232053,0.00006492848,0.000105944484,0.00011614616,0.000067402485],"domain_scores_gemma":[0.9985669,0.0006068032,0.000477518,0.00007356625,0.00007569388,0.00019956246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010655001,0.00038201065,0.0008108017,0.00016227867,0.00018242122,0.00029074043,0.00016055226,0.0006329134,0.001141171],"category_scores_gemma":[0.0021936148,0.00025301013,0.0006571724,0.0001703509,0.0002730807,0.00024911136,0.00023402246,0.0005607375,0.00017085568],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6226193,0.010570358,0.1701011,0.00044193762,0.0025012938,0.00032048495,0.00025752044,0.0008671818,0.115901515,0.000052703108,0.0003178895,0.07604875],"study_design_scores_gemma":[0.0127001805,0.35976985,0.5989743,0.000027014776,0.0016785074,0.0005475764,0.00008807113,0.0020263093,0.023167092,0.00007941243,0.0009082942,0.000033381584],"about_ca_topic_score_codex":0.00044863002,"about_ca_topic_score_gemma":0.0006364189,"teacher_disagreement_score":0.001141171,"about_ca_system_score_codex":0.00025315976,"about_ca_system_score_gemma":0.0002999805,"threshold_uncertainty_score":0.005635023},"labels":[],"label_agreement":null},{"id":"W4256199820","doi":"10.1517/eoph.4.12.2213.22421","title":"Anti-thrombotic therapy in cancer patients","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Juravinski Hospital","funders":"","keywords":"Medicine; Cancer; Internal medicine; Oncology","score_opus":0.048720981824851274,"score_gpt":0.38352336621916144,"score_spread":0.33480238439431015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256199820","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5262534,0.31899792,0.0012391817,0.031100245,0.00095356297,0.00025106882,0.0012062779,0.00007934624,0.11991894],"genre_scores_gemma":[0.9285006,0.059678942,0.000865931,0.005643527,0.0010725574,0.00012813794,0.0005843226,0.0000042864935,0.003521771],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998609,0.00006373966,0.000011380439,0.000012284787,0.00003193285,0.000019762785],"domain_scores_gemma":[0.9997224,0.00009755657,0.00007448615,0.000007802654,0.000030201161,0.00006751447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015551677,0.00006863591,0.0002359092,0.00027547104,0.00017433277,0.0002319397,0.0001101196,0.0004092804,0.0046360996],"category_scores_gemma":[0.0012386162,0.00003368267,0.00015792386,0.0005236075,0.000060310776,0.00013838294,0.00010110882,0.00027805957,0.0004593013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001466676,0.00061828655,0.26873517,0.0011042845,0.00026786482,0.0048295814,0.00021004907,0.00042041097,0.0020339668,0.0022918019,0.043884028,0.67413795],"study_design_scores_gemma":[0.0010683226,0.0030007514,0.7035072,0.0011498652,0.0006110849,0.02401062,0.00035457156,0.0012734756,0.0017221218,0.0035704367,0.25969785,0.00003361948],"about_ca_topic_score_codex":0.0008815806,"about_ca_topic_score_gemma":0.0014474707,"teacher_disagreement_score":0.0046360996,"about_ca_system_score_codex":0.00026409456,"about_ca_system_score_gemma":0.00041352402,"threshold_uncertainty_score":0.015509307},"labels":[],"label_agreement":null},{"id":"W4291513501","doi":"10.1080/14656566.2022.2112945","title":"Colesevelam – a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Bile acid; Adverse effect; Internal medicine; Cholesterol; Diabetes mellitus; Glycemic; Pharmacology; Endocrinology; Gastroenterology","score_opus":0.031668729767103776,"score_gpt":0.34460110448075304,"score_spread":0.31293237471364926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291513501","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021465735,0.96561795,0.0018651453,0.015028571,0.0031693727,0.00006469066,0.00025010057,0.00010746992,0.0117502],"genre_scores_gemma":[0.021524072,0.95149076,0.002560525,0.010016208,0.0040599774,0.00008944378,0.0005658283,0.000026226924,0.00966692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959105,0.000106173764,0.00003942718,0.000053140142,0.0001648457,0.000045422752],"domain_scores_gemma":[0.9996456,0.0001032848,0.00007650613,0.000010340381,0.00012565537,0.000038692444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051198865,0.00038973257,0.00076312025,0.00085175794,0.0001561191,0.00094372575,0.0005521762,0.0014224775,0.0058482084],"category_scores_gemma":[0.0010485337,0.00011960509,0.000684611,0.00042006458,0.00028581725,0.0005678737,0.00037107468,0.0018757042,0.0028448703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043121734,0.00013373684,0.00052652677,0.0067987195,0.00031764727,0.00051393063,0.000056713838,0.00038488288,0.007224852,0.0047566276,0.14335547,0.83549964],"study_design_scores_gemma":[0.00042466953,0.00044738932,0.00164952,0.003425266,0.00031078584,0.0025383993,0.000057909616,0.0005210414,0.003075517,0.0031697345,0.9843472,0.000032535663],"about_ca_topic_score_codex":0.0006828874,"about_ca_topic_score_gemma":0.0015529585,"teacher_disagreement_score":0.0058482084,"about_ca_system_score_codex":0.00042310078,"about_ca_system_score_gemma":0.0004252412,"threshold_uncertainty_score":0.019564152},"labels":[],"label_agreement":null},{"id":"W4292295394","doi":"10.1080/14656566.2022.2114345","title":"The pharmacotherapeutic management of premenstrual dysphoric disorder","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Premenstrual dysphoric disorder; Medicine; Psychiatry; Distress; Irritability; Psychosis; Fluoxetine; Menstrual cycle; Anxiety; Internal medicine; Clinical psychology; Serotonin","score_opus":0.03757674095811869,"score_gpt":0.3970023324843206,"score_spread":0.3594255915262019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292295394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001667018,0.98207355,0.00047929876,0.008008874,0.0008856679,0.00003836806,0.00020522856,0.000036309313,0.0066056866],"genre_scores_gemma":[0.025853539,0.96028775,0.001525712,0.0068440456,0.0021795118,0.00006144516,0.0003093556,0.000010270307,0.0029283543],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969983,0.00009845029,0.000045981466,0.00004116814,0.000088896806,0.000025698857],"domain_scores_gemma":[0.99944097,0.00025592343,0.00014203778,0.000012598975,0.0001210056,0.000027426206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042126374,0.00027847348,0.00064243196,0.00059187756,0.00014305538,0.00054601545,0.00038889714,0.00084911415,0.0060080537],"category_scores_gemma":[0.0014659726,0.00009169874,0.00049466285,0.00035413812,0.00019315827,0.00038817988,0.0002809624,0.0011295995,0.001362664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030932526,0.00007499597,0.0007094111,0.010826573,0.00025329713,0.000267302,0.000035963363,0.00020394073,0.0011421494,0.0009649886,0.041143585,0.94406843],"study_design_scores_gemma":[0.0006040801,0.0009311833,0.0113178715,0.026730638,0.0009938994,0.0051407055,0.00016464207,0.0005964804,0.0013991666,0.004149039,0.9479285,0.00004388381],"about_ca_topic_score_codex":0.0009407466,"about_ca_topic_score_gemma":0.002340097,"teacher_disagreement_score":0.0060080537,"about_ca_system_score_codex":0.00040345732,"about_ca_system_score_gemma":0.00040907483,"threshold_uncertainty_score":0.020098984},"labels":[],"label_agreement":null},{"id":"W4292495455","doi":"10.1080/14656566.2022.2116274","title":"Pharmacotherapy considerations for morning symptoms in chronic obstructive pulmonary disease","year":2022,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Pharmacotherapy; Pulmonary disease; Morning; Internal medicine; Intensive care medicine","score_opus":0.03477255731698455,"score_gpt":0.3906271809190423,"score_spread":0.3558546236020578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292495455","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053747113,0.048498936,0.00014611708,0.0652265,0.8831065,0.000040181738,0.000080621976,0.000049520113,0.0027978665],"genre_scores_gemma":[0.0005304483,0.024020974,0.00020326154,0.046308883,0.9234207,0.000043369095,0.00004443535,0.000022738512,0.005405178],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952577,0.0014219804,0.0007525415,0.00041877554,0.0018395917,0.00030947928],"domain_scores_gemma":[0.9811333,0.01026236,0.0012002531,0.0003562918,0.00524262,0.0018052615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075653777,0.0023205224,0.004700808,0.0023267218,0.0019956764,0.005980948,0.00317094,0.021118173,0.012768946],"category_scores_gemma":[0.024972666,0.0010047556,0.003134022,0.0012705971,0.0020703438,0.0035481367,0.001584221,0.019327518,0.009101278],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047509202,0.00001793111,0.000022275994,0.00097009714,0.000049829734,0.000111825495,0.000012701234,0.000017917111,0.000043392523,0.00025785007,0.9848889,0.013559719],"study_design_scores_gemma":[0.00036937097,0.000082994535,0.0005016467,0.0035859626,0.00031680416,0.00060102413,0.00005830897,0.00017636355,0.00010411654,0.0015219621,0.99263954,0.000041944902],"about_ca_topic_score_codex":0.0019874128,"about_ca_topic_score_gemma":0.0059737572,"teacher_disagreement_score":0.021118173,"about_ca_system_score_codex":0.002581324,"about_ca_system_score_gemma":0.0033718387,"threshold_uncertainty_score":0.042716384},"labels":[],"label_agreement":null},{"id":"W4306639578","doi":"10.1080/14656566.2022.2135989","title":"Fedratinib: a pharmacotherapeutic option for JAK-inhibitor naïve and exposed patients with myelofibrosis","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Extramedullary hematopoiesis; Clinical trial; Internal medicine; Bone marrow; Haematopoiesis","score_opus":0.10124681455615386,"score_gpt":0.4063206045908273,"score_spread":0.30507379003467344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306639578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011093344,0.87559134,0.0029150143,0.074516445,0.0049685086,0.00013194945,0.0007595064,0.00018992569,0.029833963],"genre_scores_gemma":[0.13331246,0.7734805,0.00404209,0.05887621,0.014073099,0.00028010007,0.0016251164,0.00004981245,0.014260521],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975497,0.00007991504,0.000034212095,0.00003410238,0.00006278911,0.000034012868],"domain_scores_gemma":[0.99961287,0.00013888814,0.0001053702,0.000007913769,0.00009069734,0.000044378277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004138718,0.00024110333,0.0005711774,0.00028087755,0.00019044382,0.0008432395,0.0005301797,0.0011279957,0.0063337064],"category_scores_gemma":[0.0013857807,0.00006273365,0.0005613083,0.00019476096,0.00023604195,0.00053874764,0.00035118574,0.0014066176,0.002087276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007829027,0.00010099943,0.0012749864,0.0049094064,0.0002047859,0.0011932218,0.00007145409,0.00046951615,0.0024247414,0.002446263,0.18179402,0.8043276],"study_design_scores_gemma":[0.0009703104,0.0007105204,0.0047296216,0.008221055,0.00049009174,0.0077990065,0.00016596049,0.0009079625,0.0018179966,0.0059082676,0.9682294,0.000049743965],"about_ca_topic_score_codex":0.00045680683,"about_ca_topic_score_gemma":0.0015454487,"teacher_disagreement_score":0.0063337064,"about_ca_system_score_codex":0.00040742627,"about_ca_system_score_gemma":0.0005005324,"threshold_uncertainty_score":0.021188378},"labels":[],"label_agreement":null},{"id":"W4310032409","doi":"10.1080/14656566.2022.2150966","title":"Perspectives on the future of urothelial carcinoma therapy: chemotherapy and beyond","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Immunotherapy; Chemotherapy; Oncology; Intensive care medicine; Clinical trial; Quality of life (healthcare); Internal medicine; Cancer","score_opus":0.06604193749230337,"score_gpt":0.38864061052098337,"score_spread":0.32259867302868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310032409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050704377,0.99575895,0.00010762346,0.0025657616,0.0006733559,0.0000031908978,0.0000140297125,0.000007510344,0.0008188424],"genre_scores_gemma":[0.0005589375,0.9961959,0.00014386291,0.0017335688,0.00080118864,0.000006148335,0.000026841844,0.0000021799228,0.0005313125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956435,0.00014572284,0.000039210892,0.000056683926,0.00014792578,0.000046136825],"domain_scores_gemma":[0.9990472,0.0004686011,0.00011184123,0.000021585765,0.00028178084,0.0000689513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012238077,0.0007060566,0.001467701,0.0012306619,0.0002628105,0.0013021898,0.0010217241,0.002308502,0.007071656],"category_scores_gemma":[0.0013731413,0.00018675513,0.00088242773,0.0012325987,0.00064460956,0.0024086265,0.0007539094,0.0035375382,0.0028868935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001299198,0.00007326699,0.0001013007,0.023063796,0.00012548217,0.0002054796,0.00007801603,0.0005876838,0.0013527747,0.009512359,0.11581858,0.84895134],"study_design_scores_gemma":[0.000031726006,0.00009799495,0.0003401843,0.007638353,0.00009445838,0.00053149235,0.00006410933,0.00013069063,0.00014769007,0.004642508,0.98626316,0.000017721346],"about_ca_topic_score_codex":0.0012663672,"about_ca_topic_score_gemma":0.0025418655,"teacher_disagreement_score":0.007071656,"about_ca_system_score_codex":0.00095357356,"about_ca_system_score_gemma":0.0016704585,"threshold_uncertainty_score":0.023657024},"labels":[],"label_agreement":null},{"id":"W4367314129","doi":"10.1080/14656566.2023.2206015","title":"Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Hypertriglyceridemia; Apolipoprotein B; Internal medicine; Disease; Clinical trial; Triglyceride; Endocrinology; Cholesterol; Bioinformatics; Pharmacology; Biology","score_opus":0.013825625386093941,"score_gpt":0.29455047781402866,"score_spread":0.2807248524279347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367314129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005740967,0.99702483,0.000096992066,0.001290204,0.00024843682,0.000009613126,0.000038039987,0.000005872572,0.0007118876],"genre_scores_gemma":[0.007822033,0.9895203,0.00047947088,0.0012008146,0.0005966224,0.00002394632,0.000095268006,0.0000027594037,0.00025881617],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951315,0.00017088867,0.00011423487,0.00006843521,0.00009865201,0.000034628498],"domain_scores_gemma":[0.99783117,0.0011315154,0.00051872566,0.00003376248,0.00039459334,0.00009025438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017368724,0.00046682116,0.0012476048,0.0010420235,0.00014567465,0.0008366693,0.00060436135,0.00077659666,0.0039249836],"category_scores_gemma":[0.0032045618,0.00018325997,0.0017228402,0.0010638032,0.0002230473,0.0006065105,0.00036415152,0.0013243702,0.0005884267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019034626,0.00013838935,0.0010563,0.055798456,0.0016720896,0.00020047947,0.00007178689,0.0005367683,0.0010816391,0.0013158019,0.019621538,0.9166033],"study_design_scores_gemma":[0.0049028657,0.0043263924,0.025896948,0.11533375,0.02178574,0.0035604108,0.00044390408,0.0017531267,0.00261732,0.0063959025,0.8128129,0.0001706681],"about_ca_topic_score_codex":0.0012177449,"about_ca_topic_score_gemma":0.002876035,"teacher_disagreement_score":0.0039249836,"about_ca_system_score_codex":0.00055244577,"about_ca_system_score_gemma":0.0012747475,"threshold_uncertainty_score":0.013130426},"labels":[],"label_agreement":null},{"id":"W4377094746","doi":"10.1080/14656566.2023.2216379","title":"Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Mepolizumab; Granulomatosis with polyangiitis; Benralizumab; Eosinophilic; Rituximab; Azathioprine; Immunology; Cyclophosphamide; Dermatology; Intensive care medicine; Asthma; Vasculitis; Internal medicine; Disease; Pathology; Chemotherapy; Eosinophil","score_opus":0.07481286407682784,"score_gpt":0.43485941717268783,"score_spread":0.36004655309586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377094746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005655136,0.99288154,0.0005205088,0.0035749148,0.0004713131,0.000012729671,0.00004866889,0.000015959764,0.0019088765],"genre_scores_gemma":[0.0068967827,0.98801476,0.0010514779,0.002291186,0.0011554261,0.000021525166,0.00010228627,0.00000502039,0.00046150712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954116,0.00014055448,0.000074725205,0.000059248294,0.00014905706,0.000035261015],"domain_scores_gemma":[0.99914527,0.00039477478,0.00017184718,0.000016222699,0.00023370054,0.00003819476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084313954,0.0005066625,0.00096460176,0.0009416012,0.00016025873,0.0007465663,0.00067810155,0.0010136816,0.0044975816],"category_scores_gemma":[0.0015498644,0.000100173216,0.0007509524,0.00074164016,0.0002829538,0.0008366478,0.00039781697,0.0014144947,0.0014440096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018055562,0.000099870835,0.00044263835,0.02914333,0.0002888809,0.00058264984,0.000053638756,0.00044871386,0.001560206,0.0018575976,0.039740354,0.9256015],"study_design_scores_gemma":[0.0002904987,0.00044313254,0.0037706918,0.027324064,0.00108636,0.005698909,0.00020394879,0.00077029096,0.0013916133,0.005063347,0.9539055,0.000051605097],"about_ca_topic_score_codex":0.0006706771,"about_ca_topic_score_gemma":0.0012177158,"teacher_disagreement_score":0.0044975816,"about_ca_system_score_codex":0.00048555693,"about_ca_system_score_gemma":0.000799941,"threshold_uncertainty_score":0.015045941},"labels":[],"label_agreement":null},{"id":"W4386347365","doi":"10.1080/14656566.2023.2254698","title":"Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness – a narrative review","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; University of Toronto; Centre for Addiction and Mental Health","funders":"Novo Nordisk Fonden; Steno Diabetes Center Copenhagen","keywords":"Medicine; Psychological intervention; Narrative review; Mental illness; Weight management; Intensive care medicine; Psychiatry; Weight loss; Mental health; Internal medicine; Obesity","score_opus":0.15446556808005968,"score_gpt":0.5043530853702125,"score_spread":0.3498875172901528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386347365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000088383415,0.9990544,0.000054563727,0.00023675017,0.000098922166,0.000013228446,0.000029546605,0.0000036693625,0.00042051685],"genre_scores_gemma":[0.00065165263,0.9988507,0.00011678926,0.00017979651,0.000053715652,0.000013135747,0.000022946955,8.6764334e-7,0.000110501955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996487,0.00008886217,0.00008106772,0.00005530669,0.00010079482,0.000025329846],"domain_scores_gemma":[0.9989184,0.0007640467,0.00015191283,0.000014877246,0.00012611659,0.000024639325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009120734,0.00075501914,0.0014415215,0.0018287819,0.00023619074,0.0010961838,0.00087489607,0.0010142999,0.0057019102],"category_scores_gemma":[0.0024366898,0.00021293588,0.0014340387,0.001579915,0.0002649432,0.0008118559,0.00051296904,0.0011395117,0.0008017971],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014701368,0.00005863129,0.00012366471,0.23782125,0.000547657,0.00012645446,0.000116621246,0.0002719084,0.0005476915,0.0021704545,0.017660385,0.7404082],"study_design_scores_gemma":[0.00015593672,0.00029882084,0.0020703424,0.28786626,0.0039445674,0.0013701922,0.0002439207,0.00028155177,0.00042663325,0.0027472333,0.70054525,0.000049166876],"about_ca_topic_score_codex":0.0017171057,"about_ca_topic_score_gemma":0.004196609,"teacher_disagreement_score":0.0057019102,"about_ca_system_score_codex":0.00055404194,"about_ca_system_score_gemma":0.0019597495,"threshold_uncertainty_score":0.019074738},"labels":[],"label_agreement":null},{"id":"W4387865677","doi":"10.1080/14656566.2023.2273395","title":"Pharmacological management of connective tissue disease-associated pulmonary arterial hypertension","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pulmonary hypertension; Connective tissue disease; Disease; Connective tissue; Cardiology; Pathology; Intensive care medicine; Internal medicine; Autoimmune disease","score_opus":0.17825983050877048,"score_gpt":0.46322636161496494,"score_spread":0.28496653110619447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387865677","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023765594,0.99704236,0.00016423293,0.00067444623,0.00031731022,0.000011281619,0.000047034006,0.0000093330445,0.0014962923],"genre_scores_gemma":[0.0018319528,0.9965055,0.00023486282,0.00055494957,0.00025999077,0.000013789259,0.00006803253,0.0000018820372,0.00052918296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997874,0.000055372424,0.000031740325,0.00003263535,0.00007419662,0.000018678153],"domain_scores_gemma":[0.99975675,0.00013017366,0.000044049255,0.000005578944,0.00005140189,0.000012050047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003064367,0.00039409107,0.00086381234,0.000746879,0.00015344852,0.0005914777,0.0005332014,0.000779836,0.0045958133],"category_scores_gemma":[0.0008483131,0.00009513627,0.000651846,0.0005191853,0.00017673199,0.0004091897,0.00035773803,0.0011311038,0.0013836938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010769019,0.00005793339,0.00015365153,0.033589095,0.0002505274,0.00020008408,0.000044945155,0.00025902706,0.0012483217,0.0018063966,0.036373124,0.9259091],"study_design_scores_gemma":[0.00011657119,0.00021192527,0.0018452898,0.025810093,0.0006541343,0.0023919586,0.00007300065,0.0002488724,0.00077734544,0.0023729042,0.96547246,0.000025489147],"about_ca_topic_score_codex":0.0006537068,"about_ca_topic_score_gemma":0.0014030661,"teacher_disagreement_score":0.0045958133,"about_ca_system_score_codex":0.00030978394,"about_ca_system_score_gemma":0.00055839476,"threshold_uncertainty_score":0.015374541},"labels":[],"label_agreement":null},{"id":"W4387893581","doi":"10.1080/14656566.2023.2272659","title":"Ivosidenib in acute myeloid leukemia","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Venetoclax; Myeloid leukemia; Midostaurin; Cytarabine; Oncology; Hedgehog; Pharmacology; Leukemia; Cancer research; Internal medicine; Signal transduction","score_opus":0.12946871703231508,"score_gpt":0.47556122090816166,"score_spread":0.34609250387584656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387893581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010678708,0.9979849,0.000055891232,0.0004038124,0.0002501028,0.0000054378193,0.000027356622,0.0000064535807,0.0011591524],"genre_scores_gemma":[0.0010683874,0.99731797,0.00009704594,0.00045885498,0.00024578805,0.000007397733,0.000059561935,0.000001684463,0.0007433515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999869,0.000028703189,0.000017002834,0.000029073708,0.00004404513,0.000012098222],"domain_scores_gemma":[0.9998286,0.00007382171,0.000038038048,0.000004065541,0.00004096601,0.000014538338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003641173,0.00047920702,0.00080483564,0.001004115,0.00014972329,0.0006884627,0.000590765,0.00069253874,0.006183565],"category_scores_gemma":[0.0006012044,0.00012645492,0.00042815603,0.0011612704,0.00026505234,0.00065415644,0.00047295316,0.0013894327,0.002521477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001000017,0.000025116065,0.00007780145,0.01755355,0.00008522673,0.00008610554,0.000028004997,0.00024047271,0.00070413016,0.0022171487,0.03462723,0.9442553],"study_design_scores_gemma":[0.000049964023,0.00009519296,0.0004524853,0.0071721547,0.00016175427,0.0008361979,0.00002684324,0.00007197469,0.00029136907,0.0014340293,0.9893974,0.000010611014],"about_ca_topic_score_codex":0.0008377547,"about_ca_topic_score_gemma":0.001601613,"teacher_disagreement_score":0.006183565,"about_ca_system_score_codex":0.00041998204,"about_ca_system_score_gemma":0.00077885605,"threshold_uncertainty_score":0.02068609},"labels":[],"label_agreement":null},{"id":"W4389244496","doi":"10.1080/14656566.2023.2291075","title":"Novel pharmacotherapy for drug-induced immune hemolytic anemia","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Blood groups and transfusion","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Medicine; Autoimmune hemolytic anemia; Drug; Pharmacotherapy; Hemolytic anemia; Immune system; Immunology; Cold agglutinin disease; Pharmacology; Anemia; Internal medicine; Antibody","score_opus":0.04252043142967242,"score_gpt":0.3930771774995247,"score_spread":0.35055674606985227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244496","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002776234,0.32395968,0.0006461402,0.094143026,0.5717401,0.000089126304,0.00027904616,0.00013374124,0.008731628],"genre_scores_gemma":[0.0021485228,0.22500093,0.0005384506,0.08626765,0.67206985,0.00007075903,0.00022941007,0.00005024615,0.013624197],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911076,0.00023768996,0.00011174343,0.00009339594,0.0003827262,0.00006376781],"domain_scores_gemma":[0.99764,0.0011125332,0.00020371929,0.000040619703,0.000796122,0.00020701504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015751768,0.0010302372,0.0015455885,0.0008246994,0.0005750988,0.0015243269,0.0015519202,0.0050157523,0.008822719],"category_scores_gemma":[0.0051585,0.00027057072,0.0011258171,0.00048718214,0.0006302194,0.0018851488,0.00055626244,0.008135533,0.0063586095],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008279316,0.000017988732,0.000024828878,0.0015294827,0.00005071466,0.00013865087,0.00001066456,0.000044002914,0.00014140102,0.0007511679,0.9400737,0.057134505],"study_design_scores_gemma":[0.00012661362,0.00007597777,0.00022624573,0.0012413836,0.00012923258,0.00050940743,0.000016395532,0.00011437454,0.00012620688,0.0011784926,0.99624074,0.000014951169],"about_ca_topic_score_codex":0.00069240376,"about_ca_topic_score_gemma":0.0019931982,"teacher_disagreement_score":0.008822719,"about_ca_system_score_codex":0.0009807233,"about_ca_system_score_gemma":0.0010705843,"threshold_uncertainty_score":0.029514909},"labels":[],"label_agreement":null},{"id":"W4389570956","doi":"10.1080/14656566.2023.2288287","title":"Can we manage gut microbiome imbalances in patients with bipolar disorder with pharmacotherapy?","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bipolar disorder; Pharmacotherapy; Microbiome; Gut microbiome; Medicine; Psychological intervention; Psychiatry; Gut flora; Bioinformatics; Mood; Immunology; Biology","score_opus":0.009650823100651452,"score_gpt":0.2983900876893935,"score_spread":0.28873926458874205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389570956","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012035002,0.83326954,0.003989668,0.12648645,0.007829566,0.00022924341,0.0007980888,0.0003063346,0.015056037],"genre_scores_gemma":[0.13279611,0.75546545,0.011405293,0.07857213,0.01213557,0.00063738227,0.0009049072,0.00009637763,0.007986799],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960417,0.00015889923,0.00004440541,0.000056730798,0.0000828636,0.000053007014],"domain_scores_gemma":[0.9991936,0.000336787,0.00015461161,0.000024025507,0.00020352117,0.00008744842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007821751,0.00036954964,0.001275647,0.00038706686,0.00037860018,0.0013643125,0.0005610831,0.0017213998,0.008144653],"category_scores_gemma":[0.0036625233,0.00009950878,0.001120601,0.00022928187,0.00033879094,0.0010869327,0.0006286504,0.002090187,0.0022199738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013342106,0.000312612,0.0036936079,0.011789757,0.0007119296,0.0006410744,0.00019659527,0.0004307404,0.0029430771,0.0037358906,0.108965464,0.86524504],"study_design_scores_gemma":[0.0030592228,0.0018710126,0.021433527,0.041208804,0.0026016699,0.0032440554,0.0015094102,0.0019703577,0.0032562632,0.036853284,0.8828322,0.00016024488],"about_ca_topic_score_codex":0.0011645865,"about_ca_topic_score_gemma":0.0036280095,"teacher_disagreement_score":0.008144653,"about_ca_system_score_codex":0.00044893697,"about_ca_system_score_gemma":0.0008851451,"threshold_uncertainty_score":0.027246535},"labels":[],"label_agreement":null},{"id":"W4390016361","doi":"10.1080/14656566.2023.2298345","title":"Levodopa-induced dyskinesia: do current clinical trials hold hope for future treatment?","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Pharmacotherapy","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Levodopa; Dyskinesia; Clinical trial; Intensive care medicine; Internal medicine; Disease; Parkinson's disease","score_opus":0.4465294891526701,"score_gpt":0.6024239904510121,"score_spread":0.15589450129834204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390016361","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085045795,0.05455462,0.00030402688,0.07012108,0.87169206,0.000056675028,0.00011775839,0.000102569546,0.0029661672],"genre_scores_gemma":[0.0009939453,0.030225934,0.00034193127,0.061428912,0.8988601,0.000057416426,0.00007244915,0.000042152427,0.007977147],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961106,0.0010522895,0.0006252644,0.00042068,0.0014920455,0.0002990993],"domain_scores_gemma":[0.98316634,0.0080710165,0.001491956,0.00040423684,0.0047760396,0.0020904515],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011284078,0.002795146,0.0055272174,0.0018675383,0.0017980771,0.0050743166,0.0037385626,0.019492095,0.01054821],"category_scores_gemma":[0.019014629,0.0011404657,0.0028088947,0.0011437164,0.0021274914,0.0037611842,0.0010912421,0.018314227,0.0088180285],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014568599,0.000013971984,0.000030365061,0.0008391165,0.000086391214,0.00015369043,0.000009008628,0.000028524819,0.00008503423,0.0003803398,0.98282385,0.015403998],"study_design_scores_gemma":[0.000472732,0.000108072934,0.00036400775,0.001840787,0.0004004341,0.0005318141,0.00003700743,0.00032798102,0.00015015836,0.002580072,0.99314535,0.000041498643],"about_ca_topic_score_codex":0.0015506948,"about_ca_topic_score_gemma":0.0047060847,"teacher_disagreement_score":0.98871595,"about_ca_system_score_codex":0.003379563,"about_ca_system_score_gemma":0.0033489033,"threshold_uncertainty_score":0.059676647},"labels":[],"label_agreement":null},{"id":"W4390506313","doi":"10.1080/14656566.2023.2298340","title":"The efficacy of zuranolone in postpartum depression and major depressive disorder: a review &amp; number needed to treat (NNT) analysis","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Toronto Western Hospital; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Medicine; Neuroactive steroid; Major depressive disorder; Antidepressant; Postpartum depression; Depression (economics); Psychiatry; Premenstrual dysphoric disorder; Vortioxetine; Childbirth; Number needed to treat; Mental health; Pregnancy; GABAA receptor; Internal medicine; Mood; Anxiety; Receptor; Relative risk; Menstrual cycle","score_opus":0.04628690862008795,"score_gpt":0.4446966970871853,"score_spread":0.39840978846709735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390506313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003213988,0.9980715,0.0001827946,0.0002411343,0.0001451216,0.00019522493,0.00032763972,0.000010454775,0.0005046534],"genre_scores_gemma":[0.009303192,0.9880905,0.0008191467,0.00058895565,0.00013730345,0.00040546004,0.00029944358,0.000009689572,0.0003463593],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99779606,0.0006760899,0.00067093474,0.00020645748,0.0005749494,0.00007541562],"domain_scores_gemma":[0.993793,0.004625464,0.0009821216,0.00006168776,0.00046840034,0.00006929975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044176653,0.0009592249,0.0072004283,0.0034776225,0.00025842222,0.0013981268,0.0014360517,0.0011345386,0.010195172],"category_scores_gemma":[0.01081372,0.0003974771,0.008208594,0.003444894,0.0004105745,0.0011710642,0.0006095445,0.0016001344,0.00057245244],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014684827,0.000051484993,0.00051021524,0.6770997,0.01642919,0.000091972055,0.000053274034,0.00048359748,0.00025697864,0.00089360826,0.0070638717,0.29559764],"study_design_scores_gemma":[0.0031130207,0.001488892,0.009782912,0.57554656,0.2177328,0.001178414,0.00026512102,0.0011709976,0.00066306203,0.00548417,0.18346079,0.00011337143],"about_ca_topic_score_codex":0.0020282161,"about_ca_topic_score_gemma":0.0065377597,"teacher_disagreement_score":0.010195172,"about_ca_system_score_codex":0.0018871282,"about_ca_system_score_gemma":0.002069756,"threshold_uncertainty_score":0.034106255},"labels":[],"label_agreement":null},{"id":"W4390881919","doi":"10.1080/14656566.2024.2305304","title":"Effectiveness and safety of oral terbinafine for dermatophyte distal subungual onychomycosis","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Terbinafine; Medicine; Adverse effect; Dermatophyte; Regimen; Intensive care medicine; Pharmacology; Dermatology; Surgery; Itraconazole; Antifungal","score_opus":0.023115722261216096,"score_gpt":0.39172699380255943,"score_spread":0.3686112715413433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390881919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.090238094,0.87460166,0.0025249985,0.009061276,0.0012001214,0.0002561388,0.0007162453,0.00006497652,0.021336457],"genre_scores_gemma":[0.62229264,0.36155632,0.003189199,0.004278643,0.0016398126,0.00018559486,0.00060972484,0.000031237374,0.0062168837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938214,0.00025793075,0.00006785839,0.0000745654,0.00017554761,0.00004178498],"domain_scores_gemma":[0.99900645,0.0004977553,0.0002727824,0.000029953871,0.00014871641,0.000044332744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091112056,0.00017792013,0.00077938766,0.0002373613,0.00013804437,0.0006069688,0.00027776734,0.00055864896,0.0070217755],"category_scores_gemma":[0.0020519267,0.00004684603,0.0006437184,0.00021508186,0.0001933901,0.00040018433,0.00016940171,0.00070929853,0.00069608405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003821409,0.00028713275,0.0019827695,0.0073917178,0.00043396497,0.00056882435,0.000074520714,0.00038510226,0.008841444,0.0010557701,0.011888521,0.9632688],"study_design_scores_gemma":[0.009665869,0.044887338,0.084884256,0.03315988,0.008014262,0.02282834,0.0011742805,0.004964768,0.06086199,0.008945668,0.7204127,0.0002006577],"about_ca_topic_score_codex":0.000529615,"about_ca_topic_score_gemma":0.0011837087,"teacher_disagreement_score":0.0070217755,"about_ca_system_score_codex":0.00043466408,"about_ca_system_score_gemma":0.00046085558,"threshold_uncertainty_score":0.02349019},"labels":[],"label_agreement":null},{"id":"W4391530799","doi":"10.1080/14656566.2024.2314087","title":"Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Minoxidil; Medicine; Finasteride; Dutasteride; Hair loss; Dermatology; Safety profile; Male-pattern baldness; Adverse effect; Pharmacology; Clinical trial; Internal medicine; Scalp; Prostate cancer; Prostate","score_opus":0.027994995930931098,"score_gpt":0.3656503400913742,"score_spread":0.3376553441604431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391530799","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009475336,0.9771657,0.0009112524,0.005087363,0.0009510367,0.00004723466,0.00019718907,0.00003135247,0.0061335624],"genre_scores_gemma":[0.16833058,0.81604755,0.0019284331,0.0057657897,0.003165581,0.00008519606,0.00042316463,0.000025101426,0.0042285826],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99964106,0.00011872433,0.000036474004,0.00005233836,0.00012003666,0.00003138181],"domain_scores_gemma":[0.9993143,0.00032962387,0.00017252131,0.00001081856,0.00014524731,0.000027531216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006840116,0.00019067712,0.0005468798,0.00022199772,0.00011430001,0.00050203636,0.0003190658,0.00065133587,0.005157186],"category_scores_gemma":[0.0013603229,0.00005484956,0.00062618975,0.00016618498,0.0001958257,0.0003924512,0.00015607415,0.000948353,0.0007911632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015282115,0.000120333665,0.0010110876,0.015886884,0.00027264538,0.00042661687,0.00006658404,0.00025407382,0.008848541,0.0011370056,0.024836592,0.94561136],"study_design_scores_gemma":[0.0024589687,0.010384945,0.029915439,0.030431578,0.0029214737,0.015093479,0.0005156223,0.0018370856,0.019431945,0.0055389386,0.88133967,0.00013074775],"about_ca_topic_score_codex":0.000386713,"about_ca_topic_score_gemma":0.00094744394,"teacher_disagreement_score":0.005157186,"about_ca_system_score_codex":0.0002616185,"about_ca_system_score_gemma":0.00034382028,"threshold_uncertainty_score":0.017252445},"labels":[],"label_agreement":null},{"id":"W4391948899","doi":"10.1080/14656566.2024.2319686","title":"An update on the current and emerging pharmacotherapy for the treatment of human ascariasis","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Ascaris lumbricoides; Ascariasis; Medicine; Pharmacotherapy; Mebendazole; Neglected tropical diseases; Pyrantel; Albendazole; Ascaris; Sanitation; Helminthiasis; Environmental health; Helminths; Public health; Immunology; Internal medicine; Surgery; Pathology; Biology","score_opus":0.12764501340618836,"score_gpt":0.513468251862264,"score_spread":0.3858232384560756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391948899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031239275,0.9831592,0.00034747744,0.0077130226,0.0039381697,0.000037206344,0.00021894365,0.000040100032,0.0042335335],"genre_scores_gemma":[0.001540304,0.98581076,0.0007365155,0.006108587,0.0031768593,0.000038532216,0.00030766343,0.000007529431,0.0022731947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953926,0.00012344755,0.00008455992,0.000041689087,0.00017528793,0.000035717785],"domain_scores_gemma":[0.9987031,0.00058167253,0.00017207034,0.000022776723,0.0004407383,0.00007965498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074159494,0.0005020536,0.0011211588,0.0014494605,0.00022283707,0.0009127493,0.0007702917,0.0014802959,0.01032272],"category_scores_gemma":[0.0020279728,0.00017219597,0.0010987389,0.0010785933,0.00027672667,0.0012276915,0.00046438983,0.0020806645,0.0029561468],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015004126,0.00007767842,0.00021008466,0.02285562,0.0001950985,0.0002738521,0.00006769588,0.00016596178,0.00097145454,0.001418825,0.23494825,0.7386654],"study_design_scores_gemma":[0.000059757196,0.0001465164,0.00071469374,0.008906808,0.0003225629,0.0008050587,0.00003683926,0.00009517325,0.00015728483,0.0007399828,0.98800176,0.000013465252],"about_ca_topic_score_codex":0.0010085098,"about_ca_topic_score_gemma":0.00314468,"teacher_disagreement_score":0.01032272,"about_ca_system_score_codex":0.0005910793,"about_ca_system_score_gemma":0.0010938107,"threshold_uncertainty_score":0.034532964},"labels":[],"label_agreement":null},{"id":"W4393091416","doi":"10.1080/14656566.2024.2334424","title":"Efficacy, safety, and tolerability of xanomeline for schizophrenia spectrum disorders: a systematic review","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Ottawa; University Health Network; University of Toronto; McMaster University; Brain and Cognition Discovery Foundation","funders":"","keywords":"Tolerability; Medicine; Placebo; Randomized controlled trial; Positive and Negative Syndrome Scale; Antipsychotic; Akathisia; Internal medicine; Nausea; Adverse effect; Schizophrenia (object-oriented programming); Constipation; Psychiatry; Psychosis; Alternative medicine","score_opus":0.06289328350617082,"score_gpt":0.44579859724465326,"score_spread":0.38290531373848247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393091416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088746997,0.9980603,0.00010254887,0.00018499047,0.000057329078,0.00017537277,0.00036345012,0.0000059256417,0.00016256573],"genre_scores_gemma":[0.012916929,0.9851023,0.0005651899,0.0005344935,0.00011724903,0.00043696864,0.00022841051,0.0000041525122,0.000094260686],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99520266,0.0014494506,0.0019812447,0.00045167652,0.0007635443,0.0001513691],"domain_scores_gemma":[0.984294,0.010352747,0.003829649,0.00019009525,0.001154767,0.00017877154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065012565,0.001358282,0.0065942337,0.009844324,0.00054770295,0.0024242948,0.0014978689,0.0015441182,0.005326973],"category_scores_gemma":[0.022193113,0.00079852407,0.0061679804,0.0070643807,0.00085737853,0.0019432444,0.0012824972,0.00082249177,0.00031701635],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014451004,0.000010328154,0.00059832196,0.9668455,0.0048203375,0.000057737263,0.00008834075,0.000053024396,0.00016147802,0.00014116583,0.00078814634,0.026291171],"study_design_scores_gemma":[0.00028510336,0.00027818652,0.0048236684,0.89864016,0.07240568,0.00043398983,0.00021152498,0.00007428172,0.00024223098,0.0003855655,0.022180162,0.000039551942],"about_ca_topic_score_codex":0.0040839463,"about_ca_topic_score_gemma":0.0115271555,"teacher_disagreement_score":0.009844324,"about_ca_system_score_codex":0.001965431,"about_ca_system_score_gemma":0.007324134,"threshold_uncertainty_score":0.034382343},"labels":[],"label_agreement":null},{"id":"W4394847340","doi":"10.1080/14656566.2024.2343079","title":"An update on antifungal resistance in dermatophytosis","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Antifungal; Itraconazole; Dermatology; Voriconazole; Terbinafine; Intensive care medicine; Pharmacology","score_opus":0.026568070107928412,"score_gpt":0.4041246774393287,"score_spread":0.3775566073314003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394847340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044563203,0.98650765,0.00041858587,0.0034726239,0.004589988,0.000017195323,0.00020670009,0.000054745633,0.004286971],"genre_scores_gemma":[0.0028909277,0.9814959,0.0008520444,0.0039988374,0.007372467,0.000023682735,0.000618656,0.000022076338,0.002725423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991906,0.0001706868,0.00021132918,0.00011521469,0.00024391508,0.00006823836],"domain_scores_gemma":[0.9974759,0.0011252145,0.000315506,0.00006641656,0.00084352255,0.00017340349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009838364,0.00085000054,0.0014343201,0.003750796,0.00030634148,0.0016093281,0.0010095999,0.001706957,0.012166182],"category_scores_gemma":[0.0035604783,0.00031951172,0.0010627923,0.0027876336,0.0004393206,0.0024970556,0.00095411466,0.0025760098,0.0042911205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010101171,0.000052936415,0.00091298996,0.012554924,0.00013995654,0.0006832767,0.00011009753,0.00025983437,0.0008450765,0.0015740226,0.18268326,0.8000827],"study_design_scores_gemma":[0.00001578984,0.000074740616,0.001345827,0.006653733,0.00018424797,0.004013851,0.000064736974,0.00010525189,0.00021385067,0.000702333,0.9866064,0.000019344749],"about_ca_topic_score_codex":0.001639659,"about_ca_topic_score_gemma":0.0028211193,"teacher_disagreement_score":0.012166182,"about_ca_system_score_codex":0.0008155859,"about_ca_system_score_gemma":0.0013907884,"threshold_uncertainty_score":0.0406999},"labels":[],"label_agreement":null},{"id":"W4394853841","doi":"10.1080/14656566.2024.2343780","title":"Momelotinib in myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Discontinuation; Anemia; Janus kinase; Bone marrow; Constitutional symptoms; Disease; Internal medicine; Immunology; Receptor","score_opus":0.041051992191448325,"score_gpt":0.4061195072751803,"score_spread":0.365067515083732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394853841","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053766747,0.94060045,0.00081429654,0.016062628,0.0032881186,0.000060197148,0.00042145673,0.00009741866,0.03327871],"genre_scores_gemma":[0.099140406,0.8391955,0.0023427396,0.01992001,0.008602708,0.00014191266,0.0018548155,0.00002924609,0.028772635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988174,0.00003166133,0.000013564899,0.000016818987,0.000034677723,0.000021512962],"domain_scores_gemma":[0.99985886,0.000039957267,0.000038804108,0.000003690479,0.000032902954,0.000025678592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031389852,0.00022160921,0.00043758005,0.0003038493,0.00015729415,0.00047398283,0.0003095132,0.00062819006,0.009013301],"category_scores_gemma":[0.0005661859,0.00004881424,0.00028333394,0.00029614338,0.00014308402,0.0003134374,0.00026971512,0.0009490028,0.0021453337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053262745,0.000064651125,0.0005383604,0.0038824417,0.00011587722,0.0006332335,0.000039073726,0.00040366882,0.002324455,0.0049450262,0.1244136,0.8621069],"study_design_scores_gemma":[0.00042652595,0.00039692374,0.0017404506,0.0030744607,0.00016744743,0.0031958255,0.000036566154,0.00034656195,0.0014044523,0.0038905318,0.9853055,0.0000147351],"about_ca_topic_score_codex":0.00048075986,"about_ca_topic_score_gemma":0.001386518,"teacher_disagreement_score":0.009013301,"about_ca_system_score_codex":0.00038267934,"about_ca_system_score_gemma":0.00045367223,"threshold_uncertainty_score":0.0301525},"labels":[],"label_agreement":null},{"id":"W4396952607","doi":"10.1080/14656566.2024.2354466","title":"A Systematic Review on Safety and Efficacy of Migalastat for the treatment of Fabry’s Disease","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine; Fabry disease; Disease; Internal medicine; Pharmacology","score_opus":0.09354327336123898,"score_gpt":0.4751570944619119,"score_spread":0.38161382110067293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396952607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008278973,0.99766254,0.00011007503,0.00022353086,0.00009500742,0.00024144823,0.00041195197,0.0000071595664,0.00042043452],"genre_scores_gemma":[0.009018104,0.98947734,0.00030571222,0.00039339185,0.000074418545,0.00034026403,0.00023215103,0.000003928512,0.00015472114],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99576294,0.0013301849,0.001730378,0.0002780469,0.00076739374,0.00013098343],"domain_scores_gemma":[0.98742086,0.008323318,0.0027521527,0.00014719318,0.0012158398,0.00014063834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004466469,0.0010221291,0.006773211,0.0055721886,0.0004328782,0.0019441536,0.0017398819,0.001598977,0.006812647],"category_scores_gemma":[0.02088993,0.0005386583,0.004659297,0.0071916427,0.00057232205,0.0014087699,0.0009065753,0.0007683489,0.0005052706],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022089356,0.000009822421,0.00022364962,0.9635275,0.0038636813,0.000083149855,0.00007957796,0.00005308953,0.00016194164,0.000140729,0.0015097595,0.030126197],"study_design_scores_gemma":[0.00035060768,0.00030428843,0.0026668732,0.90635175,0.059689183,0.00047364904,0.00015520278,0.000072573916,0.00024563944,0.00024046212,0.02942194,0.00002773717],"about_ca_topic_score_codex":0.0049607265,"about_ca_topic_score_gemma":0.012232716,"teacher_disagreement_score":0.006812647,"about_ca_system_score_codex":0.0023653924,"about_ca_system_score_gemma":0.007110261,"threshold_uncertainty_score":0.023621261},"labels":[],"label_agreement":null},{"id":"W4398221864","doi":"10.1080/14656566.2024.2357188","title":"Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Japan Society for the Promotion of Science; Bayer Yakuhin; Otsuka Pharmaceutical; Chugai Pharmaceutical; Daiichi-Sankyo; Eisai Canada; Eisai; Kyorin Pharmaceutical","keywords":"Medicine; Homeostasis; Tolvaptan; Autosomal dominant polycystic kidney disease; Polycystic kidney disease; Kidney; Kidney disease; Disease; Renin–angiotensin system; Internal medicine; Endocrinology; Vasopressin; Blood pressure","score_opus":0.017482673222393694,"score_gpt":0.3391253516318833,"score_spread":0.32164267840948957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398221864","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018249115,0.94799,0.0017408429,0.036198292,0.0056657474,0.00003037613,0.00029633287,0.000099736746,0.006153801],"genre_scores_gemma":[0.028141322,0.93133295,0.0018807494,0.019709868,0.013412132,0.000078676145,0.0003935946,0.000030365636,0.0050203246],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99957544,0.00013401087,0.000035451998,0.000070576556,0.00012214776,0.0000622691],"domain_scores_gemma":[0.9991708,0.00029633738,0.0001266945,0.000018182787,0.00029349056,0.000094543466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008638642,0.00039955994,0.0009380226,0.00041824533,0.00025132333,0.0012602359,0.00070518843,0.0020835367,0.008936742],"category_scores_gemma":[0.0016118507,0.00009631847,0.00075469975,0.00025844295,0.0005817037,0.0012720599,0.0005904225,0.0026372971,0.0023838605],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008736891,0.00015845425,0.001043874,0.016928356,0.00032092052,0.00062577095,0.00016833364,0.0007636417,0.008879773,0.016089955,0.24672207,0.7074252],"study_design_scores_gemma":[0.00026084296,0.00048737228,0.0020218682,0.006110214,0.00032731376,0.0012774379,0.00023363312,0.00081535004,0.0014477876,0.016527634,0.9704428,0.0000477713],"about_ca_topic_score_codex":0.00042783224,"about_ca_topic_score_gemma":0.0012926155,"teacher_disagreement_score":0.008936742,"about_ca_system_score_codex":0.0005754826,"about_ca_system_score_gemma":0.0009848821,"threshold_uncertainty_score":0.029896379},"labels":[],"label_agreement":null},{"id":"W4399503531","doi":"10.1080/14656566.2024.2365326","title":"Pharmacotherapeutic advances in fibromyalgia: what’s new on the horizon?","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for Exercise Physiology","funders":"","keywords":"Fibromyalgia; Medicine; Fibromyalgia syndrome; Chronic pain; Intensive care medicine; Physical therapy","score_opus":0.051220894104285104,"score_gpt":0.40547017802617996,"score_spread":0.35424928392189486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399503531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019072145,0.9896039,0.00021755062,0.00777368,0.0012054767,0.000011731426,0.00006239227,0.000012745326,0.00092191825],"genre_scores_gemma":[0.0013712622,0.9932776,0.00033864347,0.0030846163,0.0014578444,0.000012803321,0.000049547656,0.0000036402253,0.00040398608],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993697,0.00016619767,0.00009653087,0.000103125414,0.00020033945,0.000064171705],"domain_scores_gemma":[0.9967698,0.001980243,0.0003441934,0.00005218156,0.0007252383,0.00012844347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016596406,0.000539778,0.0014801183,0.0016368905,0.00039972225,0.0019268346,0.00068340305,0.001921688,0.008704839],"category_scores_gemma":[0.0040590195,0.00022157667,0.0012401456,0.0017798886,0.0006893977,0.0027899581,0.0006364577,0.0023944906,0.0020250808],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019577863,0.00007242387,0.00037459645,0.060648773,0.0002826516,0.0002429351,0.00018946944,0.00027501912,0.0011785307,0.0058851168,0.07091638,0.85973835],"study_design_scores_gemma":[0.000060461265,0.0002723022,0.0015348357,0.04176449,0.00054397446,0.001091026,0.00034648555,0.00019878593,0.0003863236,0.006614615,0.9471414,0.000045224962],"about_ca_topic_score_codex":0.0013770151,"about_ca_topic_score_gemma":0.0031759674,"teacher_disagreement_score":0.008704839,"about_ca_system_score_codex":0.0009047717,"about_ca_system_score_gemma":0.0030275688,"threshold_uncertainty_score":0.029120624},"labels":[],"label_agreement":null},{"id":"W4401219225","doi":"10.1080/14656566.2024.2387673","title":"Cytokine release syndrome after CAR T-cell therapy for B-cell acute lymphoblastic leukemia in children and young adolescents: storms make trees take deeper roots","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Chimeric antigen receptor; Cytokine release syndrome; Lymphoblastic Leukemia; Cytokine storm; Immune system; Cytokine; Immunology; Leukemia; Acute lymphocytic leukemia; Receptor; T cell; Adverse effect; Internal medicine; Disease","score_opus":0.027437902744180738,"score_gpt":0.36035886421433105,"score_spread":0.3329209614701503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401219225","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015438815,0.99757344,0.00009357946,0.0007904605,0.00038191798,0.0000062035638,0.000029447514,0.000005732157,0.00096492644],"genre_scores_gemma":[0.001376092,0.99672806,0.00012708383,0.00082561106,0.0003411977,0.000009722037,0.00004547682,0.0000020935981,0.0005446215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999819,0.000049850754,0.000026060623,0.000026922206,0.000060122544,0.000018073662],"domain_scores_gemma":[0.9997397,0.00013776433,0.000046445362,0.000005240773,0.000058172758,0.000012661276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044039337,0.0003599732,0.0007982894,0.0006101124,0.00014623636,0.0006536439,0.00052388577,0.0008438199,0.0036117174],"category_scores_gemma":[0.00087202387,0.000100978745,0.0005266136,0.0006594446,0.00020781968,0.000611356,0.0003532668,0.0012728694,0.0013241854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013825463,0.0000369251,0.0002014926,0.029342277,0.0001743652,0.00035694768,0.000065266206,0.0002566664,0.0013017079,0.0027967745,0.069708176,0.8956211],"study_design_scores_gemma":[0.00007127805,0.00011920868,0.0009532693,0.011200232,0.0002783138,0.0025527382,0.00007106222,0.00011445276,0.0005596827,0.0018431523,0.9822191,0.000017513843],"about_ca_topic_score_codex":0.0007052846,"about_ca_topic_score_gemma":0.0016049226,"teacher_disagreement_score":0.0036117174,"about_ca_system_score_codex":0.00040256427,"about_ca_system_score_gemma":0.00084220804,"threshold_uncertainty_score":0.012082398},"labels":[],"label_agreement":null},{"id":"W4402554993","doi":"10.1080/14656566.2024.2402022","title":"Current approaches to the pharmacological management of metastatic breast cancer in older women","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Context (archaeology); Breast cancer; Intensive care medicine; Oncology; Cancer; Personalized medicine; Internal medicine; Bioinformatics","score_opus":0.2769222624376801,"score_gpt":0.49914402222175996,"score_spread":0.22222175978407988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402554993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070666036,0.9979919,0.000105536485,0.000828021,0.00021047906,0.000009079433,0.00002369247,0.0000061671553,0.00075446797],"genre_scores_gemma":[0.000761313,0.9979948,0.0001557332,0.0006093063,0.0001830485,0.000010734447,0.000028638378,0.0000011420043,0.00025537016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995449,0.00012495203,0.00007402054,0.0000630096,0.0001652998,0.000027821015],"domain_scores_gemma":[0.99920803,0.00045213258,0.00014949417,0.000017982748,0.00014923081,0.000023182909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089183013,0.0006343645,0.0013699412,0.0012795975,0.00017155126,0.00092672335,0.00094026094,0.0011474431,0.0041928384],"category_scores_gemma":[0.0018518066,0.00019892349,0.0010302926,0.0010494526,0.00038159607,0.00077777094,0.0004505822,0.0016287179,0.0015674453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009635447,0.00004088708,0.00010455659,0.05198811,0.00029027078,0.00007682554,0.000049412636,0.00029570804,0.00051891524,0.002323101,0.035457805,0.908758],"study_design_scores_gemma":[0.000116720636,0.00016436579,0.001300303,0.047749296,0.0007539027,0.0010109021,0.000090300404,0.00021349486,0.00032551313,0.0036885722,0.94455874,0.000027848844],"about_ca_topic_score_codex":0.0013729185,"about_ca_topic_score_gemma":0.0029786867,"teacher_disagreement_score":0.0041928384,"about_ca_system_score_codex":0.0005857492,"about_ca_system_score_gemma":0.0011218047,"threshold_uncertainty_score":0.014026403},"labels":[],"label_agreement":null},{"id":"W4402574457","doi":"10.1080/14656566.2024.2406270","title":"Expanding therapeutic options: overview of novel pharmacotherapies for dyslipidemia","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Dyslipidemia; Intensive care medicine; Pharmacology; Internal medicine; Disease","score_opus":0.27724691296550846,"score_gpt":0.5227339994316352,"score_spread":0.24548708646612677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402574457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008706325,0.99698085,0.00023610968,0.001047203,0.00031115816,0.000013561217,0.000041748714,0.000011912097,0.001270382],"genre_scores_gemma":[0.00052135467,0.9978224,0.00030203315,0.0005360018,0.00024486976,0.000014464501,0.000049253907,0.0000022751135,0.0005073082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996953,0.00007044797,0.00004282856,0.00004485425,0.00011483672,0.00003178793],"domain_scores_gemma":[0.9995146,0.0002533202,0.00006109851,0.00001156638,0.00012893973,0.000030461932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007617304,0.00084662216,0.0012860935,0.0019507498,0.00023319545,0.0010389047,0.0010069659,0.001259336,0.0072446163],"category_scores_gemma":[0.0010853637,0.00024260959,0.00096804975,0.0012979585,0.00033183052,0.0011807797,0.0006275136,0.0026954007,0.002929349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008380368,0.000065943386,0.0000744214,0.020180888,0.00015453668,0.00013233625,0.000039176986,0.00027012816,0.0008066922,0.0034775122,0.040757872,0.93395674],"study_design_scores_gemma":[0.000051219326,0.00012966926,0.00047232708,0.00996125,0.00021405533,0.0008847607,0.000037796668,0.00015553828,0.00025898128,0.0027193483,0.9850975,0.000017568018],"about_ca_topic_score_codex":0.00080583245,"about_ca_topic_score_gemma":0.0018265732,"teacher_disagreement_score":0.0072446163,"about_ca_system_score_codex":0.0006282512,"about_ca_system_score_gemma":0.0009080384,"threshold_uncertainty_score":0.024235666},"labels":[],"label_agreement":null},{"id":"W4403353674","doi":"10.1080/14656566.2024.2416924","title":"Efinaconazole 10% solution: a comprehensive review of its use in the treatment of onychomycosis","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dermatology; Intensive care medicine","score_opus":0.2269679694706943,"score_gpt":0.49324307262383776,"score_spread":0.26627510315314346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403353674","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000097601776,0.9990159,0.00004876797,0.00017681239,0.00008698708,0.00000685954,0.00003427272,0.000004020512,0.0005287591],"genre_scores_gemma":[0.00070849695,0.9987219,0.000110500354,0.00016281396,0.000066516266,0.0000068915733,0.00003978119,0.000001171062,0.00018192401],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996952,0.000059349954,0.000072119685,0.00005360865,0.0000998582,0.000019965126],"domain_scores_gemma":[0.9994221,0.00032605187,0.00010236885,0.000010665756,0.0001168369,0.000021996362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005531563,0.0006731703,0.0011848747,0.0024233782,0.00023338784,0.0008295833,0.0007472994,0.0007612184,0.0056175697],"category_scores_gemma":[0.0013852813,0.00020546817,0.0009407744,0.0023601423,0.00025338313,0.00077046535,0.0004172328,0.0008674242,0.0012103089],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008228452,0.000046276833,0.00017361535,0.08612547,0.00025440755,0.0001609322,0.0000808008,0.00021966972,0.000683292,0.0011710657,0.02723502,0.88376725],"study_design_scores_gemma":[0.000041351977,0.00016555437,0.001700433,0.047895566,0.0010804451,0.0017731022,0.000100701785,0.00012428063,0.00038488727,0.0010495809,0.94565505,0.000029105157],"about_ca_topic_score_codex":0.0019273805,"about_ca_topic_score_gemma":0.003930347,"teacher_disagreement_score":0.0056175697,"about_ca_system_score_codex":0.000420258,"about_ca_system_score_gemma":0.0013123326,"threshold_uncertainty_score":0.01879263},"labels":[],"label_agreement":null},{"id":"W4404500638","doi":"10.1080/14656566.2024.2432488","title":"Systemic approaches in biliary tract cancers: a review in the era of multidirectional precision medicine","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"Deutsche Forschungsgemeinschaft","keywords":"Medicine; Biliary tract cancer; Precision medicine; Biliary tract; Internal medicine; Intensive care medicine; Oncology; Cancer; Pathology; Gemcitabine","score_opus":0.20856439588691122,"score_gpt":0.4589524563060369,"score_spread":0.2503880604191257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404500638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004542056,0.99916923,0.000045098568,0.0002880642,0.00012772389,0.0000030123929,0.000011909633,0.000002725335,0.00030694588],"genre_scores_gemma":[0.00028765437,0.9991788,0.000081393555,0.00021243098,0.00010483682,0.0000037218742,0.000013256337,6.756185e-7,0.00011723835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997242,0.00006488803,0.000055737557,0.000045095177,0.00008730615,0.000022693108],"domain_scores_gemma":[0.99907124,0.00059971766,0.000111467925,0.0000152451385,0.00016903832,0.000033246404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075840653,0.00068084436,0.0014224937,0.0021191572,0.00024009465,0.0010583022,0.0006839086,0.0009981418,0.0040304945],"category_scores_gemma":[0.0013470864,0.0002508711,0.0010051606,0.002132076,0.00038609284,0.0012422777,0.0006270022,0.0016246383,0.0010777115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009107489,0.00003913927,0.00014429359,0.059559997,0.00022757144,0.0001498344,0.0000832565,0.00034580397,0.000720795,0.0025505102,0.035494074,0.9005937],"study_design_scores_gemma":[0.00003311876,0.00012665508,0.0008869673,0.026243169,0.0004428197,0.0011669728,0.000082058716,0.00009934201,0.00023138872,0.0016367659,0.969028,0.000022757957],"about_ca_topic_score_codex":0.0012258949,"about_ca_topic_score_gemma":0.0026185166,"teacher_disagreement_score":0.0040304945,"about_ca_system_score_codex":0.0007097935,"about_ca_system_score_gemma":0.0013970262,"threshold_uncertainty_score":0.0134833455},"labels":[],"label_agreement":null},{"id":"W4404833735","doi":"10.1080/14656566.2024.2435946","title":"Advances in pharmacotherapy for the treatment of peritoneal metastases from colorectal cancer","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Colorectal cancer; Pharmacotherapy; Oncology; Internal medicine; Cancer","score_opus":0.08920077745056175,"score_gpt":0.4832486527606451,"score_spread":0.39404787531008334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404833735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001542182,0.9974661,0.00014412,0.00067851,0.00028026855,0.000008822174,0.000043596676,0.000008036635,0.0012163969],"genre_scores_gemma":[0.0008224728,0.99808794,0.00014404846,0.00035078955,0.0001501172,0.0000074000773,0.00004483978,0.0000015612934,0.00039084876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997725,0.0000526634,0.000030654664,0.000037882568,0.00008724911,0.000019136569],"domain_scores_gemma":[0.99961567,0.00020262695,0.000059521506,0.000008690273,0.000095656615,0.0000178859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048235795,0.00048298322,0.0008985864,0.0013008863,0.00016238734,0.0007508544,0.0005143336,0.0007470403,0.005890672],"category_scores_gemma":[0.000983715,0.00013553242,0.0007375586,0.0009804481,0.000241239,0.00076044194,0.0004673559,0.0013233084,0.0019583483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007629767,0.000049694074,0.0001378323,0.031646553,0.00018809031,0.000127881,0.000049813505,0.00035801867,0.0012988236,0.0027551034,0.033380896,0.929931],"study_design_scores_gemma":[0.000034102966,0.00013124732,0.0006849235,0.010499156,0.00026277482,0.0007286791,0.000047391684,0.00013115836,0.00044329657,0.0018302525,0.9851896,0.000017376364],"about_ca_topic_score_codex":0.0008442916,"about_ca_topic_score_gemma":0.0017523266,"teacher_disagreement_score":0.005890672,"about_ca_system_score_codex":0.00039604137,"about_ca_system_score_gemma":0.0007371841,"threshold_uncertainty_score":0.01970625},"labels":[],"label_agreement":null},{"id":"W4405694336","doi":"10.1080/14656566.2024.2444986","title":"Advances in the pharmacological management of hyperlipidemia through the use of combination therapies","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Hyperlipidemia; Combination therapy; Intensive care medicine; Ezetimibe; Disease; Pharmacology; Internal medicine; Statin; Diabetes mellitus","score_opus":0.184755032120173,"score_gpt":0.4709485409633059,"score_spread":0.2861935088431329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405694336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012947945,0.99755776,0.0002314512,0.00059803535,0.00027604957,0.000008560856,0.0000212466,0.000009392744,0.0011680378],"genre_scores_gemma":[0.00092929305,0.99753535,0.00030063518,0.00041357687,0.0002893762,0.000009700838,0.00003790465,0.0000022971296,0.0004818204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996681,0.0000835869,0.00003991107,0.000053234224,0.00013002366,0.000025083722],"domain_scores_gemma":[0.99960726,0.0001882342,0.00006340245,0.000012997315,0.000106348976,0.000021847285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072236574,0.0006185584,0.0012880831,0.0011627731,0.00013342027,0.0008377587,0.0007553128,0.00081739476,0.0061066453],"category_scores_gemma":[0.0008303465,0.00015691413,0.0009672108,0.00077954103,0.0003050245,0.000881258,0.0005217753,0.0021096307,0.0025974582],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010663666,0.00007426654,0.00009828458,0.020755671,0.00022566628,0.00010911301,0.000029623625,0.00026476753,0.0011148511,0.0030831369,0.027139667,0.94699836],"study_design_scores_gemma":[0.000093326584,0.00021082698,0.0008190292,0.00924094,0.00032766978,0.0010900073,0.000042724565,0.00020715658,0.00042049124,0.0026803634,0.984844,0.000023426068],"about_ca_topic_score_codex":0.000708834,"about_ca_topic_score_gemma":0.0012828477,"teacher_disagreement_score":0.0061066453,"about_ca_system_score_codex":0.00041401823,"about_ca_system_score_gemma":0.00067948824,"threshold_uncertainty_score":0.020428777},"labels":[],"label_agreement":null},{"id":"W4406682967","doi":"10.1080/14656566.2025.2452938","title":"Palovarotene in fibrodysplasia ossificans progressiva: review and perspective","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Medicine; Perspective (graphical); Myositis ossificans; Dermatology; Heterotopic ossification; Surgery","score_opus":0.06339211992534607,"score_gpt":0.4872423812636997,"score_spread":0.4238502613383536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406682967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059472193,0.99902093,0.000032828946,0.0002911946,0.00018934412,0.000003386002,0.00001773837,0.0000032409446,0.00038191155],"genre_scores_gemma":[0.0004983178,0.9987715,0.000061073806,0.00029130492,0.00012747462,0.0000051330594,0.000019352578,7.5259817e-7,0.00022511715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997985,0.000041868858,0.000038441915,0.000039326336,0.000064458196,0.000017420245],"domain_scores_gemma":[0.99937075,0.00034263943,0.00012316325,0.000010385225,0.00012431426,0.000028847546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006615575,0.0006129868,0.0011958652,0.0016424648,0.00019924923,0.0009020048,0.00075178733,0.001028039,0.0055952473],"category_scores_gemma":[0.0013166768,0.00019024363,0.00079717,0.0016534895,0.00029999734,0.001000106,0.00042207816,0.001305253,0.001363676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014854752,0.000042008865,0.000119634344,0.09025938,0.00025303534,0.0001631477,0.0000811192,0.000282528,0.0010397334,0.0024008516,0.04047914,0.8647309],"study_design_scores_gemma":[0.000056432156,0.00017851379,0.0009241379,0.042309776,0.0007363034,0.001315921,0.00010609181,0.00008372248,0.0003720791,0.0017695768,0.9521245,0.000023002942],"about_ca_topic_score_codex":0.0010359657,"about_ca_topic_score_gemma":0.002307145,"teacher_disagreement_score":0.0055952473,"about_ca_system_score_codex":0.00045403128,"about_ca_system_score_gemma":0.001478499,"threshold_uncertainty_score":0.018717945},"labels":[],"label_agreement":null},{"id":"W4406938337","doi":"10.1080/14656566.2025.2461169","title":"Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Dutasteride; Safety profile; Dermatology; Pharmacology; Intensive care medicine; Adverse effect; Internal medicine; Prostate cancer","score_opus":0.08395254459504231,"score_gpt":0.4553852353721652,"score_spread":0.3714326907771229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406938337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007155669,0.99927896,0.00003367788,0.00016923914,0.00008765444,0.0000046121604,0.000023452569,0.0000031744323,0.00032769027],"genre_scores_gemma":[0.00061494246,0.99885786,0.00007516154,0.00017645444,0.00008108869,0.0000054261263,0.00002799679,9.2808824e-7,0.00016005937],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99975044,0.000046566456,0.000052056646,0.000043054857,0.00009141691,0.000016419153],"domain_scores_gemma":[0.99940526,0.00033737934,0.00011136418,0.00000931999,0.000113685026,0.00002302043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058932253,0.00061299524,0.001412156,0.0017410434,0.0001983341,0.0007807576,0.00073777686,0.0007563633,0.004558387],"category_scores_gemma":[0.0013208154,0.00020358841,0.00094072643,0.0016870035,0.00024262577,0.0006856975,0.00038104973,0.00095412426,0.0010017052],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010511809,0.000030475796,0.00015682638,0.086107016,0.00030999223,0.00012256706,0.000052687246,0.00019523613,0.00074095896,0.0008324599,0.026617486,0.8847292],"study_design_scores_gemma":[0.00008952724,0.00022460682,0.0024046348,0.06241828,0.0015921002,0.0022010093,0.00012356373,0.00016681654,0.0005158496,0.0014946595,0.92873,0.000039016188],"about_ca_topic_score_codex":0.0015928099,"about_ca_topic_score_gemma":0.0032332712,"teacher_disagreement_score":0.004558387,"about_ca_system_score_codex":0.00048622664,"about_ca_system_score_gemma":0.0010637525,"threshold_uncertainty_score":0.015249312},"labels":[],"label_agreement":null},{"id":"W4410000312","doi":"10.1080/14656566.2025.2501146","title":"Advances in pharmacotherapy of juvenile idiopathic arthritis","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Pharmacotherapy; Arthritis; Juvenile; Intensive care medicine; Internal medicine","score_opus":0.04866952293392416,"score_gpt":0.44724674393646713,"score_spread":0.39857722100254295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410000312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009015963,0.9981048,0.00011211188,0.0005352304,0.0002138441,0.00000675078,0.000019625431,0.0000057372513,0.0009115848],"genre_scores_gemma":[0.00093552883,0.9980261,0.00015532084,0.00033817755,0.00018340808,0.0000072240646,0.000025877232,0.0000013620362,0.00032689603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996599,0.000085714106,0.000050599498,0.000051590054,0.00012850911,0.00002367052],"domain_scores_gemma":[0.9994412,0.000320282,0.00008030412,0.000015446427,0.0001210316,0.000021747252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006565508,0.0005488147,0.0010855761,0.0015412376,0.00017674077,0.0008663598,0.0005185298,0.00087100704,0.0050995667],"category_scores_gemma":[0.0010962636,0.00016145341,0.0008552574,0.0011197419,0.00032570402,0.0007163194,0.00051645737,0.001655806,0.0017299874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007802559,0.000049967817,0.0001268441,0.028939806,0.0001913056,0.00012122042,0.000044454588,0.00026679874,0.00080828374,0.0040081963,0.024444222,0.94092077],"study_design_scores_gemma":[0.000045396697,0.0001239393,0.00104366,0.012969207,0.00030611796,0.0010322238,0.000046356476,0.00014817106,0.00042869707,0.0030133813,0.98082227,0.000020582687],"about_ca_topic_score_codex":0.0014237366,"about_ca_topic_score_gemma":0.0019924196,"teacher_disagreement_score":0.0050995667,"about_ca_system_score_codex":0.0004890092,"about_ca_system_score_gemma":0.0010154359,"threshold_uncertainty_score":0.017059743},"labels":[],"label_agreement":null},{"id":"W4411191877","doi":"10.1080/14656566.2025.2516622","title":"Advancing care in primary biliary cholangitis: emerging insights and novel therapies","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Primary care; Primary sclerosing cholangitis; Intensive care medicine; Internal medicine; Disease; Family medicine","score_opus":0.02973413109779734,"score_gpt":0.38999110581406654,"score_spread":0.3602569747162692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411191877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051345534,0.996905,0.000098805795,0.0016591481,0.0005101493,0.000004949532,0.000014468027,0.000007387931,0.00074864505],"genre_scores_gemma":[0.00057006464,0.9973345,0.00019760613,0.0010179229,0.0004971912,0.000008431938,0.000023924975,0.0000017960766,0.00034854136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995497,0.00014337696,0.00004518886,0.00005499974,0.00014897248,0.00005783029],"domain_scores_gemma":[0.9989279,0.00057147606,0.000120707606,0.000020110798,0.00028476483,0.000075006974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011493613,0.00066526025,0.0012502576,0.0012097798,0.0002568056,0.001273975,0.0008681605,0.0016814731,0.006798166],"category_scores_gemma":[0.0018007049,0.00018150461,0.00081803685,0.0012345603,0.00048141793,0.0015298227,0.0009122721,0.0028425597,0.0023495192],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008883828,0.00004888569,0.00009812114,0.024631988,0.00013393191,0.00010658052,0.00007033868,0.00030251037,0.0004471016,0.0060752025,0.0665774,0.9014191],"study_design_scores_gemma":[0.000061671875,0.00011341787,0.0005158916,0.017069822,0.00015010888,0.0004987684,0.00009725331,0.00015890381,0.00011215051,0.0041553476,0.97704756,0.000019186891],"about_ca_topic_score_codex":0.0011486766,"about_ca_topic_score_gemma":0.0026762278,"teacher_disagreement_score":0.006798166,"about_ca_system_score_codex":0.000858036,"about_ca_system_score_gemma":0.001615992,"threshold_uncertainty_score":0.022742152},"labels":[],"label_agreement":null},{"id":"W4413590258","doi":"10.1080/14656566.2025.2552901","title":"Aprocitentan: a new horizon in the treatment of hypertension","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Intensive care medicine; Internal medicine","score_opus":0.18073181706599895,"score_gpt":0.4379124233417812,"score_spread":0.25718060627578226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413590258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006206746,0.9979962,0.0000653439,0.0009956872,0.00034774467,0.000004134413,0.00001678351,0.0000056714375,0.00050638453],"genre_scores_gemma":[0.00062858465,0.9977748,0.00012712294,0.0008218286,0.00033872918,0.000005980883,0.000025266409,0.0000013344454,0.00027634247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997167,0.00008077326,0.000043769865,0.000041190822,0.0000954767,0.000022148468],"domain_scores_gemma":[0.99944144,0.00028823531,0.00008773537,0.000010233174,0.00014217474,0.00003025603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000785737,0.00050149945,0.001124217,0.0011273029,0.0001836975,0.00085709634,0.0006506646,0.0012766132,0.0059813424],"category_scores_gemma":[0.0011864151,0.00013672297,0.00085972226,0.0010229937,0.0003129892,0.001276062,0.00044127984,0.0020768149,0.0018487445],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016774383,0.000047859445,0.0001051995,0.03697516,0.00019742164,0.00012930507,0.000052327494,0.0001774479,0.00088767294,0.0037409847,0.03950869,0.9180103],"study_design_scores_gemma":[0.00010073747,0.00020061492,0.00079471286,0.021867447,0.000402873,0.00083581265,0.00007679374,0.00011414778,0.00026817198,0.0031562604,0.9721592,0.000023165683],"about_ca_topic_score_codex":0.0008415166,"about_ca_topic_score_gemma":0.0019907362,"teacher_disagreement_score":0.0059813424,"about_ca_system_score_codex":0.00048870884,"about_ca_system_score_gemma":0.0011927286,"threshold_uncertainty_score":0.020009637},"labels":[],"label_agreement":null},{"id":"W4413955067","doi":"10.1080/14656566.2025.2557457","title":"Emerging pharmacotherapies for brain metastases: a spotlight on angiogenesis inhibitors","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Angiogenesis; Pharmacology; Internal medicine","score_opus":0.07013125570456824,"score_gpt":0.46161726607136544,"score_spread":0.3914860103667972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413955067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016068954,0.9971317,0.00017947289,0.0010144151,0.0003480394,0.000010438598,0.00003796679,0.000011939583,0.0011053073],"genre_scores_gemma":[0.0008139796,0.9975139,0.00020832602,0.00059244205,0.0002164154,0.000012019461,0.000045896282,0.0000023430098,0.00059467915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998085,0.000043714725,0.000021476826,0.000031488336,0.0000715983,0.00002330296],"domain_scores_gemma":[0.999688,0.00014890022,0.00004556331,0.000006753175,0.00008695069,0.000023844332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048904505,0.0006065793,0.0011452951,0.0012033129,0.00018091989,0.0008489815,0.00069745193,0.0010646974,0.0062258104],"category_scores_gemma":[0.000722247,0.00017124874,0.00071489654,0.0009919173,0.00030158836,0.0010566858,0.00048236852,0.0020954332,0.0021051522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009738306,0.00008473311,0.00007903834,0.01842852,0.00011530442,0.00014897385,0.000048564816,0.00033522953,0.0017275831,0.0038767003,0.049272638,0.9257853],"study_design_scores_gemma":[0.00005442242,0.0001683355,0.0004405234,0.0072245044,0.00015981945,0.00072744547,0.000040323837,0.00015945801,0.0004018493,0.0022534814,0.9883542,0.000015627029],"about_ca_topic_score_codex":0.00062661537,"about_ca_topic_score_gemma":0.0018740463,"teacher_disagreement_score":0.0062258104,"about_ca_system_score_codex":0.00047304356,"about_ca_system_score_gemma":0.00084929785,"threshold_uncertainty_score":0.020827472},"labels":[],"label_agreement":null},{"id":"W4414080279","doi":"10.1080/14656566.2025.2558999","title":"Emerging pharmacological strategies for the treatment of cannabis use disorder","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Endocannabinoid system; Clinical trial; Cannabis; Translational research; Clinical research; Effects of cannabis; Clinical efficacy","score_opus":0.056105881452332196,"score_gpt":0.44054246619941156,"score_spread":0.38443658474707937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414080279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039213646,0.98932487,0.0005782593,0.006305153,0.00054785004,0.000041923373,0.00014372505,0.00001681107,0.0026493748],"genre_scores_gemma":[0.006918169,0.987064,0.0011994726,0.0030997954,0.00074919005,0.00005622007,0.000121933306,0.0000052022615,0.0007860202],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922216,0.0002704267,0.00012935925,0.000107980464,0.00022131235,0.00004871301],"domain_scores_gemma":[0.99842465,0.00088348053,0.0002769957,0.000028372662,0.0003355377,0.00005104927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014529555,0.00059919734,0.0012117276,0.0016448778,0.00034326038,0.0014005951,0.00085695746,0.0013219877,0.010389707],"category_scores_gemma":[0.003340974,0.0001628971,0.0013723287,0.0010124153,0.00044336906,0.0011632527,0.00071585807,0.0016523313,0.0017267935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025964144,0.00007105958,0.00043912677,0.08418343,0.0009030241,0.0002865108,0.00012923256,0.0004207662,0.001218104,0.007550375,0.025647797,0.87889093],"study_design_scores_gemma":[0.0003465516,0.0005422641,0.0033250446,0.124733895,0.0037885953,0.0016624626,0.000488491,0.00069799816,0.0011021971,0.017018635,0.84622234,0.00007155617],"about_ca_topic_score_codex":0.002094195,"about_ca_topic_score_gemma":0.0083209425,"teacher_disagreement_score":0.010389707,"about_ca_system_score_codex":0.0010404988,"about_ca_system_score_gemma":0.0025234264,"threshold_uncertainty_score":0.034757078},"labels":[],"label_agreement":null},{"id":"W4417458063","doi":"10.1080/14656566.2025.2605201","title":"The relationship between cognition and the pharmacotherapy of depression","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Royal Ottawa Mental Health Centre; University of British Columbia","funders":"","keywords":"Depression (economics); Pharmacotherapy; Cognition; Disease; MEDLINE; Drug","score_opus":0.05443614985082489,"score_gpt":0.4205489728344058,"score_spread":0.3661128229835809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417458063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005176789,0.9543588,0.00060856517,0.029897438,0.0019042318,0.000026234477,0.00049536244,0.00002951552,0.0075030336],"genre_scores_gemma":[0.07137849,0.9062694,0.0012038575,0.009947295,0.00868592,0.000049047117,0.00041596484,0.000011365248,0.0020386558],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993591,0.00022813331,0.00005269632,0.00008075676,0.00022796454,0.00005140992],"domain_scores_gemma":[0.9979504,0.0009958405,0.0005547304,0.00003682829,0.00034863656,0.00011355678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010852137,0.0004624347,0.001047614,0.00038565384,0.00020213715,0.0012718363,0.00057129585,0.0013851752,0.0064416784],"category_scores_gemma":[0.0050323633,0.00013344672,0.0006580285,0.0004680003,0.00035317588,0.00058094494,0.00041222022,0.0024090756,0.0011440585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087013247,0.00026802922,0.010410096,0.0071998467,0.0013759081,0.00019248303,0.000118386706,0.00047980438,0.0012092406,0.006787413,0.08225834,0.8888303],"study_design_scores_gemma":[0.000882796,0.0027830766,0.23808825,0.019461768,0.0052566617,0.0023806028,0.00037348754,0.0025500348,0.0012778152,0.02888275,0.6978822,0.0001806226],"about_ca_topic_score_codex":0.0032936132,"about_ca_topic_score_gemma":0.0060701384,"teacher_disagreement_score":0.0064416784,"about_ca_system_score_codex":0.0006957879,"about_ca_system_score_gemma":0.00094038865,"threshold_uncertainty_score":0.021549582},"labels":[],"label_agreement":null},{"id":"W4417498622","doi":"10.1080/14656566.2025.2601050","title":"Novel pharmacotherapies and breakthroughs in psoriatic arthritis treatment","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Society; University of Toronto; University Health Network","funders":"","keywords":"Psoriatic arthritis; Disease; Precision medicine; Psoriasis; Clinical Practice; Clinical trial; Personalized medicine; Biosimilar","score_opus":0.030876277308090946,"score_gpt":0.38023486887078833,"score_spread":0.3493585915626974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417498622","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023973612,0.95644796,0.0018735225,0.024695288,0.0039211237,0.00005873686,0.00029389275,0.00013295042,0.0101792505],"genre_scores_gemma":[0.025918126,0.93487394,0.0037681148,0.020154262,0.0054123583,0.00011989281,0.00060773117,0.000039048085,0.009106489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993032,0.00020905967,0.00007648044,0.00010909974,0.00020662347,0.0000955753],"domain_scores_gemma":[0.99917245,0.00030331296,0.00012090065,0.00003189462,0.000263547,0.00010790757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013918682,0.00065280846,0.0010155496,0.0008652419,0.00034154046,0.0016107783,0.0005969196,0.0015870006,0.014128742],"category_scores_gemma":[0.0017185785,0.00018245184,0.0011628711,0.0006374035,0.00053345965,0.0016783766,0.0007964646,0.0040939506,0.0043280628],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058741163,0.00029008216,0.00035442636,0.0073982775,0.00020880207,0.0003649498,0.00010125243,0.00068090047,0.0033048051,0.013169266,0.07788793,0.89565194],"study_design_scores_gemma":[0.00050155865,0.0010968762,0.0014362799,0.006211238,0.00025956836,0.0012704751,0.0001467052,0.00075734785,0.00129094,0.015566565,0.9714192,0.00004323087],"about_ca_topic_score_codex":0.00059101084,"about_ca_topic_score_gemma":0.0019527551,"teacher_disagreement_score":0.014128742,"about_ca_system_score_codex":0.0008466185,"about_ca_system_score_gemma":0.0012304602,"threshold_uncertainty_score":0.04726535},"labels":[],"label_agreement":null},{"id":"W4417506570","doi":"10.1080/14656566.2025.2608081","title":"Recalcitrant dermatophytosis: clinicomycological features and challenges in management","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Ketoconazole; Antifungal; Itraconazole; MEDLINE; Disease management","score_opus":0.18642530198875784,"score_gpt":0.47682716906005035,"score_spread":0.2904018670712925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417506570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027039254,0.99589396,0.00023330958,0.0016154634,0.00030250777,0.000004367164,0.000016397144,0.000008577018,0.0016549334],"genre_scores_gemma":[0.004421316,0.99271894,0.0004619995,0.000976302,0.00081326615,0.0000052740265,0.000042473865,0.0000028867992,0.00055755983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966824,0.000083348896,0.000055838816,0.000047906815,0.00011183308,0.000032821412],"domain_scores_gemma":[0.99945146,0.0002553907,0.00010659151,0.0000122489955,0.00013469509,0.000039475774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046335932,0.0006134599,0.0010187571,0.0012800449,0.00030977034,0.0012491923,0.0005425846,0.0011528828,0.0037721705],"category_scores_gemma":[0.0013766899,0.00015726671,0.00045725706,0.0011382299,0.0005345387,0.0011754452,0.0005129446,0.0017276264,0.0011963419],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059033257,0.000055558776,0.00080992345,0.019611554,0.00010796533,0.0027151231,0.00013323716,0.00045371777,0.0009932014,0.0037386448,0.05558486,0.9157371],"study_design_scores_gemma":[0.000043038144,0.000099244324,0.004748016,0.037369147,0.00034627976,0.057370897,0.0007211573,0.00041625206,0.00053491467,0.008967037,0.8893253,0.000058718273],"about_ca_topic_score_codex":0.0013895432,"about_ca_topic_score_gemma":0.0028856997,"teacher_disagreement_score":0.0037721705,"about_ca_system_score_codex":0.0004907353,"about_ca_system_score_gemma":0.0010828489,"threshold_uncertainty_score":0.012619138},"labels":[],"label_agreement":null}]}